data_1ro4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ro4 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.528 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 35.2 t . . . . . 0 CA--C 1.527 0.06 0 CA-C-O 120.579 0.228 . . . . 0.0 110.838 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.49 -20.98 70.74 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.116 1.877 . . . . 0.0 111.905 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -116.79 -11.14 10.95 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.176 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.724 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 33.8 m80 -131.07 87.33 48.75 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.858 0.361 . . . . 0.0 110.603 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.93 -34.75 95.07 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.305 2.003 . . . . 0.0 111.903 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -79.4 -26.81 41.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.215 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.43 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -82.86 95.86 8.06 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 122.603 1.192 . . . . 0.0 111.599 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.535 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.89 72.61 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 112.228 -2.26 . . . . 0.0 112.956 -178.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.603 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.9 mp -19.71 108.75 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.88 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -77.0 165.81 2.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.182 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 . . . . . 0 N--CA 1.432 -1.358 0 CA-C-O 121.818 0.818 . . . . 0.0 110.105 -178.532 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.586 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 29.0 mtt . . . . . 0 C--O 1.223 -0.291 0 CA-C-O 121.428 0.633 . . . . 0.0 111.57 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.813 HD12 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -105.03 123.52 59.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.988 -176.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.749 ' O ' ' N ' ' A' ' 38' ' ' GLY . 37.9 t -87.81 96.5 0.62 Allowed Pre-proline 0 N--CA 1.45 -0.461 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.462 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.5 Cg_endo -42.4 -14.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 123.304 2.669 . . . . 0.0 114.08 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.724 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 1.1 mm-40 -89.7 -63.75 1.24 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.576 0.227 . . . . 0.0 111.06 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.439 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 8.4 p -90.54 -20.44 22.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.813 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 68.39 33.76 78.14 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.314 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -74.33 143.89 44.73 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 32' ' ' MET . 32.9 t -109.68 111.36 35.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.862 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.44 HG23 ' CD1' ' A' ' 39' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.606 0.241 . . . . 0.0 110.431 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.504 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 16.7 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.469 0.176 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.06 -18.94 63.17 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.068 1.845 . . . . 0.0 112.03 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -117.53 -9.32 10.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.35 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.657 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 37.7 m80 -130.76 88.34 46.62 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-O 120.755 0.312 . . . . 0.0 110.437 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.67 -34.41 92.14 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.414 2.076 . . . . 0.0 112.03 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.25 -26.01 31.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.395 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.499 ' CB ' ' HB3' ' A' ' 18' ' ' HIS . . . -80.32 87.87 5.57 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.242 0.544 . . . . 0.0 111.255 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.535 ' O ' ' C ' ' A' ' 23' ' ' LEU . 13.6 mm -72.29 75.19 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.353 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.586 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 2.0 mp -20.5 107.47 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.556 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -74.94 167.95 2.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.181 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.432 -1.357 0 CA-C-O 122.051 0.929 . . . . 0.0 110.648 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.534 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 8.2 mtt . . . . . 0 C--O 1.224 -0.245 0 CA-C-O 121.403 0.62 . . . . 0.0 111.597 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.526 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -103.68 121.3 54.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.826 -177.127 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.762 ' O ' ' N ' ' A' ' 38' ' ' GLY . 49.7 t -86.57 97.02 0.57 Allowed Pre-proline 0 N--CA 1.446 -0.635 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.2 Cg_endo -41.77 -15.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.343 2.695 . . . . 0.0 113.853 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.657 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 10.5 mm-40 -86.29 -66.89 0.85 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.8 0.333 . . . . 0.0 110.807 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.455 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 2.9 p -90.7 -18.7 24.59 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.762 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.24 35.18 90.0 Favored Glycine 0 N--CA 1.433 -1.551 0 CA-C-N 114.119 -1.401 . . . . 0.0 111.627 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -74.27 148.44 41.46 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.894 -0.653 . . . . 0.0 109.638 179.38 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 32' ' ' MET . 48.5 t -112.29 113.75 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 120.887 0.375 . . . . 0.0 111.847 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.442 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 55.5 t . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.063 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.468 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 14.5 t . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.518 0.199 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.87 -18.02 61.13 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.276 1.984 . . . . 0.0 112.304 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.07 -13.6 9.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.045 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.65 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.4 m80 -127.27 88.51 53.9 Favored Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.898 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.96 -40.12 55.16 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.417 2.078 . . . . 0.0 112.082 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -75.8 -35.4 60.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.346 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HB3' ' CG ' ' A' ' 36' ' ' GLU . . . -75.85 79.64 2.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.234 0.54 . . . . 0.0 110.974 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.581 ' O ' ' C ' ' A' ' 23' ' ' LEU . 12.3 mt -69.88 72.44 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.918 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.581 ' C ' ' O ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -7.61 110.77 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.73 179.163 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 32' ' ' MET . 14.2 t -83.3 155.86 3.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.514 0.673 . . . . 0.0 112.669 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.138 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.903 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.554 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 44.1 mtm . . . . . 0 N--CA 1.456 -0.144 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.691 HD12 ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -141.7 130.9 23.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.494 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.791 ' O ' ' N ' ' A' ' 38' ' ' GLY . 18.0 t -88.97 97.58 0.93 Allowed Pre-proline 0 C--O 1.217 -0.637 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -44.27 -14.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.921 2.414 . . . . 0.0 113.417 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.65 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 8.2 mm-40 -86.72 -65.14 1.05 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.567 0.222 . . . . 0.0 110.784 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.45 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 2.5 p -91.8 -24.7 19.31 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.791 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 74.1 41.19 40.39 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 113.395 -1.73 . . . . 0.0 112.103 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.655 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 1.0 OUTLIER -79.14 146.5 33.13 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.928 -0.636 . . . . 0.0 109.534 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 32' ' ' MET . 95.9 t -111.94 122.75 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 O-C-N 123.532 0.52 . . . . 0.0 111.736 -177.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.535 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 22.4 t . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.797 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 38.5 t . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.532 0.206 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.49 -20.35 65.87 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.349 2.033 . . . . 0.0 112.405 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -114.75 -12.02 12.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.241 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.717 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.9 m80 -130.46 87.95 48.72 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 120.688 0.28 . . . . 0.0 110.565 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.56 -36.75 92.01 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.328 2.018 . . . . 0.0 111.785 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.28 -33.09 55.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.233 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.436 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -76.19 88.11 3.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.098 0.475 . . . . 0.0 111.307 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.568 ' O ' ' C ' ' A' ' 23' ' ' LEU . 9.9 mt -74.49 71.22 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.807 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.596 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -12.33 107.35 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.666 0.604 . . . . 0.0 110.886 179.419 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -77.86 164.42 3.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.171 0.51 . . . . 0.0 111.406 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 . . . . . 0 N--CA 1.432 -1.326 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.746 -179.014 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.831 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 28.1 mtp . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 121.537 0.684 . . . . 0.0 112.194 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.808 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -101.49 123.41 54.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.762 -177.018 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.729 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.1 t -87.47 97.05 0.65 Allowed Pre-proline 0 N--CA 1.449 -0.495 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -40.78 -16.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.379 2.719 . . . . 0.0 114.149 -179.228 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.717 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 13.5 mm-40 -87.83 -64.81 1.09 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.634 0.254 . . . . 0.0 111.307 -178.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.471 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 5.7 p -90.37 -20.6 22.66 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.808 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.49 36.64 77.54 Favored Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 113.572 -1.649 . . . . 0.0 112.52 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -79.75 150.42 30.82 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.588 -0.806 . . . . 0.0 110.405 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.831 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.1 t -119.56 121.37 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-O 121.275 0.56 . . . . 0.0 112.429 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.456 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 87.3 t . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.01 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.472 ' HB2' HD12 ' A' ' 23' ' ' LEU . 15.0 t . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.421 0.153 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.1 -25.37 79.66 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.286 1.991 . . . . 0.0 111.961 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -108.48 -30.29 8.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.675 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.685 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 38.3 m80 -113.32 81.64 5.24 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.436 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.11 -33.48 97.44 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.03 1.82 . . . . 0.0 110.935 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -73.01 -42.39 63.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.285 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.481 ' HB1' ' HB3' ' A' ' 18' ' ' HIS . . . -74.97 87.52 2.33 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.11 0.481 . . . . 0.0 110.979 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.547 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.3 mp -68.93 74.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.713 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.65 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -14.64 112.7 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.37 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.1 t -81.18 163.24 3.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.254 0.55 . . . . 0.0 111.222 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.428 -1.54 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.852 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.501 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 35.3 mtp . . . . . 0 C--O 1.227 -0.123 0 CA-C-O 121.662 0.744 . . . . 0.0 112.39 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.807 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -104.17 126.08 58.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.89 -177.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.752 ' O ' ' N ' ' A' ' 38' ' ' GLY . 42.1 t -91.16 98.82 1.83 Allowed Pre-proline 0 C--O 1.219 -0.545 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.3 Cg_endo -43.44 -14.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.216 2.611 . . . . 0.0 113.881 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.685 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 2.9 mm-40 -87.92 -64.69 1.11 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.759 0.314 . . . . 0.0 111.08 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.443 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 3.3 p -91.19 -21.3 21.2 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.807 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.67 38.76 77.95 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 113.645 -1.616 . . . . 0.0 111.739 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -80.03 144.06 33.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.7 -0.75 . . . . 0.0 110.726 -179.48 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 32' ' ' MET . 47.4 t -104.89 112.84 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.016 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.44 HG23 ' CD1' ' A' ' 39' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 120.901 0.382 . . . . 0.0 110.868 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.622 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 47.4 t . . . . . 0 C--O 1.232 0.17 0 N-CA-C 110.442 -0.206 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.446 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 14.3 Cg_endo -56.12 -28.33 69.67 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.468 2.112 . . . . 0.0 111.865 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.41 -6.19 10.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.602 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.637 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 39.4 m80 -128.62 88.63 51.65 Favored Pre-proline 0 C--O 1.231 0.121 0 CA-C-O 120.668 0.27 . . . . 0.0 111.265 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -61.58 -32.82 87.83 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.3 2.0 . . . . 0.0 112.008 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.53 -19.41 29.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.423 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -85.3 83.33 8.01 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.198 0.523 . . . . 0.0 110.834 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.445 ' O ' ' C ' ' A' ' 23' ' ' LEU . 5.4 mm -63.44 83.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.019 -1.446 . . . . 0.0 113.869 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.604 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.9 mp -34.02 111.87 0.12 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 32' ' ' MET . 2.8 t -73.5 163.33 4.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 121.344 0.592 . . . . 0.0 110.953 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.43 -1.438 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.873 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.58 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.221 -0.4 0 CA-C-O 121.252 0.549 . . . . 0.0 111.827 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -102.76 119.18 50.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.723 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.756 ' O ' ' N ' ' A' ' 38' ' ' GLY . 35.9 t -85.79 97.14 0.53 Allowed Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 5.0 Cg_endo -44.97 -11.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.011 2.474 . . . . 0.0 113.951 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.637 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 5.5 mm-40 -89.93 -63.56 1.26 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 121.115 -0.234 . . . . 0.0 110.725 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.447 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 2.7 p -91.95 -20.25 21.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 176.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.756 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.49 40.11 91.12 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 114.068 -1.424 . . . . 0.0 111.208 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.658 ' CD1' HG23 ' A' ' 41' ' ' VAL . 1.4 pp -79.12 149.73 31.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.378 -0.911 . . . . 0.0 109.758 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 32' ' ' MET . 44.8 t -115.08 110.46 32.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.658 HG23 ' CD1' ' A' ' 39' ' ' LEU . 22.9 t . . . . . 0 N--CA 1.468 0.449 0 CA-C-O 120.917 0.389 . . . . 0.0 111.393 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.609 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 53.2 t . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.614 0.245 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.54 -30.55 71.22 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.447 2.098 . . . . 0.0 111.848 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -96.69 -14.58 21.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.895 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.609 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 37.8 m80 -130.69 86.65 52.07 Favored Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.028 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.59 -47.92 6.55 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.21 1.94 . . . . 0.0 111.912 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.91 -10.13 59.17 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.205 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.508 ' CB ' ' HG3' ' A' ' 36' ' ' GLU . . . -103.44 106.02 16.43 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.458 0.647 . . . . 0.0 111.166 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.9 mt -82.79 126.05 40.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.548 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.595 ' HB3' ' HB3' ' A' ' 32' ' ' MET . 2.8 mp -63.78 130.91 46.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.28 0.562 . . . . 0.0 109.503 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 32' ' ' MET . 11.9 t -88.24 157.65 3.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.833 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 . . . . . 0 N--CA 1.434 -1.237 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.758 -178.823 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.599 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 4.9 mtp . . . . . 0 C--O 1.222 -0.376 0 CA-C-O 121.03 0.443 . . . . 0.0 110.499 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.767 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -99.71 124.62 53.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -176.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.751 ' O ' ' N ' ' A' ' 38' ' ' GLY . 43.4 t -87.51 103.23 4.29 Favored Pre-proline 0 C--O 1.222 -0.344 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.8 Cg_endo -41.1 -21.06 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.304 2.67 . . . . 0.0 114.056 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.543 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 4.5 mm-40 -85.4 -66.16 0.93 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.886 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.424 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 3.1 p -89.87 -18.94 25.23 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.767 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 67.43 30.84 75.6 Favored Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.074 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -71.17 149.75 46.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.349 -0.926 . . . . 0.0 110.895 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 32' ' ' MET . 24.1 t -113.31 126.74 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.687 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.481 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 92.2 t . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.41 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 44.7 t . . . . . 0 CA--C 1.529 0.157 0 CA-C-O 120.548 0.213 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.14 -21.26 62.88 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.516 2.144 . . . . 0.0 112.356 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -112.05 -13.1 13.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.183 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.698 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.5 m80 -131.36 88.02 45.34 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.728 0.299 . . . . 0.0 110.622 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.0 -34.14 99.05 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.366 2.044 . . . . 0.0 111.709 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.37 -28.12 34.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.396 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.466 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -81.5 87.2 6.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.187 0.518 . . . . 0.0 111.15 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.582 ' O ' ' C ' ' A' ' 23' ' ' LEU . 2.8 mm -74.63 70.56 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.779 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.582 ' C ' ' O ' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -9.86 111.13 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.666 0.604 . . . . 0.0 110.657 179.349 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 32' ' ' MET . 7.3 t -81.9 158.78 3.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.514 0.673 . . . . 0.0 112.394 -177.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.834 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.256 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 88.6 mtp . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.75 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -115.35 136.84 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.508 0.67 . . . . 0.0 111.956 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.858 ' O ' ' N ' ' A' ' 38' ' ' GLY . 38.5 t -87.63 96.71 0.62 Allowed Pre-proline 0 N--CA 1.439 -1.024 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.435 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.8 Cg_endo -39.3 -19.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.551 2.834 . . . . 0.0 113.836 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.698 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 2.4 mm-40 -85.94 -66.18 0.93 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.72 0.295 . . . . 0.0 110.655 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.436 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 3.0 p -89.59 -17.93 27.54 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.858 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 65.63 31.28 79.53 Favored Glycine 0 N--CA 1.435 -1.424 0 CA-C-N 113.986 -1.461 . . . . 0.0 111.562 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.75 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 1.3 pp -65.25 136.65 56.87 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 32' ' ' MET . 77.3 t -107.0 114.85 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 O-C-N 123.358 0.411 . . . . 0.0 111.027 -178.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.543 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 95.8 t . . . . . 0 N--CA 1.448 -0.563 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.659 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.544 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 49.3 t . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.458 0.17 . . . . 0.0 110.571 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.85 -21.85 71.94 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.182 1.921 . . . . 0.0 111.989 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -119.73 -7.56 10.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.384 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.647 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 37.6 m80 -131.18 86.75 50.09 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-O 120.624 0.249 . . . . 0.0 111.11 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.15 -33.63 90.5 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.416 2.077 . . . . 0.0 112.011 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -83.3 -24.94 31.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.161 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 18' ' ' HIS . . . -82.39 81.93 8.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.336 0.589 . . . . 0.0 110.638 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.51 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -66.68 78.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.47 -1.241 . . . . 0.0 113.395 -178.054 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.59 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.7 mp -22.43 106.95 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.712 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.4 t -75.24 167.93 2.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.192 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 . . . . . 0 N--CA 1.432 -1.329 0 CA-C-O 121.922 0.867 . . . . 0.0 110.602 -178.387 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.557 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 53.5 mtp . . . . . 0 C--O 1.225 -0.231 0 CA-C-O 121.364 0.602 . . . . 0.0 111.882 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.809 HD12 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -103.61 123.22 57.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.056 -176.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.75 ' O ' ' N ' ' A' ' 38' ' ' GLY . 44.5 t -86.24 96.77 0.52 Allowed Pre-proline 0 N--CA 1.448 -0.529 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.2 Cg_endo -43.2 -14.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 123.232 2.622 . . . . 0.0 113.935 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.647 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 8.7 mm-40 -88.89 -64.28 1.17 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.632 0.253 . . . . 0.0 110.952 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.456 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 4.6 p -91.16 -19.52 22.99 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.809 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 67.5 37.46 89.87 Favored Glycine 0 N--CA 1.432 -1.567 0 CA-C-N 113.822 -1.535 . . . . 0.0 111.986 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.635 ' CD1' HG23 ' A' ' 41' ' ' VAL . 1.2 pp -76.91 148.66 36.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.569 -0.816 . . . . 0.0 110.053 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 32' ' ' MET . 34.8 t -113.74 113.33 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.635 HG23 ' CD1' ' A' ' 39' ' ' LEU . 42.1 t . . . . . 0 N--CA 1.462 0.155 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.497 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 48.0 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.486 0.184 . . . . 0.0 110.726 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.46 -23.2 71.23 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.403 2.069 . . . . 0.0 112.444 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -117.68 -7.28 11.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.506 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.692 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.0 m80 -130.3 83.28 63.27 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.666 0.27 . . . . 0.0 111.049 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.3 -36.47 87.55 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.323 2.015 . . . . 0.0 111.769 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.77 -34.96 62.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.043 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.492 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -76.81 85.43 3.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.016 0.436 . . . . 0.0 110.968 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' C ' ' A' ' 23' ' ' LEU . 8.9 mm -69.96 74.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.295 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.561 ' C ' ' O ' ' A' ' 22' ' ' ILE . 1.3 mp -12.86 114.2 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.596 0.56 . . . . 0.0 110.893 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 32' ' ' MET . 5.9 t -83.53 157.49 3.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.387 0.613 . . . . 0.0 111.957 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.306 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.826 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.528 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.904 0.383 . . . . 0.0 110.87 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.715 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 5.8 tp -104.13 132.72 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.767 ' O ' ' N ' ' A' ' 38' ' ' GLY . 41.7 t -90.86 96.3 0.95 Allowed Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 176.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 5.1 Cg_endo -44.56 -10.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.102 2.534 . . . . 0.0 113.878 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.692 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 3.5 mm-40 -88.21 -64.0 1.21 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.46 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 6.0 p -91.32 -23.07 20.23 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.767 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 71.82 46.83 35.7 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.341 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.715 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.6 OUTLIER -86.68 139.42 30.78 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.053 -1.074 . . . . 0.0 109.607 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 32' ' ' MET . 18.6 t -108.41 119.72 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 O-C-N 123.679 0.612 . . . . 0.0 111.476 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.495 HG21 ' CD1' ' A' ' 39' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.57 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 35.8 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.46 0.171 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.92 -19.27 66.46 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.297 1.998 . . . . 0.0 111.818 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.21 -13.0 12.4 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.011 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.688 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.5 m80 -130.79 87.63 48.76 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.284 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.96 -35.0 94.8 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.453 2.102 . . . . 0.0 111.927 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.38 -28.79 41.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.048 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.449 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -79.85 88.21 5.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.066 0.46 . . . . 0.0 111.2 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.551 ' O ' ' C ' ' A' ' 23' ' ' LEU . 17.7 mt -74.7 72.25 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.793 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.617 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 0.9 OUTLIER -14.08 103.02 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.034 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.1 t -75.19 166.27 2.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.652 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.443 -0.804 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.965 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.515 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.1 mtp . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.961 0.41 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.695 HD12 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -99.95 124.78 53.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.158 -177.573 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.77 ' O ' ' N ' ' A' ' 38' ' ' GLY . 32.1 t -87.53 97.2 0.69 Allowed Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.3 Cg_endo -40.3 -17.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.548 2.832 . . . . 0.0 113.913 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.688 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 8.4 mm-40 -87.28 -65.88 0.97 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.591 0.234 . . . . 0.0 110.877 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.447 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 3.6 p -90.07 -18.6 25.62 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.77 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.93 33.39 83.8 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 114.084 -1.416 . . . . 0.0 111.769 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -72.61 145.58 47.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.916 -0.642 . . . . 0.0 109.592 179.105 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 32' ' ' MET . 2.4 t -115.08 117.61 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 120.983 0.42 . . . . 0.0 111.586 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.482 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 86.3 t . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.408 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 40.1 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.469 0.176 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.94 -20.59 70.01 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.3 2.0 . . . . 0.0 111.976 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -116.5 -11.91 11.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.199 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.656 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.2 m80 -130.04 88.57 48.09 Favored Pre-proline 0 C--N 1.333 -0.142 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.803 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.74 -37.16 88.9 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.474 2.116 . . . . 0.0 111.922 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -78.57 -32.82 47.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.417 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.533 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . . . -75.42 84.77 2.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.238 0.542 . . . . 0.0 110.891 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.555 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.2 mp -70.61 73.67 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.177 -178.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.555 ' C ' ' O ' ' A' ' 22' ' ' ILE . 1.9 mp -15.49 118.95 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.524 0.515 . . . . 0.0 110.508 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 32' ' ' MET . 22.6 t -86.57 151.15 3.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.638 0.732 . . . . 0.0 112.469 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.441 -0.917 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.935 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.573 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 22.8 mtm . . . . . 0 N--CA 1.444 -0.77 0 CA-C-O 121.66 0.743 . . . . 0.0 111.389 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.772 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -102.15 128.4 54.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.996 -177.59 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.784 ' O ' ' N ' ' A' ' 38' ' ' GLY . 41.5 t -85.68 98.67 0.76 Allowed Pre-proline 0 N--CA 1.445 -0.717 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 1.2 Cg_endo -42.68 -16.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.16 2.573 . . . . 0.0 113.699 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.656 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 14.4 mm-40 -89.2 -63.92 1.22 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.504 0.193 . . . . 0.0 111.076 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.444 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 6.0 p -90.74 -21.46 21.56 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.784 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 70.12 38.18 72.93 Favored Glycine 0 N--CA 1.432 -1.606 0 CA-C-N 113.546 -1.661 . . . . 0.0 112.449 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.772 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -78.08 146.02 35.47 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.753 -0.724 . . . . 0.0 110.021 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 32' ' ' MET . 23.0 t -110.81 117.7 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 O-C-N 123.43 0.456 . . . . 0.0 111.705 -178.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.485 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 63.2 t . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.869 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.46 ' HB2' HD12 ' A' ' 23' ' ' LEU . 7.7 t . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.498 0.189 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -66.86 -20.91 51.3 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.327 2.018 . . . . 0.0 111.967 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -111.7 -14.83 13.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.979 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.677 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.0 m80 -130.47 87.32 50.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.668 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.87 -38.09 81.79 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.395 2.063 . . . . 0.0 111.967 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.96 -39.07 61.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.226 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.42 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -70.82 91.93 0.87 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.968 0.413 . . . . 0.0 111.149 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.586 ' O ' ' C ' ' A' ' 23' ' ' LEU . 8.6 mm -77.86 67.21 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.432 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.586 ' C ' ' O ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -5.32 102.84 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.154 179.614 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.5 t -77.22 163.58 3.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 121.339 0.59 . . . . 0.0 111.781 -178.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 N--CA 1.441 -0.916 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.782 -178.012 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.826 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 15.5 mtt . . . . . 0 C--O 1.225 -0.219 0 N-CA-C 110.619 -0.141 . . . . 0.0 110.619 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.678 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -112.99 134.07 56.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -177.719 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.821 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.4 t -87.63 97.75 0.81 Allowed Pre-proline 0 C--O 1.218 -0.569 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -39.22 -19.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.549 2.833 . . . . 0.0 113.627 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.677 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 12.1 mm-40 -85.58 -66.84 0.85 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.732 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.472 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 3.7 p -90.08 -20.69 22.88 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 177.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.821 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 70.25 32.36 68.77 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 114.025 -1.443 . . . . 0.0 112.217 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.678 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -71.51 141.41 50.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.717 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.826 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.3 t -108.8 127.0 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-O 120.692 0.282 . . . . 0.0 111.004 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.499 HG21 ' CD1' ' A' ' 39' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.986 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 48.3 t . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.508 0.194 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.62 -24.09 77.37 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.266 1.978 . . . . 0.0 112.068 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -118.06 -7.25 10.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.484 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.719 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 32.7 m80 -133.15 80.76 58.54 Favored Pre-proline 0 C--N 1.333 -0.129 0 CA-C-O 120.734 0.302 . . . . 0.0 111.692 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -57.74 -36.52 98.36 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.887 1.725 . . . . 0.0 111.06 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.53 -48.73 63.56 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.258 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.532 ' HB1' ' HB3' ' A' ' 18' ' ' HIS . . . -71.09 85.98 0.74 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.248 0.547 . . . . 0.0 111.073 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.555 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.6 mp -67.75 75.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.846 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.561 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.1 mp -14.24 112.2 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.912 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -81.31 160.19 3.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.277 0.56 . . . . 0.0 111.644 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 . . . . . 0 N--CA 1.44 -0.968 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.85 -179.075 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.558 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 73.3 mtp . . . . . 0 N--CA 1.446 -0.636 0 CA-C-O 121.475 0.655 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.688 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -100.68 125.68 54.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.403 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.731 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.0 t -88.87 98.27 1.09 Allowed Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.1 Cg_endo -43.57 -14.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.181 2.587 . . . . 0.0 114.068 -178.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.719 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 4.0 mm-40 -89.45 -63.07 1.34 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 121.215 -0.194 . . . . 0.0 111.409 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.449 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 16.1 p -91.37 -23.23 20.13 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.731 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 72.18 37.53 59.6 Favored Glycine 0 N--CA 1.428 -1.892 0 CA-C-N 113.285 -1.78 . . . . 0.0 112.651 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -77.36 145.82 37.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.155 179.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 32' ' ' MET . 59.0 t -111.35 116.1 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 O-C-N 123.847 0.717 . . . . 0.0 111.069 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.455 HG23 ' CD1' ' A' ' 39' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.471 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 10.5 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.566 0.222 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.8 -23.75 74.43 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.24 1.96 . . . . 0.0 111.995 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -106.93 -30.01 9.11 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.719 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.612 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 39.6 m80 -108.25 87.53 4.1 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.18 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.61 39.73 0.65 Allowed 'Trans proline' 0 CA--C 1.515 -0.444 0 C-N-CA 123.168 2.578 . . . . 0.0 111.013 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 18' ' ' HIS . 46.8 m-20 -152.64 -48.05 0.1 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.143 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.42 ' HB1' ' CG ' ' A' ' 36' ' ' GLU . . . -69.58 93.46 0.7 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.991 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.574 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.5 mp -76.04 71.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.946 -1.025 . . . . 0.0 113.182 -177.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.574 ' C ' ' O ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -8.84 111.35 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.901 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 32' ' ' MET . 15.4 t -81.76 152.44 4.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 121.646 0.736 . . . . 0.0 112.609 -177.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 . . . . . 0 C--N 1.318 -0.787 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.005 -179.041 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.546 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 16.7 mtp . . . . . 0 N--CA 1.434 -1.238 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 1.02 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -109.09 137.91 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 CA-C-O 122.113 0.959 . . . . 0.0 112.048 -176.396 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.811 ' O ' ' N ' ' A' ' 38' ' ' GLY . 33.1 t -91.25 99.17 2.07 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 113.542 -1.663 . . . . 0.0 109.181 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.1 Cg_endo -41.41 -15.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.312 2.675 . . . . 0.0 113.603 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.612 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 9.3 mm-40 -87.18 -65.0 1.06 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.484 0.183 . . . . 0.0 110.627 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.6 p -90.07 -21.0 22.52 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.811 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 69.06 40.16 83.66 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.963 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 1.02 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 1.5 pp -77.26 136.85 38.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.024 -1.088 . . . . 0.0 108.378 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 32' ' ' MET . 42.9 t -105.6 126.45 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 O-C-N 123.399 0.437 . . . . 0.0 111.234 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.567 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.4 t . . . . . 0 N--CA 1.448 -0.574 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.224 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 42.7 t . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.482 0.182 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.18 -28.41 56.25 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.338 2.025 . . . . 0.0 111.238 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -91.08 -20.35 22.14 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.335 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.591 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 40.5 m80 -130.66 85.92 54.36 Favored Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.325 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.73 -40.54 53.86 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.958 1.772 . . . . 0.0 110.99 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.0 -13.96 59.69 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.974 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.502 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -97.76 133.77 41.83 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.66 0.743 . . . . 0.0 110.985 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -108.11 123.98 64.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.774 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.787 ' HB3' ' HB3' ' A' ' 32' ' ' MET . 4.9 mp -67.89 93.86 0.43 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 32' ' ' MET . 2.7 t -49.91 161.83 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.208 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 . . . . . 0 N--CA 1.442 -0.833 0 CA-C-O 122.428 1.109 . . . . 0.0 112.13 -176.926 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.787 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 36.2 mtm . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 121.308 0.575 . . . . 0.0 111.413 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.779 HD12 ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -98.82 121.62 49.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.132 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.814 ' O ' ' N ' ' A' ' 38' ' ' GLY . 38.9 t -84.35 100.4 1.06 Allowed Pre-proline 0 C--O 1.221 -0.406 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.475 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 3.9 Cg_exo -36.8 -26.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.804 3.003 . . . . 0.0 114.064 -179.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.591 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 27.2 mm-40 -82.63 -67.36 0.79 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.523 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.426 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 2.6 p -87.92 -15.07 37.63 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.814 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 61.84 25.55 65.94 Favored Glycine 0 N--CA 1.433 -1.542 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.31 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.598 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -65.25 150.37 48.34 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.354 -0.923 . . . . 0.0 110.116 -179.844 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 32' ' ' MET . 2.7 t -118.17 120.19 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.471 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 84.9 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.164 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.3 t . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 120.65 0.262 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.73 -28.97 51.57 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.601 2.201 . . . . 0.0 112.03 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.19 -16.31 19.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.713 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.649 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 39.9 m80 -131.92 85.23 51.45 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.293 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.68 -43.54 37.87 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.074 1.85 . . . . 0.0 111.321 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -74.64 -12.01 60.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.372 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.605 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -102.5 102.35 12.63 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.136 0.494 . . . . 0.0 111.812 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.38 130.76 35.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.564 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 3.2 mp -72.19 135.69 46.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.657 0.742 . . . . 0.0 111.125 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 32' ' ' MET . 42.9 t -87.63 156.84 3.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.208 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.432 -1.338 0 CA-C-O 121.936 0.874 . . . . 0.0 111.314 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.549 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 75.8 mtp . . . . . 0 C--O 1.223 -0.323 0 CA-C-O 121.01 0.433 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.6 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -99.42 123.19 51.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -176.596 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.771 ' O ' ' N ' ' A' ' 38' ' ' GLY . 30.4 t -88.86 100.17 1.94 Allowed Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -40.11 -20.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.589 2.859 . . . . 0.0 114.09 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.649 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 6.4 mm-40 -87.36 -64.5 1.14 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.755 0.312 . . . . 0.0 111.409 -177.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.422 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 7.6 p -89.86 -20.23 23.68 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.771 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 68.15 29.14 73.2 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.222 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -69.0 145.95 53.14 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.159 -0.521 . . . . 0.0 110.422 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 32' ' ' MET . 40.4 t -109.3 120.51 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 O-C-N 123.904 0.753 . . . . 0.0 110.493 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.43 HG21 ' CD1' ' A' ' 39' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.367 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.42 ' HB2' HD12 ' A' ' 23' ' ' LEU . 19.2 t . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 120.532 0.206 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.85 -26.32 32.18 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.322 2.015 . . . . 0.0 111.535 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.55 -16.98 18.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.74 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.648 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 39.1 m80 -131.87 84.32 54.42 Favored Pre-proline 0 N--CA 1.455 -0.224 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.205 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.96 -44.86 27.24 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 121.937 1.758 . . . . 0.0 111.528 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.98 -12.77 60.74 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.648 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -102.12 102.37 12.83 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.826 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 mp -75.65 125.11 34.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.574 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 2.7 mp -67.63 147.69 52.38 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.391 0.615 . . . . 0.0 110.509 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 32' ' ' MET . 50.2 t -95.08 146.78 6.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.039 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 . . . . . 0 N--CA 1.43 -1.425 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.323 -178.615 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.614 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 9.4 mtt . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 121.232 0.539 . . . . 0.0 111.564 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.732 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -98.23 123.26 50.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.894 -177.604 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.763 ' O ' ' N ' ' A' ' 38' ' ' GLY . 52.8 t -88.68 102.26 3.75 Favored Pre-proline 0 C--O 1.222 -0.379 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.7 Cg_endo -40.95 -20.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.398 2.732 . . . . 0.0 113.953 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.619 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 30.9 mm-40 -86.83 -65.52 1.01 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.571 -177.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.474 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 6.4 p -90.23 -20.47 22.96 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.763 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 69.29 30.29 71.62 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 113.715 -1.584 . . . . 0.0 112.437 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -71.26 146.41 48.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.249 -0.475 . . . . 0.0 110.451 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 32' ' ' MET . 26.6 t -106.28 119.29 55.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 O-C-N 123.905 0.753 . . . . 0.0 109.489 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.401 ' CG2' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.44 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.824 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 42.9 t . . . . . 0 CA--C 1.53 0.173 0 CA-C-O 120.633 0.254 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.11 -28.49 48.72 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.389 2.06 . . . . 0.0 111.772 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -95.82 -18.18 20.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.522 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.682 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 40.1 m80 -131.31 86.18 51.23 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.329 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.31 -45.33 19.11 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 121.995 1.797 . . . . 0.0 111.309 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -72.33 -14.41 61.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.419 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -100.76 105.94 17.31 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.582 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.6 mm -81.89 128.17 38.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.564 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.513 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 3.5 mp -67.32 137.55 56.14 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.095 0.474 . . . . 0.0 110.465 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 32' ' ' MET . 43.7 t -88.18 142.28 13.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.332 0.587 . . . . 0.0 111.482 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.443 -0.805 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.09 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.671 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.66 0 CA-C-O 121.068 0.461 . . . . 0.0 111.451 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.745 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -102.71 126.24 56.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.517 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.792 ' O ' ' N ' ' A' ' 38' ' ' GLY . 41.0 t -90.18 99.96 2.27 Favored Pre-proline 0 C--O 1.22 -0.453 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.8 Cg_endo -40.24 -21.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.458 2.772 . . . . 0.0 114.097 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.682 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 31.7 mm-40 -84.52 -65.31 1.02 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.669 0.271 . . . . 0.0 111.216 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.7 p -89.82 -18.51 26.12 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.792 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.51 28.49 73.6 Favored Glycine 0 N--CA 1.433 -1.545 0 CA-C-N 113.641 -1.618 . . . . 0.0 112.074 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 1.3 pp -67.09 140.67 57.6 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.615 -0.793 . . . . 0.0 110.558 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 32' ' ' MET . 29.3 t -110.32 118.71 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.508 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.508 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.5 t . . . . . 0 C--O 1.207 -1.183 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.479 ' HB2' HD12 ' A' ' 23' ' ' LEU . 11.3 t . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.523 0.202 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.3 -19.32 44.1 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.264 1.976 . . . . 0.0 111.6 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -115.09 -11.06 12.12 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.304 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.625 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 38.6 m80 -130.96 87.31 49.26 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-O 120.624 0.249 . . . . 0.0 110.583 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.33 -36.2 88.33 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.313 2.008 . . . . 0.0 112.004 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -79.26 -31.92 43.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.005 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.471 ' CB ' ' HB3' ' A' ' 18' ' ' HIS . . . -75.05 88.45 2.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.058 0.456 . . . . 0.0 111.278 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.55 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.7 mp -75.2 70.12 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.201 -0.908 . . . . 0.0 112.827 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.582 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -12.22 111.25 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.536 179.481 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.3 t -79.34 167.35 2.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.137 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.431 -1.393 0 CA-C-O 121.71 0.766 . . . . 0.0 110.229 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.559 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.9 mtt . . . . . 0 C--O 1.221 -0.403 0 CA-C-O 121.402 0.62 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.805 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -99.97 123.4 52.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -176.149 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.74 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.8 t -88.56 96.28 0.65 Allowed Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.2 Cg_endo -41.84 -15.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.382 2.722 . . . . 0.0 113.743 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.625 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 18.2 mm-40 -85.1 -67.49 0.8 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.905 0.383 . . . . 0.0 111.034 -178.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.45 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 2.9 p -90.85 -19.56 23.25 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.805 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.18 38.72 82.99 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.149 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.605 ' CD1' ' CG2' ' A' ' 41' ' ' VAL . 1.6 pp -78.05 147.0 34.96 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.438 -0.881 . . . . 0.0 110.281 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 32' ' ' MET . 49.1 t -112.23 118.63 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 123.354 0.409 . . . . 0.0 111.945 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.605 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.241 178.043 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.473 ' HB2' HD12 ' A' ' 23' ' ' LEU . 32.8 t . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.433 0.159 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.5 -19.97 65.54 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.259 1.973 . . . . 0.0 111.911 179.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.16 -10.88 10.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.258 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.712 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.9 m80 -130.58 87.99 48.24 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.797 0.332 . . . . 0.0 110.829 179.575 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.32 -34.75 97.84 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.306 2.004 . . . . 0.0 111.752 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.96 -25.49 37.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.385 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.467 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -84.33 83.9 7.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.158 0.504 . . . . 0.0 111.377 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' C ' ' A' ' 23' ' ' LEU . 16.1 mm -72.18 74.27 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.737 -178.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.608 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -15.37 113.52 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.439 179.511 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 32' ' ' MET . 5.0 t -81.23 160.58 3.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.271 0.558 . . . . 0.0 111.822 -178.151 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.319 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.829 -178.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.538 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 6.7 mtm . . . . . 0 CA--C 1.531 0.238 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.743 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -106.51 124.07 61.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.844 -178.154 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.752 ' O ' ' N ' ' A' ' 38' ' ' GLY . 40.4 t -86.83 97.04 0.59 Allowed Pre-proline 0 C--O 1.221 -0.446 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.3 Cg_endo -41.86 -15.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.378 2.719 . . . . 0.0 114.267 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.712 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 6.2 mm-40 -88.55 -64.51 1.14 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.738 0.304 . . . . 0.0 111.173 -178.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.466 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 4.5 p -90.94 -19.6 23.11 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.38 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.752 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.1 36.42 90.45 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.684 -179.397 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.706 ' CD1' ' CG2' ' A' ' 41' ' ' VAL . 1.2 pp -73.16 145.01 46.66 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.569 -0.816 . . . . 0.0 109.315 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 32' ' ' MET . 53.7 t -114.66 119.94 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 121.044 0.45 . . . . 0.0 112.08 -176.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.706 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.2 t . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.247 179.563 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 9.3 t . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.518 0.199 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.1 -18.9 39.9 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.285 1.99 . . . . 0.0 111.861 179.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -115.91 -9.46 11.8 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.266 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.6 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.1 m80 -131.03 88.06 46.67 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.653 0.263 . . . . 0.0 111.043 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.19 -33.24 90.87 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.433 2.089 . . . . 0.0 112.072 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.79 -23.58 27.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.504 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.557 ' CB ' ' HB3' ' A' ' 18' ' ' HIS . . . -84.06 82.45 8.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.289 0.566 . . . . 0.0 110.671 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.535 ' O ' ' C ' ' A' ' 23' ' ' LEU . 3.7 mt -69.42 75.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.552 -177.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.545 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.3 mp -18.68 109.83 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 O-C-N 123.618 0.574 . . . . 0.0 110.577 179.04 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.4 t -78.24 163.02 3.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.234 0.54 . . . . 0.0 111.959 -178.108 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 . . . . . 0 N--CA 1.44 -0.957 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.395 -178.639 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.541 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 1.3 mtt . . . . . 0 C--O 1.222 -0.387 0 CA-C-O 121.205 0.526 . . . . 0.0 111.935 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -104.03 125.96 58.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.898 0.38 . . . . 0.0 111.754 -178.87 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.813 ' O ' ' N ' ' A' ' 38' ' ' GLY . 40.5 t -85.8 97.62 0.61 Allowed Pre-proline 0 N--CA 1.447 -0.61 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.068 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -41.11 -17.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.319 2.679 . . . . 0.0 113.742 -179.231 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.6 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 9.9 mm-40 -88.06 -65.48 1.01 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.672 0.273 . . . . 0.0 110.789 -178.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.451 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 4.0 p -90.36 -18.59 25.25 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.271 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.813 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.12 33.3 84.91 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.681 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -72.44 143.64 48.41 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.949 -0.626 . . . . 0.0 109.58 179.099 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 32' ' ' MET . 16.1 t -110.35 112.94 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 O-C-N 123.236 0.335 . . . . 0.0 111.514 -178.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.459 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 67.0 t . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.117 178.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.725 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 14.5 t . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.579 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 29.5 Cg_endo -62.12 -44.33 20.2 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.91 2.407 . . . . 0.0 112.716 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.526 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 94.1 m-20 -107.48 38.12 2.23 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 122.119 0.962 . . . . 0.0 108.588 178.353 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.725 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 24.7 m80 -161.9 65.13 1.84 Allowed Pre-proline 0 C--N 1.308 -1.226 0 CA-C-O 123.114 1.435 . . . . 0.0 108.93 175.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 18' ' ' HIS . 55.6 Cg_endo -70.3 13.6 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.649 3.566 . . . . 0.0 113.103 -179.244 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.58 -17.48 1.49 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 120.999 0.428 . . . . 0.0 110.033 178.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.497 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -98.21 131.02 44.91 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.435 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.614 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.3 mp -106.87 87.51 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.614 ' C ' ' O ' ' A' ' 22' ' ' ILE . 3.9 mp -15.99 105.02 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 121.037 0.446 . . . . 0.0 109.934 178.43 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 32' ' ' MET . 2.7 t -63.53 170.85 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.174 -178.309 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.43 -1.436 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.501 -178.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.51 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 66.3 mtm . . . . . 0 CA--C 1.53 0.176 0 CA-C-O 120.923 0.392 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.741 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -110.43 123.81 66.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.402 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.873 ' O ' ' N ' ' A' ' 38' ' ' GLY . 6.5 t -83.45 101.69 1.48 Allowed Pre-proline 0 C--O 1.215 -0.744 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.6 Cg_endo -44.24 -20.99 0.35 Allowed 'Trans proline' 0 N--CA 1.475 0.413 0 C-N-CA 122.152 1.901 . . . . 0.0 112.809 -179.333 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.604 ' HB3' ' NE2' ' A' ' 18' ' ' HIS . 29.8 mm-40 -85.03 -60.52 2.02 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.457 -178.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.529 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 25.6 p -93.61 -11.97 30.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.636 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.873 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 54.32 26.28 36.22 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 114.79 -1.096 . . . . 0.0 113.581 178.574 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.741 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.6 OUTLIER -71.6 157.22 38.36 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.005 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 32' ' ' MET . 5.9 t -118.41 118.12 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.054 0.454 . . . . 0.0 111.936 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.521 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 68.1 t . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.546 178.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 49.2 t . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.51 0.195 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.73 -21.28 72.85 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.334 2.023 . . . . 0.0 112.189 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -116.96 -9.52 11.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.367 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.68 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 37.2 m80 -130.24 88.78 46.87 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.786 0.327 . . . . 0.0 110.676 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.23 -34.61 93.83 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.356 2.038 . . . . 0.0 111.891 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.86 -23.84 33.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.32 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.511 ' CB ' ' HB3' ' A' ' 18' ' ' HIS . . . -83.81 84.15 7.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.22 0.534 . . . . 0.0 111.197 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.522 ' O ' ' C ' ' A' ' 23' ' ' LEU . 6.3 mt -70.4 77.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.658 -1.155 . . . . 0.0 113.147 -178.205 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.607 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -20.04 106.26 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.902 179.327 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -74.9 168.24 2.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.155 -178.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.432 -1.338 0 CA-C-O 121.996 0.903 . . . . 0.0 110.895 -178.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.626 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.8 mtm . . . . . 0 C--O 1.224 -0.251 0 CA-C-O 121.09 0.471 . . . . 0.0 111.638 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.851 HD12 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -104.22 123.03 57.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.121 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.745 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.0 t -87.23 96.58 0.58 Allowed Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.492 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.6 Cg_endo -42.52 -14.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.373 2.716 . . . . 0.0 114.072 -179.001 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.68 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 9.2 mm-40 -87.94 -65.19 1.04 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.66 0.266 . . . . 0.0 110.881 -178.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.454 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 4.5 p -91.0 -19.16 23.52 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.323 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.851 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 67.23 35.91 88.99 Favored Glycine 0 N--CA 1.433 -1.505 0 CA-C-N 113.87 -1.514 . . . . 0.0 111.929 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -75.51 147.82 39.46 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.75 179.192 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 32' ' ' MET . 18.6 t -114.87 113.74 44.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.71 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.483 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 86.0 t . . . . . 0 CA--C 1.518 -0.269 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.879 178.033 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 41.8 t . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.534 0.207 . . . . 0.0 110.577 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.84 -22.74 68.99 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.426 2.084 . . . . 0.0 112.656 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -115.79 -8.9 11.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.431 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.707 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.0 m80 -131.58 85.88 50.96 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.746 0.308 . . . . 0.0 110.809 179.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.05 -34.47 98.95 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.318 2.012 . . . . 0.0 111.64 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.13 -30.65 39.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.368 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.441 ' CB ' ' HB3' ' A' ' 18' ' ' HIS . . . -79.0 87.72 4.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.182 0.515 . . . . 0.0 111.419 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' C ' ' A' ' 23' ' ' LEU . 22.3 mm -73.24 72.98 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.734 -178.705 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.585 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -13.71 110.25 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.49 179.258 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 32' ' ' MET . 4.2 t -79.52 160.72 4.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.322 0.582 . . . . 0.0 112.181 -177.84 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.316 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.028 -177.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.53 0.198 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.527 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -109.4 126.8 66.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.781 -178.223 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.783 ' O ' ' N ' ' A' ' 38' ' ' GLY . 38.5 t -86.12 97.51 0.62 Allowed Pre-proline 0 C--O 1.22 -0.475 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.027 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -41.43 -16.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.321 2.681 . . . . 0.0 113.946 -179.141 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.707 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 2.2 mm-40 -87.82 -65.21 1.04 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.703 0.287 . . . . 0.0 111.073 -178.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.489 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 6.1 p -90.9 -19.68 23.06 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.479 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.783 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.89 34.95 88.74 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 113.86 -1.518 . . . . 0.0 111.741 -179.552 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.698 ' CD1' ' CG2' ' A' ' 41' ' ' VAL . 1.3 pp -71.22 145.65 49.51 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 32' ' ' MET . 86.5 t -113.54 121.99 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-O 121.209 0.528 . . . . 0.0 112.138 -176.591 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.698 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.4 t . . . . . 0 N--CA 1.45 -0.431 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.64 179.298 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.472 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 47.4 t . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.576 0.227 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.76 -21.61 73.17 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.28 1.986 . . . . 0.0 112.319 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -116.6 -9.53 11.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.348 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.715 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.1 m80 -131.48 87.19 47.39 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.775 0.322 . . . . 0.0 110.883 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.13 -34.1 94.61 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.345 2.03 . . . . 0.0 111.917 179.78 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.41 -26.76 35.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.231 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.463 ' CB ' ' HB3' ' A' ' 18' ' ' HIS . . . -81.52 87.62 6.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.201 0.524 . . . . 0.0 111.283 -179.882 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.569 ' O ' ' C ' ' A' ' 23' ' ' LEU . 15.3 mt -72.86 73.25 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.871 -178.556 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.569 ' C ' ' O ' ' A' ' 22' ' ' ILE . 1.5 mp -15.13 110.11 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.549 0.531 . . . . 0.0 110.513 179.321 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.8 t -79.09 161.58 4.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.202 0.525 . . . . 0.0 111.922 -177.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 . . . . . 0 N--CA 1.433 -1.277 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.733 -178.24 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.531 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 6.8 mtm . . . . . 0 C--O 1.227 -0.129 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -110.46 126.18 67.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.887 -178.226 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.791 ' O ' ' N ' ' A' ' 38' ' ' GLY . 42.0 t -85.7 98.07 0.67 Allowed Pre-proline 0 C--O 1.219 -0.546 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.158 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -41.61 -16.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.333 2.688 . . . . 0.0 114.05 -178.964 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.715 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 9.7 mm-40 -88.82 -64.37 1.16 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.725 0.298 . . . . 0.0 111.143 -178.792 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.47 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 5.9 p -90.62 -19.42 23.7 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.389 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.791 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.31 33.72 85.85 Favored Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 113.789 -1.55 . . . . 0.0 111.667 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -69.77 143.08 53.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.954 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 32' ' ' MET . 72.9 t -109.75 114.55 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 O-C-N 123.384 0.428 . . . . 0.0 111.549 -177.777 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.515 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 76.0 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.467 178.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.577 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 45.9 t . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 120.577 0.227 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.51 -29.86 71.11 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.457 2.105 . . . . 0.0 111.589 179.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -93.96 -16.66 23.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.503 179.62 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 38.9 m80 -131.73 85.86 50.35 Favored Pre-proline 0 N--CA 1.453 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.337 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.85 -53.55 0.9 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.233 1.955 . . . . 0.0 111.701 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.24 -14.75 63.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.716 -179.832 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.47 ' CB ' ' HB3' ' A' ' 18' ' ' HIS . . . -101.09 114.01 27.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.113 0.482 . . . . 0.0 110.413 179.22 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.0 mt -91.83 127.5 44.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.823 -179.078 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.451 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.5 mp -59.45 102.07 0.13 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.845 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.532 HG22 ' HD3' ' A' ' 35' ' ' PRO . 3.1 t -66.48 157.17 5.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 121.293 0.568 . . . . 0.0 111.715 -178.603 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 . . . . . 0 C--N 1.317 -0.824 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.007 -179.26 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.095 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.915 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 1.2 tt -112.42 139.55 36.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.027 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.835 ' O ' ' N ' ' A' ' 38' ' ' GLY . 52.7 t -91.68 102.38 5.87 Favored Pre-proline 0 N--CA 1.448 -0.55 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.61 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.532 ' HD3' HG22 ' A' ' 24' ' ' VAL . 1.9 Cg_endo -40.13 -21.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.456 2.771 . . . . 0.0 113.614 -178.773 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.515 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 5.7 mm-40 -81.01 -68.25 0.7 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.743 -178.816 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.447 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 4.4 p -88.18 -18.68 28.19 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.548 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.835 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.66 22.39 71.67 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.089 -179.581 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.915 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -58.7 140.92 54.03 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.963 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 32' ' ' MET . 5.5 t -113.15 131.19 65.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.762 0.315 . . . . 0.0 110.586 -179.073 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.532 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 12.5 t . . . . . 0 N--CA 1.452 -0.361 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.273 179.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 45.5 t . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.501 0.191 . . . . 0.0 110.724 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.04 -23.83 76.08 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.52 2.147 . . . . 0.0 112.522 -179.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -117.3 -7.69 11.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.449 -179.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.703 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.6 m80 -131.18 85.83 52.92 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.699 0.285 . . . . 0.0 110.779 179.63 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.98 -35.5 93.02 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.271 1.981 . . . . 0.0 111.897 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -78.57 -30.73 46.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.189 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.455 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -78.63 85.63 4.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.091 0.472 . . . . 0.0 111.246 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.529 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.8 mp -71.25 75.73 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.722 -178.6 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.612 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -18.09 107.53 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.002 179.419 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -75.91 167.6 2.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.225 -178.815 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 . . . . . 0 N--CA 1.433 -1.298 0 CA-C-O 122.105 0.955 . . . . 0.0 111.207 -177.882 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 52.6 mtp . . . . . 0 C--O 1.225 -0.196 0 CA-C-O 121.38 0.61 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.828 HD12 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -100.82 123.24 53.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.496 -0.775 . . . . 0.0 113.047 -176.783 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.729 ' O ' ' N ' ' A' ' 38' ' ' GLY . 52.1 t -87.71 96.2 0.58 Allowed Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.525 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.5 Cg_endo -41.89 -15.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.405 2.737 . . . . 0.0 114.077 -179.089 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.703 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 4.2 mm-40 -87.14 -65.58 1.0 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.625 0.25 . . . . 0.0 111.057 -178.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.483 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 4.7 p -91.1 -20.68 21.77 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.221 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.828 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 69.99 38.56 74.43 Favored Glycine 0 N--CA 1.432 -1.624 0 CA-C-N 113.76 -1.564 . . . . 0.0 111.996 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.681 ' CD1' ' CG2' ' A' ' 41' ' ' VAL . 1.6 pp -76.53 149.11 36.72 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.835 -0.683 . . . . 0.0 109.872 179.375 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 32' ' ' MET . 38.4 t -117.53 119.68 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 121.088 0.471 . . . . 0.0 112.14 -177.427 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.681 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.385 179.57 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 47.3 t . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.583 0.23 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.1 -21.96 73.2 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.316 2.011 . . . . 0.0 112.002 179.687 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -116.14 -10.16 11.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.19 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.735 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 41.9 m80 -130.61 88.43 46.79 Favored Pre-proline 0 C--O 1.232 0.18 0 CA-C-O 120.701 0.286 . . . . 0.0 110.525 178.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.78 -35.27 94.83 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.292 1.995 . . . . 0.0 111.788 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.41 -29.74 42.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.038 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -77.01 97.91 4.81 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 122.241 1.02 . . . . 0.0 111.168 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.515 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -80.84 74.94 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 112.787 -2.006 . . . . 0.0 113.698 -177.696 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.601 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.1 mp -20.85 102.71 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.768 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.4 t -71.7 166.3 2.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.15 -178.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.433 -1.317 0 CA-C-O 121.922 0.868 . . . . 0.0 110.76 -178.192 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.537 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 6.2 mtm . . . . . 0 C--O 1.222 -0.349 0 CA-C-O 121.375 0.607 . . . . 0.0 111.569 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.756 HD12 ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -102.81 121.63 54.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -176.885 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.743 ' O ' ' N ' ' A' ' 38' ' ' GLY . 25.7 t -86.79 96.84 0.57 Allowed Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.083 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.5 Cg_endo -41.79 -15.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.466 2.777 . . . . 0.0 114.069 -179.239 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.735 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 3.6 mm-40 -86.76 -65.9 0.96 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.675 0.274 . . . . 0.0 110.758 -178.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.465 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 3.9 p -90.71 -19.52 23.47 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.416 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.756 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 67.23 35.94 89.03 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 113.772 -1.558 . . . . 0.0 111.914 -179.728 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -74.27 150.54 40.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.762 -0.719 . . . . 0.0 109.878 179.379 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 32' ' ' MET . 23.7 t -115.87 116.11 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.825 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.499 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 97.6 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.931 178.256 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 36.9 t . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 120.528 0.204 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.44 -21.72 73.12 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.275 1.984 . . . . 0.0 111.995 179.452 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -115.92 -12.32 11.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.241 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.677 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 31.6 m80 -125.14 86.71 56.49 Favored Pre-proline 0 N--CA 1.455 -0.193 0 CA-C-O 120.857 0.36 . . . . 0.0 111.456 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.84 38.3 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.192 2.595 . . . . 0.0 110.805 178.432 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -150.59 -43.03 0.12 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.76 179.742 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -78.62 86.1 4.63 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.894 178.612 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.566 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.2 mp -70.06 75.69 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.339 -178.119 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.566 ' C ' ' O ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -14.52 113.74 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.735 179.656 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.8 t -82.06 159.33 3.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.223 0.535 . . . . 0.0 111.84 -178.231 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 . . . . . 0 N--CA 1.436 -1.142 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.077 -178.073 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.593 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.243 0 CA-C-O 121.579 0.704 . . . . 0.0 112.257 . . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.839 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -105.75 125.43 61.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.148 -177.712 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.721 ' O ' ' N ' ' A' ' 38' ' ' GLY . 39.8 t -88.43 97.33 0.81 Allowed Pre-proline 0 C--O 1.221 -0.398 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 177.23 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.0 Cg_endo -42.63 -14.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.405 2.737 . . . . 0.0 114.222 -178.877 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.677 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 1.9 mm-40 -89.25 -63.82 1.23 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.623 0.249 . . . . 0.0 111.326 -178.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.49 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 4.1 p -90.96 -21.15 21.47 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.247 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.839 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.38 39.0 81.17 Favored Glycine 0 N--CA 1.429 -1.772 0 CA-C-N 113.511 -1.677 . . . . 0.0 111.879 -179.692 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.69 ' CD1' ' CG2' ' A' ' 41' ' ' VAL . 1.4 pp -76.54 141.82 41.06 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.481 -0.859 . . . . 0.0 109.87 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 32' ' ' MET . 26.0 t -111.0 123.6 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-O 121.068 0.461 . . . . 0.0 111.46 -177.323 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.69 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.4 t . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.396 179.778 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.1 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.596 0.236 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.41 -21.33 53.86 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.481 2.12 . . . . 0.0 112.247 179.722 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -105.03 -29.61 10.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.862 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.632 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.8 m80 -118.42 88.59 34.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.065 179.784 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.12 -31.82 94.13 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.931 1.754 . . . . 0.0 110.993 179.188 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -81.33 -36.62 29.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.371 -179.911 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . . . -71.76 91.27 1.12 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.082 0.468 . . . . 0.0 110.697 179.808 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.548 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.8 mt -79.06 69.0 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.869 -178.411 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.601 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -12.27 123.44 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.229 179.43 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.657 ' O ' ' HA ' ' A' ' 32' ' ' MET . 21.2 t -85.94 157.47 3.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-O 121.413 0.625 . . . . 0.0 112.361 -178.022 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.007 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.009 -178.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.657 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 20.8 mtm . . . . . 0 N--CA 1.441 -0.885 0 CA-C-O 121.43 0.633 . . . . 0.0 111.39 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -100.46 126.2 54.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.049 -177.481 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.84 ' O ' ' N ' ' A' ' 38' ' ' GLY . 7.0 t -86.85 99.73 1.24 Allowed Pre-proline 0 C--O 1.216 -0.671 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.527 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.0 Cg_endo -40.27 -20.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.19 2.594 . . . . 0.0 113.542 -179.351 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.632 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 14.8 mm-40 -89.78 -63.13 1.33 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.332 -178.569 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.467 ' SG ' ' CD2' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -89.44 -18.84 25.98 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 177.729 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.84 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 63.42 28.57 72.57 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 114.112 -1.403 . . . . 0.0 111.783 -179.551 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 1.3 pp -71.36 148.59 46.86 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.774 -0.713 . . . . 0.0 109.908 179.317 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 32' ' ' MET . 35.0 t -110.09 118.19 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 O-C-N 123.445 0.466 . . . . 0.0 110.983 -179.386 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.555 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 54.8 t . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 121.236 0.541 . . . . 0.0 111.238 179.892 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 11.3 t . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.604 0.24 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.98 -19.67 45.61 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.264 1.976 . . . . 0.0 111.516 178.837 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -112.56 -11.58 13.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.133 179.878 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.641 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 31.6 m80 -131.79 84.72 53.56 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-O 120.619 0.247 . . . . 0.0 111.455 179.838 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.57 -41.68 62.07 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.979 1.786 . . . . 0.0 110.773 178.832 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.54 -8.83 57.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.574 179.975 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.508 ' CB ' ' HB3' ' A' ' 18' ' ' HIS . . . -100.99 109.04 20.91 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.734 0.778 . . . . 0.0 110.856 179.187 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.567 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -90.98 66.24 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 114.024 -1.444 . . . . 0.0 113.422 -177.632 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.596 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 2.7 mp -10.9 115.29 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.445 179.038 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 32' ' ' MET . 16.2 t -82.39 154.88 3.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.435 0.636 . . . . 0.0 112.708 -177.518 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.718 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.989 -178.584 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.644 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 15.7 mtp . . . . . 0 N--CA 1.446 -0.629 0 CA-C-O 121.574 0.702 . . . . 0.0 111.929 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.855 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -101.41 128.22 53.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.55 -177.198 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.794 ' O ' ' N ' ' A' ' 38' ' ' GLY . 45.0 t -83.22 99.43 0.69 Allowed Pre-proline 0 N--CA 1.448 -0.541 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.522 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -39.9 -20.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.281 2.654 . . . . 0.0 113.742 -179.464 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.641 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 5.3 mm-40 -87.9 -64.9 1.08 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.592 -178.262 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.459 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 7.0 p -89.84 -20.02 23.94 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.788 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.794 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.25 32.0 78.77 Favored Glycine 0 N--CA 1.431 -1.657 0 CA-C-N 113.652 -1.613 . . . . 0.0 112.754 179.406 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.855 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -71.12 155.33 40.89 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.725 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 32' ' ' MET . 4.1 t -118.34 120.28 63.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 O-C-N 123.309 0.381 . . . . 0.0 111.595 -178.35 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.574 ' O ' ' HB2' ' A' ' 32' ' ' MET . 53.1 t . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.714 178.916 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 13.3 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.492 0.187 . . . . 0.0 110.804 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -68.38 -18.38 44.1 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.115 1.877 . . . . 0.0 111.95 179.256 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.35 -8.1 11.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.336 179.929 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.654 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 37.9 m80 -130.95 88.35 46.05 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 120.693 0.282 . . . . 0.0 110.529 179.216 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.78 -35.02 90.78 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.408 2.072 . . . . 0.0 112.082 179.875 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.39 -28.25 31.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.308 -179.747 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.494 ' CB ' ' HB3' ' A' ' 18' ' ' HIS . . . -78.12 87.73 4.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.23 0.538 . . . . 0.0 111.057 -179.881 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.55 ' O ' ' C ' ' A' ' 23' ' ' LEU . 14.3 mt -72.09 73.9 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.091 -178.347 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.55 ' C ' ' O ' ' A' ' 22' ' ' ILE . 2.2 mp -17.78 109.14 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.709 179.333 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.5 t -76.57 165.67 3.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.564 -178.512 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.236 0 CA-C-O 121.941 0.877 . . . . 0.0 110.968 -177.874 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.537 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.584 0.707 . . . . 0.0 111.733 . . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.554 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -103.63 123.7 57.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.621 -176.817 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.766 ' O ' ' N ' ' A' ' 38' ' ' GLY . 47.9 t -86.87 96.81 0.57 Allowed Pre-proline 0 N--CA 1.445 -0.687 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.898 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.2 Cg_endo -41.91 -15.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.28 2.654 . . . . 0.0 113.695 -179.278 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.654 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 13.1 mm-40 -86.3 -66.83 0.86 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.76 0.314 . . . . 0.0 110.845 -179.155 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.454 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 3.7 p -90.93 -19.86 22.83 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.429 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.766 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.68 36.24 87.26 Favored Glycine 0 N--CA 1.432 -1.626 0 CA-C-N 114.011 -1.45 . . . . 0.0 111.81 -179.737 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -75.5 148.84 38.66 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.884 -0.658 . . . . 0.0 109.772 179.229 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 32' ' ' MET . 37.0 t -111.74 115.7 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 123.295 0.372 . . . . 0.0 111.926 -178.39 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.44 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 54.4 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.253 178.551 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 39.1 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.581 0.229 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.46 -19.89 54.73 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.379 2.053 . . . . 0.0 112.248 179.643 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -115.16 -10.25 12.18 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.411 -179.974 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.711 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.5 m80 -130.83 87.81 48.07 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.757 0.313 . . . . 0.0 110.663 179.508 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.84 -34.51 95.57 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.269 1.979 . . . . 0.0 111.812 179.789 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.44 -27.09 38.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.287 -179.892 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.446 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -82.85 85.14 7.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.146 0.498 . . . . 0.0 111.296 -179.78 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.2 mp -70.4 74.92 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.856 -1.066 . . . . 0.0 112.768 -178.69 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.582 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.1 mp -16.98 109.58 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.535 179.386 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.5 t -78.07 162.8 3.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.157 0.503 . . . . 0.0 111.758 -178.249 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 . . . . . 0 N--CA 1.434 -1.259 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.579 -178.303 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.53 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 9.4 mtm . . . . . 0 C--O 1.225 -0.194 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.82 HD11 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -107.56 125.43 63.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.301 -177.876 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.743 ' O ' ' N ' ' A' ' 38' ' ' GLY . 34.8 t -87.13 97.06 0.62 Allowed Pre-proline 0 C--O 1.222 -0.395 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.863 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.5 Cg_endo -41.9 -15.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.384 2.722 . . . . 0.0 114.244 -179.084 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.711 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 2.3 mm-40 -88.74 -64.38 1.15 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.697 0.284 . . . . 0.0 111.133 -178.787 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.458 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 4.1 p -90.84 -18.96 23.95 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.322 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.82 ' HA2' HD11 ' A' ' 33' ' ' ILE . . . 66.28 35.86 90.91 Favored Glycine 0 N--CA 1.431 -1.682 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.771 -179.374 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -72.97 144.45 47.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.621 -0.79 . . . . 0.0 109.49 179.378 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.9 t -112.53 116.0 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-O 121.027 0.441 . . . . 0.0 111.779 -178.001 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.506 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 97.0 t . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.788 177.96 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 45.4 t . . . . . 0 C--O 1.231 0.091 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.89 -22.32 68.02 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.177 1.918 . . . . 0.0 111.954 179.197 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.19 -9.09 10.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.345 179.995 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 38.5 m80 -129.89 89.1 46.96 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.736 0.303 . . . . 0.0 110.937 179.238 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.46 -37.23 90.71 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.241 1.961 . . . . 0.0 111.791 179.632 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.54 -32.96 36.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.548 -179.695 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -71.45 89.46 0.94 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.169 0.509 . . . . 0.0 111.004 -179.85 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.511 ' O ' ' C ' ' A' ' 23' ' ' LEU . 9.8 mm -70.64 78.95 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.958 -177.757 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.601 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 2.2 mp -26.93 107.23 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.173 0.511 . . . . 0.0 110.242 178.913 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -75.34 164.16 3.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.887 -178.283 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 N--CA 1.441 -0.889 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.633 -179.29 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.545 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 5.6 mtm . . . . . 0 N--CA 1.446 -0.643 0 CA-C-O 121.682 0.753 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.715 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -100.78 124.09 54.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.565 -176.588 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.74 ' O ' ' N ' ' A' ' 38' ' ' GLY . 47.2 t -85.73 97.85 0.64 Allowed Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.366 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 3.9 Cg_endo -45.61 -12.76 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.844 2.363 . . . . 0.0 113.628 -179.112 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.577 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 4.8 mm-40 -88.81 -63.98 1.21 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.66 0.266 . . . . 0.0 111.204 -179.413 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.449 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 4.7 p -91.45 -22.59 20.35 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.398 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.74 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 70.4 41.63 66.86 Favored Glycine 0 N--CA 1.43 -1.74 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.033 -179.964 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.635 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -81.91 152.97 26.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.65 -0.775 . . . . 0.0 109.992 179.819 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 32' ' ' MET . 66.1 t -117.1 116.63 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.701 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.511 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 95.5 t . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.767 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.909 0.385 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.7 m -99.44 38.17 1.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.959 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.34 -31.94 13.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.913 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.54 138.99 49.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.34 -71.14 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.78 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.4 mt -158.1 -71.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.718 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 52.8 25.85 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.123 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -100.82 143.38 31.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.032 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.48 163.94 16.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.749 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.56 -173.57 0.3 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.559 2.173 . . . . 0.0 112.207 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.33 139.21 37.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.525 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.4 p -47.33 96.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.182 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.5 p 55.46 -173.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.19 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.528 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 35.2 t -70.33 136.96 86.44 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.838 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.49 -20.98 70.74 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.116 1.877 . . . . 0.0 111.905 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -116.79 -11.14 10.95 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.176 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.724 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 33.8 m80 -131.07 87.33 48.75 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.858 0.361 . . . . 0.0 110.603 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.93 -34.75 95.07 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.305 2.003 . . . . 0.0 111.903 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -79.4 -26.81 41.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.215 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.43 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -82.86 95.86 8.06 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 122.603 1.192 . . . . 0.0 111.599 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.535 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.89 72.61 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 112.228 -2.26 . . . . 0.0 112.956 -178.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.603 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.9 mp -19.71 108.75 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.88 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -77.0 165.81 2.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.182 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -83.02 137.1 34.27 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.818 0.818 . . . . 0.0 110.105 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.571 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 0.1 OUTLIER 62.33 89.86 0.08 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 178.357 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.632 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 1.0 OUTLIER -61.56 98.62 0.09 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.652 177.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.499 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER 49.47 38.48 14.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.955 0.407 . . . . 0.0 110.044 -179.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.499 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 91.53 35.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.487 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -134.11 -124.67 2.5 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.761 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 27' ' ' TYR . 0.8 OUTLIER -95.03 -144.33 0.26 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.467 0.175 . . . . 0.0 111.139 -179.36 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.586 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 29.0 mtt -89.52 118.53 29.23 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 121.428 0.633 . . . . 0.0 111.57 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.813 HD12 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -105.03 123.52 59.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.988 -176.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.749 ' O ' ' N ' ' A' ' 38' ' ' GLY . 37.9 t -87.81 96.5 0.62 Allowed Pre-proline 0 N--CA 1.45 -0.461 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.462 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.5 Cg_endo -42.4 -14.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 123.304 2.669 . . . . 0.0 114.08 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.724 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 1.1 mm-40 -89.7 -63.75 1.24 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.576 0.227 . . . . 0.0 111.06 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.439 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 8.4 p -90.54 -20.44 22.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.813 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 68.39 33.76 78.14 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.314 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -74.33 143.89 44.73 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 32' ' ' MET . 32.9 t -109.68 111.36 35.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.862 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -111.3 134.78 52.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.606 0.241 . . . . 0.0 110.431 179.274 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.84 160.21 10.81 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.55 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -173.85 110.31 0.16 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.624 -0.288 . . . . 0.0 110.269 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? 60.91 92.35 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.853 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.422 ' O ' ' CG1' ' A' ' 46' ' ' ILE . 19.6 t -103.46 -28.52 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.127 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.422 ' CG1' ' O ' ' A' ' 45' ' ' VAL . 39.4 pt 44.03 29.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.743 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 t0 54.08 101.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.178 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.18 -172.67 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.04 -95.9 2.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.534 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.9 t 60.36 98.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.774 0.321 . . . . 0.0 110.941 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.48 16.79 2.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.251 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 8.3 m0 61.88 -81.48 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.021 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 57.06 70.8 0.62 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.954 0.407 . . . . 0.0 110.991 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.68 -170.47 3.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -121.62 125.03 45.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.887 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.7 m 63.54 139.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.954 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -119.39 165.15 14.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.23 -45.42 2.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.805 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.879 -179.944 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.746 0.308 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.99 -33.73 21.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.847 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.9 p -65.57 -42.29 91.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.2 174.08 6.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -87.43 -74.57 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.019 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.6 mt -177.09 161.45 1.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.831 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -88.78 112.48 23.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.77 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -158.89 105.91 1.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.265 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.418 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 1.4 mt -175.51 -61.95 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.795 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.418 ' HD3' ' CB ' ' A' ' 10' ' ' LEU . 95.7 Cg_endo -79.39 165.29 23.36 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.437 2.091 . . . . 0.0 112.139 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.83 143.55 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.964 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.4 t -99.2 30.18 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.44 169.11 17.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.825 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.504 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 16.7 t -78.23 134.91 62.42 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.897 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.06 -18.94 63.17 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.068 1.845 . . . . 0.0 112.03 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -117.53 -9.32 10.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.35 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.657 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 37.7 m80 -130.76 88.34 46.62 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-O 120.755 0.312 . . . . 0.0 110.437 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.67 -34.41 92.14 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.414 2.076 . . . . 0.0 112.03 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.25 -26.01 31.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.395 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.499 ' CB ' ' HB3' ' A' ' 18' ' ' HIS . . . -80.32 87.87 5.57 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.242 0.544 . . . . 0.0 111.255 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.535 ' O ' ' C ' ' A' ' 23' ' ' LEU . 13.6 mm -72.29 75.19 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.353 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.586 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 2.0 mp -20.5 107.47 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.556 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -74.94 167.95 2.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.181 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.26 138.56 32.87 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 122.051 0.929 . . . . 0.0 110.648 -178.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.565 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 0.1 OUTLIER 57.55 93.38 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.958 -1.473 . . . . 0.0 114.48 178.746 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.622 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -65.64 104.44 1.03 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 45.76 36.09 2.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.932 0.396 . . . . 0.0 110.193 -179.267 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 93.27 38.47 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.587 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -134.81 -126.49 2.63 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.617 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.45 ' O ' ' CA ' ' A' ' 26' ' ' ASP . 1.1 m-20 -94.98 -144.14 0.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.616 0.246 . . . . 0.0 110.981 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.534 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 8.2 mtt -86.23 116.9 24.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.403 0.62 . . . . 0.0 111.597 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.526 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -103.68 121.3 54.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.826 -177.127 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.762 ' O ' ' N ' ' A' ' 38' ' ' GLY . 49.7 t -86.57 97.02 0.57 Allowed Pre-proline 0 N--CA 1.446 -0.635 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.2 Cg_endo -41.77 -15.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.343 2.695 . . . . 0.0 113.853 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.657 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 10.5 mm-40 -86.29 -66.89 0.85 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.8 0.333 . . . . 0.0 110.807 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.455 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 2.9 p -90.7 -18.7 24.59 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.762 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.24 35.18 90.0 Favored Glycine 0 N--CA 1.433 -1.551 0 CA-C-N 114.119 -1.401 . . . . 0.0 111.627 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -74.27 148.44 41.46 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.894 -0.653 . . . . 0.0 109.638 179.38 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 32' ' ' MET . 48.5 t -112.29 113.75 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 120.887 0.375 . . . . 0.0 111.847 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.442 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 55.5 t -119.32 135.66 58.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.063 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.54 164.76 11.38 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.641 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -175.85 -82.34 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.722 0.296 . . . . 0.0 110.48 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 46.22 29.03 0.75 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.773 0.32 . . . . 0.0 111.394 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.4 m -116.2 -17.35 7.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.559 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.8 tt -54.02 98.19 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.879 0.371 . . . . 0.0 111.244 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 62.02 146.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.983 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.1 t -116.33 161.52 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.959 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -47.43 98.38 0.01 OUTLIER Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.636 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.47 61.2 2.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.921 0.391 . . . . 0.0 111.146 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.1 75.34 9.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.557 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 2.4 t90 76.16 -57.77 0.55 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.019 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.86 81.31 0.12 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.945 0.402 . . . . 0.0 110.813 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.5 m -144.28 111.68 6.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.847 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -107.41 104.43 14.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m 62.14 118.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.978 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -83.52 119.05 24.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -98.12 -68.32 0.81 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.975 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.798 0.333 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.1 m -102.45 73.88 1.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.936 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.41 -30.28 7.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.971 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.4 -175.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.989 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.4 mtp85 -104.25 -75.58 0.62 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 mp -113.1 112.93 24.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.055 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -113.92 63.25 0.66 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.724 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.96 58.9 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.335 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.703 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 3.0 pp -115.37 17.5 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.703 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 65.2 Cg_endo -83.35 -36.47 0.21 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 121.876 1.717 . . . . 0.0 112.646 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.17 26.18 10.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.619 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.4 ' CG2' ' HA ' ' A' ' 10' ' ' LEU . 63.8 t -92.7 144.55 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.739 0.304 . . . . 0.0 110.884 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.64 165.72 32.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.028 0.442 . . . . 0.0 111.094 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.468 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 14.5 t -72.49 135.99 81.27 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.91 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.87 -18.02 61.13 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.276 1.984 . . . . 0.0 112.304 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.07 -13.6 9.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.045 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.65 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.4 m80 -127.27 88.51 53.9 Favored Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.898 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.96 -40.12 55.16 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.417 2.078 . . . . 0.0 112.082 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -75.8 -35.4 60.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.346 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HB3' ' CG ' ' A' ' 36' ' ' GLU . . . -75.85 79.64 2.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.234 0.54 . . . . 0.0 110.974 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.581 ' O ' ' C ' ' A' ' 23' ' ' LEU . 12.3 mt -69.88 72.44 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.918 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.581 ' C ' ' O ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -7.61 110.77 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.73 179.163 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 32' ' ' MET . 14.2 t -83.3 155.86 3.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.514 0.673 . . . . 0.0 112.669 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.44 123.77 23.12 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.903 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.614 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 2.8 m-20 80.42 -151.55 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.499 -1.228 . . . . 0.0 113.213 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.511 ' CB ' HG21 ' A' ' 33' ' ' ILE . 3.2 t80 89.02 114.48 0.03 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.254 0.55 . . . . 0.0 110.379 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 27' ' ' TYR . 0.6 OUTLIER 70.95 -87.08 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.489 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.82 -82.5 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.767 0.318 . . . . 0.0 111.175 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.614 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -178.32 -38.65 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.797 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.549 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 2.7 p30 -74.86 -157.36 0.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.554 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 44.1 mtm -73.8 157.53 36.24 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.691 HD12 ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -141.7 130.9 23.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.494 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.791 ' O ' ' N ' ' A' ' 38' ' ' GLY . 18.0 t -88.97 97.58 0.93 Allowed Pre-proline 0 C--O 1.217 -0.637 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -44.27 -14.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.921 2.414 . . . . 0.0 113.417 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.65 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 8.2 mm-40 -86.72 -65.14 1.05 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.567 0.222 . . . . 0.0 110.784 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.45 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 2.5 p -91.8 -24.7 19.31 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.791 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 74.1 41.19 40.39 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 113.395 -1.73 . . . . 0.0 112.103 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.655 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 1.0 OUTLIER -79.14 146.5 33.13 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.928 -0.636 . . . . 0.0 109.534 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 32' ' ' MET . 95.9 t -111.94 122.75 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 O-C-N 123.532 0.52 . . . . 0.0 111.736 -177.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.549 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 22.4 t -130.66 127.67 62.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.797 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.501 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 119.95 -159.27 15.04 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.848 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.484 ' N ' ' HB3' ' A' ' 31' ' ' ASP . 5.1 t70 77.51 130.62 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.04 0.447 . . . . 0.0 111.129 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.87 -169.63 1.98 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.793 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 p -172.55 54.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.04 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.4 tt -112.35 -44.99 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.166 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.95 81.33 0.15 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.953 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.6 m -85.55 82.12 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.064 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.13 -98.65 0.25 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.449 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.4 t 60.73 31.32 20.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.792 0.33 . . . . 0.0 110.881 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -129.83 49.89 2.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.841 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.6 m0 62.53 -80.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.952 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.75 103.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 0.0 111.013 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.18 174.33 12.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.976 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -95.86 8.7 42.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.363 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 54.86 175.86 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.84 0.352 . . . . 0.0 111.089 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -121.12 -173.11 2.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -78.82 -57.85 3.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.819 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.902 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.724 0.297 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.8 m -89.79 53.23 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.909 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.9 40.45 3.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.85 123.13 41.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.65 -63.15 1.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.9 mt -175.23 77.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.93 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.29 120.75 24.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.783 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 60.66 -168.0 0.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.998 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.461 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . 6.2 mt -166.83 -64.86 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.461 ' CD ' ' CB ' ' A' ' 10' ' ' LEU . 19.1 Cg_endo -58.22 -168.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.511 2.141 . . . . 0.0 112.227 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.27 -177.59 4.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.798 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.4 p -132.26 23.46 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.33 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.87 170.08 14.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.972 0.415 . . . . 0.0 110.967 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 38.5 t -72.47 135.68 81.45 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.642 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.49 -20.35 65.87 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.349 2.033 . . . . 0.0 112.405 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -114.75 -12.02 12.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.241 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.717 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.9 m80 -130.46 87.95 48.72 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 120.688 0.28 . . . . 0.0 110.565 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.56 -36.75 92.01 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.328 2.018 . . . . 0.0 111.785 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.28 -33.09 55.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.233 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.436 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -76.19 88.11 3.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.098 0.475 . . . . 0.0 111.307 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.568 ' O ' ' C ' ' A' ' 23' ' ' LEU . 9.9 mt -74.49 71.22 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.807 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.596 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -12.33 107.35 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.666 0.604 . . . . 0.0 110.886 179.419 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -77.86 164.42 3.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.171 0.51 . . . . 0.0 111.406 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.46 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 4.0 mm-40 -78.18 127.7 32.66 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.746 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.642 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.8 OUTLIER 89.72 -165.56 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.615 179.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.799 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 16.1 t80 164.08 74.99 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 5.0 mmp_? 59.32 41.21 20.19 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -178.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 84.42 41.8 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.8 -178.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -127.42 -153.87 8.33 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.499 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.642 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -95.31 -124.21 0.11 Allowed 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 122.576 0.35 . . . . 0.0 111.614 -179.432 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.831 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 28.1 mtp -96.1 116.06 28.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 118.789 0.722 . . . . 0.0 112.194 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.808 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -101.49 123.41 54.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.762 -177.018 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.729 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.1 t -87.47 97.05 0.65 Allowed Pre-proline 0 N--CA 1.449 -0.495 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -40.78 -16.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.379 2.719 . . . . 0.0 114.149 -179.228 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.717 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 13.5 mm-40 -87.83 -64.81 1.09 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.634 0.254 . . . . 0.0 111.307 -178.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.471 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 5.7 p -90.37 -20.6 22.66 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.808 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.49 36.64 77.54 Favored Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 113.572 -1.649 . . . . 0.0 112.52 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -79.75 150.42 30.82 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.588 -0.806 . . . . 0.0 110.405 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.831 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.1 t -119.56 121.37 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-O 121.275 0.56 . . . . 0.0 112.429 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.593 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 87.3 t -125.71 132.04 71.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.01 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.55 166.05 11.41 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.543 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.15 -71.86 0.54 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.914 0.388 . . . . 0.0 110.578 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 169.68 -71.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.912 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 p -120.52 116.32 49.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.244 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 47' ' ' ASP . 0.3 OUTLIER -73.12 -157.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.391 179.612 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.451 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 11.1 m-20 -46.35 -53.91 9.99 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 120.745 0.307 . . . . 0.0 111.217 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.1 p 43.62 33.26 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.69 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -120.6 159.23 15.4 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.538 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 63.04 -159.79 0.31 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.656 0.265 . . . . 0.0 110.771 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.27 -77.37 0.05 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.098 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -165.34 -58.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.996 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.71 36.59 8.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.76 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.55 161.29 19.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -124.75 38.38 4.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.013 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 m 60.26 172.92 0.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -96.43 168.67 10.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -74.81 -64.9 0.94 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.897 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.771 0.32 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 m -98.59 30.18 3.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.95 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.4 p -121.42 -42.89 2.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -94.32 -175.49 3.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.939 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.8 mtp85 -128.54 -69.02 0.73 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.822 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.9 mp -142.66 -179.55 6.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -142.16 30.05 1.61 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.914 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.95 135.68 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.553 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -133.85 -61.22 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.359 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.553 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 52.4 Cg_endo -68.43 64.42 1.14 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.031 1.821 . . . . 0.0 112.515 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.424 ' O ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -85.13 110.26 18.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.552 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.424 HG11 ' O ' ' A' ' 12' ' ' ARG . 0.4 OUTLIER 75.52 164.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.623 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.3 p -90.07 -145.64 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.541 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.472 ' HB2' HD12 ' A' ' 23' ' ' LEU . 15.0 t -71.63 136.07 83.43 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.421 0.153 . . . . 0.0 110.778 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.1 -25.37 79.66 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.286 1.991 . . . . 0.0 111.961 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -108.48 -30.29 8.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.675 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.685 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 38.3 m80 -113.32 81.64 5.24 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.436 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.11 -33.48 97.44 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.03 1.82 . . . . 0.0 110.935 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -73.01 -42.39 63.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.285 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.481 ' HB1' ' HB3' ' A' ' 18' ' ' HIS . . . -74.97 87.52 2.33 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.11 0.481 . . . . 0.0 110.979 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.547 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.3 mp -68.93 74.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.713 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.65 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -14.64 112.7 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.37 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.1 t -81.18 163.24 3.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.254 0.55 . . . . 0.0 111.222 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -78.67 133.42 37.22 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.852 -178.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.658 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER 81.99 -157.94 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.056 178.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.58 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 45.9 t80 129.06 -84.48 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.908 0.883 . . . . 0.0 110.751 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.433 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -102.94 -62.36 1.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.371 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -106.95 28.72 7.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.811 0.339 . . . . 0.0 111.773 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.465 ' HA2' ' CG ' ' A' ' 26' ' ' ASP . . . 69.23 21.96 75.96 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.092 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.658 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -103.66 -161.77 0.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.794 0.33 . . . . 0.0 110.666 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.501 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 35.3 mtp -91.29 119.23 31.17 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-O 121.662 0.744 . . . . 0.0 112.39 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.807 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -104.17 126.08 58.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.89 -177.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.752 ' O ' ' N ' ' A' ' 38' ' ' GLY . 42.1 t -91.16 98.82 1.83 Allowed Pre-proline 0 C--O 1.219 -0.545 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.3 Cg_endo -43.44 -14.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.216 2.611 . . . . 0.0 113.881 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.685 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 2.9 mm-40 -87.92 -64.69 1.11 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.759 0.314 . . . . 0.0 111.08 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.443 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 3.3 p -91.19 -21.3 21.2 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.807 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.67 38.76 77.95 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 113.645 -1.616 . . . . 0.0 111.739 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -80.03 144.06 33.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.7 -0.75 . . . . 0.0 110.726 -179.48 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 32' ' ' MET . 47.4 t -104.89 112.84 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.016 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.44 HG23 ' CD1' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -109.02 133.46 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.901 0.382 . . . . 0.0 110.868 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.91 155.48 18.74 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.415 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 176.45 -172.75 0.09 Allowed 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.8 mtt85 54.06 104.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.267 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -93.75 168.83 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.094 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.5 pt -121.17 146.55 25.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.185 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.48 ' O ' HG12 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -118.02 27.84 8.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.93 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 47' ' ' ASP . 0.3 OUTLIER 49.62 179.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.692 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -131.06 61.75 0.66 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.437 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.9 t 61.32 65.56 0.96 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.79 0.328 . . . . 0.0 110.861 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -88.03 5.64 39.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.376 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 40.4 m95 61.75 -82.3 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.986 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 55.26 97.32 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.062 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.9 m -140.99 138.36 33.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 19.0 p90 -62.93 82.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.8 m 59.49 161.84 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -106.65 132.25 52.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.73 -40.42 8.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.908 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.802 0.334 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.3 m -98.82 31.58 2.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.893 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.7 p -158.75 35.88 0.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.73 -176.3 4.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.001 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.4 mtp85 -93.12 -161.85 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.654 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.6 mp -47.28 120.02 2.95 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.832 0.349 . . . . 0.0 111.139 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.16 -33.52 15.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.39 10.49 29.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.51 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mp 58.77 162.34 0.09 OUTLIER Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.729 0.299 . . . . 0.0 110.977 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.94 86.7 1.22 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.544 2.163 . . . . 0.0 112.098 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.3 mtm105 60.65 -176.58 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.612 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.0 m -104.7 -48.85 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.255 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.506 ' CG2' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -95.51 -153.31 0.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.717 0.294 . . . . 0.0 110.654 -179.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.622 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 47.4 t -70.05 142.23 90.13 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.442 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.446 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 14.3 Cg_endo -56.12 -28.33 69.67 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.468 2.112 . . . . 0.0 111.865 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.41 -6.19 10.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.602 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.637 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 39.4 m80 -128.62 88.63 51.65 Favored Pre-proline 0 C--O 1.231 0.121 0 CA-C-O 120.668 0.27 . . . . 0.0 111.265 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -61.58 -32.82 87.83 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.3 2.0 . . . . 0.0 112.008 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.53 -19.41 29.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.423 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -85.3 83.33 8.01 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.198 0.523 . . . . 0.0 110.834 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.506 ' HA ' ' CG2' ' A' ' 14' ' ' THR . 5.4 mm -63.44 83.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.019 -1.446 . . . . 0.0 113.869 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.604 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.9 mp -34.02 111.87 0.12 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 32' ' ' MET . 2.8 t -73.5 163.33 4.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 121.344 0.592 . . . . 0.0 110.953 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.577 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -89.18 89.33 7.89 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.873 -178.622 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 25' ' ' GLU . 7.6 m-20 111.65 99.67 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 O-C-N 124.529 1.143 . . . . 0.0 113.676 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.534 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -72.2 105.81 4.15 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.424 178.277 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 47.74 34.89 4.08 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.011 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 90.93 40.17 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.189 -178.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.8 -120.18 2.06 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.913 -0.661 . . . . 0.0 113.014 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -100.32 -153.58 0.45 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.643 0.259 . . . . 0.0 111.088 -179.203 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.58 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER -75.82 111.43 11.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.252 0.549 . . . . 0.0 111.827 -178.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -102.76 119.18 50.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.723 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.756 ' O ' ' N ' ' A' ' 38' ' ' GLY . 35.9 t -85.79 97.14 0.53 Allowed Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 5.0 Cg_endo -44.97 -11.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.011 2.474 . . . . 0.0 113.951 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.637 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 5.5 mm-40 -89.93 -63.56 1.26 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 121.115 -0.234 . . . . 0.0 110.725 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.447 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 2.7 p -91.95 -20.25 21.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 176.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.756 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.49 40.11 91.12 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 114.068 -1.424 . . . . 0.0 111.208 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.658 ' CD1' HG23 ' A' ' 41' ' ' VAL . 1.4 pp -79.12 149.73 31.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.378 -0.911 . . . . 0.0 109.758 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 32' ' ' MET . 44.8 t -115.08 110.46 32.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.658 HG23 ' CD1' ' A' ' 39' ' ' LEU . 22.9 t -106.08 138.34 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.917 0.389 . . . . 0.0 111.393 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.27 93.89 2.19 Favored Glycine 0 CA--C 1.497 -1.076 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.484 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -123.89 106.95 10.86 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.87 147.9 17.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.923 0.392 . . . . 0.0 110.847 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.7 p -179.65 42.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.946 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.9 mt -88.97 -75.34 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.257 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 p30 173.08 138.69 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.843 0.354 . . . . 0.0 110.822 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.6 p -153.85 142.02 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.041 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.59 61.3 0.59 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.395 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.3 t -86.33 93.55 9.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.835 0.35 . . . . 0.0 110.945 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.69 -77.24 0.56 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 171.6 -77.43 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.802 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 59.48 108.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.968 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.3 -175.32 2.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.826 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -131.54 -44.55 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.961 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m 64.81 166.28 0.16 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.913 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -110.23 -71.74 0.75 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.921 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -177.45 -69.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.914 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.153 -0.927 . . . . 0.0 111.025 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.822 0.344 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.0 m -98.9 31.61 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.22 -33.66 13.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.7 t -65.75 145.12 56.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 -69.19 -48.12 63.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.49 166.27 25.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.876 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.62 -60.91 1.82 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.012 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -173.24 38.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.809 0.337 . . . . 0.0 111.425 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.429 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER 62.5 167.08 0.1 Allowed Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.134 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 12' ' ' ARG . 16.8 Cg_endo -57.6 -157.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.809 2.34 . . . . 0.0 111.99 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.533 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -45.96 -101.18 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.156 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.533 ' HB ' ' O ' ' A' ' 12' ' ' ARG . 14.4 p 172.03 21.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 p -164.95 170.0 15.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.098 0.475 . . . . 0.0 111.502 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.609 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 53.2 t -64.96 137.38 97.13 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.192 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.54 -30.55 71.22 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.447 2.098 . . . . 0.0 111.848 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -96.69 -14.58 21.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.895 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.609 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 37.8 m80 -130.69 86.65 52.07 Favored Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.028 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.59 -47.92 6.55 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.21 1.94 . . . . 0.0 111.912 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.91 -10.13 59.17 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.205 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.508 ' CB ' ' HG3' ' A' ' 36' ' ' GLU . . . -103.44 106.02 16.43 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.458 0.647 . . . . 0.0 111.166 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.9 mt -82.79 126.05 40.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.548 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.595 ' HB3' ' HB3' ' A' ' 32' ' ' MET . 2.8 mp -63.78 130.91 46.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.28 0.562 . . . . 0.0 109.503 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 32' ' ' MET . 11.9 t -88.24 157.65 3.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.833 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.558 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 8.1 mm-40 -76.2 111.31 11.48 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.758 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.613 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 17.9 m-20 108.39 179.29 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.966 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.691 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 8.2 t80 179.67 84.15 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.858 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.451 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 7.2 mtt85 52.52 35.58 18.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 85.99 47.14 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.782 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.39 -141.23 4.52 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.404 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.613 ' O ' ' CA ' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -91.91 -126.75 0.09 Allowed 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 122.512 0.325 . . . . 0.0 110.952 -179.388 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.599 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 4.9 mtp -102.54 120.64 40.88 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 121.03 0.443 . . . . 0.0 110.499 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.767 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -99.71 124.62 53.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -176.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.751 ' O ' ' N ' ' A' ' 38' ' ' GLY . 43.4 t -87.51 103.23 4.29 Favored Pre-proline 0 C--O 1.222 -0.344 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.8 Cg_endo -41.1 -21.06 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.304 2.67 . . . . 0.0 114.056 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.543 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 4.5 mm-40 -85.4 -66.16 0.93 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.886 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.424 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 3.1 p -89.87 -18.94 25.23 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.767 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 67.43 30.84 75.6 Favored Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.074 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -71.17 149.75 46.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.349 -0.926 . . . . 0.0 110.895 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 32' ' ' MET . 24.1 t -113.31 126.74 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.687 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.481 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 92.2 t -135.63 128.33 47.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.41 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 133.89 -163.83 24.47 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.968 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.8 OUTLIER 92.83 57.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.591 -179.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -100.18 138.05 37.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.198 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -179.76 -77.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.975 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 39.15 -87.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.063 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 45' ' ' VAL . 0.4 OUTLIER -133.26 109.11 9.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.769 0.318 . . . . 0.0 110.887 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.5 t -105.86 145.38 13.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.035 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.84 166.74 3.57 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.641 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 t -101.05 42.12 1.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 111.003 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 12.0 mt-10 -83.68 -11.17 57.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.331 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.469 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 6.4 m0 70.73 -0.06 3.12 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 45.64 99.37 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.876 0.369 . . . . 0.0 111.851 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.9 158.64 16.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.821 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -143.98 89.33 2.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.926 0.393 . . . . 0.0 111.064 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 m 60.82 177.48 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.953 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -167.13 175.32 7.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.869 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -106.66 -32.08 8.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.878 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.822 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 120.818 0.342 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.04 -36.58 3.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.04 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.81 -34.91 65.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.057 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.7 t -78.86 157.9 28.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.809 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -83.51 -70.07 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.819 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.417 ' N ' HD13 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -165.91 -96.53 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.878 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.5 t0 44.91 52.36 8.16 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.81 0.338 . . . . 0.0 111.439 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.4 141.27 27.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.3 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.408 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 9.2 mt -91.69 163.34 28.46 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.783 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 10' ' ' LEU . 6.3 Cg_endo -48.37 -64.68 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.721 2.281 . . . . 0.0 112.179 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -155.31 -167.78 2.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.932 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -92.16 53.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.649 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.3 p -155.26 162.84 40.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.958 0.409 . . . . 0.0 111.206 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 44.7 t -73.66 136.36 77.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.898 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.14 -21.26 62.88 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.516 2.144 . . . . 0.0 112.356 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -112.05 -13.1 13.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.183 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.698 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.5 m80 -131.36 88.02 45.34 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.728 0.299 . . . . 0.0 110.622 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.0 -34.14 99.05 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.366 2.044 . . . . 0.0 111.709 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.37 -28.12 34.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.396 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.466 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -81.5 87.2 6.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.187 0.518 . . . . 0.0 111.15 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.582 ' O ' ' C ' ' A' ' 23' ' ' LEU . 2.8 mm -74.63 70.56 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.779 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.582 ' C ' ' O ' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -9.86 111.13 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.666 0.604 . . . . 0.0 110.657 179.349 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 32' ' ' MET . 7.3 t -81.9 158.78 3.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.514 0.673 . . . . 0.0 112.394 -177.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -83.52 124.87 31.17 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.256 -178.71 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 31' ' ' ASP . 2.5 m-20 50.55 111.78 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.396 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 173.07 139.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.211 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.406 ' CB ' HD11 ' A' ' 33' ' ' ILE . 0.2 OUTLIER 51.97 26.17 3.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.461 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 174.46 -74.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.477 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.03 -36.14 0.37 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.807 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.617 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . 1.8 p30 -89.92 -127.39 0.07 Allowed 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 88.6 mtp -106.51 125.0 50.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 118.248 0.477 . . . . 0.0 111.842 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.75 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -115.35 136.84 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.508 0.67 . . . . 0.0 111.956 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.858 ' O ' ' N ' ' A' ' 38' ' ' GLY . 38.5 t -87.63 96.71 0.62 Allowed Pre-proline 0 N--CA 1.439 -1.024 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.435 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.8 Cg_endo -39.3 -19.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.551 2.834 . . . . 0.0 113.836 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.698 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 2.4 mm-40 -85.94 -66.18 0.93 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.72 0.295 . . . . 0.0 110.655 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.436 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 3.0 p -89.59 -17.93 27.54 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.858 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 65.63 31.28 79.53 Favored Glycine 0 N--CA 1.435 -1.424 0 CA-C-N 113.986 -1.461 . . . . 0.0 111.562 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.75 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 1.3 pp -65.25 136.65 56.87 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.498 HG12 ' OD2' ' A' ' 31' ' ' ASP . 77.3 t -107.0 114.85 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 O-C-N 123.358 0.411 . . . . 0.0 111.027 -178.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.543 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 95.8 t -128.47 135.63 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.659 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.617 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 123.74 -161.69 18.0 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.567 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -40.4 105.58 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.989 0.423 . . . . 0.0 111.75 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -30.14 59.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.018 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.55 -130.16 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.51 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.1 tp -177.17 138.58 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.154 0 O-C-N 122.184 -0.322 . . . . 0.0 111.132 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -170.56 93.37 0.2 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.923 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.7 t -119.76 -58.99 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.111 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.52 53.45 0.61 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.548 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.6 t -78.88 -27.99 44.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.72 0.295 . . . . 0.0 110.995 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -57.67 103.29 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.029 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 62.08 -83.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.781 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.1 67.11 0.67 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.877 0.37 . . . . 0.0 111.358 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.64 -167.43 1.77 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.001 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -100.0 62.23 1.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.3 m 61.66 168.19 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -71.78 136.98 47.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -110.6 -61.22 1.71 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.78 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.842 0.353 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.2 m -120.16 121.14 38.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.874 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.9 m -120.02 94.79 4.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -164.12 -60.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.85 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? 63.57 -79.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.889 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.37 -77.5 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.81 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 56.94 87.52 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.024 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.5 132.4 0.28 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.149 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.469 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . 1.2 mp -153.77 -66.92 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.966 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.469 ' CD ' ' CB ' ' A' ' 10' ' ' LEU . 73.7 Cg_endo -76.62 -168.26 0.55 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.291 1.994 . . . . 0.0 112.284 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -90.76 -56.64 3.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.811 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 p -169.7 -50.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.943 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.4 p -116.4 -139.35 0.37 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.279 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.544 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 49.3 t -73.4 137.9 78.07 Favored Pre-proline 0 C--O 1.232 0.172 0 O-C-N 122.402 -0.186 . . . . 0.0 110.571 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.85 -21.85 71.94 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.182 1.921 . . . . 0.0 111.989 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -119.73 -7.56 10.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.384 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.647 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 37.6 m80 -131.18 86.75 50.09 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-O 120.624 0.249 . . . . 0.0 111.11 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.15 -33.63 90.5 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.416 2.077 . . . . 0.0 112.011 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -83.3 -24.94 31.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.161 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 18' ' ' HIS . . . -82.39 81.93 8.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.336 0.589 . . . . 0.0 110.638 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.51 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -66.68 78.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.47 -1.241 . . . . 0.0 113.395 -178.054 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.59 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.7 mp -22.43 106.95 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.712 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.4 t -75.24 167.93 2.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.192 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -82.96 141.18 32.32 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-O 121.922 0.867 . . . . 0.0 110.602 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 0.1 OUTLIER 55.42 94.49 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.06 -1.427 . . . . 0.0 114.675 178.67 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.548 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -68.82 111.05 4.66 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.492 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 43.51 33.59 0.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.903 0.382 . . . . 0.0 110.168 -179.438 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 92.17 41.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.519 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -136.18 -123.21 2.25 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.792 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 1.6 m-20 -97.14 -145.04 0.3 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.475 0.178 . . . . 0.0 111.065 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.557 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 53.5 mtp -85.83 116.85 24.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.364 0.602 . . . . 0.0 111.882 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.809 HD12 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -103.61 123.22 57.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.056 -176.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.75 ' O ' ' N ' ' A' ' 38' ' ' GLY . 44.5 t -86.24 96.77 0.52 Allowed Pre-proline 0 N--CA 1.448 -0.529 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.2 Cg_endo -43.2 -14.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 123.232 2.622 . . . . 0.0 113.935 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.647 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 8.7 mm-40 -88.89 -64.28 1.17 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.632 0.253 . . . . 0.0 110.952 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.456 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 4.6 p -91.16 -19.52 22.99 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.809 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 67.5 37.46 89.87 Favored Glycine 0 N--CA 1.432 -1.567 0 CA-C-N 113.822 -1.535 . . . . 0.0 111.986 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.635 ' CD1' HG23 ' A' ' 41' ' ' VAL . 1.2 pp -76.91 148.66 36.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.569 -0.816 . . . . 0.0 110.053 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 32' ' ' MET . 34.8 t -113.74 113.33 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.635 HG23 ' CD1' ' A' ' 39' ' ' LEU . 42.1 t -109.88 133.06 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.497 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.36 159.03 10.7 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.871 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 45' ' ' VAL . 2.9 m-20 173.02 -89.08 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.538 ' O ' ' CG2' ' A' ' 45' ' ' VAL . 0.1 OUTLIER 58.94 -73.8 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 112.035 0.384 . . . . 0.0 112.035 178.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.538 ' CG2' ' O ' ' A' ' 44' ' ' ARG . 1.2 m 87.66 -9.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.497 0.719 . . . . 0.0 111.123 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.6 mt -131.96 112.59 20.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.743 0.306 . . . . 0.0 110.609 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.06 -79.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.323 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 m -112.81 113.86 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.091 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.84 -32.41 2.46 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.432 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.9 t -65.02 144.97 56.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.755 0.312 . . . . 0.0 110.906 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 58.71 -169.08 0.13 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.742 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -78.06 -91.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.82 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.19 138.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.915 0.388 . . . . 0.0 111.134 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -137.88 162.64 33.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.769 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.4 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 13.2 p90 -100.68 86.96 3.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.901 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m 60.87 91.73 0.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.89 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -68.0 168.22 12.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.0 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.6 -47.18 0.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.869 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.812 0.339 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.65 31.71 3.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.94 -35.18 9.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.886 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.05 96.5 5.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.813 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -59.4 -38.36 80.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.822 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.5 mp -90.65 141.79 28.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.752 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.2 -56.63 0.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.06 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -153.67 178.12 10.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.903 0.383 . . . . 0.0 111.483 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.646 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER 168.7 -44.5 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.398 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 10' ' ' LEU . 18.9 Cg_endo -57.94 -158.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.924 1.749 . . . . 0.0 112.224 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 11' ' ' PRO . 7.6 tpp180 83.95 21.41 0.15 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.011 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.2 t -88.11 -17.64 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.834 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 58.79 176.93 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.807 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 48.0 t -77.01 137.31 65.64 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.726 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.46 -23.2 71.23 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.403 2.069 . . . . 0.0 112.444 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -117.68 -7.28 11.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.506 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.692 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.0 m80 -130.3 83.28 63.27 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.666 0.27 . . . . 0.0 111.049 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.3 -36.47 87.55 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.323 2.015 . . . . 0.0 111.769 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.77 -34.96 62.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.043 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.492 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -76.81 85.43 3.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.016 0.436 . . . . 0.0 110.968 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' C ' ' A' ' 23' ' ' LEU . 8.9 mm -69.96 74.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.295 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.561 ' C ' ' O ' ' A' ' 22' ' ' ILE . 1.3 mp -12.86 114.2 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.596 0.56 . . . . 0.0 110.893 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 32' ' ' MET . 5.9 t -83.53 157.49 3.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.387 0.613 . . . . 0.0 111.957 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.6 136.44 42.03 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.826 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.529 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 0.9 OUTLIER 59.28 89.44 0.06 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.843 -1.526 . . . . 0.0 114.257 178.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.634 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 3.2 t80 -55.69 84.14 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.42 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.505 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 53.7 42.48 31.81 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.354 -0.539 . . . . 0.0 109.698 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 93.65 33.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.338 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.529 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -132.83 -129.8 3.03 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.426 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.9 OUTLIER -96.68 -139.32 0.27 Allowed 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.528 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -95.8 114.17 25.88 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.086 -0.384 . . . . 0.0 110.87 -179.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.715 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 5.8 tp -104.13 132.72 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.767 ' O ' ' N ' ' A' ' 38' ' ' GLY . 41.7 t -90.86 96.3 0.95 Allowed Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 176.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 5.1 Cg_endo -44.56 -10.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.102 2.534 . . . . 0.0 113.878 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.692 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 3.5 mm-40 -88.21 -64.0 1.21 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.46 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 6.0 p -91.32 -23.07 20.23 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.767 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 71.82 46.83 35.7 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.341 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.715 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.6 OUTLIER -86.68 139.42 30.78 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.053 -1.074 . . . . 0.0 109.607 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 32' ' ' MET . 18.6 t -108.41 119.72 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 O-C-N 123.679 0.612 . . . . 0.0 111.476 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.495 HG21 ' CD1' ' A' ' 39' ' ' LEU . 0.8 OUTLIER -119.47 133.14 67.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.57 179.038 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.98 159.55 10.93 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.472 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -174.21 105.16 0.11 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.792 0.33 . . . . 0.0 110.244 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.3 125.75 6.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.042 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.3 p -117.09 -39.24 2.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.107 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.6 tp -80.27 111.99 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.106 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.61 -165.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.815 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.86 113.35 42.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.138 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -162.14 28.81 0.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.46 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.6 p -89.2 -31.02 18.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.75 0.309 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -120.51 74.17 1.04 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.811 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.5 m0 63.36 -79.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.061 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? 59.93 69.22 0.72 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.883 0.373 . . . . 0.0 110.796 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.89 167.19 17.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -103.0 64.56 0.85 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.7 m 59.69 177.94 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -113.53 153.3 28.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.032 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -85.15 -44.1 13.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.746 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.846 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.924 0.392 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.5 m -93.82 -21.52 19.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.128 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -53.58 -62.57 1.57 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.123 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 t -63.78 -172.66 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.831 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -68.92 0.29 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 mp -109.68 -177.57 3.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.999 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -89.66 -67.08 0.86 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.94 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.43 142.85 34.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.194 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.478 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . 7.6 mt -102.92 -67.29 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.532 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 10' ' ' LEU . 42.0 Cg_endo -68.02 136.21 37.32 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.312 2.008 . . . . 0.0 112.549 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.7 -167.19 1.19 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.549 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 m -113.71 97.11 5.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.883 0.373 . . . . 0.0 111.459 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.5 p 57.45 -177.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.479 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 35.8 t -70.4 137.57 86.35 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.008 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.92 -19.27 66.46 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.297 1.998 . . . . 0.0 111.818 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.21 -13.0 12.4 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.011 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.688 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.5 m80 -130.79 87.63 48.76 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.284 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.96 -35.0 94.8 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.453 2.102 . . . . 0.0 111.927 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.38 -28.79 41.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.048 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.449 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -79.85 88.21 5.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.066 0.46 . . . . 0.0 111.2 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.551 ' O ' ' C ' ' A' ' 23' ' ' LEU . 17.7 mt -74.7 72.25 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.793 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.617 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 0.9 OUTLIER -14.08 103.02 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.034 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.1 t -75.19 166.27 2.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.652 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.535 ' O ' ' O ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -85.72 124.5 32.3 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.965 -179.172 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.535 ' O ' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER 46.95 127.32 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.437 -1.256 . . . . 0.0 113.158 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.469 ' HB2' HG21 ' A' ' 33' ' ' ILE . 0.5 OUTLIER 178.09 -51.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.204 178.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.407 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -87.4 -54.94 4.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.716 0.293 . . . . 0.0 111.008 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.2 14.21 5.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.369 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.19 -19.47 53.99 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.973 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.478 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -90.2 -142.07 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.515 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.1 mtp -92.35 110.42 21.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.961 0.41 . . . . 0.0 110.398 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.695 HD12 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -99.95 124.78 53.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.158 -177.573 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.77 ' O ' ' N ' ' A' ' 38' ' ' GLY . 32.1 t -87.53 97.2 0.69 Allowed Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.3 Cg_endo -40.3 -17.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.548 2.832 . . . . 0.0 113.913 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.688 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 8.4 mm-40 -87.28 -65.88 0.97 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.591 0.234 . . . . 0.0 110.877 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.447 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 3.6 p -90.07 -18.6 25.62 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.77 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.93 33.39 83.8 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 114.084 -1.416 . . . . 0.0 111.769 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -72.61 145.58 47.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.916 -0.642 . . . . 0.0 109.592 179.105 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 32' ' ' MET . 2.4 t -115.08 117.61 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 120.983 0.42 . . . . 0.0 111.586 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.482 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 86.3 t -117.12 137.34 51.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.408 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.79 159.45 11.09 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.486 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.432 ' C ' ' HG2' ' A' ' 44' ' ' ARG . 8.0 t0 -178.94 31.37 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.576 -0.312 . . . . 0.0 110.426 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.432 ' HG2' ' C ' ' A' ' 43' ' ' ASP . 0.0 OUTLIER 41.42 -169.93 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.559 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.0 t -82.41 -24.86 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.922 0.391 . . . . 0.0 110.75 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -176.69 -177.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.32 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -55.91 89.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.819 0.342 . . . . 0.0 110.812 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.0 t -124.44 161.05 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.042 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.31 74.43 0.17 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.433 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -103.16 179.94 4.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.403 . . . . 0.0 110.96 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -177.39 -70.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.683 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 11.5 t90 64.08 -77.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.054 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.1 ttm-85 45.84 93.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.862 0.363 . . . . 0.0 111.39 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.2 p -68.36 158.92 32.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.801 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -127.27 3.97 6.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.537 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.4 m 55.21 -177.95 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.858 0.361 . . . . 0.0 111.02 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -139.5 -167.2 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.956 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -58.32 -57.26 13.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.967 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.86 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.739 0.304 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -95.21 53.19 1.5 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.904 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.21 31.15 3.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.687 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.6 83.8 2.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.881 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -88.2 -176.17 5.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.3 mt -51.2 94.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.134 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 -70.27 -30.41 67.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.49 128.86 47.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.12 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.89 -55.55 0.42 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.012 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -78.35 -160.09 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.46 2.106 . . . . 0.0 112.107 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.49 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -87.27 24.03 1.7 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.139 179.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.49 ' CG2' ' O ' ' A' ' 12' ' ' ARG . 16.9 m 51.48 8.84 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 176.85 -173.78 0.11 Allowed 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.016 0.436 . . . . 0.0 110.908 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 40.1 t -70.37 136.79 86.37 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.904 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.94 -20.59 70.01 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.3 2.0 . . . . 0.0 111.976 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -116.5 -11.91 11.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.199 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.656 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.2 m80 -130.04 88.57 48.09 Favored Pre-proline 0 C--N 1.333 -0.142 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.803 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.74 -37.16 88.9 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.474 2.116 . . . . 0.0 111.922 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -78.57 -32.82 47.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.417 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.533 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . . . -75.42 84.77 2.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.238 0.542 . . . . 0.0 110.891 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.555 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.2 mp -70.61 73.67 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.177 -178.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.555 ' C ' ' O ' ' A' ' 22' ' ' ILE . 1.9 mp -15.49 118.95 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.524 0.515 . . . . 0.0 110.508 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 32' ' ' MET . 22.6 t -86.57 151.15 3.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.638 0.732 . . . . 0.0 112.469 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.49 ' O ' ' O ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -71.13 130.12 40.68 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.935 -179.365 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 25' ' ' GLU . 1.8 t70 45.68 111.21 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.558 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.484 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.5 OUTLIER -166.9 166.99 15.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.493 179.361 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 50.25 32.67 6.39 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.07 35.04 16.1 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.237 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -147.11 -155.81 6.7 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.101 -1.047 . . . . 0.0 114.937 -178.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 7.9 m-20 -78.27 -115.93 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.896 0.878 . . . . 0.0 112.357 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.573 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 22.8 mtm -95.47 113.77 25.46 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.66 0.743 . . . . 0.0 111.389 -178.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.772 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -102.15 128.4 54.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.996 -177.59 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.784 ' O ' ' N ' ' A' ' 38' ' ' GLY . 41.5 t -85.68 98.67 0.76 Allowed Pre-proline 0 N--CA 1.445 -0.717 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 1.2 Cg_endo -42.68 -16.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.16 2.573 . . . . 0.0 113.699 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.656 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 14.4 mm-40 -89.2 -63.92 1.22 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.504 0.193 . . . . 0.0 111.076 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.444 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 6.0 p -90.74 -21.46 21.56 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.784 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 70.12 38.18 72.93 Favored Glycine 0 N--CA 1.432 -1.606 0 CA-C-N 113.546 -1.661 . . . . 0.0 112.449 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.772 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -78.08 146.02 35.47 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.753 -0.724 . . . . 0.0 110.021 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 32' ' ' MET . 23.0 t -110.81 117.7 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 O-C-N 123.43 0.456 . . . . 0.0 111.705 -178.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.485 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 63.2 t -125.23 138.1 55.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.869 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.34 160.56 10.09 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.754 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 t0 177.39 99.32 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.574 -0.313 . . . . 0.0 110.186 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.26 121.76 26.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.935 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.2 m -146.48 115.92 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.142 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.6 tt -132.79 -45.56 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.124 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -177.19 77.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.812 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.6 p -106.76 157.8 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.099 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.15 -60.87 0.45 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.377 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.25 89.71 1.57 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.81 0.338 . . . . 0.0 110.856 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -114.2 22.36 13.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.285 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.418 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 3.4 m0 57.63 -167.95 0.13 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.977 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.418 ' CB ' ' O ' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 82.08 115.54 0.06 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.959 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.65 -163.06 1.38 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.638 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -96.5 36.28 1.39 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.975 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 m 62.74 147.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.899 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -76.54 160.17 29.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -112.53 -36.63 5.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.873 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.817 0.342 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.4 m -79.64 -31.87 41.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 p -68.9 79.58 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.1 t -177.19 42.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.73 -79.79 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 176.89 141.03 0.07 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.785 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -130.29 31.36 4.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.834 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.25 137.66 45.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.188 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.433 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -157.09 -64.81 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 10' ' ' LEU . 32.0 Cg_endo -63.42 154.75 66.45 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.336 2.024 . . . . 0.0 112.263 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.05 -42.81 91.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.8 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.2 t 66.54 103.34 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.647 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.413 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 0.2 OUTLIER 66.14 169.84 0.23 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.456 179.467 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.46 ' HB2' HD12 ' A' ' 23' ' ' LEU . 7.7 t -70.31 136.26 86.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.227 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -66.86 -20.91 51.3 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.327 2.018 . . . . 0.0 111.967 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -111.7 -14.83 13.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.979 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.677 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.0 m80 -130.47 87.32 50.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.668 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.87 -38.09 81.79 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.395 2.063 . . . . 0.0 111.967 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.96 -39.07 61.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.226 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.42 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -70.82 91.93 0.87 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.968 0.413 . . . . 0.0 111.149 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.586 ' O ' ' C ' ' A' ' 23' ' ' LEU . 8.6 mm -77.86 67.21 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.432 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.586 ' C ' ' O ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -5.32 102.84 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.154 179.614 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.5 t -77.22 163.58 3.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 121.339 0.59 . . . . 0.0 111.781 -178.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -60.33 -164.46 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.782 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 7.6 t0 -36.67 116.27 0.42 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.888 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.52 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 0.8 OUTLIER 176.0 140.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.327 179.111 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? 64.43 16.06 9.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.871 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 173.67 -70.31 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.436 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 161.78 -27.74 0.27 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.32 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.624 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -94.58 -118.03 0.1 Allowed 'General case' 0 CA--C 1.536 0.417 0 O-C-N 122.824 -0.221 . . . . 0.0 110.705 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.826 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 15.5 mtt -112.86 126.81 55.85 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 121.698 -0.626 . . . . 0.0 110.619 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.678 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -112.99 134.07 56.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -177.719 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.821 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.4 t -87.63 97.75 0.81 Allowed Pre-proline 0 C--O 1.218 -0.569 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -39.22 -19.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.549 2.833 . . . . 0.0 113.627 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.677 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 12.1 mm-40 -85.58 -66.84 0.85 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.732 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.472 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 3.7 p -90.08 -20.69 22.88 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 177.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.821 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 70.25 32.36 68.77 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 114.025 -1.443 . . . . 0.0 112.217 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.678 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -71.51 141.41 50.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.717 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.826 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.3 t -108.8 127.0 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-O 120.692 0.282 . . . . 0.0 111.004 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.624 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.6 OUTLIER -128.86 126.67 65.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.986 178.448 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.421 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 133.54 -176.61 19.57 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.261 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.55 84.03 0.13 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.822 0.344 . . . . 0.0 110.646 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.17 -75.3 0.59 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.164 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -175.72 -81.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.306 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.463 HG22 ' H ' ' A' ' 47' ' ' ASP . 0.4 OUTLIER 44.37 -83.55 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.706 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 45' ' ' VAL . 1.5 m-20 67.12 137.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.899 0.38 . . . . 0.0 111.129 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.32 80.75 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.834 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.42 -89.85 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.608 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.7 t -60.14 86.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.942 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -178.51 37.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.976 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 13.3 m0 61.33 -145.3 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.59 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.67 36.16 1.3 Allowed 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 120.975 0.417 . . . . 0.0 110.807 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -137.7 172.99 12.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.682 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.504 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 40.8 p90 -74.08 62.61 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.036 0.446 . . . . 0.0 110.951 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 m 60.34 165.59 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -114.56 174.69 5.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.944 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.25 -69.07 0.89 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.898 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.822 0.344 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.3 m -75.13 65.2 1.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 p -140.96 88.02 2.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -168.14 73.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.08 121.51 12.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mt -60.27 162.37 6.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.61 107.04 4.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.859 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 63.26 125.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.087 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.682 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.6 OUTLIER -88.97 -19.83 0.25 Allowed Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.682 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 95.1 Cg_endo -85.15 -168.89 0.55 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.803 1.669 . . . . 0.0 112.379 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.2 112.1 17.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.932 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -48.84 -68.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.491 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.9 p -97.92 -143.21 0.3 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.233 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 48.3 t -73.28 136.71 78.6 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-O 120.508 0.194 . . . . 0.0 110.757 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.62 -24.09 77.37 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.266 1.978 . . . . 0.0 112.068 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -118.06 -7.25 10.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.484 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.719 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 32.7 m80 -133.15 80.76 58.54 Favored Pre-proline 0 C--N 1.333 -0.129 0 CA-C-O 120.734 0.302 . . . . 0.0 111.692 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -57.74 -36.52 98.36 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.887 1.725 . . . . 0.0 111.06 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.53 -48.73 63.56 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.258 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.532 ' HB1' ' HB3' ' A' ' 18' ' ' HIS . . . -71.09 85.98 0.74 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.248 0.547 . . . . 0.0 111.073 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.555 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.6 mp -67.75 75.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.846 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.561 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.1 mp -14.24 112.2 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.912 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -81.31 160.19 3.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.277 0.56 . . . . 0.0 111.644 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.489 ' O ' ' O ' ' A' ' 26' ' ' ASP . 15.6 mm-40 -81.04 129.22 34.44 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.85 -179.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 25' ' ' GLU . 6.5 t70 45.68 116.29 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.403 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.626 ' CG ' HG22 ' A' ' 33' ' ' ILE . 2.1 t80 -146.67 145.88 30.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.125 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.461 ' O ' ' CG ' ' A' ' 28' ' ' ARG . 0.2 OUTLIER 51.19 31.99 7.47 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.395 -179.014 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 68.07 38.32 2.74 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.996 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -128.62 -155.73 8.72 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.579 -0.82 . . . . 0.0 114.412 -178.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.641 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 4.5 m-20 -88.88 -128.19 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.655 -0.772 . . . . 0.0 111.801 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.558 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 73.3 mtp -90.64 112.69 24.52 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.475 0.655 . . . . 0.0 110.247 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.688 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -100.68 125.68 54.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.403 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.731 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.0 t -88.87 98.27 1.09 Allowed Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.1 Cg_endo -43.57 -14.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.181 2.587 . . . . 0.0 114.068 -178.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.719 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 4.0 mm-40 -89.45 -63.07 1.34 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 121.215 -0.194 . . . . 0.0 111.409 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.449 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 16.1 p -91.37 -23.23 20.13 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.731 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 72.18 37.53 59.6 Favored Glycine 0 N--CA 1.428 -1.892 0 CA-C-N 113.285 -1.78 . . . . 0.0 112.651 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -77.36 145.82 37.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.155 179.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 32' ' ' MET . 59.0 t -111.35 116.1 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 O-C-N 123.847 0.717 . . . . 0.0 111.069 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.641 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -113.9 143.88 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.471 179.005 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . -27.62 -72.21 0.04 OUTLIER Glycine 0 CA--C 1.507 -0.423 0 O-C-N 123.657 0.598 . . . . 0.0 113.329 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 1.0 OUTLIER 156.63 -172.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.01 0.434 . . . . 0.0 110.969 179.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -103.64 -41.16 6.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.257 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER 57.99 110.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.45 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.6 tt -160.56 42.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.954 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -111.5 -23.9 10.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.136 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.4 t 74.02 163.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.847 0.356 . . . . 0.0 110.952 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.56 -50.42 30.61 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.821 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.0 p -172.65 -178.78 2.0 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 110.902 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -173.08 40.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.964 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.406 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER 69.35 -60.03 0.47 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.374 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.406 ' CB ' ' O ' ' A' ' 52' ' ' TRP . 0.9 OUTLIER 79.86 51.88 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.95 0.405 . . . . 0.0 110.823 -179.815 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -152.01 175.71 12.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.648 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.421 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 26.6 p90 -111.43 66.11 0.63 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.993 0.425 . . . . 0.0 110.994 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 m 61.48 162.23 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.886 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -68.93 168.92 12.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.967 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -62.4 -41.91 99.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.851 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.826 0.346 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 m -100.04 31.61 3.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.825 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 p -142.91 84.19 1.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.2 t -146.49 177.21 9.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.6 mmp_? -101.25 -73.84 0.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.902 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -165.15 70.37 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.934 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -128.29 140.24 51.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.775 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.03 143.19 33.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.322 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.438 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 3.8 mm? -59.07 165.91 3.12 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.749 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 10' ' ' LEU . 76.8 Cg_endo -78.18 9.99 2.87 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.551 2.168 . . . . 0.0 112.984 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -86.76 7.63 26.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.608 0.242 . . . . 0.0 111.42 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.47 -58.14 3.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.925 0.393 . . . . 0.0 111.053 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.52 171.13 0.19 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.898 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 10.5 t -67.69 135.73 92.57 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.119 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.8 -23.75 74.43 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.24 1.96 . . . . 0.0 111.995 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -106.93 -30.01 9.11 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.719 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.612 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 39.6 m80 -108.25 87.53 4.1 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.18 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.61 39.73 0.65 Allowed 'Trans proline' 0 CA--C 1.515 -0.444 0 C-N-CA 123.168 2.578 . . . . 0.0 111.013 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 18' ' ' HIS . 46.8 m-20 -152.64 -48.05 0.1 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.143 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.42 ' HB1' ' CG ' ' A' ' 36' ' ' GLU . . . -69.58 93.46 0.7 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.991 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.574 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.5 mp -76.04 71.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.946 -1.025 . . . . 0.0 113.182 -177.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.574 ' C ' ' O ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -8.84 111.35 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.901 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 32' ' ' MET . 15.4 t -81.76 152.44 4.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 121.646 0.736 . . . . 0.0 112.609 -177.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 26' ' ' ASP . 8.0 mt-10 -85.8 122.86 30.47 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.005 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.632 ' O ' ' HB3' ' A' ' 27' ' ' TYR . 24.7 m-20 47.84 115.67 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.762 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.632 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER 166.02 151.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.403 177.62 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.48 ' CG ' ' CE1' ' A' ' 27' ' ' TYR . 5.3 mmp_? 62.34 37.4 13.86 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.044 -176.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.56 34.96 24.29 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.82 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -138.27 155.18 23.29 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 119.873 -1.156 . . . . 0.0 115.577 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 26' ' ' ASP . 5.9 m-20 -60.76 -100.91 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.391 -0.904 . . . . 0.0 109.087 177.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.546 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 16.7 mtp -106.52 105.06 14.92 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 1.02 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -109.09 137.91 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 CA-C-O 122.113 0.959 . . . . 0.0 112.048 -176.396 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.811 ' O ' ' N ' ' A' ' 38' ' ' GLY . 33.1 t -91.25 99.17 2.07 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 113.542 -1.663 . . . . 0.0 109.181 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.1 Cg_endo -41.41 -15.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.312 2.675 . . . . 0.0 113.603 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.612 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 9.3 mm-40 -87.18 -65.0 1.06 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.484 0.183 . . . . 0.0 110.627 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.6 p -90.07 -21.0 22.52 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.811 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 69.06 40.16 83.66 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.963 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 1.02 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 1.5 pp -77.26 136.85 38.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.024 -1.088 . . . . 0.0 108.378 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 32' ' ' MET . 42.9 t -105.6 126.45 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 O-C-N 123.399 0.437 . . . . 0.0 111.234 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.567 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.4 t -125.77 127.69 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.224 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.91 159.57 10.11 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.723 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -171.67 69.61 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.866 0.365 . . . . 0.0 110.342 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.3 tpp85 62.59 20.63 12.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.133 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.2 p -126.44 9.41 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.338 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.3 pp -132.49 15.31 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.307 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -70.12 155.9 39.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.75 0.309 . . . . 0.0 110.729 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.93 -83.55 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.156 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 49.15 -136.13 21.19 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.611 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 57.68 -160.5 0.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.639 0.257 . . . . 0.0 110.882 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 73.55 8.01 5.06 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.485 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 52.0 m0 62.89 -77.32 0.03 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.254 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 64.61 115.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.864 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.26 -168.49 1.7 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.889 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -124.1 12.03 8.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.29 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.64 166.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.826 0.346 . . . . 0.0 110.935 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -171.79 174.66 4.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -63.12 -68.05 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.875 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.88 0.371 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.2 m -134.17 37.34 3.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.25 97.09 9.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -134.0 -65.74 0.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.6 mmp_? 61.74 -83.3 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.026 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 174.7 170.25 0.25 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.74 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -175.73 36.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.025 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -152.93 22.38 0.58 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.263 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.45 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 5.8 tp -86.94 -48.01 0.49 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.453 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 86.9 Cg_endo -82.61 -32.46 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.389 2.059 . . . . 0.0 112.456 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.29 172.73 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.749 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 t -131.19 6.1 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.792 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.25 169.96 16.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.077 0.465 . . . . 0.0 111.016 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 42.7 t -69.96 134.29 87.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.065 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.18 -28.41 56.25 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.338 2.025 . . . . 0.0 111.238 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -91.08 -20.35 22.14 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.335 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.591 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 40.5 m80 -130.66 85.92 54.36 Favored Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.325 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.73 -40.54 53.86 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.958 1.772 . . . . 0.0 110.99 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.0 -13.96 59.69 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.974 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.502 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -97.76 133.77 41.83 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.66 0.743 . . . . 0.0 110.985 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -108.11 123.98 64.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.774 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.787 ' HB3' ' HB3' ' A' ' 32' ' ' MET . 4.9 mp -67.89 93.86 0.43 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 32' ' ' MET . 2.7 t -49.91 161.83 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.208 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -89.38 121.7 31.89 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 122.428 1.109 . . . . 0.0 112.13 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER 56.75 105.42 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 113.121 -1.854 . . . . 0.0 113.15 179.137 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.53 ' CG ' HG21 ' A' ' 33' ' ' ILE . 2.6 t80 -140.13 148.96 42.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.194 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.478 ' HD3' ' O ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER 41.39 47.09 3.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.347 -178.667 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.38 40.77 23.95 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.88 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 27' ' ' TYR . . . -130.52 -164.93 11.43 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.735 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.684 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -89.25 -105.58 0.09 Allowed 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 115.406 -0.397 . . . . 0.0 111.231 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.787 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 36.2 mtm -106.58 115.04 29.51 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.308 0.575 . . . . 0.0 111.413 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.779 HD12 ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -98.82 121.62 49.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.132 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.814 ' O ' ' N ' ' A' ' 38' ' ' GLY . 38.9 t -84.35 100.4 1.06 Allowed Pre-proline 0 C--O 1.221 -0.406 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.475 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 3.9 Cg_exo -36.8 -26.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.804 3.003 . . . . 0.0 114.064 -179.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.591 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 27.2 mm-40 -82.63 -67.36 0.79 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.523 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.426 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 2.6 p -87.92 -15.07 37.63 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.814 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 61.84 25.55 65.94 Favored Glycine 0 N--CA 1.433 -1.542 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.31 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.598 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -65.25 150.37 48.34 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.354 -0.923 . . . . 0.0 110.116 -179.844 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 32' ' ' MET . 2.7 t -118.17 120.19 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.684 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 84.9 t -130.3 132.84 64.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.164 178.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.69 -170.94 19.13 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.456 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 47.06 -160.69 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.769 0.319 . . . . 0.0 111.464 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.407 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 25.5 mmm-85 73.98 -77.39 0.05 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.367 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -171.23 116.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.809 0.337 . . . . 0.0 111.32 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.437 ' CG2' ' H ' ' A' ' 47' ' ' ASP . 0.6 OUTLIER -160.03 -95.11 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.582 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.437 ' H ' ' CG2' ' A' ' 46' ' ' ILE . 3.2 p-10 29.17 52.12 0.08 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.9 p -101.54 155.48 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.32 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.58 126.21 4.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.27 97.86 5.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.809 0.338 . . . . 0.0 110.896 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.83 44.05 0.44 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.796 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 15.1 m0 62.47 -81.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.71 49.03 21.74 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.825 0.345 . . . . 0.0 111.095 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.94 -170.95 1.77 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.797 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -87.59 56.63 4.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.81 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.2 m 64.69 158.13 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.868 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -71.99 147.07 47.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.21 -64.27 0.78 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.922 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.837 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.734 0.302 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.68 -31.87 14.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.919 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.7 p -144.0 137.79 27.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.805 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.4 t -175.02 136.05 0.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.973 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -168.1 0.05 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.808 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.05 168.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.139 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -81.9 -176.71 6.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.976 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.08 113.1 1.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.467 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -75.9 -50.26 3.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.317 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 10' ' ' LEU . 73.3 Cg_endo -76.56 170.17 20.43 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.272 1.981 . . . . 0.0 112.397 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.92 131.88 54.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.0 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.4 p -96.11 20.08 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.281 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -179.35 -178.78 0.51 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.562 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.3 t -70.26 133.47 87.47 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.207 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.73 -28.97 51.57 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.601 2.201 . . . . 0.0 112.03 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.19 -16.31 19.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.713 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.649 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 39.9 m80 -131.92 85.23 51.45 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.293 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.68 -43.54 37.87 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.074 1.85 . . . . 0.0 111.321 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -74.64 -12.01 60.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.372 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.605 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -102.5 102.35 12.63 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.136 0.494 . . . . 0.0 111.812 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.38 130.76 35.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.564 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 3.2 mp -72.19 135.69 46.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.657 0.742 . . . . 0.0 111.125 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 32' ' ' MET . 42.9 t -87.63 156.84 3.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.208 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.21 124.45 29.92 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.936 0.874 . . . . 0.0 111.314 -177.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 31' ' ' ASP . 16.8 m-20 74.87 80.29 0.11 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.857 -1.519 . . . . 0.0 114.615 177.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.568 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 1.4 t80 -51.48 92.97 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.453 ' CD ' ' CE1' ' A' ' 27' ' ' TYR . 22.5 mtp180 66.21 -73.41 0.07 Allowed 'General case' 0 CA--C 1.522 -0.1 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 27' ' ' TYR . . . -143.96 31.92 1.26 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.324 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -123.3 -135.75 4.63 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 115.511 -0.768 . . . . 0.0 114.445 -178.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -91.56 -131.31 0.11 Allowed 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 122.871 0.468 . . . . 0.0 111.892 -178.397 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.549 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 75.8 mtp -96.84 117.47 31.16 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.992 -0.443 . . . . 0.0 110.913 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.6 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -99.42 123.19 51.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -176.596 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.771 ' O ' ' N ' ' A' ' 38' ' ' GLY . 30.4 t -88.86 100.17 1.94 Allowed Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -40.11 -20.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.589 2.859 . . . . 0.0 114.09 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.649 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 6.4 mm-40 -87.36 -64.5 1.14 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.755 0.312 . . . . 0.0 111.409 -177.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.422 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 7.6 p -89.86 -20.23 23.68 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.771 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 68.15 29.14 73.2 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.222 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -69.0 145.95 53.14 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.159 -0.521 . . . . 0.0 110.422 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 32' ' ' MET . 40.4 t -109.3 120.51 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 O-C-N 123.904 0.753 . . . . 0.0 110.493 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -123.58 126.26 72.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.1 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.643 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 124.18 -156.5 18.33 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.643 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 27.7 t70 111.76 25.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.984 0.514 . . . . 0.0 111.317 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -178.77 170.04 1.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.894 0.378 . . . . 0.0 111.162 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -105.38 133.42 49.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.846 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.5 tt -54.19 119.04 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.249 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -55.9 97.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.125 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.4 t -151.65 29.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.062 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.94 59.22 4.77 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.45 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.27 30.21 1.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.814 0.34 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -154.88 80.85 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 42.9 m0 61.51 -92.66 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.805 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.04 43.33 5.43 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.764 0.316 . . . . 0.0 111.386 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.01 -177.11 3.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.048 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -100.2 37.34 1.68 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.0 m 61.28 -177.07 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -120.41 -174.07 2.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -117.55 -42.14 2.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.935 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.843 0.354 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.5 94.94 4.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.798 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.57 73.6 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.986 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.4 -80.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.805 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.1 mtt85 53.81 -173.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.071 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.2 mt -102.23 -179.55 4.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.854 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -99.34 95.64 7.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.103 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.56 14.97 2.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.45 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.466 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 1.2 mt -98.63 -50.91 0.21 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.453 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 10' ' ' LEU . 56.3 Cg_endo -86.42 -85.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.459 2.106 . . . . 0.0 112.82 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -179.93 132.07 0.1 Allowed 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 120.81 0.338 . . . . 0.0 110.945 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.5 t -129.11 106.32 13.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.92 177.3 0.13 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.943 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.42 ' HB2' HD12 ' A' ' 23' ' ' LEU . 19.2 t -73.01 132.83 82.33 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.318 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.85 -26.32 32.18 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.322 2.015 . . . . 0.0 111.535 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.55 -16.98 18.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.74 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.648 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 39.1 m80 -131.87 84.32 54.42 Favored Pre-proline 0 N--CA 1.455 -0.224 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.205 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.96 -44.86 27.24 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 121.937 1.758 . . . . 0.0 111.528 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.98 -12.77 60.74 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.648 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -102.12 102.37 12.83 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.826 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 mp -75.65 125.11 34.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.574 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 2.7 mp -67.63 147.69 52.38 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.391 0.615 . . . . 0.0 110.509 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 32' ' ' MET . 50.2 t -95.08 146.78 6.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.039 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -71.68 124.47 24.81 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.323 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER 73.48 81.58 0.13 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.263 -1.335 . . . . 0.0 114.424 178.244 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.66 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -56.15 100.28 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.023 178.287 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.511 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 5.9 ttp-105 46.41 38.42 5.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.348 . . . . 0.0 110.372 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 92.03 34.57 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.59 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -133.06 -123.84 2.46 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.739 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -97.41 -135.63 0.25 Allowed 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 122.057 0.143 . . . . 0.0 110.88 -179.704 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.614 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 9.4 mtt -99.37 116.07 30.69 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-O 121.232 0.539 . . . . 0.0 111.564 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.732 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -98.23 123.26 50.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.894 -177.604 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.763 ' O ' ' N ' ' A' ' 38' ' ' GLY . 52.8 t -88.68 102.26 3.75 Favored Pre-proline 0 C--O 1.222 -0.379 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.7 Cg_endo -40.95 -20.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.398 2.732 . . . . 0.0 113.953 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.619 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 30.9 mm-40 -86.83 -65.52 1.01 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.571 -177.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.474 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 6.4 p -90.23 -20.47 22.96 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.763 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 69.29 30.29 71.62 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 113.715 -1.584 . . . . 0.0 112.437 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -71.26 146.41 48.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.249 -0.475 . . . . 0.0 110.451 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.533 HG21 ' CG ' ' A' ' 27' ' ' TYR . 26.6 t -106.28 119.29 55.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 O-C-N 123.905 0.753 . . . . 0.0 109.489 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.441 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -126.33 133.89 67.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.824 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.3 160.56 10.41 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.086 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.452 ' O ' ' C ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER 179.37 70.16 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.452 ' C ' ' O ' ' A' ' 43' ' ' ASP . 3.7 ptm180 -18.34 -54.1 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 m -39.66 100.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.949 0.404 . . . . 0.0 111.929 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.8 tt -97.83 -39.64 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.196 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.17 176.52 8.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.884 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.0 t -105.12 -31.81 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.06 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.82 -144.53 17.35 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.523 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 m 60.06 44.42 13.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.926 0.393 . . . . 0.0 110.874 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -111.14 -67.46 1.0 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.003 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.422 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 0.5 OUTLIER -161.25 -41.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.0 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 52' ' ' TRP . 0.4 OUTLIER 82.43 -50.58 0.2 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.32 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.7 m -46.57 143.45 2.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.791 0.329 . . . . 0.0 111.279 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -155.08 131.48 10.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 65.5 m 59.28 86.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -60.28 177.56 0.26 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.25 -34.03 76.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.971 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.959 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.799 0.333 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -100.06 31.29 3.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.891 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.7 p -136.66 -47.47 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.45 -168.49 1.73 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.825 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.33 -55.74 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.896 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.1 mt -109.15 -48.83 3.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.993 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 63.04 -80.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.003 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.69 121.58 14.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.866 0.365 . . . . 0.0 110.895 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.445 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 1.3 mt -178.13 -61.93 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.022 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 10' ' ' LEU . 17.8 Cg_endo -58.07 128.66 29.66 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.546 2.164 . . . . 0.0 112.511 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.32 140.64 49.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.664 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.4 p -99.4 34.51 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.163 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.6 p -145.26 156.73 44.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.04 0.448 . . . . 0.0 111.139 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 42.9 t -65.88 135.81 95.5 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.001 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.11 -28.49 48.72 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.389 2.06 . . . . 0.0 111.772 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -95.82 -18.18 20.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.522 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.682 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 40.1 m80 -131.31 86.18 51.23 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.329 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.31 -45.33 19.11 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 121.995 1.797 . . . . 0.0 111.309 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -72.33 -14.41 61.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.419 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -100.76 105.94 17.31 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.582 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.6 mm -81.89 128.17 38.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.564 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.513 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 3.5 mp -67.32 137.55 56.14 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.095 0.474 . . . . 0.0 110.465 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 32' ' ' MET . 43.7 t -88.18 142.28 13.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.332 0.587 . . . . 0.0 111.482 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.32 120.42 23.05 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.09 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' A' ' 31' ' ' ASP . 1.8 t70 56.27 102.15 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.191 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.625 ' HB3' HG21 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -162.54 161.91 27.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.944 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 52.13 40.08 27.96 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.8 31.89 18.49 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.281 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -137.85 -160.4 8.5 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.516 -0.85 . . . . 0.0 114.243 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.854 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 1.2 m-20 -86.16 -99.14 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.366 0.666 . . . . 0.0 112.423 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.671 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -108.86 113.2 25.91 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.068 0.461 . . . . 0.0 111.451 -178.665 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.745 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -102.71 126.24 56.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.517 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.792 ' O ' ' N ' ' A' ' 38' ' ' GLY . 41.0 t -90.18 99.96 2.27 Favored Pre-proline 0 C--O 1.22 -0.453 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.8 Cg_endo -40.24 -21.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.458 2.772 . . . . 0.0 114.097 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.682 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 31.7 mm-40 -84.52 -65.31 1.02 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.669 0.271 . . . . 0.0 111.216 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.7 p -89.82 -18.51 26.12 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.792 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.51 28.49 73.6 Favored Glycine 0 N--CA 1.433 -1.545 0 CA-C-N 113.641 -1.618 . . . . 0.0 112.074 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 1.3 pp -67.09 140.67 57.6 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.615 -0.793 . . . . 0.0 110.558 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 32' ' ' MET . 29.3 t -110.32 118.71 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.508 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.854 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 1.5 t -107.52 -165.69 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.183 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.43 -160.23 32.77 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.286 -0.959 . . . . 0.0 110.898 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.402 ' CB ' ' OD2' ' A' ' 31' ' ' ASP . 28.0 t0 -168.59 -39.43 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.071 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.09 -82.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.447 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.47 ' CG1' ' N ' ' A' ' 46' ' ' ILE . 0.6 OUTLIER 38.3 -160.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.832 179.417 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.47 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 9.4 tp -148.71 157.36 7.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.696 0.284 . . . . 0.0 110.743 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -47.83 95.39 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.883 0.373 . . . . 0.0 111.178 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.4 m -84.34 161.16 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.224 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.44 58.98 4.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.481 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.77 95.88 2.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.34 . . . . 0.0 110.793 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -141.04 40.43 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.935 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 69.6 -60.41 0.47 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.272 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? 77.04 98.23 0.07 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.964 0.412 . . . . 0.0 110.959 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.67 178.02 10.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.743 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -132.24 103.2 6.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.8 m 59.57 174.09 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.018 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -129.74 170.35 13.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.13 -38.07 8.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.866 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.824 0.345 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.6 m -65.18 -31.48 72.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 65.7 p -60.81 -65.06 0.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.923 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.07 176.6 0.31 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.2 mtt85 -138.72 -75.86 0.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.989 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mt -108.58 85.81 2.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -133.01 70.53 1.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.844 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -167.35 38.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.183 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.411 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 1.0 OUTLIER -128.99 52.35 9.1 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.889 179.887 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 91.1 Cg_endo -78.45 78.01 3.8 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.533 2.155 . . . . 0.0 112.607 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -85.89 141.95 29.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.615 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.65 18.66 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.634 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -166.09 169.49 14.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 110.809 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.479 ' HB2' HD12 ' A' ' 23' ' ' LEU . 11.3 t -79.46 134.58 58.07 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.188 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.3 -19.32 44.1 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.264 1.976 . . . . 0.0 111.6 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -115.09 -11.06 12.12 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.304 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.625 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 38.6 m80 -130.96 87.31 49.26 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-O 120.624 0.249 . . . . 0.0 110.583 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.33 -36.2 88.33 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.313 2.008 . . . . 0.0 112.004 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -79.26 -31.92 43.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.005 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.471 ' CB ' ' HB3' ' A' ' 18' ' ' HIS . . . -75.05 88.45 2.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.058 0.456 . . . . 0.0 111.278 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.55 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.7 mp -75.2 70.12 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.201 -0.908 . . . . 0.0 112.827 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.582 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -12.22 111.25 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.536 179.481 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.3 t -79.34 167.35 2.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.137 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -81.35 129.51 34.65 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 121.71 0.766 . . . . 0.0 110.229 -178.463 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.59 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 6.3 m-20 85.71 -160.28 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.222 -1.354 . . . . 0.0 112.975 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.802 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 14.3 t80 155.16 78.22 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 124.08 0.952 . . . . 0.0 108.788 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? 61.96 41.43 11.29 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 79.97 42.08 0.07 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.693 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -124.45 -156.66 9.5 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.749 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.538 ' O ' ' CA ' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -89.17 -135.7 0.1 Allowed 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 122.952 0.501 . . . . 0.0 111.216 -179.557 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.559 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.9 mtt -88.1 117.11 26.76 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-O 121.402 0.62 . . . . 0.0 110.904 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.805 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -99.97 123.4 52.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -176.149 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.74 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.8 t -88.56 96.28 0.65 Allowed Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.2 Cg_endo -41.84 -15.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.382 2.722 . . . . 0.0 113.743 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.625 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 18.2 mm-40 -85.1 -67.49 0.8 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.905 0.383 . . . . 0.0 111.034 -178.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.45 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 2.9 p -90.85 -19.56 23.25 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.805 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.18 38.72 82.99 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.149 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.605 ' CD1' ' CG2' ' A' ' 41' ' ' VAL . 1.6 pp -78.05 147.0 34.96 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.438 -0.881 . . . . 0.0 110.281 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 32' ' ' MET . 49.1 t -112.23 118.63 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 123.354 0.409 . . . . 0.0 111.945 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.605 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -124.15 131.52 72.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.241 178.043 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.29 -173.9 18.94 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.047 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -111.47 138.05 48.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.841 0.353 . . . . 0.0 111.084 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -95.7 78.35 3.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.629 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.419 ' O ' ' CB ' ' A' ' 46' ' ' ILE . 2.1 p -150.29 175.82 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.928 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.419 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER 84.42 154.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.0 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.97 140.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.705 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.97 -79.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.128 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.84 165.92 28.92 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.436 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.92 83.56 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.83 0.348 . . . . 0.0 110.913 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -122.0 21.47 10.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.223 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.42 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 57.33 -156.28 0.31 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.814 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.42 ' CB ' ' O ' ' A' ' 52' ' ' TRP . 1.0 OUTLIER 81.95 117.1 0.05 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.95 0.405 . . . . 0.0 111.016 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.44 -167.07 1.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.66 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -85.84 61.69 7.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.961 0.41 . . . . 0.0 110.837 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.4 m 63.27 165.97 0.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.951 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -100.5 121.69 41.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.985 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -70.06 -31.63 69.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.834 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.872 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.784 0.326 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -99.6 29.32 4.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.976 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.3 92.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.813 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.0 m -147.92 147.42 29.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.978 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -82.27 144.62 30.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.784 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 mt -76.88 126.52 31.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.98 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.84 -127.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.378 179.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.515 ' O ' ' C ' ' A' ' 10' ' ' LEU . . . 76.22 -56.75 0.57 Allowed 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 179.809 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.515 ' C ' ' O ' ' A' ' 9' ' ' ALA . 3.9 mt -2.62 -70.65 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.66 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.515 ' CD ' ' CB ' ' A' ' 10' ' ' LEU . 67.9 Cg_endo -73.95 -92.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.05 1.834 . . . . 0.0 112.591 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 170.33 -50.99 0.01 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.958 0.409 . . . . 0.0 110.286 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.8 t 62.16 93.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.696 179.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.6 p 55.27 -175.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.527 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.473 ' HB2' HD12 ' A' ' 23' ' ' LEU . 32.8 t -74.43 135.3 75.75 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.922 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.5 -19.97 65.54 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.259 1.973 . . . . 0.0 111.911 179.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.16 -10.88 10.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.258 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.712 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.9 m80 -130.58 87.99 48.24 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.797 0.332 . . . . 0.0 110.829 179.575 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.32 -34.75 97.84 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.306 2.004 . . . . 0.0 111.752 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.96 -25.49 37.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.385 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.467 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -84.33 83.9 7.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.158 0.504 . . . . 0.0 111.377 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' C ' ' A' ' 23' ' ' LEU . 16.1 mm -72.18 74.27 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.737 -178.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.608 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -15.37 113.52 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.439 179.511 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 32' ' ' MET . 5.0 t -81.23 160.58 3.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.271 0.558 . . . . 0.0 111.822 -178.151 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.39 136.5 37.68 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.829 -178.115 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 31' ' ' ASP . 8.3 m-20 62.54 86.91 0.11 Allowed 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 113.833 -1.531 . . . . 0.0 114.128 179.024 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.574 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 2.0 t80 -58.84 85.92 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.007 178.302 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.484 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 51.71 49.11 21.52 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.965 -179.965 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 88.96 30.4 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.459 -178.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -131.75 -130.27 3.12 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.432 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.618 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 2.1 p30 -102.57 -127.96 0.22 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.462 0.171 . . . . 0.0 111.462 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.538 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 6.7 mtm -98.56 116.95 31.9 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.743 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -106.51 124.07 61.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.844 -178.154 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.752 ' O ' ' N ' ' A' ' 38' ' ' GLY . 40.4 t -86.83 97.04 0.59 Allowed Pre-proline 0 C--O 1.221 -0.446 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.3 Cg_endo -41.86 -15.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.378 2.719 . . . . 0.0 114.267 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.712 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 6.2 mm-40 -88.55 -64.51 1.14 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.738 0.304 . . . . 0.0 111.173 -178.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.466 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 4.5 p -90.94 -19.6 23.11 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.38 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.752 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.1 36.42 90.45 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.684 -179.397 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.706 ' CD1' ' CG2' ' A' ' 41' ' ' VAL . 1.2 pp -73.16 145.01 46.66 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.569 -0.816 . . . . 0.0 109.315 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.49 ' CG2' ' CD2' ' A' ' 27' ' ' TYR . 53.7 t -114.66 119.94 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 121.044 0.45 . . . . 0.0 112.08 -176.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.706 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.2 t -131.98 139.18 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.247 179.563 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.446 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 128.83 155.49 8.61 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.135 178.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.5 t0 178.56 -67.61 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.985 -0.608 . . . . 0.0 110.003 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.21 86.74 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.985 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.77 178.28 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.9 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 mp 75.05 38.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.917 0.389 . . . . 0.0 110.944 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.47 137.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.895 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.6 p -146.67 148.95 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.99 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 142.67 -130.36 4.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.399 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.6 35.43 19.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 110.894 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.68 35.75 4.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.824 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 54.1 m0 62.61 -81.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.015 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 53.4 81.75 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.847 0.356 . . . . 0.0 111.025 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.91 175.91 11.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -104.94 39.14 1.77 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.31 159.61 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.878 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -125.39 165.07 19.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.934 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -101.23 -31.58 10.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.314 -0.85 . . . . 0.0 110.805 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.822 0.344 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.33 121.79 44.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.78 72.57 0.73 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.845 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.7 t -176.73 106.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.84 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -96.15 -34.77 11.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.952 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 59.42 69.26 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.724 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -168.97 -149.92 0.08 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.683 -179.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 77.18 160.0 0.21 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.901 0.382 . . . . 0.0 111.106 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.7 56.55 5.18 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.834 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.18 -70.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.632 2.221 . . . . 0.0 112.328 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 58.0 mtm-85 -99.95 109.03 21.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.906 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.3 p -65.77 -32.34 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.859 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 54.11 -174.39 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.843 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 9.3 t -88.09 135.13 33.67 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.15 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.1 -18.9 39.9 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.285 1.99 . . . . 0.0 111.861 179.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -115.91 -9.46 11.8 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.266 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.6 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.1 m80 -131.03 88.06 46.67 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.653 0.263 . . . . 0.0 111.043 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.19 -33.24 90.87 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.433 2.089 . . . . 0.0 112.072 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.79 -23.58 27.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.504 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.557 ' CB ' ' HB3' ' A' ' 18' ' ' HIS . . . -84.06 82.45 8.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.289 0.566 . . . . 0.0 110.671 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.535 ' O ' ' C ' ' A' ' 23' ' ' LEU . 3.7 mt -69.42 75.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.552 -177.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.545 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.3 mp -18.68 109.83 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 O-C-N 123.618 0.574 . . . . 0.0 110.577 179.04 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.4 t -78.24 163.02 3.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.234 0.54 . . . . 0.0 111.959 -178.108 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 26' ' ' ASP . 5.7 mt-10 -81.75 134.48 35.45 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.395 -178.639 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 25' ' ' GLU . 1.4 m-20 42.69 114.92 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.518 -1.219 . . . . 0.0 113.675 179.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.471 ' CB ' HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -171.68 129.34 0.66 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.966 179.165 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER 80.02 -60.35 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.723 -179.346 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -114.07 -38.73 4.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.345 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.42 -7.29 3.67 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.911 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 0.2 OUTLIER -96.29 -151.2 0.34 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.742 0.271 . . . . 0.0 110.527 179.857 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.541 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 1.3 mtt -89.85 116.53 28.0 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 121.205 0.526 . . . . 0.0 111.935 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -104.03 125.96 58.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.898 0.38 . . . . 0.0 111.754 -178.87 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.813 ' O ' ' N ' ' A' ' 38' ' ' GLY . 40.5 t -85.8 97.62 0.61 Allowed Pre-proline 0 N--CA 1.447 -0.61 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.068 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -41.11 -17.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.319 2.679 . . . . 0.0 113.742 -179.231 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.6 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 9.9 mm-40 -88.06 -65.48 1.01 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.672 0.273 . . . . 0.0 110.789 -178.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.451 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 4.0 p -90.36 -18.59 25.25 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.271 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.813 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.12 33.3 84.91 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.681 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -72.44 143.64 48.41 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.949 -0.626 . . . . 0.0 109.58 179.099 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 32' ' ' MET . 16.1 t -110.35 112.94 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 O-C-N 123.236 0.335 . . . . 0.0 111.514 -178.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.459 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 67.0 t -114.47 138.08 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.117 178.535 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.01 159.58 10.58 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.53 178.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -175.02 44.05 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.782 0.325 . . . . 0.0 110.372 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.92 11.22 21.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.428 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.417 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 5.2 t 75.95 -54.71 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.417 ' HB ' ' O ' ' A' ' 45' ' ' VAL . 3.1 mm 67.96 102.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 120.848 0.356 . . . . 0.0 110.666 -179.453 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -128.36 149.32 50.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.837 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.0 m -97.79 -178.03 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.06 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.87 -44.65 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.587 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.37 -78.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 110.848 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 68.23 -69.8 0.14 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.996 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 31.1 m0 56.78 -90.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.053 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? 44.66 84.21 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.792 0.329 . . . . 0.0 111.347 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.49 -175.62 3.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.09 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -148.7 61.68 1.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.902 -179.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 62.32 174.66 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -121.12 167.58 12.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.756 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -72.2 -45.76 58.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.851 0.358 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.44 72.86 1.4 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.854 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.1 p -141.57 -70.91 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.846 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.0 m -90.64 125.02 35.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.818 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.9 mtt85 -86.63 -68.56 0.74 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.986 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.0 mt -68.81 -83.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.965 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 42.0 78.76 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.548 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -173.44 129.03 0.44 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.426 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 1.4 mp -88.26 -62.62 0.22 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.226 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.426 ' HD3' ' CB ' ' A' ' 10' ' ' LEU . 90.4 Cg_endo -78.15 -101.24 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.385 2.057 . . . . 0.0 112.395 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 168.36 -80.22 0.0 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.725 0.297 . . . . 0.0 110.893 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -166.72 -95.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.141 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -175.56 169.42 3.1 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-O 121.337 0.589 . . . . 0.0 111.327 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.725 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 14.5 t -78.96 147.0 69.33 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.732 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.579 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 29.5 Cg_endo -62.12 -44.33 20.2 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.91 2.407 . . . . 0.0 112.716 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.526 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 94.1 m-20 -107.48 38.12 2.23 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 122.119 0.962 . . . . 0.0 108.588 178.353 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.725 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 24.7 m80 -161.9 65.13 1.84 Allowed Pre-proline 0 C--N 1.308 -1.226 0 CA-C-O 123.114 1.435 . . . . 0.0 108.93 175.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 18' ' ' HIS . 55.6 Cg_endo -70.3 13.6 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.649 3.566 . . . . 0.0 113.103 -179.244 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.58 -17.48 1.49 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 120.999 0.428 . . . . 0.0 110.033 178.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.497 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -98.21 131.02 44.91 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.435 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.614 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.3 mp -106.87 87.51 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.614 ' C ' ' O ' ' A' ' 22' ' ' ILE . 3.9 mp -15.99 105.02 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 121.037 0.446 . . . . 0.0 109.934 178.43 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 32' ' ' MET . 2.7 t -63.53 170.85 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.174 -178.309 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.83 97.25 7.15 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.501 -178.66 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 31' ' ' ASP . 1.6 m-20 82.08 89.44 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 179.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.571 ' CB ' HG22 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -167.66 143.94 4.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.35 179.136 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.476 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 71.14 6.59 5.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.631 -178.855 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.476 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 158.2 -78.21 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.985 0.422 . . . . 0.0 110.489 179.752 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.02 -179.65 47.5 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.586 179.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.5 OUTLIER 64.43 -141.69 0.27 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 117.436 0.618 . . . . 0.0 109.544 -179.157 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.51 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 66.3 mtm -112.72 116.5 30.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.923 0.392 . . . . 0.0 111.121 -179.551 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.741 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -110.43 123.81 66.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.402 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.873 ' O ' ' N ' ' A' ' 38' ' ' GLY . 6.5 t -83.45 101.69 1.48 Allowed Pre-proline 0 C--O 1.215 -0.744 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.6 Cg_endo -44.24 -20.99 0.35 Allowed 'Trans proline' 0 N--CA 1.475 0.413 0 C-N-CA 122.152 1.901 . . . . 0.0 112.809 -179.333 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.604 ' HB3' ' NE2' ' A' ' 18' ' ' HIS . 29.8 mm-40 -85.03 -60.52 2.02 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.457 -178.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.529 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 25.6 p -93.61 -11.97 30.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.636 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.873 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 54.32 26.28 36.22 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 114.79 -1.096 . . . . 0.0 113.581 178.574 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.741 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.6 OUTLIER -71.6 157.22 38.36 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.005 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.423 ' CG1' ' HB2' ' A' ' 31' ' ' ASP . 5.9 t -118.41 118.12 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.054 0.454 . . . . 0.0 111.936 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.521 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 68.1 t -132.14 133.8 60.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.546 178.633 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.06 165.2 10.53 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.073 -1.061 . . . . 0.0 112.967 179.464 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -142.14 -39.99 0.36 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.689 0.28 . . . . 0.0 110.531 179.567 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.84 81.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.432 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' A' ' 43' ' ' ASP . 1.2 p -50.2 -69.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.555 -179.506 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.404 HG23 ' O ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER 58.85 151.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.899 0.38 . . . . 0.0 110.919 -179.839 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 p30 176.28 175.5 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.944 -179.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.9 m -130.44 -51.83 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.974 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 44.72 56.04 5.91 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.047 -0.596 . . . . 0.0 113.011 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.9 t -176.87 97.03 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.327 . . . . 0.0 111.141 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.4 OUTLIER -138.32 11.6 2.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.339 179.888 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 9.7 m0 61.41 -80.72 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.81 0.338 . . . . 0.0 111.067 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER 66.33 140.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.837 0.351 . . . . 0.0 110.963 179.897 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.1 m -161.9 164.28 28.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.791 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -140.35 109.74 6.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.043 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.0 m 58.31 173.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.028 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -165.54 -175.94 3.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.808 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -108.07 -38.09 5.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.915 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.858 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.841 0.353 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.1 m -118.79 31.52 6.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.9 p -94.55 -31.55 13.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.907 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.53 -169.6 2.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.852 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.9 mtp85 -80.08 -74.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.94 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.32 -169.13 2.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.876 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -170.76 117.84 0.5 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.95 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.98 61.56 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.073 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.8 mt -109.29 159.13 32.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.866 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -62.04 177.82 0.97 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.52 2.147 . . . . 0.0 112.061 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -130.01 5.7 4.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.593 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.7 p -178.88 121.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.758 0.313 . . . . 0.0 111.359 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.7 p 51.88 -169.63 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.226 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 49.2 t -73.21 137.0 78.68 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.73 -21.28 72.85 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.334 2.023 . . . . 0.0 112.189 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -116.96 -9.52 11.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.367 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.68 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 37.2 m80 -130.24 88.78 46.87 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.786 0.327 . . . . 0.0 110.676 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.23 -34.61 93.83 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.356 2.038 . . . . 0.0 111.891 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.86 -23.84 33.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.32 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.511 ' CB ' ' HB3' ' A' ' 18' ' ' HIS . . . -83.81 84.15 7.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.22 0.534 . . . . 0.0 111.197 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.522 ' O ' ' C ' ' A' ' 23' ' ' LEU . 6.3 mt -70.4 77.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.658 -1.155 . . . . 0.0 113.147 -178.205 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.607 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -20.04 106.26 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.902 179.327 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -74.9 168.24 2.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.155 -178.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.44 138.61 32.72 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.996 0.903 . . . . 0.0 110.895 -178.153 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 32.1 m-20 60.09 91.24 0.05 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 113.899 -1.501 . . . . 0.0 114.873 178.487 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.613 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 2.0 t80 -62.78 95.43 0.08 Allowed 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.827 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.443 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 52.74 41.92 31.65 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.444 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 86.67 36.02 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.321 -178.75 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -132.87 -124.62 2.55 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.886 -179.674 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.564 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -96.2 -146.42 0.29 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 122.3 0.24 . . . . 0.0 111.014 -179.097 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.626 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.8 mtm -86.2 116.8 24.62 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-O 121.09 0.471 . . . . 0.0 111.638 -179.195 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.851 HD12 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -104.22 123.03 57.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.121 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.745 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.0 t -87.23 96.58 0.58 Allowed Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.492 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.6 Cg_endo -42.52 -14.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.373 2.716 . . . . 0.0 114.072 -179.001 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.68 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 9.2 mm-40 -87.94 -65.19 1.04 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.66 0.266 . . . . 0.0 110.881 -178.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.454 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 4.5 p -91.0 -19.16 23.52 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.323 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.851 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 67.23 35.91 88.99 Favored Glycine 0 N--CA 1.433 -1.505 0 CA-C-N 113.87 -1.514 . . . . 0.0 111.929 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -75.51 147.82 39.46 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.75 179.192 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 32' ' ' MET . 18.6 t -114.87 113.74 44.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.71 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.483 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 86.0 t -119.15 138.5 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.879 178.033 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.401 ' O ' ' OD2' ' A' ' 31' ' ' ASP . . . 105.26 -171.32 18.52 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 179.554 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.412 ' CB ' ' OD1' ' A' ' 31' ' ' ASP . 0.4 OUTLIER 40.84 -163.7 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 179.162 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 177.43 149.76 0.17 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.818 179.656 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 46' ' ' ILE . 13.5 t -56.51 130.81 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.221 -179.872 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER 52.5 176.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.432 179.857 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.01 97.37 0.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.91 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.2 t -101.43 36.74 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.004 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -135.45 114.95 1.29 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.478 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.51 100.98 10.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.798 0.332 . . . . 0.0 110.959 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.18 66.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.838 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 41.2 m0 62.34 -81.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.956 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? 56.66 78.46 0.21 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.978 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.0 m -154.9 168.82 25.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 55' ' ' PHE . 2.8 p90 -133.56 97.89 4.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.94 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 m 60.98 110.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -60.22 153.65 21.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.905 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -64.85 -62.25 1.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.956 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.854 0.359 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.3 m -77.73 -27.28 50.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.002 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.44 67.36 0.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.82 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.3 t -135.95 133.65 37.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.867 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -48.99 79.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.93 124.24 6.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.82 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -80.84 -49.06 11.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.043 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.92 99.29 3.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.153 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.517 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 1.1 mp -70.81 -50.21 13.1 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.411 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 10' ' ' LEU . 56.0 Cg_endo -70.37 156.9 60.76 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.167 1.912 . . . . 0.0 112.316 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -87.44 175.93 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.009 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.3 t -109.63 -23.13 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.171 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.64 168.55 19.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.9 0.381 . . . . 0.0 110.942 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 41.8 t -75.75 136.03 70.88 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.577 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.84 -22.74 68.99 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.426 2.084 . . . . 0.0 112.656 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -115.79 -8.9 11.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.431 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.707 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.0 m80 -131.58 85.88 50.96 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.746 0.308 . . . . 0.0 110.809 179.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.05 -34.47 98.95 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.318 2.012 . . . . 0.0 111.64 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.13 -30.65 39.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.368 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.441 ' CB ' ' HB3' ' A' ' 18' ' ' HIS . . . -79.0 87.72 4.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.182 0.515 . . . . 0.0 111.419 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' C ' ' A' ' 23' ' ' LEU . 22.3 mm -73.24 72.98 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.734 -178.705 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.585 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -13.71 110.25 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.49 179.258 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 32' ' ' MET . 4.2 t -79.52 160.72 4.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.322 0.582 . . . . 0.0 112.181 -177.84 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.53 133.95 37.32 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.028 -177.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.684 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.4 OUTLIER 70.77 81.27 0.16 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.708 -1.587 . . . . 0.0 114.3 178.479 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.566 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -60.33 107.35 0.64 Allowed 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.309 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.48 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER 44.36 36.61 1.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.958 0.409 . . . . 0.0 110.418 -179.474 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 90.58 36.19 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.586 -179.039 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -133.22 -119.16 1.99 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.692 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.684 ' O ' ' N ' ' A' ' 26' ' ' ASP . 2.0 p30 -100.94 -127.23 0.2 Allowed 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.642 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -100.65 120.16 39.64 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.079 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -109.4 126.8 66.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.781 -178.223 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.783 ' O ' ' N ' ' A' ' 38' ' ' GLY . 38.5 t -86.12 97.51 0.62 Allowed Pre-proline 0 C--O 1.22 -0.475 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.027 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -41.43 -16.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.321 2.681 . . . . 0.0 113.946 -179.141 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.707 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 2.2 mm-40 -87.82 -65.21 1.04 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.703 0.287 . . . . 0.0 111.073 -178.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.489 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 6.1 p -90.9 -19.68 23.06 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.479 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.783 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.89 34.95 88.74 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 113.86 -1.518 . . . . 0.0 111.741 -179.552 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.698 ' CD1' ' CG2' ' A' ' 41' ' ' VAL . 1.3 pp -71.22 145.65 49.51 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.488 HG21 ' CG ' ' A' ' 27' ' ' TYR . 86.5 t -113.54 121.99 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-O 121.209 0.528 . . . . 0.0 112.138 -176.591 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.698 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.4 t -134.01 133.69 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.64 179.298 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.564 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 128.67 171.81 13.06 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.308 179.287 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -103.68 129.09 50.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.86 0.362 . . . . 0.0 111.15 -179.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.72 -43.52 1.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.751 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.3 p 178.0 111.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.009 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.5 mp -114.58 26.81 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.195 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 t0 56.61 28.06 13.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.033 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -67.34 77.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 174.4 39.28 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.474 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.6 t -97.45 -33.67 11.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.764 0.316 . . . . 0.0 110.836 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -106.64 108.44 19.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.904 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 15.1 m0 59.31 -89.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? 44.58 60.06 3.05 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.826 0.346 . . . . 0.0 111.355 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.92 158.14 18.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.925 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -101.27 48.99 0.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.818 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.9 m 63.74 173.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.92 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -60.24 132.18 53.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -75.15 -54.28 7.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.851 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.904 0.383 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -79.12 86.36 4.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.961 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.36 26.47 1.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.014 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.27 122.64 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.889 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -122.98 -46.2 2.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.1 mp -94.96 154.27 17.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.861 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -167.2 47.31 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -173.31 83.79 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.093 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.405 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . 0.4 OUTLIER -76.45 -61.03 0.83 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.823 179.914 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 10' ' ' LEU . 75.4 Cg_endo -77.01 -168.06 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.607 2.205 . . . . 0.0 112.261 179.911 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.427 ' O ' ' CB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -100.15 -3.54 31.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.274 179.779 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.427 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 6.7 t 84.85 -23.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.775 -179.844 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.82 172.62 6.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.825 179.944 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.472 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 47.4 t -74.41 136.08 75.32 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.554 179.726 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.76 -21.61 73.17 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.28 1.986 . . . . 0.0 112.319 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -116.6 -9.53 11.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.348 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.715 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.1 m80 -131.48 87.19 47.39 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.775 0.322 . . . . 0.0 110.883 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.13 -34.1 94.61 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.345 2.03 . . . . 0.0 111.917 179.78 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.41 -26.76 35.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.231 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.463 ' CB ' ' HB3' ' A' ' 18' ' ' HIS . . . -81.52 87.62 6.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.201 0.524 . . . . 0.0 111.283 -179.882 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.569 ' O ' ' C ' ' A' ' 23' ' ' LEU . 15.3 mt -72.86 73.25 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.871 -178.556 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.569 ' C ' ' O ' ' A' ' 22' ' ' ILE . 1.5 mp -15.13 110.11 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.549 0.531 . . . . 0.0 110.513 179.321 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.8 t -79.09 161.58 4.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.202 0.525 . . . . 0.0 111.922 -177.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -80.8 133.88 35.7 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.733 -178.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.4 OUTLIER 72.32 80.83 0.14 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.98 -1.464 . . . . 0.0 114.331 178.488 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.561 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -60.86 108.43 0.86 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.312 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.485 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 44.1 35.83 1.31 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.996 0.427 . . . . 0.0 110.417 -179.604 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.485 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 90.68 36.64 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.582 -178.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -134.01 -119.32 1.97 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.71 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.68 ' O ' ' N ' ' A' ' 26' ' ' ASP . 2.0 p30 -99.72 -128.64 0.2 Allowed 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -179.698 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.531 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 6.8 mtm -100.61 121.96 42.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.998 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -110.46 126.18 67.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.887 -178.226 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.791 ' O ' ' N ' ' A' ' 38' ' ' GLY . 42.0 t -85.7 98.07 0.67 Allowed Pre-proline 0 C--O 1.219 -0.546 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.158 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -41.61 -16.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.333 2.688 . . . . 0.0 114.05 -178.964 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.715 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 9.7 mm-40 -88.82 -64.37 1.16 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.725 0.298 . . . . 0.0 111.143 -178.792 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.47 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 5.9 p -90.62 -19.42 23.7 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.389 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.791 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.31 33.72 85.85 Favored Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 113.789 -1.55 . . . . 0.0 111.667 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -69.77 143.08 53.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.954 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.527 HG21 ' CG ' ' A' ' 27' ' ' TYR . 72.9 t -109.75 114.55 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 O-C-N 123.384 0.428 . . . . 0.0 111.549 -177.777 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.635 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 76.0 t -121.46 134.42 64.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.467 178.711 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.572 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 130.34 19.14 1.39 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.543 178.672 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.69 -169.32 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 120.809 0.338 . . . . 0.0 111.464 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.62 133.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.301 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.1 p -94.28 -42.34 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.762 -179.146 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.402 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 17.6 mt 75.33 -57.37 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.033 -179.42 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 76.99 -74.3 0.07 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.981 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.402 ' CG2' ' CG2' ' A' ' 46' ' ' ILE . 15.9 t 62.0 28.84 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.049 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -127.24 -126.87 2.96 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.0 t 59.17 68.65 0.79 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.948 0.404 . . . . 0.0 110.865 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -109.34 -162.58 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.852 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -47.87 -58.45 4.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.151 -179.886 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 60.16 66.22 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 m -108.68 159.36 16.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -129.32 30.07 5.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.2 m 59.74 171.62 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -115.2 172.54 7.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.19 -65.9 1.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.927 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.869 0.366 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.62 27.85 6.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.22 18.68 13.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.184 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.6 m -88.46 -176.03 5.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.767 0.317 . . . . 0.0 110.759 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -132.2 -93.64 0.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.029 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.5 mp -148.31 -132.0 0.06 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.846 -0.161 . . . . 0.0 110.614 179.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.42 ' CB ' ' CD1' ' A' ' 10' ' ' LEU . 0.6 OUTLIER 69.68 -67.66 0.22 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.842 0.353 . . . . 0.0 110.487 -179.858 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 55.63 68.65 0.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.81 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.682 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -120.62 23.27 0.1 Allowed Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 179.292 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.682 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 61.1 Cg_endo -83.14 102.35 1.07 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.136 1.891 . . . . 0.0 112.342 179.726 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -176.32 168.23 2.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.938 0.399 . . . . 0.0 111.056 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.6 t -125.69 -22.19 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.786 -179.782 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.5 p -149.82 158.17 43.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.961 0.41 . . . . 0.0 111.253 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.577 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 45.9 t -61.94 137.88 95.52 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.139 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.51 -29.86 71.11 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.457 2.105 . . . . 0.0 111.589 179.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -93.96 -16.66 23.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.503 179.62 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 38.9 m80 -131.73 85.86 50.35 Favored Pre-proline 0 N--CA 1.453 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.337 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.85 -53.55 0.9 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.233 1.955 . . . . 0.0 111.701 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.24 -14.75 63.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.716 -179.832 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.47 ' CB ' ' HB3' ' A' ' 18' ' ' HIS . . . -101.09 114.01 27.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.113 0.482 . . . . 0.0 110.413 179.22 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.0 mt -91.83 127.5 44.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.823 -179.078 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.451 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.5 mp -59.45 102.07 0.13 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.845 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.532 HG22 ' HD3' ' A' ' 35' ' ' PRO . 3.1 t -66.48 157.17 5.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 121.293 0.568 . . . . 0.0 111.715 -178.603 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -86.95 102.6 14.52 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.007 -179.26 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.4 OUTLIER 70.66 118.03 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.672 179.321 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.483 ' HB3' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER 178.99 36.13 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.767 179.767 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 170.99 -84.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.68 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.12 -29.33 38.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.92 -7.66 21.68 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.169 178.733 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 23.2 m-20 -92.36 -119.42 0.08 Allowed 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.127 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.7 OUTLIER -117.39 110.23 17.78 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.637 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.915 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 1.2 tt -112.42 139.55 36.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.027 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.835 ' O ' ' N ' ' A' ' 38' ' ' GLY . 52.7 t -91.68 102.38 5.87 Favored Pre-proline 0 N--CA 1.448 -0.55 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.61 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.532 ' HD3' HG22 ' A' ' 24' ' ' VAL . 1.9 Cg_endo -40.13 -21.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.456 2.771 . . . . 0.0 113.614 -178.773 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.515 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 5.7 mm-40 -81.01 -68.25 0.7 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.743 -178.816 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.447 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 4.4 p -88.18 -18.68 28.19 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.548 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.835 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.66 22.39 71.67 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.089 -179.581 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.915 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -58.7 140.92 54.03 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.963 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 32' ' ' MET . 5.5 t -113.15 131.19 65.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.762 0.315 . . . . 0.0 110.586 -179.073 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.532 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 12.5 t -130.09 130.03 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.273 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.583 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 122.18 165.88 12.62 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.086 179.545 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.583 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 9.2 t0 138.72 -54.73 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.792 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.6 -168.43 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.425 179.655 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.51 -81.14 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.151 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.9 mp -86.47 127.07 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 0.0 111.02 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -63.32 -73.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.6 t -152.01 146.94 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 158.43 -28.53 0.44 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.545 179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.2 m -69.27 -57.13 5.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 0.0 110.863 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -72.46 155.34 40.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.891 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -64.53 -75.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 59.48 96.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -158.35 171.57 19.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -119.6 58.18 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.859 -179.983 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.1 m 60.56 -174.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.87 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -114.49 -174.85 2.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -101.99 -34.78 9.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.88 179.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.811 0.339 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 m -117.26 132.66 56.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.901 -179.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.67 104.68 1.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.831 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.86 38.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.002 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.16 109.27 7.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.67 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.71 112.27 16.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.16 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.71 -154.83 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.412 179.797 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.605 ' O ' ' CB ' ' A' ' 10' ' ' LEU . . . 76.72 179.67 0.15 Allowed 'General case' 0 C--N 1.334 -0.078 0 CA-C-O 120.576 0.227 . . . . 0.0 111.198 179.892 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.605 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 10.4 tt 120.72 -48.64 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 123.786 0.834 . . . . 0.0 110.485 -179.693 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 10' ' ' LEU . 72.7 Cg_endo -87.88 2.71 6.43 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.596 2.197 . . . . 0.0 112.48 179.676 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.29 48.41 12.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.905 0.384 . . . . 0.0 110.952 -179.813 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 m -54.79 -29.15 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.317 -179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 p -149.25 161.09 42.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.955 0.407 . . . . 0.0 111.348 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 45.5 t -75.81 136.41 70.4 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.724 179.839 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.04 -23.83 76.08 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.52 2.147 . . . . 0.0 112.522 -179.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -117.3 -7.69 11.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.449 -179.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.703 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.6 m80 -131.18 85.83 52.92 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.699 0.285 . . . . 0.0 110.779 179.63 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.98 -35.5 93.02 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.271 1.981 . . . . 0.0 111.897 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -78.57 -30.73 46.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.189 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.455 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -78.63 85.63 4.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.091 0.472 . . . . 0.0 111.246 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.529 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.8 mp -71.25 75.73 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.722 -178.6 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.612 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -18.09 107.53 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.002 179.419 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -75.91 167.6 2.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.225 -178.815 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -81.91 139.32 34.71 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 122.105 0.955 . . . . 0.0 111.207 -177.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 0.5 OUTLIER 53.97 95.5 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.68 -1.6 . . . . 0.0 114.64 178.701 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.569 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -68.68 110.18 4.15 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 177.913 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 4.8 mtt85 44.64 33.89 1.03 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.976 0.417 . . . . 0.0 110.105 -179.373 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 91.82 40.07 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.492 -178.86 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -134.0 -124.72 2.51 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.834 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.455 ' O ' ' CA ' ' A' ' 26' ' ' ASP . 0.2 OUTLIER -95.8 -145.97 0.28 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.61 0.243 . . . . 0.0 111.009 -179.589 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 52.6 mtp -85.73 116.06 23.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.38 0.61 . . . . 0.0 111.249 -179.31 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.828 HD12 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -100.82 123.24 53.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.496 -0.775 . . . . 0.0 113.047 -176.783 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.729 ' O ' ' N ' ' A' ' 38' ' ' GLY . 52.1 t -87.71 96.2 0.58 Allowed Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.525 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.5 Cg_endo -41.89 -15.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.405 2.737 . . . . 0.0 114.077 -179.089 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.703 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 4.2 mm-40 -87.14 -65.58 1.0 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.625 0.25 . . . . 0.0 111.057 -178.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.483 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 4.7 p -91.1 -20.68 21.77 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.221 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.828 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 69.99 38.56 74.43 Favored Glycine 0 N--CA 1.432 -1.624 0 CA-C-N 113.76 -1.564 . . . . 0.0 111.996 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.681 ' CD1' ' CG2' ' A' ' 41' ' ' VAL . 1.6 pp -76.53 149.11 36.72 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.835 -0.683 . . . . 0.0 109.872 179.375 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 32' ' ' MET . 38.4 t -117.53 119.68 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 121.088 0.471 . . . . 0.0 112.14 -177.427 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.681 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -132.73 136.07 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.385 179.57 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.93 162.52 10.98 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.755 179.455 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 45' ' ' VAL . 2.6 m-20 -158.98 -86.09 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.476 0.179 . . . . 0.0 110.572 179.783 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 44.48 -89.3 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.575 179.65 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' A' ' 43' ' ' ASP . 23.7 t 65.24 78.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.92 0.39 . . . . 0.0 111.217 179.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.404 HD13 HG22 ' A' ' 46' ' ' ILE . 13.4 tt -73.76 -30.03 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.048 179.856 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 t70 60.26 92.12 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.897 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.22 -75.4 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.005 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 133.71 -102.21 0.45 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.523 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.7 p -59.62 137.79 57.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.359 . . . . 0.0 110.948 -179.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -120.64 25.79 9.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.996 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.5 m0 59.94 -84.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.022 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? 48.66 79.68 0.07 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.733 0.301 . . . . 0.0 111.18 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.45 -172.96 3.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.952 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.434 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 27.4 p90 -109.92 64.39 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.87 172.56 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.812 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -117.1 176.3 5.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.937 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -74.01 -58.94 2.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.827 179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.939 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.803 0.335 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -68.34 -31.51 70.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.878 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.3 p -116.67 69.67 0.75 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.19 -70.18 0.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.783 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.9 mtt180 65.29 -76.48 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.107 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.53 -46.97 4.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.142 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 61.68 23.18 13.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.867 -179.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 179.64 173.11 0.91 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.799 180.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.453 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . 1.5 mt -164.75 -64.81 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.043 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' A' ' 10' ' ' LEU . 55.6 Cg_endo -70.21 -176.31 1.57 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.365 2.043 . . . . 0.0 112.36 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.86 -169.41 1.92 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.682 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.4 t -74.43 -79.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.596 -179.608 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.402 ' CG2' HG22 ' A' ' 22' ' ' ILE . 18.5 p -96.27 -148.74 0.3 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.999 -179.518 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 47.3 t -69.86 137.92 87.75 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.76 179.86 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.1 -21.96 73.2 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.316 2.011 . . . . 0.0 112.002 179.687 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -116.14 -10.16 11.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.19 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.735 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 41.9 m80 -130.61 88.43 46.79 Favored Pre-proline 0 C--O 1.232 0.18 0 CA-C-O 120.701 0.286 . . . . 0.0 110.525 178.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.78 -35.27 94.83 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.292 1.995 . . . . 0.0 111.788 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.41 -29.74 42.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.038 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -77.01 97.91 4.81 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 122.241 1.02 . . . . 0.0 111.168 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.515 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -80.84 74.94 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 112.787 -2.006 . . . . 0.0 113.698 -177.696 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.601 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.1 mp -20.85 102.71 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.768 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.4 t -71.7 166.3 2.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.15 -178.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -83.06 139.07 33.45 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-O 121.922 0.868 . . . . 0.0 110.76 -178.192 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.53 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 16.5 m-20 55.15 94.39 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 113.913 -1.494 . . . . 0.0 114.299 178.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.594 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 1.0 OUTLIER -63.35 90.32 0.05 OUTLIER 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.337 177.774 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.468 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 7.8 ttp-105 55.16 43.19 29.82 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.366 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 87.64 34.1 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.379 -178.715 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -130.1 -128.97 3.06 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.681 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.595 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -95.58 -146.19 0.28 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 -179.777 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.537 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 6.2 mtm -87.06 116.61 25.23 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 121.375 0.607 . . . . 0.0 111.569 -179.309 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.756 HD12 ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -102.81 121.63 54.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -176.885 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.743 ' O ' ' N ' ' A' ' 38' ' ' GLY . 25.7 t -86.79 96.84 0.57 Allowed Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.083 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.5 Cg_endo -41.79 -15.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.466 2.777 . . . . 0.0 114.069 -179.239 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.735 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 3.6 mm-40 -86.76 -65.9 0.96 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.675 0.274 . . . . 0.0 110.758 -178.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.465 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 3.9 p -90.71 -19.52 23.47 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.416 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.756 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 67.23 35.94 89.03 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 113.772 -1.558 . . . . 0.0 111.914 -179.728 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -74.27 150.54 40.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.762 -0.719 . . . . 0.0 109.878 179.379 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 32' ' ' MET . 23.7 t -115.87 116.11 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.825 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.499 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 97.6 t -123.3 133.16 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.931 178.256 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.426 ' CA ' ' HB3' ' A' ' 31' ' ' ASP . . . 125.25 -158.95 19.8 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.703 179.42 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.412 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . 7.4 t0 62.84 81.31 0.21 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.792 0.33 . . . . 0.0 110.626 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.405 ' CZ ' ' HB2' ' A' ' 44' ' ' ARG . 11.9 mtm105 -110.02 -70.32 0.82 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.397 -179.424 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 p -155.82 170.32 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.828 0.346 . . . . 0.0 111.172 -179.714 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.0 mt -115.06 127.7 72.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.933 0.397 . . . . 0.0 111.177 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -178.31 -39.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.3 p -56.21 -32.14 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.236 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -88.83 73.87 2.12 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.538 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.9 t -172.93 76.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 110.937 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.9 145.08 25.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.673 179.793 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 39.3 t90 -63.06 -89.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.845 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.78 91.55 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.766 0.317 . . . . 0.0 111.555 179.784 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.5 m -97.27 151.03 20.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.94 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.423 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 42.3 p90 -88.29 108.91 19.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.828 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 m 53.89 96.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.054 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -62.89 155.86 25.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.815 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.78 -65.62 0.97 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.936 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.909 -179.989 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.804 0.335 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.7 m -64.96 -31.41 72.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.876 179.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.9 p -75.65 -32.35 60.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.905 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -61.53 149.27 39.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.1 mtp85 -101.55 -78.76 0.52 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 179.62 -174.33 0.23 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.859 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -117.43 92.35 3.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.741 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -99.45 112.76 24.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.254 -179.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.4 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -179.84 -59.96 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.66 179.784 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.4 ' HD3' ' CB ' ' A' ' 10' ' ' LEU . 84.2 Cg_endo -81.03 -168.67 0.66 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.658 2.238 . . . . 0.0 112.407 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -141.77 129.5 21.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.504 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 94.5 t -51.16 -88.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.081 -179.83 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.74 177.18 2.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.046 0.451 . . . . 0.0 110.728 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 36.9 t -70.19 136.19 86.88 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.918 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.44 -21.72 73.12 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.275 1.984 . . . . 0.0 111.995 179.452 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -115.92 -12.32 11.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.241 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.677 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 31.6 m80 -125.14 86.71 56.49 Favored Pre-proline 0 N--CA 1.455 -0.193 0 CA-C-O 120.857 0.36 . . . . 0.0 111.456 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.84 38.3 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.192 2.595 . . . . 0.0 110.805 178.432 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -150.59 -43.03 0.12 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.76 179.742 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -78.62 86.1 4.63 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.894 178.612 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.566 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.2 mp -70.06 75.69 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.339 -178.119 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.566 ' C ' ' O ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -14.52 113.74 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.735 179.656 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.8 t -82.06 159.33 3.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.223 0.535 . . . . 0.0 111.84 -178.231 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 26' ' ' ASP . 2.4 mt-10 -79.26 139.15 37.95 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.077 -178.073 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 31' ' ' ASP . 1.0 OUTLIER 40.44 110.57 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.912 -1.495 . . . . 0.0 114.78 179.237 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.632 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -148.86 130.17 14.67 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.124 178.494 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.466 ' HB2' ' CE1' ' A' ' 27' ' ' TYR . 13.6 mmm-85 55.38 22.81 5.2 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.471 -179.779 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 170.04 -76.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.449 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.43 ' HA2' ' CB ' ' A' ' 26' ' ' ASP . . . 168.53 14.26 0.02 OUTLIER Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.473 179.464 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.496 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 65.4 m-20 -103.16 -166.69 1.3 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.71 0.255 . . . . 0.0 110.9 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.593 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -97.34 120.37 37.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.579 0.704 . . . . 0.0 112.257 -179.173 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.839 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -105.75 125.43 61.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.148 -177.712 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.721 ' O ' ' N ' ' A' ' 38' ' ' GLY . 39.8 t -88.43 97.33 0.81 Allowed Pre-proline 0 C--O 1.221 -0.398 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 177.23 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.0 Cg_endo -42.63 -14.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.405 2.737 . . . . 0.0 114.222 -178.877 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.677 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 1.9 mm-40 -89.25 -63.82 1.23 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.623 0.249 . . . . 0.0 111.326 -178.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.49 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 4.1 p -90.96 -21.15 21.47 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.247 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.839 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.38 39.0 81.17 Favored Glycine 0 N--CA 1.429 -1.772 0 CA-C-N 113.511 -1.677 . . . . 0.0 111.879 -179.692 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.69 ' CD1' ' CG2' ' A' ' 41' ' ' VAL . 1.4 pp -76.54 141.82 41.06 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.481 -0.859 . . . . 0.0 109.87 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 32' ' ' MET . 26.0 t -111.0 123.6 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-O 121.068 0.461 . . . . 0.0 111.46 -177.323 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.69 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.4 t -133.19 132.25 58.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.396 179.778 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.61 23.77 1.47 Allowed Glycine 0 CA--C 1.5 -0.881 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.012 179.835 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.15 62.88 6.1 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.607 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.5 mtt-85 -105.05 161.53 14.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.779 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.7 t -108.53 -94.71 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.87 179.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.403 ' N ' ' CD1' ' A' ' 46' ' ' ILE . 3.4 mp 42.08 86.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-O 120.817 0.342 . . . . 0.0 111.57 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.44 -30.66 61.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.996 -179.819 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.7 t 64.15 82.14 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.016 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -120.97 -34.27 0.91 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.694 -179.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.4 t -72.25 64.32 0.56 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.876 0.37 . . . . 0.0 111.035 -179.882 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 53' ' ' ARG . 2.4 tm-20 -177.47 35.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 12.3 m0 64.34 -71.15 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.168 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.8 OUTLIER 70.06 59.16 0.27 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.871 -179.91 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.68 174.84 11.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.886 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.405 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 14.7 p90 -123.91 86.01 2.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.887 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.22 172.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.857 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -164.18 154.31 14.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.92 -40.97 68.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.842 0.353 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 m -92.53 54.24 2.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 179.921 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.3 p -149.84 36.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.5 t -153.37 116.59 4.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.953 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.9 mtt85 -102.25 -31.54 10.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.906 179.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.5 mp -76.68 73.62 3.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -120.52 77.93 1.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.796 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -172.91 129.1 0.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.105 179.942 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tp -65.09 132.54 95.44 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.52 -60.66 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.387 2.058 . . . . 0.0 112.194 179.929 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.435 ' O ' ' CB ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -154.39 -68.42 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.86 179.959 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.435 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.3 OUTLIER 88.64 -20.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.669 -179.969 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -170.35 174.39 5.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.951 0.405 . . . . 0.0 110.972 179.75 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.1 t -77.84 135.32 63.68 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.963 -179.937 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.41 -21.33 53.86 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.481 2.12 . . . . 0.0 112.247 179.722 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -105.03 -29.61 10.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.862 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.632 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.8 m80 -118.42 88.59 34.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.065 179.784 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.12 -31.82 94.13 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.931 1.754 . . . . 0.0 110.993 179.188 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -81.33 -36.62 29.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.371 -179.911 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . . . -71.76 91.27 1.12 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.082 0.468 . . . . 0.0 110.697 179.808 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.548 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.8 mt -79.06 69.0 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.869 -178.411 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.601 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -12.27 123.44 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.229 179.43 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.657 ' O ' ' HA ' ' A' ' 32' ' ' MET . 21.2 t -85.94 157.47 3.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-O 121.413 0.625 . . . . 0.0 112.361 -178.022 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -76.84 127.79 33.39 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.009 -178.892 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.627 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 36.2 m-20 48.21 112.76 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.211 -0.904 . . . . 0.0 113.03 179.51 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.485 ' CG ' HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -160.26 150.25 18.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.787 178.898 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.425 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 22.6 tpp180 55.78 36.69 27.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.821 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.79 32.47 20.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.13 -178.143 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -135.49 -167.83 11.42 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.312 -0.947 . . . . 0.0 114.475 -178.619 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 10.2 m-20 -72.38 -118.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.681 0.792 . . . . 0.0 111.284 179.985 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.657 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 20.8 mtm -94.29 118.45 31.61 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.43 0.633 . . . . 0.0 111.39 -178.471 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -100.46 126.2 54.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.049 -177.481 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.84 ' O ' ' N ' ' A' ' 38' ' ' GLY . 7.0 t -86.85 99.73 1.24 Allowed Pre-proline 0 C--O 1.216 -0.671 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.527 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.0 Cg_endo -40.27 -20.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.19 2.594 . . . . 0.0 113.542 -179.351 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.632 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 14.8 mm-40 -89.78 -63.13 1.33 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.332 -178.569 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.467 ' SG ' ' CD2' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -89.44 -18.84 25.98 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 177.729 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.84 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 63.42 28.57 72.57 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 114.112 -1.403 . . . . 0.0 111.783 -179.551 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 1.3 pp -71.36 148.59 46.86 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.774 -0.713 . . . . 0.0 109.908 179.317 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 32' ' ' MET . 35.0 t -110.09 118.19 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 O-C-N 123.445 0.466 . . . . 0.0 110.983 -179.386 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.555 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 54.8 t -130.76 140.1 49.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.236 0.541 . . . . 0.0 111.238 179.892 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.15 162.37 10.36 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.533 179.046 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -173.32 -39.66 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.638 0.256 . . . . 0.0 110.896 179.887 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.24 121.86 2.34 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.418 -179.699 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.411 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 7.8 p -131.97 167.83 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.067 -179.558 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.411 ' HB ' ' O ' ' A' ' 45' ' ' VAL . 24.1 mt 79.99 127.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.012 0.434 . . . . 0.0 111.235 -179.94 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -141.92 28.7 1.73 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.77 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t 60.4 97.89 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.169 -179.949 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.29 27.84 1.97 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.502 -179.922 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.86 66.25 0.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.957 0.408 . . . . 0.0 110.906 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 53' ' ' ARG . 8.4 mt-10 -152.97 70.67 0.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.965 -179.934 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 66.21 -66.07 0.18 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.283 -179.985 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER 69.45 80.0 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.017 0.437 . . . . 0.0 110.752 -179.904 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.34 -164.16 1.85 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.723 -179.987 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -70.31 65.66 0.28 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.992 0.425 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.0 t 61.6 153.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.83 179.915 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -118.0 123.3 45.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -147.6 73.18 1.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.886 179.941 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.846 0.355 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 m -80.15 -49.08 12.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.987 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.3 m -106.51 68.31 0.75 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.91 -179.966 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.99 -39.53 3.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.857 -179.982 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? 60.97 172.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.853 -179.963 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.8 mp -131.64 -45.33 0.97 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 179.962 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -178.36 -74.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.964 179.968 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 76.29 -79.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.286 -179.933 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.459 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -84.85 -60.72 0.29 Allowed Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.702 -179.566 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.459 ' CD ' ' HB2' ' A' ' 10' ' ' LEU . 14.6 Cg_endo -56.85 -66.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.335 2.023 . . . . 0.0 112.697 -179.604 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 69.09 76.64 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.95 0.405 . . . . 0.0 110.586 -179.512 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.7 m -64.06 138.84 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.183 -179.759 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.9 p 57.69 179.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.712 -179.667 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 11.3 t -75.38 134.56 73.29 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.333 -179.776 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.98 -19.67 45.61 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.264 1.976 . . . . 0.0 111.516 178.837 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -112.56 -11.58 13.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.133 179.878 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.641 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 31.6 m80 -131.79 84.72 53.56 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-O 120.619 0.247 . . . . 0.0 111.455 179.838 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.57 -41.68 62.07 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.979 1.786 . . . . 0.0 110.773 178.832 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.54 -8.83 57.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.574 179.975 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.508 ' CB ' ' HB3' ' A' ' 18' ' ' HIS . . . -100.99 109.04 20.91 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.734 0.778 . . . . 0.0 110.856 179.187 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.567 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -90.98 66.24 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 114.024 -1.444 . . . . 0.0 113.422 -177.632 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.596 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 2.7 mp -10.9 115.29 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.445 179.038 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 32' ' ' MET . 16.2 t -82.39 154.88 3.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.435 0.636 . . . . 0.0 112.708 -177.518 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.4 126.87 31.89 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.989 -178.584 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.4 OUTLIER 50.54 105.68 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.349 179.881 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.448 ' HB3' HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -158.0 159.99 37.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.711 179.419 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 51.49 35.19 13.73 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.143 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.92 33.51 19.83 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.178 -178.249 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -138.57 -158.45 7.73 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.455 -0.879 . . . . 0.0 114.504 -178.634 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.641 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -82.34 -106.3 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.965 -0.617 . . . . 0.0 111.847 -179.479 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.644 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 15.7 mtp -103.4 114.85 29.44 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.574 0.702 . . . . 0.0 111.929 -177.756 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.855 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -101.41 128.22 53.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.55 -177.198 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.794 ' O ' ' N ' ' A' ' 38' ' ' GLY . 45.0 t -83.22 99.43 0.69 Allowed Pre-proline 0 N--CA 1.448 -0.541 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.522 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -39.9 -20.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.281 2.654 . . . . 0.0 113.742 -179.464 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.641 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 5.3 mm-40 -87.9 -64.9 1.08 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.592 -178.262 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.459 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 7.0 p -89.84 -20.02 23.94 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.788 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.794 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.25 32.0 78.77 Favored Glycine 0 N--CA 1.431 -1.657 0 CA-C-N 113.652 -1.613 . . . . 0.0 112.754 179.406 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.855 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -71.12 155.33 40.89 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.725 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 32' ' ' MET . 4.1 t -118.34 120.28 63.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 O-C-N 123.309 0.381 . . . . 0.0 111.595 -178.35 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 53.1 t -132.89 134.27 58.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.714 178.916 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.513 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 135.28 -172.65 22.02 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.42 178.824 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 3.1 t0 83.22 99.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.897 0.38 . . . . 0.0 110.549 -179.667 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -53.12 -44.17 67.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.175 -179.815 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.3 t 68.11 32.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.994 -179.921 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.2 mt -107.86 143.56 18.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.063 179.949 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -111.38 -26.84 8.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.152 -179.964 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.7 p -55.13 148.44 3.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.251 -179.915 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -160.04 161.66 32.59 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.403 179.907 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 t -175.06 45.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.888 0.375 . . . . 0.0 110.94 -179.931 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.43 16.68 21.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.153 179.974 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER 64.56 -75.81 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.091 179.92 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.99 83.55 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.934 -179.992 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.35 177.17 8.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.805 179.95 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -145.15 21.84 1.56 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 179.95 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 53.45 -168.6 0.06 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.809 0.338 . . . . 0.0 111.09 179.902 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -113.99 176.64 4.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 179.906 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -60.15 -63.54 1.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 179.924 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.826 0.346 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 m -95.81 14.5 23.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.271 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 49.7 p -86.72 -21.44 26.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.968 179.855 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.5 m -58.24 106.8 0.41 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.996 -179.995 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.1 mtt85 -147.2 -166.94 2.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.652 179.989 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.1 mt -51.49 98.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.015 179.953 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -142.29 -166.8 2.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.027 -179.892 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 66.1 -87.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.265 179.979 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.3 mt -158.73 161.17 28.82 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.817 -179.963 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.31 -166.08 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.488 2.125 . . . . 0.0 112.205 179.864 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.96 138.44 34.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.113 -179.814 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.5 m -99.47 35.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.964 179.773 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 172.45 -173.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.63 -179.99 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 13.3 t -83.69 135.07 43.56 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.804 179.657 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -68.38 -18.38 44.1 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.115 1.877 . . . . 0.0 111.95 179.256 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.35 -8.1 11.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.336 179.929 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.654 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 37.9 m80 -130.95 88.35 46.05 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 120.693 0.282 . . . . 0.0 110.529 179.216 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.78 -35.02 90.78 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.408 2.072 . . . . 0.0 112.082 179.875 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.39 -28.25 31.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.308 -179.747 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.494 ' CB ' ' HB3' ' A' ' 18' ' ' HIS . . . -78.12 87.73 4.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.23 0.538 . . . . 0.0 111.057 -179.881 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.55 ' O ' ' C ' ' A' ' 23' ' ' LEU . 14.3 mt -72.09 73.9 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.091 -178.347 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.55 ' C ' ' O ' ' A' ' 22' ' ' ILE . 2.2 mp -17.78 109.14 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.709 179.333 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.5 t -76.57 165.67 3.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.564 -178.512 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.13 137.03 35.96 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-O 121.941 0.877 . . . . 0.0 110.968 -177.874 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 18.8 m-20 59.27 91.98 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 178.273 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.613 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -63.71 99.46 0.23 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.552 177.935 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.507 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 6.8 mtp85 48.55 37.31 8.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.982 0.42 . . . . 0.0 110.098 -179.821 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 92.35 36.95 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.554 -178.911 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -133.25 -126.73 2.71 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.472 179.944 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 27' ' ' TYR . 4.5 m-20 -95.38 -143.49 0.26 Allowed 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 179.787 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.537 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -88.79 119.23 29.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.584 0.707 . . . . 0.0 111.733 -179.028 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.613 ' HB ' ' HB2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -103.63 123.7 57.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.621 -176.817 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.766 ' O ' ' N ' ' A' ' 38' ' ' GLY . 47.9 t -86.87 96.81 0.57 Allowed Pre-proline 0 N--CA 1.445 -0.687 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.898 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.2 Cg_endo -41.91 -15.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.28 2.654 . . . . 0.0 113.695 -179.278 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.654 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 13.1 mm-40 -86.3 -66.83 0.86 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.76 0.314 . . . . 0.0 110.845 -179.155 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.454 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 3.7 p -90.93 -19.86 22.83 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.429 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.766 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.68 36.24 87.26 Favored Glycine 0 N--CA 1.432 -1.626 0 CA-C-N 114.011 -1.45 . . . . 0.0 111.81 -179.737 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -75.5 148.84 38.66 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.884 -0.658 . . . . 0.0 109.772 179.229 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 32' ' ' MET . 37.0 t -111.74 115.7 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 123.295 0.372 . . . . 0.0 111.926 -178.39 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.44 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 54.4 t -123.82 135.55 63.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.253 178.551 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.09 164.24 10.79 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.914 178.837 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -167.39 -55.09 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.832 0.349 . . . . 0.0 110.573 179.74 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -139.41 144.57 38.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.907 179.858 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.95 128.65 52.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.292 -179.893 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.0 tp -148.42 136.52 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.027 179.928 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.18 -78.42 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.933 -179.962 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.1 p -178.77 -44.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 -179.94 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -132.19 100.08 0.41 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.508 -179.949 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.89 118.34 1.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.729 0.3 . . . . 0.0 110.912 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -171.44 150.06 2.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.983 0.42 . . . . 0.0 111.059 -179.943 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 29.6 t90 61.05 -97.95 0.07 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.067 179.923 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 24.5 ttm-85 51.8 100.4 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.828 0.347 . . . . 0.0 111.343 179.829 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.9 m -111.07 163.24 14.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.872 179.816 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -105.04 30.62 5.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.948 179.948 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 59.61 -173.57 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.953 179.894 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -173.04 170.24 4.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 179.956 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.48 -55.05 23.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.973 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.908 179.951 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.827 0.346 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.59 83.33 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.903 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.8 m -89.75 135.07 33.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.3 m -128.71 -50.87 1.25 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.997 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? 58.46 103.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.829 -179.87 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.28 60.16 3.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.939 -179.861 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -82.26 59.83 4.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.676 179.738 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.63 66.64 1.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.218 -179.769 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.504 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -126.41 45.29 1.45 Allowed Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.281 179.831 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 83.0 Cg_endo -79.79 133.12 10.09 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.385 2.056 . . . . 0.0 112.257 179.691 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -124.03 90.81 3.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.819 179.815 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.1 p -130.65 133.11 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.313 -179.824 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 p 56.72 179.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.08 179.968 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 39.1 t -78.69 135.07 60.32 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.876 -179.971 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.46 -19.89 54.73 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.379 2.053 . . . . 0.0 112.248 179.643 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -115.16 -10.25 12.18 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.411 -179.974 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.711 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.5 m80 -130.83 87.81 48.07 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.757 0.313 . . . . 0.0 110.663 179.508 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.84 -34.51 95.57 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.269 1.979 . . . . 0.0 111.812 179.789 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.44 -27.09 38.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.287 -179.892 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.446 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -82.85 85.14 7.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.146 0.498 . . . . 0.0 111.296 -179.78 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.2 mp -70.4 74.92 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.856 -1.066 . . . . 0.0 112.768 -178.69 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.582 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.1 mp -16.98 109.58 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.535 179.386 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.5 t -78.07 162.8 3.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.157 0.503 . . . . 0.0 111.758 -178.249 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -80.81 135.4 35.95 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.579 -178.303 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.618 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.4 OUTLIER 67.64 85.13 0.15 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.095 -1.412 . . . . 0.0 114.7 178.271 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.574 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 1.2 t80 -57.47 97.52 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.052 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.562 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 48.16 33.17 3.43 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.409 -179.908 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.562 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 100.65 28.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.855 -179.223 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -126.48 -124.49 2.75 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.132 179.679 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.618 ' O ' ' N ' ' A' ' 26' ' ' ASP . 2.3 p30 -99.14 -130.7 0.22 Allowed 'General case' 0 C--O 1.223 -0.329 0 O-C-N 122.958 -0.142 . . . . 0.0 110.866 179.606 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.53 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 9.4 mtm -97.86 119.72 36.98 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -177.907 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.82 HD11 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -107.56 125.43 63.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.301 -177.876 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.743 ' O ' ' N ' ' A' ' 38' ' ' GLY . 34.8 t -87.13 97.06 0.62 Allowed Pre-proline 0 C--O 1.222 -0.395 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.863 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.5 Cg_endo -41.9 -15.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.384 2.722 . . . . 0.0 114.244 -179.084 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.711 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 2.3 mm-40 -88.74 -64.38 1.15 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.697 0.284 . . . . 0.0 111.133 -178.787 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.458 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 4.1 p -90.84 -18.96 23.95 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.322 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.82 ' HA2' HD11 ' A' ' 33' ' ' ILE . . . 66.28 35.86 90.91 Favored Glycine 0 N--CA 1.431 -1.682 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.771 -179.374 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -72.97 144.45 47.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.621 -0.79 . . . . 0.0 109.49 179.378 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.512 ' CG1' ' OD1' ' A' ' 31' ' ' ASP . 1.9 t -112.53 116.0 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-O 121.027 0.441 . . . . 0.0 111.779 -178.001 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.554 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 97.0 t -122.6 132.74 70.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.788 177.96 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.604 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 119.46 -164.44 13.37 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.69 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.572 ' C ' ' O ' ' A' ' 42' ' ' GLY . 10.1 t0 -9.37 86.44 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.864 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.9 55.37 0.67 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.993 -179.662 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.1 t 64.99 54.24 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.186 179.903 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 pp -130.66 80.86 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.941 179.843 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.76 -75.89 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.96 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.96 73.36 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.066 -179.907 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.25 70.19 0.48 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.468 179.941 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.1 t 61.2 31.99 19.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.767 0.318 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.1 16.65 25.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.296 179.98 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 2.1 m0 63.84 -78.31 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.022 179.937 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.95 82.8 0.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.84 -179.922 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.88 152.92 38.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 -179.909 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -98.05 39.07 1.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 179.969 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.65 164.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.978 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -74.13 135.13 42.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.883 -179.971 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -86.6 -34.64 19.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.867 -179.97 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.927 179.968 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.761 0.315 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.3 m -70.98 -43.18 68.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.827 179.983 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.1 p -124.27 30.81 5.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.05 137.36 38.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 179.918 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.24 144.54 31.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 -179.973 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.84 154.62 21.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.818 -179.949 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -79.06 -3.48 45.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.509 179.981 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.0 104.84 5.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.9 0.381 . . . . 0.0 111.081 179.968 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.425 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . 2.0 mt -177.2 -62.42 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.721 179.941 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.425 ' CD ' ' CB ' ' A' ' 10' ' ' LEU . 39.7 Cg_endo -66.92 -28.24 42.51 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.472 2.115 . . . . 0.0 111.96 179.747 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 63.27 142.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.011 179.838 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.3 -84.14 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.798 179.77 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.596 ' CG2' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -88.79 -154.45 0.29 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.714 0.292 . . . . 0.0 110.519 179.864 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 45.4 t -67.22 138.66 94.6 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.403 178.936 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.89 -22.32 68.02 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.177 1.918 . . . . 0.0 111.954 179.197 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.19 -9.09 10.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.345 179.995 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 38.5 m80 -129.89 89.1 46.96 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.736 0.303 . . . . 0.0 110.937 179.238 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.46 -37.23 90.71 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.241 1.961 . . . . 0.0 111.791 179.632 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.54 -32.96 36.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.548 -179.695 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -71.45 89.46 0.94 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.169 0.509 . . . . 0.0 111.004 -179.85 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.596 ' HA ' ' CG2' ' A' ' 14' ' ' THR . 9.8 mm -70.64 78.95 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.958 -177.757 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.601 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 2.2 mp -26.93 107.23 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.173 0.511 . . . . 0.0 110.242 178.913 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -75.34 164.16 3.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.887 -178.283 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.595 ' O ' ' O ' ' A' ' 26' ' ' ASP . 1.7 mm-40 -80.97 135.86 35.93 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.633 -179.29 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.595 ' O ' ' O ' ' A' ' 25' ' ' GLU . 6.3 t70 36.79 123.19 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 179.827 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.473 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 56.0 t80 -138.97 120.45 15.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.67 177.887 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 60.5 42.53 14.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.286 -178.525 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 64.89 37.38 7.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.384 -178.534 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -120.15 -158.91 10.7 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.669 -0.777 . . . . 0.0 114.022 -178.725 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -91.88 -139.55 0.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.1 0.56 . . . . 0.0 110.248 179.96 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.545 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 5.6 mtm -81.86 114.64 20.61 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.682 0.753 . . . . 0.0 110.921 -179.723 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.715 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -100.78 124.09 54.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.565 -176.588 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.74 ' O ' ' N ' ' A' ' 38' ' ' GLY . 47.2 t -85.73 97.85 0.64 Allowed Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.366 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 3.9 Cg_endo -45.61 -12.76 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.844 2.363 . . . . 0.0 113.628 -179.112 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.577 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 4.8 mm-40 -88.81 -63.98 1.21 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.66 0.266 . . . . 0.0 111.204 -179.413 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.449 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 4.7 p -91.45 -22.59 20.35 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.398 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.74 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 70.4 41.63 66.86 Favored Glycine 0 N--CA 1.43 -1.74 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.033 -179.964 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.635 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -81.91 152.97 26.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.65 -0.775 . . . . 0.0 109.992 179.819 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 32' ' ' MET . 66.1 t -117.1 116.63 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.701 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.511 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 95.5 t -127.5 132.4 69.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.767 178.234 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.76 -159.09 21.54 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.066 -1.064 . . . . 0.0 111.974 179.614 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.427 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . 26.3 t70 67.02 32.82 6.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.904 0.383 . . . . 0.0 110.751 179.994 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -75.09 -176.01 2.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.033 -179.952 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 m -63.37 103.42 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.094 179.965 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.8 tp -178.69 110.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.118 -179.984 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.06 140.61 52.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.907 179.975 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.4 t -135.48 33.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.0 98.1 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.629 -179.94 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.85 100.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.791 0.329 . . . . 0.0 110.915 179.918 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.4 ' O ' ' CD1' ' A' ' 52' ' ' TRP . 2.7 mm-40 -63.48 -72.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.801 -179.988 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.4 ' CD1' ' O ' ' A' ' 51' ' ' GLU . 3.9 m-90 -143.32 -44.52 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.072 -179.984 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.37 34.56 2.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.964 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.65 179.36 2.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.875 179.925 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 55' ' ' PHE . 3.2 p90 -163.6 31.55 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 179.906 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m 59.29 174.94 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 179.974 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -131.66 168.31 17.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 -179.959 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -62.45 -60.22 3.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.813 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.894 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 35.2 t . . . . . 0 CA--C 1.527 0.06 0 CA-C-O 120.579 0.228 . . . . 0.0 110.838 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.49 -20.98 70.74 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.116 1.877 . . . . 0.0 111.905 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -116.79 -11.14 10.95 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.176 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.749 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 33.8 m80 -131.07 87.33 48.75 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.858 0.361 . . . . 0.0 110.603 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.93 -34.75 95.07 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.305 2.003 . . . . 0.0 111.903 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -79.4 -26.81 41.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.215 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -82.86 95.86 8.06 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 122.603 1.192 . . . . 0.0 111.599 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.535 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.89 72.61 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 112.228 -2.26 . . . . 0.0 112.956 -178.672 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.615 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.9 mp -19.71 108.75 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.88 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -77.0 165.81 2.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.182 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.467 ' H ' HG12 ' A' ' 24' ' ' VAL . 8.2 mt-10 . . . . . 0 N--CA 1.432 -1.358 0 CA-C-O 121.818 0.818 . . . . 0.0 110.105 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.607 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 29.0 mtt . . . . . 0 C--O 1.223 -0.291 0 CA-C-O 121.428 0.633 . . . . 0.0 111.57 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.692 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -105.03 123.52 59.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.988 -176.876 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.749 ' O ' ' N ' ' A' ' 38' ' ' GLY . 37.9 t -87.81 96.5 0.62 Allowed Pre-proline 0 N--CA 1.45 -0.461 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.5 Cg_endo -42.4 -14.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 123.304 2.669 . . . . 0.0 114.08 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.749 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 1.1 mm-40 -89.7 -63.75 1.24 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.576 0.227 . . . . 0.0 111.06 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.542 ' SG ' HD23 ' A' ' 39' ' ' LEU . 8.4 p -90.54 -20.44 22.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.749 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 68.39 33.76 78.14 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.314 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.774 ' CD1' HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -74.33 143.89 44.73 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 32' ' ' MET . 32.9 t -109.68 111.36 35.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.862 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.774 HG22 ' CD1' ' A' ' 39' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.606 0.241 . . . . 0.0 110.431 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 16.7 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.469 0.176 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.06 -18.94 63.17 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.068 1.845 . . . . 0.0 112.03 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -117.53 -9.32 10.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.35 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.683 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . 37.7 m80 -130.76 88.34 46.62 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-O 120.755 0.312 . . . . 0.0 110.437 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.67 -34.41 92.14 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.414 2.076 . . . . 0.0 112.03 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.25 -26.01 31.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.395 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.683 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -80.32 87.87 5.57 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.242 0.544 . . . . 0.0 111.255 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.535 ' O ' ' C ' ' A' ' 23' ' ' LEU . 13.6 mm -72.29 75.19 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.353 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.599 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 2.0 mp -20.5 107.47 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.556 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -74.94 167.95 2.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.181 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.512 ' H ' HG12 ' A' ' 24' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.432 -1.357 0 CA-C-O 122.051 0.929 . . . . 0.0 110.648 -178.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.561 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 8.2 mtt . . . . . 0 C--O 1.224 -0.245 0 CA-C-O 121.403 0.62 . . . . 0.0 111.597 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.603 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -103.68 121.3 54.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.826 -177.127 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.762 ' O ' ' N ' ' A' ' 38' ' ' GLY . 49.7 t -86.57 97.02 0.57 Allowed Pre-proline 0 N--CA 1.446 -0.635 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.2 Cg_endo -41.77 -15.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.343 2.695 . . . . 0.0 113.853 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.68 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 10.5 mm-40 -86.29 -66.89 0.85 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.8 0.333 . . . . 0.0 110.807 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.577 ' SG ' HD23 ' A' ' 39' ' ' LEU . 2.9 p -90.7 -18.7 24.59 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.762 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.24 35.18 90.0 Favored Glycine 0 N--CA 1.433 -1.551 0 CA-C-N 114.119 -1.401 . . . . 0.0 111.627 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.855 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -74.27 148.44 41.46 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.894 -0.653 . . . . 0.0 109.638 179.38 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 32' ' ' MET . 48.5 t -112.29 113.75 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 120.887 0.375 . . . . 0.0 111.847 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.855 HG23 ' CD1' ' A' ' 39' ' ' LEU . 55.5 t . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.063 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 14.5 t . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.518 0.199 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.87 -18.02 61.13 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.276 1.984 . . . . 0.0 112.304 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.07 -13.6 9.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.045 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.742 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 35.4 m80 -127.27 88.51 53.9 Favored Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.898 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.96 -40.12 55.16 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.417 2.078 . . . . 0.0 112.082 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -75.8 -35.4 60.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.346 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.783 ' HB2' ' HG2' ' A' ' 36' ' ' GLU . . . -75.85 79.64 2.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.234 0.54 . . . . 0.0 110.974 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.581 ' O ' ' C ' ' A' ' 23' ' ' LEU . 12.3 mt -69.88 72.44 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.918 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.817 HD11 HD21 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -7.61 110.77 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.73 179.163 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 32' ' ' MET . 14.2 t -83.3 155.86 3.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.514 0.673 . . . . 0.0 112.669 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.428 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.138 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.903 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.567 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 44.1 mtm . . . . . 0 N--CA 1.456 -0.144 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.773 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -141.7 130.9 23.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.494 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.791 ' O ' ' N ' ' A' ' 38' ' ' GLY . 18.0 t -88.97 97.58 0.93 Allowed Pre-proline 0 C--O 1.217 -0.637 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 2.7 Cg_endo -44.27 -14.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.921 2.414 . . . . 0.0 113.417 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.783 ' HG2' ' HB2' ' A' ' 21' ' ' ALA . 8.2 mm-40 -86.72 -65.14 1.05 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.567 0.222 . . . . 0.0 110.784 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.571 ' SG ' HD23 ' A' ' 39' ' ' LEU . 2.5 p -91.8 -24.7 19.31 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.791 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 74.1 41.19 40.39 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 113.395 -1.73 . . . . 0.0 112.103 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.817 HD21 HD11 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -79.14 146.5 33.13 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.928 -0.636 . . . . 0.0 109.534 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 32' ' ' MET . 95.9 t -111.94 122.75 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 O-C-N 123.532 0.52 . . . . 0.0 111.736 -177.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.734 HG23 ' CD1' ' A' ' 39' ' ' LEU . 22.4 t . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.797 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB2' HD12 ' A' ' 23' ' ' LEU . 38.5 t . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.532 0.206 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.49 -20.35 65.87 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.349 2.033 . . . . 0.0 112.405 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -114.75 -12.02 12.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.241 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.739 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.9 m80 -130.46 87.95 48.72 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 120.688 0.28 . . . . 0.0 110.565 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.56 -36.75 92.01 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.328 2.018 . . . . 0.0 111.785 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.28 -33.09 55.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.233 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -76.19 88.11 3.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.098 0.475 . . . . 0.0 111.307 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.568 ' O ' ' C ' ' A' ' 23' ' ' LEU . 9.9 mt -74.49 71.22 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.807 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.691 HD11 HD21 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -12.33 107.35 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.666 0.604 . . . . 0.0 110.886 179.419 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -77.86 164.42 3.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.171 0.51 . . . . 0.0 111.406 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.439 ' N ' HG12 ' A' ' 24' ' ' VAL . 4.0 mm-40 . . . . . 0 N--CA 1.432 -1.326 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.746 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.854 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 28.1 mtp . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 121.537 0.684 . . . . 0.0 112.194 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.857 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -101.49 123.41 54.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.762 -177.018 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.729 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.1 t -87.47 97.05 0.65 Allowed Pre-proline 0 N--CA 1.449 -0.495 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -40.78 -16.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.379 2.719 . . . . 0.0 114.149 -179.228 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.739 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 13.5 mm-40 -87.83 -64.81 1.09 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.634 0.254 . . . . 0.0 111.307 -178.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.684 ' SG ' HD23 ' A' ' 39' ' ' LEU . 5.7 p -90.37 -20.6 22.66 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.857 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.49 36.64 77.54 Favored Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 113.572 -1.649 . . . . 0.0 112.52 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.792 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -79.75 150.42 30.82 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.588 -0.806 . . . . 0.0 110.405 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.854 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.1 t -119.56 121.37 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-O 121.275 0.56 . . . . 0.0 112.429 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.792 HG23 ' CD1' ' A' ' 39' ' ' LEU . 87.3 t . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.01 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 15.0 t . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.421 0.153 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.1 -25.37 79.66 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.286 1.991 . . . . 0.0 111.961 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -108.48 -30.29 8.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.675 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.712 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 38.3 m80 -113.32 81.64 5.24 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.436 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.11 -33.48 97.44 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.03 1.82 . . . . 0.0 110.935 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -73.01 -42.39 63.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.285 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.579 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -74.97 87.52 2.33 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.11 0.481 . . . . 0.0 110.979 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.547 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.3 mp -68.93 74.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.713 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.72 HD22 HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -14.64 112.7 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.37 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.1 t -81.18 163.24 3.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.254 0.55 . . . . 0.0 111.222 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.415 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.428 -1.54 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.852 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 35.3 mtp . . . . . 0 C--O 1.227 -0.123 0 CA-C-O 121.662 0.744 . . . . 0.0 112.39 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.851 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -104.17 126.08 58.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.89 -177.9 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.752 ' O ' ' N ' ' A' ' 38' ' ' GLY . 42.1 t -91.16 98.82 1.83 Allowed Pre-proline 0 C--O 1.219 -0.545 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.3 Cg_endo -43.44 -14.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.216 2.611 . . . . 0.0 113.881 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.712 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 2.9 mm-40 -87.92 -64.69 1.11 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.759 0.314 . . . . 0.0 111.08 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.46 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 3.3 p -91.19 -21.3 21.2 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.851 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.67 38.76 77.95 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 113.645 -1.616 . . . . 0.0 111.739 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.977 HD11 HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -80.03 144.06 33.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.7 -0.75 . . . . 0.0 110.726 -179.48 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 32' ' ' MET . 47.4 t -104.89 112.84 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.016 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.977 HG22 HD11 ' A' ' 39' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 120.901 0.382 . . . . 0.0 110.868 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.652 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 47.4 t . . . . . 0 C--O 1.232 0.17 0 N-CA-C 110.442 -0.206 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 14.3 Cg_endo -56.12 -28.33 69.67 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.468 2.112 . . . . 0.0 111.865 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.41 -6.19 10.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.602 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.706 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . 39.4 m80 -128.62 88.63 51.65 Favored Pre-proline 0 C--O 1.231 0.121 0 CA-C-O 120.668 0.27 . . . . 0.0 111.265 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -61.58 -32.82 87.83 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.3 2.0 . . . . 0.0 112.008 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.53 -19.41 29.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.423 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.752 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -85.3 83.33 8.01 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.198 0.523 . . . . 0.0 110.834 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.445 ' O ' ' C ' ' A' ' 23' ' ' LEU . 5.4 mm -63.44 83.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.019 -1.446 . . . . 0.0 113.869 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.854 HD21 HD11 ' A' ' 39' ' ' LEU . 1.9 mp -34.02 111.87 0.12 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 32' ' ' MET . 2.8 t -73.5 163.33 4.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 121.344 0.592 . . . . 0.0 110.953 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.409 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.43 -1.438 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.873 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.602 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.221 -0.4 0 CA-C-O 121.252 0.549 . . . . 0.0 111.827 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.619 HG23 ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -102.76 119.18 50.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.723 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.756 ' O ' ' N ' ' A' ' 38' ' ' GLY . 35.9 t -85.79 97.14 0.53 Allowed Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 5.0 Cg_endo -44.97 -11.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.011 2.474 . . . . 0.0 113.951 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.752 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 5.5 mm-40 -89.93 -63.56 1.26 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 121.115 -0.234 . . . . 0.0 110.725 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.761 ' SG ' HD23 ' A' ' 39' ' ' LEU . 2.7 p -91.95 -20.25 21.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 176.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.756 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.49 40.11 91.12 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 114.068 -1.424 . . . . 0.0 111.208 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.854 HD11 HD21 ' A' ' 23' ' ' LEU . 1.4 pp -79.12 149.73 31.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.378 -0.911 . . . . 0.0 109.758 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 32' ' ' MET . 44.8 t -115.08 110.46 32.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.782 HG23 HD11 ' A' ' 39' ' ' LEU . 22.9 t . . . . . 0 N--CA 1.468 0.449 0 CA-C-O 120.917 0.389 . . . . 0.0 111.393 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.632 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 53.2 t . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.614 0.245 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.54 -30.55 71.22 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.447 2.098 . . . . 0.0 111.848 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -96.69 -14.58 21.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.895 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.86 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 37.8 m80 -130.69 86.65 52.07 Favored Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.028 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.59 -47.92 6.55 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.21 1.94 . . . . 0.0 111.912 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.91 -10.13 59.17 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.205 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.86 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -103.44 106.02 16.43 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.458 0.647 . . . . 0.0 111.166 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.9 mt -82.79 126.05 40.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.548 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.788 HD23 ' O ' ' A' ' 32' ' ' MET . 2.8 mp -63.78 130.91 46.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.28 0.562 . . . . 0.0 109.503 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 32' ' ' MET . 11.9 t -88.24 157.65 3.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.833 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 . . . . . 0 N--CA 1.434 -1.237 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.758 -178.823 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.788 ' O ' HD23 ' A' ' 23' ' ' LEU . 4.9 mtp . . . . . 0 C--O 1.222 -0.376 0 CA-C-O 121.03 0.443 . . . . 0.0 110.499 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.807 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -99.71 124.62 53.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -176.323 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.751 ' O ' ' N ' ' A' ' 38' ' ' GLY . 43.4 t -87.51 103.23 4.29 Favored Pre-proline 0 C--O 1.222 -0.344 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.8 Cg_endo -41.1 -21.06 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.304 2.67 . . . . 0.0 114.056 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.633 ' HG3' ' HB2' ' A' ' 21' ' ' ALA . 4.5 mm-40 -85.4 -66.16 0.93 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.886 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.693 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.1 p -89.87 -18.94 25.23 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.807 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 67.43 30.84 75.6 Favored Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.074 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.826 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -71.17 149.75 46.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.349 -0.926 . . . . 0.0 110.895 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' A' ' 32' ' ' MET . 24.1 t -113.31 126.74 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.687 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.826 HG23 ' CD1' ' A' ' 39' ' ' LEU . 92.2 t . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.41 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.517 ' HB2' HD12 ' A' ' 23' ' ' LEU . 44.7 t . . . . . 0 CA--C 1.529 0.157 0 CA-C-O 120.548 0.213 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.14 -21.26 62.88 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.516 2.144 . . . . 0.0 112.356 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -112.05 -13.1 13.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.183 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.722 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.5 m80 -131.36 88.02 45.34 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.728 0.299 . . . . 0.0 110.622 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.0 -34.14 99.05 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.366 2.044 . . . . 0.0 111.709 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.37 -28.12 34.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.396 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.633 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -81.5 87.2 6.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.187 0.518 . . . . 0.0 111.15 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.582 ' O ' ' C ' ' A' ' 23' ' ' LEU . 2.8 mm -74.63 70.56 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.779 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.899 HD21 HD11 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -9.86 111.13 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.666 0.604 . . . . 0.0 110.657 179.349 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 32' ' ' MET . 7.3 t -81.9 158.78 3.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.514 0.673 . . . . 0.0 112.394 -177.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.422 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.834 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.256 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 88.6 mtp . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.754 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -115.35 136.84 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.508 0.67 . . . . 0.0 111.956 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.858 ' O ' ' N ' ' A' ' 38' ' ' GLY . 38.5 t -87.63 96.71 0.62 Allowed Pre-proline 0 N--CA 1.439 -1.024 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.435 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.8 Cg_endo -39.3 -19.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.551 2.834 . . . . 0.0 113.836 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.722 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 2.4 mm-40 -85.94 -66.18 0.93 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.72 0.295 . . . . 0.0 110.655 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.554 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.0 p -89.59 -17.93 27.54 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.858 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 65.63 31.28 79.53 Favored Glycine 0 N--CA 1.435 -1.424 0 CA-C-N 113.986 -1.461 . . . . 0.0 111.562 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.943 ' CD1' HG23 ' A' ' 41' ' ' VAL . 1.3 pp -65.25 136.65 56.87 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 32' ' ' MET . 77.3 t -107.0 114.85 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 O-C-N 123.358 0.411 . . . . 0.0 111.027 -178.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.943 HG23 ' CD1' ' A' ' 39' ' ' LEU . 95.8 t . . . . . 0 N--CA 1.448 -0.563 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.659 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.57 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 49.3 t . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.458 0.17 . . . . 0.0 110.571 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.85 -21.85 71.94 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.182 1.921 . . . . 0.0 111.989 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -119.73 -7.56 10.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.384 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.691 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . 37.6 m80 -131.18 86.75 50.09 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-O 120.624 0.249 . . . . 0.0 111.11 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.15 -33.63 90.5 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.416 2.077 . . . . 0.0 112.011 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -83.3 -24.94 31.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.161 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.758 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -82.39 81.93 8.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.336 0.589 . . . . 0.0 110.638 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.51 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -66.68 78.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.47 -1.241 . . . . 0.0 113.395 -178.054 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.839 HD21 HD11 ' A' ' 39' ' ' LEU . 1.7 mp -22.43 106.95 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.712 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.509 HG12 ' H ' ' A' ' 25' ' ' GLU . 3.4 t -75.24 167.93 2.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.192 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.509 ' H ' HG12 ' A' ' 24' ' ' VAL . 2.9 mm-40 . . . . . 0 N--CA 1.432 -1.329 0 CA-C-O 121.922 0.867 . . . . 0.0 110.602 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.586 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 53.5 mtp . . . . . 0 C--O 1.225 -0.231 0 CA-C-O 121.364 0.602 . . . . 0.0 111.882 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.698 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -103.61 123.22 57.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.056 -176.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.75 ' O ' ' N ' ' A' ' 38' ' ' GLY . 44.5 t -86.24 96.77 0.52 Allowed Pre-proline 0 N--CA 1.448 -0.529 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 2.2 Cg_endo -43.2 -14.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 123.232 2.622 . . . . 0.0 113.935 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.758 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 8.7 mm-40 -88.89 -64.28 1.17 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.632 0.253 . . . . 0.0 110.952 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.774 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.6 p -91.16 -19.52 22.99 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.75 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.5 37.46 89.87 Favored Glycine 0 N--CA 1.432 -1.567 0 CA-C-N 113.822 -1.535 . . . . 0.0 111.986 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.839 HD11 HD21 ' A' ' 23' ' ' LEU . 1.2 pp -76.91 148.66 36.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.569 -0.816 . . . . 0.0 110.053 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 32' ' ' MET . 34.8 t -113.74 113.33 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.776 HG23 HD11 ' A' ' 39' ' ' LEU . 42.1 t . . . . . 0 N--CA 1.462 0.155 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.497 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 48.0 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.486 0.184 . . . . 0.0 110.726 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.46 -23.2 71.23 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.403 2.069 . . . . 0.0 112.444 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -117.68 -7.28 11.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.506 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.717 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.0 m80 -130.3 83.28 63.27 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.666 0.27 . . . . 0.0 111.049 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.3 -36.47 87.55 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.323 2.015 . . . . 0.0 111.769 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.77 -34.96 62.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.043 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -76.81 85.43 3.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.016 0.436 . . . . 0.0 110.968 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' C ' ' A' ' 23' ' ' LEU . 8.9 mm -69.96 74.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.295 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.704 HD11 HD21 ' A' ' 39' ' ' LEU . 1.3 mp -12.86 114.2 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.596 0.56 . . . . 0.0 110.893 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 32' ' ' MET . 5.9 t -83.53 157.49 3.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.387 0.613 . . . . 0.0 111.957 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.306 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.826 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.561 ' O ' HD23 ' A' ' 23' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.904 0.383 . . . . 0.0 110.87 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.73 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 5.8 tp -104.13 132.72 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.767 ' O ' ' N ' ' A' ' 38' ' ' GLY . 41.7 t -90.86 96.3 0.95 Allowed Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 176.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 5.1 Cg_endo -44.56 -10.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.102 2.534 . . . . 0.0 113.878 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.717 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 3.5 mm-40 -88.21 -64.0 1.21 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.632 ' SG ' HD23 ' A' ' 39' ' ' LEU . 6.0 p -91.32 -23.07 20.23 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.767 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 71.82 46.83 35.7 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.341 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.73 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.6 OUTLIER -86.68 139.42 30.78 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.053 -1.074 . . . . 0.0 109.607 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 32' ' ' MET . 18.6 t -108.41 119.72 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 O-C-N 123.679 0.612 . . . . 0.0 111.476 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.607 HG22 ' CD1' ' A' ' 39' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.57 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.567 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 35.8 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.46 0.171 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.92 -19.27 66.46 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.297 1.998 . . . . 0.0 111.818 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.21 -13.0 12.4 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.011 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.712 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.5 m80 -130.79 87.63 48.76 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.284 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.96 -35.0 94.8 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.453 2.102 . . . . 0.0 111.927 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.38 -28.79 41.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.048 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.613 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -79.85 88.21 5.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.066 0.46 . . . . 0.0 111.2 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.551 ' O ' ' C ' ' A' ' 23' ' ' LEU . 17.7 mt -74.7 72.25 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.793 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 32' ' ' MET . 0.9 OUTLIER -14.08 103.02 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.034 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.1 t -75.19 166.27 2.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.652 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.463 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.443 -0.804 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.965 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.738 ' O ' HD23 ' A' ' 23' ' ' LEU . 1.1 mtp . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.961 0.41 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.628 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -99.95 124.78 53.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.158 -177.573 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.77 ' O ' ' N ' ' A' ' 38' ' ' GLY . 32.1 t -87.53 97.2 0.69 Allowed Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.3 Cg_endo -40.3 -17.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.548 2.832 . . . . 0.0 113.913 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.712 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 8.4 mm-40 -87.28 -65.88 0.97 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.591 0.234 . . . . 0.0 110.877 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.628 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.6 p -90.07 -18.6 25.62 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.77 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.93 33.39 83.8 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 114.084 -1.416 . . . . 0.0 111.769 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.82 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -72.61 145.58 47.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.916 -0.642 . . . . 0.0 109.592 179.105 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 32' ' ' MET . 2.4 t -115.08 117.61 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 120.983 0.42 . . . . 0.0 111.586 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.82 HG23 ' CD1' ' A' ' 39' ' ' LEU . 86.3 t . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.408 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.557 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 40.1 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.469 0.176 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.94 -20.59 70.01 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.3 2.0 . . . . 0.0 111.976 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -116.5 -11.91 11.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.199 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.679 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.2 m80 -130.04 88.57 48.09 Favored Pre-proline 0 C--N 1.333 -0.142 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.803 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.74 -37.16 88.9 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.474 2.116 . . . . 0.0 111.922 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -78.57 -32.82 47.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.417 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.774 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -75.42 84.77 2.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.238 0.542 . . . . 0.0 110.891 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.555 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.2 mp -70.61 73.67 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.177 -178.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.603 HD11 HD21 ' A' ' 39' ' ' LEU . 1.9 mp -15.49 118.95 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.524 0.515 . . . . 0.0 110.508 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 32' ' ' MET . 22.6 t -86.57 151.15 3.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.638 0.732 . . . . 0.0 112.469 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.441 -0.917 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.935 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.621 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 22.8 mtm . . . . . 0 N--CA 1.444 -0.77 0 CA-C-O 121.66 0.743 . . . . 0.0 111.389 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.908 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -102.15 128.4 54.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.996 -177.59 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.784 ' O ' ' N ' ' A' ' 38' ' ' GLY . 41.5 t -85.68 98.67 0.76 Allowed Pre-proline 0 N--CA 1.445 -0.717 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 1.2 Cg_endo -42.68 -16.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.16 2.573 . . . . 0.0 113.699 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.774 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 14.4 mm-40 -89.2 -63.92 1.22 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.504 0.193 . . . . 0.0 111.076 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.589 ' SG ' HD23 ' A' ' 39' ' ' LEU . 6.0 p -90.74 -21.46 21.56 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.908 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 70.12 38.18 72.93 Favored Glycine 0 N--CA 1.432 -1.606 0 CA-C-N 113.546 -1.661 . . . . 0.0 112.449 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.889 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -78.08 146.02 35.47 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.753 -0.724 . . . . 0.0 110.021 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 32' ' ' MET . 23.0 t -110.81 117.7 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 O-C-N 123.43 0.456 . . . . 0.0 111.705 -178.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.889 HG23 ' CD1' ' A' ' 39' ' ' LEU . 63.2 t . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.869 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.435 ' HB2' HD12 ' A' ' 23' ' ' LEU . 7.7 t . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.498 0.189 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -66.86 -20.91 51.3 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.327 2.018 . . . . 0.0 111.967 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -111.7 -14.83 13.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.979 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.703 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.0 m80 -130.47 87.32 50.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.668 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.87 -38.09 81.79 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.395 2.063 . . . . 0.0 111.967 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.96 -39.07 61.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.226 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -70.82 91.93 0.87 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.968 0.413 . . . . 0.0 111.149 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.586 ' O ' ' C ' ' A' ' 23' ' ' LEU . 8.6 mm -77.86 67.21 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.432 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.639 HD11 HD21 ' A' ' 39' ' ' LEU . 0.9 OUTLIER -5.32 102.84 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.154 179.614 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.5 t -77.22 163.58 3.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 121.339 0.59 . . . . 0.0 111.781 -178.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.445 ' N ' HG12 ' A' ' 24' ' ' VAL . 2.0 mm-40 . . . . . 0 N--CA 1.441 -0.916 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.782 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.833 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 15.5 mtt . . . . . 0 C--O 1.225 -0.219 0 N-CA-C 110.619 -0.141 . . . . 0.0 110.619 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.714 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -112.99 134.07 56.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -177.719 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.821 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.4 t -87.63 97.75 0.81 Allowed Pre-proline 0 C--O 1.218 -0.569 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.8 Cg_endo -39.22 -19.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.549 2.833 . . . . 0.0 113.627 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.703 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 12.1 mm-40 -85.58 -66.84 0.85 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.732 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.668 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.7 p -90.08 -20.69 22.88 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 177.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.821 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 70.25 32.36 68.77 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 114.025 -1.443 . . . . 0.0 112.217 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.714 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -71.51 141.41 50.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.717 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.833 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.3 t -108.8 127.0 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-O 120.692 0.282 . . . . 0.0 111.004 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.603 HG22 ' CD1' ' A' ' 39' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.986 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.495 ' CB ' ' HG ' ' A' ' 34' ' ' CYS . 48.3 t . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.508 0.194 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.62 -24.09 77.37 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.266 1.978 . . . . 0.0 112.068 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -118.06 -7.25 10.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.484 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.744 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 32.7 m80 -133.15 80.76 58.54 Favored Pre-proline 0 C--N 1.333 -0.129 0 CA-C-O 120.734 0.302 . . . . 0.0 111.692 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -57.74 -36.52 98.36 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.887 1.725 . . . . 0.0 111.06 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.53 -48.73 63.56 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.258 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.604 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -71.09 85.98 0.74 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.248 0.547 . . . . 0.0 111.073 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.555 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.6 mp -67.75 75.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.846 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.667 HD11 HD21 ' A' ' 39' ' ' LEU . 1.1 mp -14.24 112.2 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.912 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -81.31 160.19 3.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.277 0.56 . . . . 0.0 111.644 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.408 ' N ' HG12 ' A' ' 24' ' ' VAL . 15.6 mm-40 . . . . . 0 N--CA 1.44 -0.968 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.85 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.598 ' O ' HD23 ' A' ' 23' ' ' LEU . 73.3 mtp . . . . . 0 N--CA 1.446 -0.636 0 CA-C-O 121.475 0.655 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.73 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -100.68 125.68 54.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.403 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.731 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.0 t -88.87 98.27 1.09 Allowed Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.1 Cg_endo -43.57 -14.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.181 2.587 . . . . 0.0 114.068 -178.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.744 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 4.0 mm-40 -89.45 -63.07 1.34 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 121.215 -0.194 . . . . 0.0 111.409 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.658 ' SG ' HD23 ' A' ' 39' ' ' LEU . 16.1 p -91.37 -23.23 20.13 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.731 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 72.18 37.53 59.6 Favored Glycine 0 N--CA 1.428 -1.892 0 CA-C-N 113.285 -1.78 . . . . 0.0 112.651 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.698 ' CD1' HG22 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -77.36 145.82 37.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.155 179.672 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 32' ' ' MET . 59.0 t -111.35 116.1 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 O-C-N 123.847 0.717 . . . . 0.0 111.069 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.698 HG22 ' CD1' ' A' ' 39' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.471 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 10.5 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.566 0.222 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.8 -23.75 74.43 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.24 1.96 . . . . 0.0 111.995 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -106.93 -30.01 9.11 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.719 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.636 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 39.6 m80 -108.25 87.53 4.1 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.18 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.61 39.73 0.65 Allowed 'Trans proline' 0 CA--C 1.515 -0.444 0 C-N-CA 123.168 2.578 . . . . 0.0 111.013 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 18' ' ' HIS . 46.8 m-20 -152.64 -48.05 0.1 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.143 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.436 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -69.58 93.46 0.7 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.991 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.574 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.5 mp -76.04 71.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.946 -1.025 . . . . 0.0 113.182 -177.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.092 HD21 HD11 ' A' ' 39' ' ' LEU . 0.9 OUTLIER -8.84 111.35 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.901 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 32' ' ' MET . 15.4 t -81.76 152.44 4.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 121.646 0.736 . . . . 0.0 112.609 -177.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 . . . . . 0 C--N 1.318 -0.787 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.005 -179.041 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.577 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 16.7 mtp . . . . . 0 N--CA 1.434 -1.238 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.028 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -109.09 137.91 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 CA-C-O 122.113 0.959 . . . . 0.0 112.048 -176.396 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.811 ' O ' ' N ' ' A' ' 38' ' ' GLY . 33.1 t -91.25 99.17 2.07 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 113.542 -1.663 . . . . 0.0 109.181 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.476 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.1 Cg_endo -41.41 -15.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.312 2.675 . . . . 0.0 113.603 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.636 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 9.3 mm-40 -87.18 -65.0 1.06 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.484 0.183 . . . . 0.0 110.627 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.545 ' SG ' HD23 ' A' ' 39' ' ' LEU . 1.6 p -90.07 -21.0 22.52 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 176.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.811 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 69.06 40.16 83.66 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.963 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.092 HD11 HD21 ' A' ' 23' ' ' LEU . 1.5 pp -77.26 136.85 38.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.024 -1.088 . . . . 0.0 108.378 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 32' ' ' MET . 42.9 t -105.6 126.45 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 O-C-N 123.399 0.437 . . . . 0.0 111.234 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.567 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.4 t . . . . . 0 N--CA 1.448 -0.574 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.224 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 42.7 t . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.482 0.182 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.18 -28.41 56.25 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.338 2.025 . . . . 0.0 111.238 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -91.08 -20.35 22.14 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.335 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.612 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 40.5 m80 -130.66 85.92 54.36 Favored Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.325 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.73 -40.54 53.86 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.958 1.772 . . . . 0.0 110.99 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.0 -13.96 59.69 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.974 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.58 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -97.76 133.77 41.83 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.66 0.743 . . . . 0.0 110.985 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.539 ' H ' HD12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -108.11 123.98 64.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.774 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.93 HD23 ' O ' ' A' ' 32' ' ' MET . 4.9 mp -67.89 93.86 0.43 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 32' ' ' MET . 2.7 t -49.91 161.83 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.208 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 . . . . . 0 N--CA 1.442 -0.833 0 CA-C-O 122.428 1.109 . . . . 0.0 112.13 -176.926 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.93 ' O ' HD23 ' A' ' 23' ' ' LEU . 36.2 mtm . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 121.308 0.575 . . . . 0.0 111.413 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.814 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -98.82 121.62 49.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.132 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.814 ' O ' ' N ' ' A' ' 38' ' ' GLY . 38.9 t -84.35 100.4 1.06 Allowed Pre-proline 0 C--O 1.221 -0.406 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.484 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 3.9 Cg_exo -36.8 -26.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.804 3.003 . . . . 0.0 114.064 -179.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.612 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 27.2 mm-40 -82.63 -67.36 0.79 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.523 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.731 ' SG ' HD23 ' A' ' 39' ' ' LEU . 2.6 p -87.92 -15.07 37.63 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.814 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 61.84 25.55 65.94 Favored Glycine 0 N--CA 1.433 -1.542 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.31 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.858 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -65.25 150.37 48.34 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.354 -0.923 . . . . 0.0 110.116 -179.844 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 32' ' ' MET . 2.7 t -118.17 120.19 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.858 HG23 ' CD1' ' A' ' 39' ' ' LEU . 84.9 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.164 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 43.3 t . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 120.65 0.262 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.73 -28.97 51.57 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.601 2.201 . . . . 0.0 112.03 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.19 -16.31 19.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.713 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.672 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 39.9 m80 -131.92 85.23 51.45 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.293 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.68 -43.54 37.87 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.074 1.85 . . . . 0.0 111.321 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -74.64 -12.01 60.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.372 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -102.5 102.35 12.63 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.136 0.494 . . . . 0.0 111.812 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.494 ' H ' HD12 ' A' ' 22' ' ' ILE . 1.8 mp -76.38 130.76 35.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.755 HD23 ' O ' ' A' ' 32' ' ' MET . 3.2 mp -72.19 135.69 46.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.657 0.742 . . . . 0.0 111.125 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 32' ' ' MET . 42.9 t -87.63 156.84 3.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.208 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.432 -1.338 0 CA-C-O 121.936 0.874 . . . . 0.0 111.314 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.755 ' O ' HD23 ' A' ' 23' ' ' LEU . 75.8 mtp . . . . . 0 C--O 1.223 -0.323 0 CA-C-O 121.01 0.433 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.662 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -99.42 123.19 51.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -176.596 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.771 ' O ' ' N ' ' A' ' 38' ' ' GLY . 30.4 t -88.86 100.17 1.94 Allowed Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -40.11 -20.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.589 2.859 . . . . 0.0 114.09 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.672 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 6.4 mm-40 -87.36 -64.5 1.14 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.755 0.312 . . . . 0.0 111.409 -177.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.445 ' SG ' HD23 ' A' ' 39' ' ' LEU . 7.6 p -89.86 -20.23 23.68 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.771 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 68.15 29.14 73.2 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.222 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.808 HD11 HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -69.0 145.95 53.14 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.159 -0.521 . . . . 0.0 110.422 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' MET . 40.4 t -109.3 120.51 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 O-C-N 123.904 0.753 . . . . 0.0 110.493 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.808 HG22 HD11 ' A' ' 39' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.367 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 19.2 t . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 120.532 0.206 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.85 -26.32 32.18 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.322 2.015 . . . . 0.0 111.535 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.55 -16.98 18.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.74 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.643 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 39.1 m80 -131.87 84.32 54.42 Favored Pre-proline 0 N--CA 1.455 -0.224 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.205 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.96 -44.86 27.24 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 121.937 1.758 . . . . 0.0 111.528 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.98 -12.77 60.74 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -102.12 102.37 12.83 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.826 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.461 ' H ' HD12 ' A' ' 22' ' ' ILE . 1.3 mp -75.65 125.11 34.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.797 HD22 HG23 ' A' ' 41' ' ' VAL . 2.7 mp -67.63 147.69 52.38 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.391 0.615 . . . . 0.0 110.509 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 32' ' ' MET . 50.2 t -95.08 146.78 6.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.039 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 . . . . . 0 N--CA 1.43 -1.425 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.323 -178.615 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.636 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 9.4 mtt . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 121.232 0.539 . . . . 0.0 111.564 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.771 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -98.23 123.26 50.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.894 -177.604 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.763 ' O ' ' N ' ' A' ' 38' ' ' GLY . 52.8 t -88.68 102.26 3.75 Favored Pre-proline 0 C--O 1.222 -0.379 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.489 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.7 Cg_endo -40.95 -20.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.398 2.732 . . . . 0.0 113.953 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.643 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 30.9 mm-40 -86.83 -65.52 1.01 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.571 -177.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.483 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 6.4 p -90.23 -20.47 22.96 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.771 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.29 30.29 71.62 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 113.715 -1.584 . . . . 0.0 112.437 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.737 ' CD1' HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -71.26 146.41 48.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.249 -0.475 . . . . 0.0 110.451 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 32' ' ' MET . 26.6 t -106.28 119.29 55.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 O-C-N 123.905 0.753 . . . . 0.0 109.489 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.797 HG23 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.44 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.824 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 42.9 t . . . . . 0 CA--C 1.53 0.173 0 CA-C-O 120.633 0.254 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.11 -28.49 48.72 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.389 2.06 . . . . 0.0 111.772 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -95.82 -18.18 20.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.522 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.706 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 40.1 m80 -131.31 86.18 51.23 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.329 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.31 -45.33 19.11 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 121.995 1.797 . . . . 0.0 111.309 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -72.33 -14.41 61.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.419 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -100.76 105.94 17.31 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.582 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.6 mm -81.89 128.17 38.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.564 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.871 HD21 HD11 ' A' ' 39' ' ' LEU . 3.5 mp -67.32 137.55 56.14 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.095 0.474 . . . . 0.0 110.465 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.717 ' O ' ' HA ' ' A' ' 32' ' ' MET . 43.7 t -88.18 142.28 13.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.332 0.587 . . . . 0.0 111.482 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.443 -0.805 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.09 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.717 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.66 0 CA-C-O 121.068 0.461 . . . . 0.0 111.451 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.787 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -102.71 126.24 56.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.517 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.792 ' O ' ' N ' ' A' ' 38' ' ' GLY . 41.0 t -90.18 99.96 2.27 Favored Pre-proline 0 C--O 1.22 -0.453 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.8 Cg_endo -40.24 -21.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.458 2.772 . . . . 0.0 114.097 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.706 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 31.7 mm-40 -84.52 -65.31 1.02 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.669 0.271 . . . . 0.0 111.216 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.774 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.7 p -89.82 -18.51 26.12 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.792 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.51 28.49 73.6 Favored Glycine 0 N--CA 1.433 -1.545 0 CA-C-N 113.641 -1.618 . . . . 0.0 112.074 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.871 HD11 HD21 ' A' ' 23' ' ' LEU . 1.3 pp -67.09 140.67 57.6 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.615 -0.793 . . . . 0.0 110.558 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' A' ' 32' ' ' MET . 29.3 t -110.32 118.71 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.508 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.608 HG22 ' CD1' ' A' ' 39' ' ' LEU . 1.5 t . . . . . 0 C--O 1.207 -1.183 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 11.3 t . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.523 0.202 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.3 -19.32 44.1 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.264 1.976 . . . . 0.0 111.6 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -115.09 -11.06 12.12 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.304 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.655 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . 38.6 m80 -130.96 87.31 49.26 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-O 120.624 0.249 . . . . 0.0 110.583 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.33 -36.2 88.33 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.313 2.008 . . . . 0.0 112.004 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -79.26 -31.92 43.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.005 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.655 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -75.05 88.45 2.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.058 0.456 . . . . 0.0 111.278 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.55 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.7 mp -75.2 70.12 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.201 -0.908 . . . . 0.0 112.827 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.832 HD21 HD11 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -12.22 111.25 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.536 179.481 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 25' ' ' GLU . 3.3 t -79.34 167.35 2.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.137 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.48 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.431 -1.393 0 CA-C-O 121.71 0.766 . . . . 0.0 110.229 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.657 ' O ' HD23 ' A' ' 23' ' ' LEU . 1.9 mtt . . . . . 0 C--O 1.221 -0.403 0 CA-C-O 121.402 0.62 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.851 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -99.97 123.4 52.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -176.149 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.74 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.8 t -88.56 96.28 0.65 Allowed Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.2 Cg_endo -41.84 -15.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.382 2.722 . . . . 0.0 113.743 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.646 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 18.2 mm-40 -85.1 -67.49 0.8 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.905 0.383 . . . . 0.0 111.034 -178.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.792 ' SG ' HD23 ' A' ' 39' ' ' LEU . 2.9 p -90.85 -19.56 23.25 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.851 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.18 38.72 82.99 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.149 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.832 HD11 HD21 ' A' ' 23' ' ' LEU . 1.6 pp -78.05 147.0 34.96 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.438 -0.881 . . . . 0.0 110.281 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 32' ' ' MET . 49.1 t -112.23 118.63 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 123.354 0.409 . . . . 0.0 111.945 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.692 HG22 ' CD1' ' A' ' 39' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.241 178.043 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 32.8 t . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.433 0.159 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.5 -19.97 65.54 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.259 1.973 . . . . 0.0 111.911 179.39 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.16 -10.88 10.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.258 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.734 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.9 m80 -130.58 87.99 48.24 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.797 0.332 . . . . 0.0 110.829 179.575 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.32 -34.75 97.84 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.306 2.004 . . . . 0.0 111.752 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.96 -25.49 37.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.385 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.623 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -84.33 83.9 7.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.158 0.504 . . . . 0.0 111.377 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' C ' ' A' ' 23' ' ' LEU . 16.1 mm -72.18 74.27 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.737 -178.715 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.78 HD11 HD21 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -15.37 113.52 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.439 179.511 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 32' ' ' MET . 5.0 t -81.23 160.58 3.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.271 0.558 . . . . 0.0 111.822 -178.151 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.418 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.319 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.829 -178.115 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.569 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 6.7 mtm . . . . . 0 CA--C 1.531 0.238 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.794 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -106.51 124.07 61.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.844 -178.154 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.752 ' O ' ' N ' ' A' ' 38' ' ' GLY . 40.4 t -86.83 97.04 0.59 Allowed Pre-proline 0 C--O 1.221 -0.446 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.3 Cg_endo -41.86 -15.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.378 2.719 . . . . 0.0 114.267 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.734 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 6.2 mm-40 -88.55 -64.51 1.14 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.738 0.304 . . . . 0.0 111.173 -178.73 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.75 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.5 p -90.94 -19.6 23.11 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.38 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.794 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 67.1 36.42 90.45 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.684 -179.397 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.78 HD21 HD11 ' A' ' 23' ' ' LEU . 1.2 pp -73.16 145.01 46.66 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.569 -0.816 . . . . 0.0 109.315 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 32' ' ' MET . 53.7 t -114.66 119.94 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 121.044 0.45 . . . . 0.0 112.08 -176.669 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.706 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.2 t . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.247 179.563 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB2' HD12 ' A' ' 23' ' ' LEU . 9.3 t . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.518 0.199 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.1 -18.9 39.9 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.285 1.99 . . . . 0.0 111.861 179.473 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -115.91 -9.46 11.8 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.266 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.738 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 36.1 m80 -131.03 88.06 46.67 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.653 0.263 . . . . 0.0 111.043 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.19 -33.24 90.87 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.433 2.089 . . . . 0.0 112.072 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.79 -23.58 27.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.504 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.745 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -84.06 82.45 8.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.289 0.566 . . . . 0.0 110.671 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.535 ' O ' ' C ' ' A' ' 23' ' ' LEU . 3.7 mt -69.42 75.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.552 -177.857 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.621 HD11 HD21 ' A' ' 39' ' ' LEU . 1.3 mp -18.68 109.83 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 O-C-N 123.618 0.574 . . . . 0.0 110.577 179.04 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.4 t -78.24 163.02 3.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.234 0.54 . . . . 0.0 111.959 -178.108 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.438 ' N ' HG12 ' A' ' 24' ' ' VAL . 5.7 mt-10 . . . . . 0 N--CA 1.44 -0.957 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.395 -178.639 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.558 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 1.3 mtt . . . . . 0 C--O 1.222 -0.387 0 CA-C-O 121.205 0.526 . . . . 0.0 111.935 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.665 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -104.03 125.96 58.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.898 0.38 . . . . 0.0 111.754 -178.87 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.813 ' O ' ' N ' ' A' ' 38' ' ' GLY . 40.5 t -85.8 97.62 0.61 Allowed Pre-proline 0 N--CA 1.447 -0.61 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.068 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 1.0 OUTLIER -41.11 -17.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.319 2.679 . . . . 0.0 113.742 -179.231 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.745 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 9.9 mm-40 -88.06 -65.48 1.01 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.672 0.273 . . . . 0.0 110.789 -178.927 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.662 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.0 p -90.36 -18.59 25.25 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.271 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.813 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.12 33.3 84.91 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.681 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.86 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -72.44 143.64 48.41 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.949 -0.626 . . . . 0.0 109.58 179.099 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 32' ' ' MET . 16.1 t -110.35 112.94 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 O-C-N 123.236 0.335 . . . . 0.0 111.514 -178.856 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.86 HG23 ' CD1' ' A' ' 39' ' ' LEU . 67.0 t . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.117 178.535 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.752 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 14.5 t . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.573 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 29.5 Cg_endo -62.12 -44.33 20.2 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.91 2.407 . . . . 0.0 112.716 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.526 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 94.1 m-20 -107.48 38.12 2.23 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 122.119 0.962 . . . . 0.0 108.588 178.353 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.752 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 24.7 m80 -161.9 65.13 1.84 Allowed Pre-proline 0 C--N 1.308 -1.226 0 CA-C-O 123.114 1.435 . . . . 0.0 108.93 175.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 18' ' ' HIS . 55.6 Cg_endo -70.3 13.6 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.649 3.566 . . . . 0.0 113.103 -179.244 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.58 -17.48 1.49 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 120.999 0.428 . . . . 0.0 110.033 178.802 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.492 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -98.21 131.02 44.91 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.435 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.614 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.3 mp -106.87 87.51 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.781 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.614 ' C ' ' O ' ' A' ' 22' ' ' ILE . 3.9 mp -15.99 105.02 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 121.037 0.446 . . . . 0.0 109.934 178.43 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 25' ' ' GLU . 2.7 t -63.53 170.85 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.174 -178.309 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.557 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.43 -1.436 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.501 -178.66 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.58 ' O ' HD23 ' A' ' 23' ' ' LEU . 66.3 mtm . . . . . 0 CA--C 1.53 0.176 0 CA-C-O 120.923 0.392 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.762 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -110.43 123.81 66.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.402 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.873 ' O ' ' N ' ' A' ' 38' ' ' GLY . 6.5 t -83.45 101.69 1.48 Allowed Pre-proline 0 C--O 1.215 -0.744 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.725 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.463 ' HD3' HG23 ' A' ' 24' ' ' VAL . 1.6 Cg_endo -44.24 -20.99 0.35 Allowed 'Trans proline' 0 N--CA 1.475 0.413 0 C-N-CA 122.152 1.901 . . . . 0.0 112.809 -179.333 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.636 ' HB3' ' NE2' ' A' ' 18' ' ' HIS . 29.8 mm-40 -85.03 -60.52 2.02 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.457 -178.89 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.916 ' SG ' HD23 ' A' ' 39' ' ' LEU . 25.6 p -93.61 -11.97 30.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.636 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.873 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 54.32 26.28 36.22 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 114.79 -1.096 . . . . 0.0 113.581 178.574 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.011 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.6 OUTLIER -71.6 157.22 38.36 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.005 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.539 ' N ' HD12 ' A' ' 39' ' ' LEU . 5.9 t -118.41 118.12 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.054 0.454 . . . . 0.0 111.936 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.011 HG23 ' CD1' ' A' ' 39' ' ' LEU . 68.1 t . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.546 178.633 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 49.2 t . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.51 0.195 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.73 -21.28 72.85 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.334 2.023 . . . . 0.0 112.189 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -116.96 -9.52 11.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.367 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.702 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 37.2 m80 -130.24 88.78 46.87 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.786 0.327 . . . . 0.0 110.676 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.23 -34.61 93.83 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.356 2.038 . . . . 0.0 111.891 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.86 -23.84 33.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.32 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.705 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -83.81 84.15 7.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.22 0.534 . . . . 0.0 111.197 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.522 ' O ' ' C ' ' A' ' 23' ' ' LEU . 6.3 mt -70.4 77.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.658 -1.155 . . . . 0.0 113.147 -178.205 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.662 HD11 HD21 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -20.04 106.26 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.902 179.327 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 25' ' ' GLU . 3.2 t -74.9 168.24 2.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.155 -178.919 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.516 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.432 -1.338 0 CA-C-O 121.996 0.903 . . . . 0.0 110.895 -178.153 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.648 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.8 mtm . . . . . 0 C--O 1.224 -0.251 0 CA-C-O 121.09 0.471 . . . . 0.0 111.638 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.713 HD13 ' N ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -104.22 123.03 57.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.121 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.745 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.0 t -87.23 96.58 0.58 Allowed Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.492 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.6 Cg_endo -42.52 -14.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.373 2.716 . . . . 0.0 114.072 -179.001 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.705 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 9.2 mm-40 -87.94 -65.19 1.04 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.66 0.266 . . . . 0.0 110.881 -178.962 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.646 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.5 p -91.0 -19.16 23.52 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.323 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.745 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.23 35.91 88.99 Favored Glycine 0 N--CA 1.433 -1.505 0 CA-C-N 113.87 -1.514 . . . . 0.0 111.929 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.841 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -75.51 147.82 39.46 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.75 179.192 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.648 ' HA ' ' O ' ' A' ' 32' ' ' MET . 18.6 t -114.87 113.74 44.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.71 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.841 HG23 ' CD1' ' A' ' 39' ' ' LEU . 86.0 t . . . . . 0 CA--C 1.518 -0.269 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.879 178.033 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.507 ' HB2' HD12 ' A' ' 23' ' ' LEU . 41.8 t . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.534 0.207 . . . . 0.0 110.577 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.84 -22.74 68.99 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.426 2.084 . . . . 0.0 112.656 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -115.79 -8.9 11.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.431 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.731 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.0 m80 -131.58 85.88 50.96 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.746 0.308 . . . . 0.0 110.809 179.581 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.05 -34.47 98.95 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.318 2.012 . . . . 0.0 111.64 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.13 -30.65 39.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.368 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -79.0 87.72 4.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.182 0.515 . . . . 0.0 111.419 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' C ' ' A' ' 23' ' ' LEU . 22.3 mm -73.24 72.98 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.734 -178.705 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.729 HD11 HD21 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -13.71 110.25 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.49 179.258 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 32' ' ' MET . 4.2 t -79.52 160.72 4.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.322 0.582 . . . . 0.0 112.181 -177.84 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.424 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.316 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.028 -177.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.55 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.53 0.198 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.805 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -109.4 126.8 66.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.781 -178.223 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.783 ' O ' ' N ' ' A' ' 38' ' ' GLY . 38.5 t -86.12 97.51 0.62 Allowed Pre-proline 0 C--O 1.22 -0.475 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.027 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -41.43 -16.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.321 2.681 . . . . 0.0 113.946 -179.141 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.731 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 2.2 mm-40 -87.82 -65.21 1.04 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.703 0.287 . . . . 0.0 111.073 -178.797 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.762 ' SG ' HD23 ' A' ' 39' ' ' LEU . 6.1 p -90.9 -19.68 23.06 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.479 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.805 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 66.89 34.95 88.74 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 113.86 -1.518 . . . . 0.0 111.741 -179.552 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.762 HD23 ' SG ' ' A' ' 37' ' ' CYS . 1.3 pp -71.22 145.65 49.51 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.877 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 32' ' ' MET . 86.5 t -113.54 121.99 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-O 121.209 0.528 . . . . 0.0 112.138 -176.591 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.698 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.4 t . . . . . 0 N--CA 1.45 -0.431 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.64 179.298 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 47.4 t . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.576 0.227 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.76 -21.61 73.17 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.28 1.986 . . . . 0.0 112.319 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -116.6 -9.53 11.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.348 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.738 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.1 m80 -131.48 87.19 47.39 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.775 0.322 . . . . 0.0 110.883 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.13 -34.1 94.61 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.345 2.03 . . . . 0.0 111.917 179.78 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.41 -26.76 35.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.231 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.62 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -81.52 87.62 6.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.201 0.524 . . . . 0.0 111.283 -179.882 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.569 ' O ' ' C ' ' A' ' 23' ' ' LEU . 15.3 mt -72.86 73.25 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.871 -178.556 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.663 HD11 HD21 ' A' ' 39' ' ' LEU . 1.5 mp -15.13 110.11 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.549 0.531 . . . . 0.0 110.513 179.321 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.8 t -79.09 161.58 4.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.202 0.525 . . . . 0.0 111.922 -177.997 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.422 ' N ' HG12 ' A' ' 24' ' ' VAL . 19.4 mm-40 . . . . . 0 N--CA 1.433 -1.277 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.733 -178.24 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.549 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 6.8 mtm . . . . . 0 C--O 1.227 -0.129 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.818 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -110.46 126.18 67.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.887 -178.226 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.791 ' O ' ' N ' ' A' ' 38' ' ' GLY . 42.0 t -85.7 98.07 0.67 Allowed Pre-proline 0 C--O 1.219 -0.546 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.158 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -41.61 -16.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.333 2.688 . . . . 0.0 114.05 -178.964 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.738 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 9.7 mm-40 -88.82 -64.37 1.16 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.725 0.298 . . . . 0.0 111.143 -178.792 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.634 ' SG ' HD23 ' A' ' 39' ' ' LEU . 5.9 p -90.62 -19.42 23.7 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.389 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.818 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 66.31 33.72 85.85 Favored Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 113.789 -1.55 . . . . 0.0 111.667 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.918 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.7 OUTLIER -69.77 143.08 53.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.954 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 32' ' ' MET . 72.9 t -109.75 114.55 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 O-C-N 123.384 0.428 . . . . 0.0 111.549 -177.777 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.918 HG23 ' CD1' ' A' ' 39' ' ' LEU . 76.0 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.467 178.711 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.6 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 45.9 t . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 120.577 0.227 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.51 -29.86 71.11 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.457 2.105 . . . . 0.0 111.589 179.328 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -93.96 -16.66 23.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.503 179.62 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.973 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 38.9 m80 -131.73 85.86 50.35 Favored Pre-proline 0 N--CA 1.453 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.337 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.85 -53.55 0.9 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.233 1.955 . . . . 0.0 111.701 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.24 -14.75 63.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.716 -179.832 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.973 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -101.09 114.01 27.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.113 0.482 . . . . 0.0 110.413 179.22 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.0 mt -91.83 127.5 44.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.823 -179.078 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.925 HD21 HD11 ' A' ' 39' ' ' LEU . 1.5 mp -59.45 102.07 0.13 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.845 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.527 HG23 ' HD3' ' A' ' 35' ' ' PRO . 3.1 t -66.48 157.17 5.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 121.293 0.568 . . . . 0.0 111.715 -178.603 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 . . . . . 0 C--N 1.317 -0.824 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.007 -179.26 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.725 ' O ' HD23 ' A' ' 23' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.095 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.895 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 1.2 tt -112.42 139.55 36.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.027 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.835 ' O ' ' N ' ' A' ' 38' ' ' GLY . 52.7 t -91.68 102.38 5.87 Favored Pre-proline 0 N--CA 1.448 -0.55 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.61 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.527 ' HD3' HG23 ' A' ' 24' ' ' VAL . 1.9 Cg_endo -40.13 -21.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.456 2.771 . . . . 0.0 113.614 -178.773 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.537 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 5.7 mm-40 -81.01 -68.25 0.7 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.743 -178.816 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.57 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.4 p -88.18 -18.68 28.19 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.548 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.835 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.66 22.39 71.67 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.089 -179.581 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.925 HD11 HD21 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -58.7 140.92 54.03 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.963 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 32' ' ' MET . 5.5 t -113.15 131.19 65.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.762 0.315 . . . . 0.0 110.586 -179.073 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.608 HG23 ' CD1' ' A' ' 39' ' ' LEU . 12.5 t . . . . . 0 N--CA 1.452 -0.361 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.273 179.375 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.504 ' HB2' HD12 ' A' ' 23' ' ' LEU . 45.5 t . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.501 0.191 . . . . 0.0 110.724 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.04 -23.83 76.08 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.52 2.147 . . . . 0.0 112.522 -179.82 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -117.3 -7.69 11.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.449 -179.778 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.726 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.6 m80 -131.18 85.83 52.92 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.699 0.285 . . . . 0.0 110.779 179.63 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.98 -35.5 93.02 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.271 1.981 . . . . 0.0 111.897 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -78.57 -30.73 46.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.189 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -78.63 85.63 4.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.091 0.472 . . . . 0.0 111.246 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.529 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.8 mp -71.25 75.73 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.722 -178.6 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.847 HD21 HD11 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -18.09 107.53 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.002 179.419 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -75.91 167.6 2.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.225 -178.815 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.504 ' H ' HG12 ' A' ' 24' ' ' VAL . 1.9 mm-40 . . . . . 0 N--CA 1.433 -1.298 0 CA-C-O 122.105 0.955 . . . . 0.0 111.207 -177.882 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.709 ' O ' HD23 ' A' ' 23' ' ' LEU . 52.6 mtp . . . . . 0 C--O 1.225 -0.196 0 CA-C-O 121.38 0.61 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.669 HD13 ' N ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -100.82 123.24 53.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.496 -0.775 . . . . 0.0 113.047 -176.783 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.729 ' O ' ' N ' ' A' ' 38' ' ' GLY . 52.1 t -87.71 96.2 0.58 Allowed Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.525 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.5 Cg_endo -41.89 -15.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.405 2.737 . . . . 0.0 114.077 -179.089 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.726 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 4.2 mm-40 -87.14 -65.58 1.0 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.625 0.25 . . . . 0.0 111.057 -178.981 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.818 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.7 p -91.1 -20.68 21.77 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.221 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.729 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 69.99 38.56 74.43 Favored Glycine 0 N--CA 1.432 -1.624 0 CA-C-N 113.76 -1.564 . . . . 0.0 111.996 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.847 HD11 HD21 ' A' ' 23' ' ' LEU . 1.6 pp -76.53 149.11 36.72 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.835 -0.683 . . . . 0.0 109.872 179.375 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 32' ' ' MET . 38.4 t -117.53 119.68 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 121.088 0.471 . . . . 0.0 112.14 -177.427 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.681 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.385 179.57 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.585 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 47.3 t . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.583 0.23 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.1 -21.96 73.2 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.316 2.011 . . . . 0.0 112.002 179.687 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -116.14 -10.16 11.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.19 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.762 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 41.9 m80 -130.61 88.43 46.79 Favored Pre-proline 0 C--O 1.232 0.18 0 CA-C-O 120.701 0.286 . . . . 0.0 110.525 178.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.78 -35.27 94.83 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.292 1.995 . . . . 0.0 111.788 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.41 -29.74 42.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.038 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.654 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -77.01 97.91 4.81 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 122.241 1.02 . . . . 0.0 111.168 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.515 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -80.84 74.94 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 112.787 -2.006 . . . . 0.0 113.698 -177.696 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.625 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.1 mp -20.85 102.71 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.768 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.4 t -71.7 166.3 2.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.15 -178.976 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.472 ' H ' HG12 ' A' ' 24' ' ' VAL . 6.1 mm-40 . . . . . 0 N--CA 1.433 -1.317 0 CA-C-O 121.922 0.868 . . . . 0.0 110.76 -178.192 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.559 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 6.2 mtm . . . . . 0 C--O 1.222 -0.349 0 CA-C-O 121.375 0.607 . . . . 0.0 111.569 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.758 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -102.81 121.63 54.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -176.885 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.743 ' O ' ' N ' ' A' ' 38' ' ' GLY . 25.7 t -86.79 96.84 0.57 Allowed Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.083 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.5 Cg_endo -41.79 -15.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.466 2.777 . . . . 0.0 114.069 -179.239 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.762 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 3.6 mm-40 -86.76 -65.9 0.96 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.675 0.274 . . . . 0.0 110.758 -178.764 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.694 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.9 p -90.71 -19.52 23.47 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.416 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.758 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 67.23 35.94 89.03 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 113.772 -1.558 . . . . 0.0 111.914 -179.728 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.906 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -74.27 150.54 40.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.762 -0.719 . . . . 0.0 109.878 179.379 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 32' ' ' MET . 23.7 t -115.87 116.11 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.825 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.906 HG23 ' CD1' ' A' ' 39' ' ' LEU . 97.6 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.931 178.256 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 36.9 t . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 120.528 0.204 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.44 -21.72 73.12 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.275 1.984 . . . . 0.0 111.995 179.452 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -115.92 -12.32 11.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.241 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.701 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 31.6 m80 -125.14 86.71 56.49 Favored Pre-proline 0 N--CA 1.455 -0.193 0 CA-C-O 120.857 0.36 . . . . 0.0 111.456 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.84 38.3 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.192 2.595 . . . . 0.0 110.805 178.432 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -150.59 -43.03 0.12 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.76 179.742 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.52 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -78.62 86.1 4.63 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.894 178.612 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.566 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.2 mp -70.06 75.69 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.339 -178.119 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.839 HD11 HD21 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -14.52 113.74 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.735 179.656 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.603 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.8 t -82.06 159.33 3.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.223 0.535 . . . . 0.0 111.84 -178.231 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.416 ' N ' HG12 ' A' ' 24' ' ' VAL . 2.4 mt-10 . . . . . 0 N--CA 1.436 -1.142 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.077 -178.073 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.603 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.243 0 CA-C-O 121.579 0.704 . . . . 0.0 112.257 . . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.888 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -105.75 125.43 61.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.148 -177.712 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.721 ' O ' ' N ' ' A' ' 38' ' ' GLY . 39.8 t -88.43 97.33 0.81 Allowed Pre-proline 0 C--O 1.221 -0.398 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 177.23 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.0 Cg_endo -42.63 -14.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.405 2.737 . . . . 0.0 114.222 -178.877 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.701 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 1.9 mm-40 -89.25 -63.82 1.23 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.623 0.249 . . . . 0.0 111.326 -178.97 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.775 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.1 p -90.96 -21.15 21.47 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.247 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.888 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.38 39.0 81.17 Favored Glycine 0 N--CA 1.429 -1.772 0 CA-C-N 113.511 -1.677 . . . . 0.0 111.879 -179.692 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.839 HD21 HD11 ' A' ' 23' ' ' LEU . 1.4 pp -76.54 141.82 41.06 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.481 -0.859 . . . . 0.0 109.87 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 32' ' ' MET . 26.0 t -111.0 123.6 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-O 121.068 0.461 . . . . 0.0 111.46 -177.323 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.69 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.4 t . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.396 179.778 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.498 ' HB2' HD12 ' A' ' 23' ' ' LEU . 18.1 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.596 0.236 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.41 -21.33 53.86 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.481 2.12 . . . . 0.0 112.247 179.722 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -105.03 -29.61 10.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.862 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.655 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.8 m80 -118.42 88.59 34.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.065 179.784 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.12 -31.82 94.13 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.931 1.754 . . . . 0.0 110.993 179.188 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -81.33 -36.62 29.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.371 -179.911 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.643 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . . . -71.76 91.27 1.12 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.082 0.468 . . . . 0.0 110.697 179.808 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.548 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.8 mt -79.06 69.0 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.869 -178.411 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.697 HD21 ' HG ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -12.27 123.44 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.229 179.43 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 32' ' ' MET . 21.2 t -85.94 157.47 3.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-O 121.413 0.625 . . . . 0.0 112.361 -178.022 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.433 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.007 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.009 -178.892 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.689 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 20.8 mtm . . . . . 0 N--CA 1.441 -0.885 0 CA-C-O 121.43 0.633 . . . . 0.0 111.39 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.786 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -100.46 126.2 54.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.049 -177.481 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.84 ' O ' ' N ' ' A' ' 38' ' ' GLY . 7.0 t -86.85 99.73 1.24 Allowed Pre-proline 0 C--O 1.216 -0.671 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.527 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.0 Cg_endo -40.27 -20.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.19 2.594 . . . . 0.0 113.542 -179.351 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.655 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 14.8 mm-40 -89.78 -63.13 1.33 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.332 -178.569 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.965 ' SG ' HD23 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -89.44 -18.84 25.98 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 177.729 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.84 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 63.42 28.57 72.57 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 114.112 -1.403 . . . . 0.0 111.783 -179.551 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.965 HD23 ' SG ' ' A' ' 37' ' ' CYS . 1.3 pp -71.36 148.59 46.86 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.774 -0.713 . . . . 0.0 109.908 179.317 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 32' ' ' MET . 35.0 t -110.09 118.19 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 O-C-N 123.445 0.466 . . . . 0.0 110.983 -179.386 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.917 HG23 ' CD1' ' A' ' 39' ' ' LEU . 54.8 t . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 121.236 0.541 . . . . 0.0 111.238 179.892 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 11.3 t . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.604 0.24 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.98 -19.67 45.61 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.264 1.976 . . . . 0.0 111.516 178.837 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -112.56 -11.58 13.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.133 179.878 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.664 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 31.6 m80 -131.79 84.72 53.56 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-O 120.619 0.247 . . . . 0.0 111.455 179.838 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.57 -41.68 62.07 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.979 1.786 . . . . 0.0 110.773 178.832 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.54 -8.83 57.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.574 179.975 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -100.99 109.04 20.91 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.734 0.778 . . . . 0.0 110.856 179.187 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.598 HD13 ' N ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -90.98 66.24 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 114.024 -1.444 . . . . 0.0 113.422 -177.632 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.599 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 2.7 mp -10.9 115.29 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.445 179.038 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 32' ' ' MET . 16.2 t -82.39 154.88 3.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.435 0.636 . . . . 0.0 112.708 -177.518 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.404 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.718 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.989 -178.584 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.679 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 15.7 mtp . . . . . 0 N--CA 1.446 -0.629 0 CA-C-O 121.574 0.702 . . . . 0.0 111.929 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.911 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -101.41 128.22 53.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.55 -177.198 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.794 ' O ' ' N ' ' A' ' 38' ' ' GLY . 45.0 t -83.22 99.43 0.69 Allowed Pre-proline 0 N--CA 1.448 -0.541 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.522 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.0 Cg_endo -39.9 -20.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.281 2.654 . . . . 0.0 113.742 -179.464 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.664 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 5.3 mm-40 -87.9 -64.9 1.08 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.592 -178.262 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.488 ' SG ' HD23 ' A' ' 39' ' ' LEU . 7.0 p -89.84 -20.02 23.94 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.788 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.911 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 67.25 32.0 78.77 Favored Glycine 0 N--CA 1.431 -1.657 0 CA-C-N 113.652 -1.613 . . . . 0.0 112.754 179.406 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.892 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -71.12 155.33 40.89 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.725 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 32' ' ' MET . 4.1 t -118.34 120.28 63.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 O-C-N 123.309 0.381 . . . . 0.0 111.595 -178.35 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.795 HG23 ' CD1' ' A' ' 39' ' ' LEU . 53.1 t . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.714 178.916 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 13.3 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.492 0.187 . . . . 0.0 110.804 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -68.38 -18.38 44.1 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.115 1.877 . . . . 0.0 111.95 179.256 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.35 -8.1 11.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.336 179.929 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.677 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 37.9 m80 -130.95 88.35 46.05 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 120.693 0.282 . . . . 0.0 110.529 179.216 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.78 -35.02 90.78 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.408 2.072 . . . . 0.0 112.082 179.875 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.39 -28.25 31.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.308 -179.747 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.665 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -78.12 87.73 4.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.23 0.538 . . . . 0.0 111.057 -179.881 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.55 ' O ' ' C ' ' A' ' 23' ' ' LEU . 14.3 mt -72.09 73.9 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.091 -178.347 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.602 HD11 HD21 ' A' ' 39' ' ' LEU . 2.2 mp -17.78 109.14 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.709 179.333 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.5 t -76.57 165.67 3.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.564 -178.512 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.462 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.236 0 CA-C-O 121.941 0.877 . . . . 0.0 110.968 -177.874 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.56 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.584 0.707 . . . . 0.0 111.733 . . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.659 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -103.63 123.7 57.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.621 -176.817 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.766 ' O ' ' N ' ' A' ' 38' ' ' GLY . 47.9 t -86.87 96.81 0.57 Allowed Pre-proline 0 N--CA 1.445 -0.687 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.898 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.2 Cg_endo -41.91 -15.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.28 2.654 . . . . 0.0 113.695 -179.278 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.677 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 13.1 mm-40 -86.3 -66.83 0.86 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.76 0.314 . . . . 0.0 110.845 -179.155 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.599 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.7 p -90.93 -19.86 22.83 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.429 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.766 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.68 36.24 87.26 Favored Glycine 0 N--CA 1.432 -1.626 0 CA-C-N 114.011 -1.45 . . . . 0.0 111.81 -179.737 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.835 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -75.5 148.84 38.66 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.884 -0.658 . . . . 0.0 109.772 179.229 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 32' ' ' MET . 37.0 t -111.74 115.7 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 123.295 0.372 . . . . 0.0 111.926 -178.39 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.835 HG23 ' CD1' ' A' ' 39' ' ' LEU . 54.4 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.253 178.551 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.553 ' CB ' ' HG ' ' A' ' 34' ' ' CYS . 39.1 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.581 0.229 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.46 -19.89 54.73 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.379 2.053 . . . . 0.0 112.248 179.643 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -115.16 -10.25 12.18 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.411 -179.974 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.734 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.5 m80 -130.83 87.81 48.07 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.757 0.313 . . . . 0.0 110.663 179.508 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.84 -34.51 95.57 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.269 1.979 . . . . 0.0 111.812 179.789 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.44 -27.09 38.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.287 -179.892 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.602 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -82.85 85.14 7.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.146 0.498 . . . . 0.0 111.296 -179.78 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.2 mp -70.4 74.92 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.856 -1.066 . . . . 0.0 112.768 -178.69 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.721 HD11 HD21 ' A' ' 39' ' ' LEU . 1.1 mp -16.98 109.58 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.535 179.386 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.5 t -78.07 162.8 3.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.157 0.503 . . . . 0.0 111.758 -178.249 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.429 ' N ' HG12 ' A' ' 24' ' ' VAL . 3.0 mm-40 . . . . . 0 N--CA 1.434 -1.259 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.579 -178.303 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.547 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 9.4 mtm . . . . . 0 C--O 1.225 -0.194 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.827 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -107.56 125.43 63.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.301 -177.876 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.743 ' O ' ' N ' ' A' ' 38' ' ' GLY . 34.8 t -87.13 97.06 0.62 Allowed Pre-proline 0 C--O 1.222 -0.395 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.863 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.5 Cg_endo -41.9 -15.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.384 2.722 . . . . 0.0 114.244 -179.084 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.734 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 2.3 mm-40 -88.74 -64.38 1.15 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.697 0.284 . . . . 0.0 111.133 -178.787 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.644 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.1 p -90.84 -18.96 23.95 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.322 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.827 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 66.28 35.86 90.91 Favored Glycine 0 N--CA 1.431 -1.682 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.771 -179.374 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.898 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -72.97 144.45 47.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.621 -0.79 . . . . 0.0 109.49 179.378 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.9 t -112.53 116.0 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-O 121.027 0.441 . . . . 0.0 111.779 -178.001 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.898 HG23 ' CD1' ' A' ' 39' ' ' LEU . 97.0 t . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.788 177.96 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.587 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 45.4 t . . . . . 0 C--O 1.231 0.091 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.89 -22.32 68.02 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.177 1.918 . . . . 0.0 111.954 179.197 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.19 -9.09 10.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.345 179.995 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.711 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . 38.5 m80 -129.89 89.1 46.96 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.736 0.303 . . . . 0.0 110.937 179.238 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.46 -37.23 90.71 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.241 1.961 . . . . 0.0 111.791 179.632 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.54 -32.96 36.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.548 -179.695 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.797 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -71.45 89.46 0.94 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.169 0.509 . . . . 0.0 111.004 -179.85 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.511 ' O ' ' C ' ' A' ' 23' ' ' LEU . 9.8 mm -70.64 78.95 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.958 -177.757 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.631 HD11 HD21 ' A' ' 39' ' ' LEU . 2.2 mp -26.93 107.23 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.173 0.511 . . . . 0.0 110.242 178.913 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -75.34 164.16 3.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.887 -178.283 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.441 ' N ' HG12 ' A' ' 24' ' ' VAL . 1.7 mm-40 . . . . . 0 N--CA 1.441 -0.889 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.633 -179.29 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.582 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 5.6 mtm . . . . . 0 N--CA 1.446 -0.643 0 CA-C-O 121.682 0.753 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.76 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -100.78 124.09 54.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.565 -176.588 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.74 ' O ' ' N ' ' A' ' 38' ' ' GLY . 47.2 t -85.73 97.85 0.64 Allowed Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.366 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 3.9 Cg_endo -45.61 -12.76 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.844 2.363 . . . . 0.0 113.628 -179.112 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.797 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 4.8 mm-40 -88.81 -63.98 1.21 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.66 0.266 . . . . 0.0 111.204 -179.413 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.691 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.7 p -91.45 -22.59 20.35 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.398 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.76 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 70.4 41.63 66.86 Favored Glycine 0 N--CA 1.43 -1.74 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.033 -179.964 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.924 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -81.91 152.97 26.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.65 -0.775 . . . . 0.0 109.992 179.819 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 32' ' ' MET . 66.1 t -117.1 116.63 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.701 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.924 HG23 ' CD1' ' A' ' 39' ' ' LEU . 95.5 t . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.767 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.909 0.385 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.7 m -99.44 38.17 1.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.959 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.34 -31.94 13.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.913 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.54 138.99 49.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.34 -71.14 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.78 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.635 ' HB2' HG11 ' A' ' 48' ' ' VAL . 15.4 mt -158.1 -71.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.718 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 52.8 25.85 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.123 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -100.82 143.38 31.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.032 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.48 163.94 16.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.749 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.56 -173.57 0.3 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.559 2.173 . . . . 0.0 112.207 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.33 139.21 37.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.525 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.65 ' O ' HG13 ' A' ' 13' ' ' VAL . 8.4 p -47.33 96.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.182 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.5 p 55.46 -173.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.19 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 35.2 t -70.33 136.96 86.44 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.838 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.49 -20.98 70.74 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.116 1.877 . . . . 0.0 111.905 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -116.79 -11.14 10.95 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.176 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.749 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 33.8 m80 -131.07 87.33 48.75 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.858 0.361 . . . . 0.0 110.603 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.93 -34.75 95.07 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.305 2.003 . . . . 0.0 111.903 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -79.4 -26.81 41.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.215 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -82.86 95.86 8.06 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 122.603 1.192 . . . . 0.0 111.599 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.535 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.89 72.61 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 112.228 -2.26 . . . . 0.0 112.956 -178.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.615 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.9 mp -19.71 108.75 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.88 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -77.0 165.81 2.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.182 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.467 ' H ' HG12 ' A' ' 24' ' ' VAL . 8.2 mt-10 -83.02 137.1 34.27 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.818 0.818 . . . . 0.0 110.105 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.592 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 0.1 OUTLIER 62.33 89.86 0.08 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 178.357 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.683 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 1.0 OUTLIER -61.56 98.62 0.09 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.652 177.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.638 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.1 OUTLIER 49.47 38.48 14.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.955 0.407 . . . . 0.0 110.044 -179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 91.53 35.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.487 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -134.11 -124.67 2.5 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.761 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 27' ' ' TYR . 0.8 OUTLIER -95.03 -144.33 0.26 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.467 0.175 . . . . 0.0 111.139 -179.36 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.607 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 29.0 mtt -89.52 118.53 29.23 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 121.428 0.633 . . . . 0.0 111.57 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.692 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -105.03 123.52 59.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.988 -176.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.749 ' O ' ' N ' ' A' ' 38' ' ' GLY . 37.9 t -87.81 96.5 0.62 Allowed Pre-proline 0 N--CA 1.45 -0.461 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.5 Cg_endo -42.4 -14.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 123.304 2.669 . . . . 0.0 114.08 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.749 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 1.1 mm-40 -89.7 -63.75 1.24 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.576 0.227 . . . . 0.0 111.06 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.542 ' SG ' HD23 ' A' ' 39' ' ' LEU . 8.4 p -90.54 -20.44 22.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.749 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 68.39 33.76 78.14 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.314 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.774 ' CD1' HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -74.33 143.89 44.73 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 32' ' ' MET . 32.9 t -109.68 111.36 35.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.862 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.774 HG22 ' CD1' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -111.3 134.78 52.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.606 0.241 . . . . 0.0 110.431 179.274 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.84 160.21 10.81 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.55 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -173.85 110.31 0.16 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.624 -0.288 . . . . 0.0 110.269 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? 60.91 92.35 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.853 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.422 ' O ' ' CG1' ' A' ' 46' ' ' ILE . 19.6 t -103.46 -28.52 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.127 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.422 ' CG1' ' O ' ' A' ' 45' ' ' VAL . 39.4 pt 44.03 29.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.743 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 t0 54.08 101.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.178 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.635 HG11 ' HB2' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -105.18 -172.67 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.04 -95.9 2.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.534 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.9 t 60.36 98.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.774 0.321 . . . . 0.0 110.941 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.48 16.79 2.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.251 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 8.3 m0 61.88 -81.48 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.021 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 57.06 70.8 0.62 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.954 0.407 . . . . 0.0 110.991 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -141.68 -170.47 3.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.435 ' H ' HG22 ' A' ' 54' ' ' THR . 18.7 p90 -121.62 125.03 45.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.887 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.7 m 63.54 139.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.954 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -119.39 165.15 14.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.23 -45.42 2.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.805 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.879 -179.944 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.746 0.308 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.99 -33.73 21.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.847 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.9 p -65.57 -42.29 91.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.2 174.08 6.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -87.43 -74.57 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.019 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.6 mt -177.09 161.45 1.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.831 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -88.78 112.48 23.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.77 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -158.89 105.91 1.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.265 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.435 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 1.4 mt -175.51 -61.95 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.795 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.435 ' HD3' ' CB ' ' A' ' 10' ' ' LEU . 95.7 Cg_endo -79.39 165.29 23.36 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.437 2.091 . . . . 0.0 112.139 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.83 143.55 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.964 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.57 ' O ' HG12 ' A' ' 13' ' ' VAL . 14.4 t -99.2 30.18 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -164.44 169.11 17.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.825 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 16.7 t -78.23 134.91 62.42 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.897 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.06 -18.94 63.17 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.068 1.845 . . . . 0.0 112.03 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -117.53 -9.32 10.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.35 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.683 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . 37.7 m80 -130.76 88.34 46.62 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-O 120.755 0.312 . . . . 0.0 110.437 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.67 -34.41 92.14 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.414 2.076 . . . . 0.0 112.03 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.25 -26.01 31.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.395 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.683 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -80.32 87.87 5.57 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.242 0.544 . . . . 0.0 111.255 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.535 ' O ' ' C ' ' A' ' 23' ' ' LEU . 13.6 mm -72.29 75.19 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.353 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.599 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 2.0 mp -20.5 107.47 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.556 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -74.94 167.95 2.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.181 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.512 ' H ' HG12 ' A' ' 24' ' ' VAL . 1.0 OUTLIER -84.26 138.56 32.87 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 122.051 0.929 . . . . 0.0 110.648 -178.185 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 0.1 OUTLIER 57.55 93.38 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.958 -1.473 . . . . 0.0 114.48 178.746 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.622 ' CG ' ' O ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -65.64 104.44 1.03 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.629 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 45.76 36.09 2.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.932 0.396 . . . . 0.0 110.193 -179.267 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 93.27 38.47 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.587 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -134.81 -126.49 2.63 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.617 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 1.1 m-20 -94.98 -144.14 0.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.616 0.246 . . . . 0.0 110.981 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.561 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 8.2 mtt -86.23 116.9 24.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.403 0.62 . . . . 0.0 111.597 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.603 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -103.68 121.3 54.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.826 -177.127 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.762 ' O ' ' N ' ' A' ' 38' ' ' GLY . 49.7 t -86.57 97.02 0.57 Allowed Pre-proline 0 N--CA 1.446 -0.635 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.2 Cg_endo -41.77 -15.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.343 2.695 . . . . 0.0 113.853 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.68 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 10.5 mm-40 -86.29 -66.89 0.85 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.8 0.333 . . . . 0.0 110.807 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.577 ' SG ' HD23 ' A' ' 39' ' ' LEU . 2.9 p -90.7 -18.7 24.59 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.762 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.24 35.18 90.0 Favored Glycine 0 N--CA 1.433 -1.551 0 CA-C-N 114.119 -1.401 . . . . 0.0 111.627 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.855 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -74.27 148.44 41.46 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.894 -0.653 . . . . 0.0 109.638 179.38 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 32' ' ' MET . 48.5 t -112.29 113.75 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 120.887 0.375 . . . . 0.0 111.847 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.855 HG23 ' CD1' ' A' ' 39' ' ' LEU . 55.5 t -119.32 135.66 58.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.063 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.54 164.76 11.38 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.641 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.726 ' O ' HG13 ' A' ' 45' ' ' VAL . 23.8 t70 -175.85 -82.34 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.722 0.296 . . . . 0.0 110.48 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 46.22 29.03 0.75 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.773 0.32 . . . . 0.0 111.394 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.726 HG13 ' O ' ' A' ' 43' ' ' ASP . 27.4 m -116.2 -17.35 7.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.559 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.627 ' O ' HG23 ' A' ' 46' ' ' ILE . 16.8 tt -54.02 98.19 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.879 0.371 . . . . 0.0 111.244 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 62.02 146.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.983 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 49' ' ' GLY . 15.1 t -116.33 161.52 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.959 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.495 ' N ' HG12 ' A' ' 48' ' ' VAL . . . -47.43 98.38 0.01 OUTLIER Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.636 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.47 61.2 2.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.921 0.391 . . . . 0.0 111.146 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.1 75.34 9.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.557 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 2.4 t90 76.16 -57.77 0.55 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.019 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.86 81.31 0.12 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.945 0.402 . . . . 0.0 110.813 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.5 m -144.28 111.68 6.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.847 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -107.41 104.43 14.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m 62.14 118.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.978 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -83.52 119.05 24.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -98.12 -68.32 0.81 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.975 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.798 0.333 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.1 m -102.45 73.88 1.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.936 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.41 -30.28 7.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.971 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.4 -175.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.989 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.404 ' HB3' HD12 ' A' ' 7' ' ' LEU . 4.4 mtp85 -104.25 -75.58 0.62 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.404 HD12 ' HB3' ' A' ' 6' ' ' ARG . 2.0 mp -113.1 112.93 24.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.055 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -113.92 63.25 0.66 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.724 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.96 58.9 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.335 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.703 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 3.0 pp -115.37 17.5 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.703 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 65.2 Cg_endo -83.35 -36.47 0.21 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 121.876 1.717 . . . . 0.0 112.646 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.17 26.18 10.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.619 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.481 HG11 ' CE ' ' A' ' 32' ' ' MET . 63.8 t -92.7 144.55 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.739 0.304 . . . . 0.0 110.884 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.64 165.72 32.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.028 0.442 . . . . 0.0 111.094 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 14.5 t -72.49 135.99 81.27 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.91 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.87 -18.02 61.13 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.276 1.984 . . . . 0.0 112.304 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.07 -13.6 9.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.045 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.742 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 35.4 m80 -127.27 88.51 53.9 Favored Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.898 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.96 -40.12 55.16 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.417 2.078 . . . . 0.0 112.082 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -75.8 -35.4 60.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.346 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.783 ' HB2' ' HG2' ' A' ' 36' ' ' GLU . . . -75.85 79.64 2.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.234 0.54 . . . . 0.0 110.974 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.581 ' O ' ' C ' ' A' ' 23' ' ' LEU . 12.3 mt -69.88 72.44 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.918 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.817 HD11 HD21 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -7.61 110.77 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.73 179.163 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 32' ' ' MET . 14.2 t -83.3 155.86 3.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.514 0.673 . . . . 0.0 112.669 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.428 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -71.44 123.77 23.12 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.903 -178.436 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.614 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 2.8 m-20 80.42 -151.55 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.499 -1.228 . . . . 0.0 113.213 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.505 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 3.2 t80 89.02 114.48 0.03 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.254 0.55 . . . . 0.0 110.379 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.431 ' HD3' ' CD2' ' A' ' 27' ' ' TYR . 0.6 OUTLIER 70.95 -87.08 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.489 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.82 -82.5 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.767 0.318 . . . . 0.0 111.175 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.614 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -178.32 -38.65 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.797 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 2.7 p30 -74.86 -157.36 0.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.567 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 44.1 mtm -73.8 157.53 36.24 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.773 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -141.7 130.9 23.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.494 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.791 ' O ' ' N ' ' A' ' 38' ' ' GLY . 18.0 t -88.97 97.58 0.93 Allowed Pre-proline 0 C--O 1.217 -0.637 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 2.7 Cg_endo -44.27 -14.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.921 2.414 . . . . 0.0 113.417 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.783 ' HG2' ' HB2' ' A' ' 21' ' ' ALA . 8.2 mm-40 -86.72 -65.14 1.05 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.567 0.222 . . . . 0.0 110.784 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.571 ' SG ' HD23 ' A' ' 39' ' ' LEU . 2.5 p -91.8 -24.7 19.31 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.791 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 74.1 41.19 40.39 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 113.395 -1.73 . . . . 0.0 112.103 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.817 HD21 HD11 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -79.14 146.5 33.13 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.928 -0.636 . . . . 0.0 109.534 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 32' ' ' MET . 95.9 t -111.94 122.75 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 O-C-N 123.532 0.52 . . . . 0.0 111.736 -177.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.734 HG23 ' CD1' ' A' ' 39' ' ' LEU . 22.4 t -130.66 127.67 62.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.797 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.515 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 119.95 -159.27 15.04 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.848 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.509 ' N ' ' HB3' ' A' ' 31' ' ' ASP . 5.1 t70 77.51 130.62 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.04 0.447 . . . . 0.0 111.129 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.87 -169.63 1.98 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.793 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 45' ' ' VAL . 11.0 p -172.55 54.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.04 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 47' ' ' ASP . 18.4 tt -112.35 -44.99 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.166 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.489 ' N ' HG23 ' A' ' 46' ' ' ILE . 0.9 OUTLIER 57.95 81.33 0.15 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.953 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.486 ' O ' HG23 ' A' ' 48' ' ' VAL . 12.6 m -85.55 82.12 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.064 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.13 -98.65 0.25 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.449 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.4 t 60.73 31.32 20.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.792 0.33 . . . . 0.0 110.881 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -129.83 49.89 2.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.841 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.6 m0 62.53 -80.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.952 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.75 103.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 0.0 111.013 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.467 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -149.18 174.33 12.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.976 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.467 ' H ' HG22 ' A' ' 54' ' ' THR . 18.6 p90 -95.86 8.7 42.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.363 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 54.86 175.86 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.84 0.352 . . . . 0.0 111.089 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -121.12 -173.11 2.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -78.82 -57.85 3.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.819 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.902 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.724 0.297 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.8 m -89.79 53.23 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.909 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.9 40.45 3.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.85 123.13 41.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.65 -63.15 1.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.9 mt -175.23 77.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.93 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.29 120.75 24.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.783 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 60.66 -168.0 0.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.998 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.461 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . 6.2 mt -166.83 -64.86 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.461 ' CD ' ' CB ' ' A' ' 10' ' ' LEU . 19.1 Cg_endo -58.22 -168.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.511 2.141 . . . . 0.0 112.227 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.27 -177.59 4.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.798 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 13' ' ' VAL . 14.4 p -132.26 23.46 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.33 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.87 170.08 14.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.972 0.415 . . . . 0.0 110.967 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB2' HD12 ' A' ' 23' ' ' LEU . 38.5 t -72.47 135.68 81.45 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.642 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.49 -20.35 65.87 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.349 2.033 . . . . 0.0 112.405 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -114.75 -12.02 12.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.241 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.739 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.9 m80 -130.46 87.95 48.72 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 120.688 0.28 . . . . 0.0 110.565 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.56 -36.75 92.01 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.328 2.018 . . . . 0.0 111.785 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.28 -33.09 55.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.233 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -76.19 88.11 3.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.098 0.475 . . . . 0.0 111.307 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.568 ' O ' ' C ' ' A' ' 23' ' ' LEU . 9.9 mt -74.49 71.22 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.807 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.691 HD11 HD21 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -12.33 107.35 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.666 0.604 . . . . 0.0 110.886 179.419 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -77.86 164.42 3.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.171 0.51 . . . . 0.0 111.406 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.46 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 4.0 mm-40 -78.18 127.7 32.66 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.746 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.642 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.8 OUTLIER 89.72 -165.56 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.615 179.652 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.824 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 16.1 t80 164.08 74.99 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.597 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 5.0 mmp_? 59.32 41.21 20.19 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 84.42 41.8 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.8 -178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -127.42 -153.87 8.33 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.499 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.831 ' CG ' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -95.31 -124.21 0.11 Allowed 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 122.576 0.35 . . . . 0.0 111.614 -179.432 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.854 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 28.1 mtp -96.1 116.06 28.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 118.789 0.722 . . . . 0.0 112.194 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.857 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -101.49 123.41 54.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.762 -177.018 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.729 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.1 t -87.47 97.05 0.65 Allowed Pre-proline 0 N--CA 1.449 -0.495 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -40.78 -16.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.379 2.719 . . . . 0.0 114.149 -179.228 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.739 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 13.5 mm-40 -87.83 -64.81 1.09 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.634 0.254 . . . . 0.0 111.307 -178.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.684 ' SG ' HD23 ' A' ' 39' ' ' LEU . 5.7 p -90.37 -20.6 22.66 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.857 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.49 36.64 77.54 Favored Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 113.572 -1.649 . . . . 0.0 112.52 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.792 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -79.75 150.42 30.82 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.588 -0.806 . . . . 0.0 110.405 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.854 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.1 t -119.56 121.37 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-O 121.275 0.56 . . . . 0.0 112.429 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.792 HG23 ' CD1' ' A' ' 39' ' ' LEU . 87.3 t -125.71 132.04 71.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.01 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.55 166.05 11.41 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.543 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.15 -71.86 0.54 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.914 0.388 . . . . 0.0 110.578 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 169.68 -71.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.912 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 45' ' ' VAL . 11.1 p -120.52 116.32 49.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.244 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.691 HG23 ' N ' ' A' ' 47' ' ' ASP . 0.3 OUTLIER -73.12 -157.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.391 179.612 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.691 ' N ' HG23 ' A' ' 46' ' ' ILE . 11.1 m-20 -46.35 -53.91 9.99 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 120.745 0.307 . . . . 0.0 111.217 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 48' ' ' VAL . 11.1 p 43.62 33.26 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.69 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -120.6 159.23 15.4 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.538 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 63.04 -159.79 0.31 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.656 0.265 . . . . 0.0 110.771 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.27 -77.37 0.05 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.098 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -165.34 -58.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.996 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.71 36.59 8.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.76 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.55 161.29 19.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -124.75 38.38 4.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.013 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 m 60.26 172.92 0.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -96.43 168.67 10.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -74.81 -64.9 0.94 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.897 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.771 0.32 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 m -98.59 30.18 3.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.95 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.4 p -121.42 -42.89 2.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -94.32 -175.49 3.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.939 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.568 ' HB3' HD12 ' A' ' 7' ' ' LEU . 6.8 mtp85 -128.54 -69.02 0.73 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.822 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.568 HD12 ' HB3' ' A' ' 6' ' ' ARG . 4.9 mp -142.66 -179.55 6.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -142.16 30.05 1.61 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.914 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.95 135.68 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.659 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -133.85 -61.22 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.359 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.659 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 52.4 Cg_endo -68.43 64.42 1.14 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.031 1.821 . . . . 0.0 112.515 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.569 ' O ' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -85.13 110.26 18.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.552 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 12' ' ' ARG . 0.4 OUTLIER 75.52 164.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.623 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.798 HG22 HG23 ' A' ' 22' ' ' ILE . 52.3 p -90.07 -145.64 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.541 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 15.0 t -71.63 136.07 83.43 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.421 0.153 . . . . 0.0 110.778 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.1 -25.37 79.66 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.286 1.991 . . . . 0.0 111.961 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -108.48 -30.29 8.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.675 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.712 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 38.3 m80 -113.32 81.64 5.24 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.436 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.11 -33.48 97.44 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.03 1.82 . . . . 0.0 110.935 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -73.01 -42.39 63.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.285 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.579 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -74.97 87.52 2.33 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.11 0.481 . . . . 0.0 110.979 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.798 HG23 HG22 ' A' ' 14' ' ' THR . 1.3 mp -68.93 74.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.713 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.72 HD22 HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -14.64 112.7 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.37 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.1 t -81.18 163.24 3.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.254 0.55 . . . . 0.0 111.222 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -78.67 133.42 37.22 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.852 -178.727 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.658 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER 81.99 -157.94 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.056 178.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.58 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 45.9 t80 129.06 -84.48 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.908 0.883 . . . . 0.0 110.751 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.428 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -102.94 -62.36 1.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.371 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.576 ' HB3' ' OD1' ' A' ' 31' ' ' ASP . . . -106.95 28.72 7.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.811 0.339 . . . . 0.0 111.773 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.478 ' HA2' ' CG ' ' A' ' 26' ' ' ASP . . . 69.23 21.96 75.96 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.092 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.658 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -103.66 -161.77 0.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.794 0.33 . . . . 0.0 110.666 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 35.3 mtp -91.29 119.23 31.17 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-O 121.662 0.744 . . . . 0.0 112.39 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.851 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -104.17 126.08 58.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.89 -177.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.752 ' O ' ' N ' ' A' ' 38' ' ' GLY . 42.1 t -91.16 98.82 1.83 Allowed Pre-proline 0 C--O 1.219 -0.545 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.3 Cg_endo -43.44 -14.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.216 2.611 . . . . 0.0 113.881 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.712 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 2.9 mm-40 -87.92 -64.69 1.11 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.759 0.314 . . . . 0.0 111.08 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.46 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 3.3 p -91.19 -21.3 21.2 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.851 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.67 38.76 77.95 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 113.645 -1.616 . . . . 0.0 111.739 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.977 HD11 HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -80.03 144.06 33.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.7 -0.75 . . . . 0.0 110.726 -179.48 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 32' ' ' MET . 47.4 t -104.89 112.84 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.016 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.977 HG22 HD11 ' A' ' 39' ' ' LEU . 0.6 OUTLIER -109.02 133.46 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.901 0.382 . . . . 0.0 110.868 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.91 155.48 18.74 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.415 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 176.45 -172.75 0.09 Allowed 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.8 mtt85 54.06 104.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.267 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -93.75 168.83 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.094 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.5 pt -121.17 146.55 25.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.185 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -118.02 27.84 8.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.93 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.531 HG22 ' H ' ' A' ' 49' ' ' GLY . 0.3 OUTLIER 49.62 179.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.692 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.531 ' H ' HG22 ' A' ' 48' ' ' VAL . . . -131.06 61.75 0.66 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.437 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.9 t 61.32 65.56 0.96 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.79 0.328 . . . . 0.0 110.861 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -88.03 5.64 39.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.376 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 40.4 m95 61.75 -82.3 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.986 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 55.26 97.32 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.062 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.9 m -140.99 138.36 33.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.433 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 19.0 p90 -62.93 82.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.8 m 59.49 161.84 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -106.65 132.25 52.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.73 -40.42 8.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.908 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.802 0.334 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.494 ' O ' HG23 ' A' ' 4' ' ' THR . 58.3 m -98.82 31.58 2.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.893 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 3' ' ' SER . 7.7 p -158.75 35.88 0.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.73 -176.3 4.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.001 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.4 mtp85 -93.12 -161.85 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.654 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.6 mp -47.28 120.02 2.95 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.832 0.349 . . . . 0.0 111.139 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.16 -33.52 15.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.39 10.49 29.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.51 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mp 58.77 162.34 0.09 OUTLIER Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.729 0.299 . . . . 0.0 110.977 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.94 86.7 1.22 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.544 2.163 . . . . 0.0 112.098 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.3 mtm105 60.65 -176.58 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.612 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.516 HG23 ' N ' ' A' ' 14' ' ' THR . 28.0 m -104.7 -48.85 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.255 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.684 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -95.51 -153.31 0.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.717 0.294 . . . . 0.0 110.654 -179.741 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.652 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 47.4 t -70.05 142.23 90.13 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.442 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 14.3 Cg_endo -56.12 -28.33 69.67 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.468 2.112 . . . . 0.0 111.865 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.41 -6.19 10.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.602 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.706 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . 39.4 m80 -128.62 88.63 51.65 Favored Pre-proline 0 C--O 1.231 0.121 0 CA-C-O 120.668 0.27 . . . . 0.0 111.265 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.551 ' O ' HG21 ' A' ' 14' ' ' THR . 23.3 Cg_endo -61.58 -32.82 87.83 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.3 2.0 . . . . 0.0 112.008 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.53 -19.41 29.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.423 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.752 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -85.3 83.33 8.01 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.198 0.523 . . . . 0.0 110.834 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.684 ' HA ' HG23 ' A' ' 14' ' ' THR . 5.4 mm -63.44 83.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.019 -1.446 . . . . 0.0 113.869 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.854 HD21 HD11 ' A' ' 39' ' ' LEU . 1.9 mp -34.02 111.87 0.12 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 32' ' ' MET . 2.8 t -73.5 163.33 4.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 121.344 0.592 . . . . 0.0 110.953 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.577 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -89.18 89.33 7.89 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.873 -178.622 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 25' ' ' GLU . 7.6 m-20 111.65 99.67 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 O-C-N 124.529 1.143 . . . . 0.0 113.676 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.6 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -72.2 105.81 4.15 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.424 178.277 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.628 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 47.74 34.89 4.08 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.011 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 90.93 40.17 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.189 -178.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -133.8 -120.18 2.06 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.913 -0.661 . . . . 0.0 113.014 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -100.32 -153.58 0.45 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.643 0.259 . . . . 0.0 111.088 -179.203 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.602 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER -75.82 111.43 11.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.252 0.549 . . . . 0.0 111.827 -178.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.619 HG23 ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -102.76 119.18 50.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.723 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.756 ' O ' ' N ' ' A' ' 38' ' ' GLY . 35.9 t -85.79 97.14 0.53 Allowed Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 5.0 Cg_endo -44.97 -11.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.011 2.474 . . . . 0.0 113.951 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.752 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 5.5 mm-40 -89.93 -63.56 1.26 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 121.115 -0.234 . . . . 0.0 110.725 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.761 ' SG ' HD23 ' A' ' 39' ' ' LEU . 2.7 p -91.95 -20.25 21.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 176.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.756 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.49 40.11 91.12 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 114.068 -1.424 . . . . 0.0 111.208 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.854 HD11 HD21 ' A' ' 23' ' ' LEU . 1.4 pp -79.12 149.73 31.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.378 -0.911 . . . . 0.0 109.758 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 32' ' ' MET . 44.8 t -115.08 110.46 32.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.782 HG23 HD11 ' A' ' 39' ' ' LEU . 22.9 t -106.08 138.34 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.917 0.389 . . . . 0.0 111.393 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.27 93.89 2.19 Favored Glycine 0 CA--C 1.497 -1.076 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.484 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -123.89 106.95 10.86 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.87 147.9 17.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.923 0.392 . . . . 0.0 110.847 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 45' ' ' VAL . 13.7 p -179.65 42.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.946 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.421 HG22 ' OD2' ' A' ' 47' ' ' ASP . 38.9 mt -88.97 -75.34 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.257 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.421 ' OD2' HG22 ' A' ' 46' ' ' ILE . 1.2 p30 173.08 138.69 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.843 0.354 . . . . 0.0 110.822 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.6 p -153.85 142.02 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.041 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.59 61.3 0.59 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.395 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.3 t -86.33 93.55 9.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.835 0.35 . . . . 0.0 110.945 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.69 -77.24 0.56 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 171.6 -77.43 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.802 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 59.48 108.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.968 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.3 -175.32 2.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.826 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -131.54 -44.55 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.961 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m 64.81 166.28 0.16 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.913 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -110.23 -71.74 0.75 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.921 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -177.45 -69.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.914 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.153 -0.927 . . . . 0.0 111.025 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.822 0.344 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.0 m -98.9 31.61 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.22 -33.66 13.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.7 t -65.75 145.12 56.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 -69.19 -48.12 63.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.49 166.27 25.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.876 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.62 -60.91 1.82 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.012 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -173.24 38.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.809 0.337 . . . . 0.0 111.425 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.434 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER 62.5 167.08 0.1 Allowed Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.134 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 12' ' ' ARG . 16.8 Cg_endo -57.6 -157.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.809 2.34 . . . . 0.0 111.99 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.542 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -45.96 -101.18 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.156 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.679 ' O ' HG23 ' A' ' 14' ' ' THR . 14.4 p 172.03 21.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 13' ' ' VAL . 1.1 p -164.95 170.0 15.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.098 0.475 . . . . 0.0 111.502 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.632 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 53.2 t -64.96 137.38 97.13 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.192 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.54 -30.55 71.22 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.447 2.098 . . . . 0.0 111.848 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -96.69 -14.58 21.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.895 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.86 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 37.8 m80 -130.69 86.65 52.07 Favored Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.028 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.59 -47.92 6.55 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.21 1.94 . . . . 0.0 111.912 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.91 -10.13 59.17 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.205 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.86 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -103.44 106.02 16.43 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.458 0.647 . . . . 0.0 111.166 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.496 ' HA ' HG22 ' A' ' 14' ' ' THR . 16.9 mt -82.79 126.05 40.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.548 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.788 HD23 ' O ' ' A' ' 32' ' ' MET . 2.8 mp -63.78 130.91 46.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.28 0.562 . . . . 0.0 109.503 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 32' ' ' MET . 11.9 t -88.24 157.65 3.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.833 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.558 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 8.1 mm-40 -76.2 111.31 11.48 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.758 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.613 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 17.9 m-20 108.39 179.29 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.966 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.749 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 8.2 t80 179.67 84.15 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.858 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.607 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 7.2 mtt85 52.52 35.58 18.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 85.99 47.14 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.782 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.39 -141.23 4.52 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.404 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.613 ' O ' ' CA ' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -91.91 -126.75 0.09 Allowed 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 122.512 0.325 . . . . 0.0 110.952 -179.388 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.788 ' O ' HD23 ' A' ' 23' ' ' LEU . 4.9 mtp -102.54 120.64 40.88 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 121.03 0.443 . . . . 0.0 110.499 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.807 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -99.71 124.62 53.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -176.323 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.751 ' O ' ' N ' ' A' ' 38' ' ' GLY . 43.4 t -87.51 103.23 4.29 Favored Pre-proline 0 C--O 1.222 -0.344 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.8 Cg_endo -41.1 -21.06 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.304 2.67 . . . . 0.0 114.056 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.633 ' HG3' ' HB2' ' A' ' 21' ' ' ALA . 4.5 mm-40 -85.4 -66.16 0.93 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.886 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.693 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.1 p -89.87 -18.94 25.23 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.807 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 67.43 30.84 75.6 Favored Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.074 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.826 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -71.17 149.75 46.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.349 -0.926 . . . . 0.0 110.895 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.722 HG21 ' CD2' ' A' ' 27' ' ' TYR . 24.1 t -113.31 126.74 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.687 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.826 HG23 ' CD1' ' A' ' 39' ' ' LEU . 92.2 t -135.63 128.33 47.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.41 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 133.89 -163.83 24.47 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.968 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.8 OUTLIER 92.83 57.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.591 -179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.708 ' O ' HG13 ' A' ' 45' ' ' VAL . 2.1 ttt85 -100.18 138.05 37.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.198 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.708 HG13 ' O ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -179.76 -77.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.975 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.501 HD12 ' O ' ' A' ' 45' ' ' VAL . 0.3 OUTLIER 39.15 -87.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.063 179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 45' ' ' VAL . 0.4 OUTLIER -133.26 109.11 9.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.769 0.318 . . . . 0.0 110.887 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.5 t -105.86 145.38 13.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.035 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.84 166.74 3.57 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.641 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 t -101.05 42.12 1.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 111.003 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 12.0 mt-10 -83.68 -11.17 57.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.331 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.486 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 6.4 m0 70.73 -0.06 3.12 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 45.64 99.37 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.876 0.369 . . . . 0.0 111.851 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.9 158.64 16.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.821 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -143.98 89.33 2.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.926 0.393 . . . . 0.0 111.064 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 m 60.82 177.48 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.953 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -167.13 175.32 7.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.869 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -106.66 -32.08 8.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.878 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.822 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 120.818 0.342 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.04 -36.58 3.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.04 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.81 -34.91 65.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.057 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.7 t -78.86 157.9 28.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.809 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -83.51 -70.07 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.819 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.604 HD12 ' N ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -165.91 -96.53 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.878 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.414 ' H ' HD13 ' A' ' 7' ' ' LEU . 19.5 t0 44.91 52.36 8.16 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.81 0.338 . . . . 0.0 111.439 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.4 141.27 27.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.3 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.408 ' CD2' ' HD2' ' A' ' 11' ' ' PRO . 9.2 mt -91.69 163.34 28.46 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.783 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.408 ' HD2' ' CD2' ' A' ' 10' ' ' LEU . 6.3 Cg_endo -48.37 -64.68 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.721 2.281 . . . . 0.0 112.179 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -155.31 -167.78 2.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.932 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 13' ' ' VAL . 27.2 m -92.16 53.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.649 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.444 HG22 HD12 ' A' ' 22' ' ' ILE . 75.3 p -155.26 162.84 40.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.958 0.409 . . . . 0.0 111.206 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.517 ' HB2' HD12 ' A' ' 23' ' ' LEU . 44.7 t -73.66 136.36 77.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.898 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.14 -21.26 62.88 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.516 2.144 . . . . 0.0 112.356 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -112.05 -13.1 13.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.183 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.722 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.5 m80 -131.36 88.02 45.34 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.728 0.299 . . . . 0.0 110.622 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.0 -34.14 99.05 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.366 2.044 . . . . 0.0 111.709 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.37 -28.12 34.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.396 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.633 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -81.5 87.2 6.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.187 0.518 . . . . 0.0 111.15 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.582 ' O ' ' C ' ' A' ' 23' ' ' LEU . 2.8 mm -74.63 70.56 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.779 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.899 HD21 HD11 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -9.86 111.13 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.666 0.604 . . . . 0.0 110.657 179.349 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 32' ' ' MET . 7.3 t -81.9 158.78 3.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.514 0.673 . . . . 0.0 112.394 -177.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.422 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -83.52 124.87 31.17 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.256 -178.71 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 31' ' ' ASP . 2.5 m-20 50.55 111.78 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.396 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.573 ' HB3' HG21 ' A' ' 33' ' ' ILE . 0.1 OUTLIER 173.07 139.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.211 179.374 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.587 ' HB3' HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER 51.97 26.17 3.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.461 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 28' ' ' ARG . . . 174.46 -74.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.477 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.03 -36.14 0.37 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.807 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.638 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . 1.8 p30 -89.92 -127.39 0.07 Allowed 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 88.6 mtp -106.51 125.0 50.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 118.248 0.477 . . . . 0.0 111.842 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.754 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -115.35 136.84 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.508 0.67 . . . . 0.0 111.956 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.858 ' O ' ' N ' ' A' ' 38' ' ' GLY . 38.5 t -87.63 96.71 0.62 Allowed Pre-proline 0 N--CA 1.439 -1.024 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.435 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.8 Cg_endo -39.3 -19.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.551 2.834 . . . . 0.0 113.836 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.722 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 2.4 mm-40 -85.94 -66.18 0.93 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.72 0.295 . . . . 0.0 110.655 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.554 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.0 p -89.59 -17.93 27.54 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.858 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 65.63 31.28 79.53 Favored Glycine 0 N--CA 1.435 -1.424 0 CA-C-N 113.986 -1.461 . . . . 0.0 111.562 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.943 ' CD1' HG23 ' A' ' 41' ' ' VAL . 1.3 pp -65.25 136.65 56.87 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.513 HG12 ' OD2' ' A' ' 31' ' ' ASP . 77.3 t -107.0 114.85 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 O-C-N 123.358 0.411 . . . . 0.0 111.027 -178.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.943 HG23 ' CD1' ' A' ' 39' ' ' LEU . 95.8 t -128.47 135.63 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.659 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.638 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 123.74 -161.69 18.0 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.567 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -40.4 105.58 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.989 0.423 . . . . 0.0 111.75 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.436 ' HG3' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -55.26 -30.14 59.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.018 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.436 HG23 ' HG3' ' A' ' 44' ' ' ARG . 2.7 t -134.55 -130.16 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.51 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.1 tp -177.17 138.58 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.154 0 O-C-N 122.184 -0.322 . . . . 0.0 111.132 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -170.56 93.37 0.2 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.923 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.7 t -119.76 -58.99 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.111 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.52 53.45 0.61 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.548 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.6 t -78.88 -27.99 44.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.72 0.295 . . . . 0.0 110.995 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -57.67 103.29 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.029 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 62.08 -83.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.781 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.1 67.11 0.67 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.877 0.37 . . . . 0.0 111.358 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.64 -167.43 1.77 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.001 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -100.0 62.23 1.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.3 m 61.66 168.19 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -71.78 136.98 47.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -110.6 -61.22 1.71 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.78 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.842 0.353 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.2 m -120.16 121.14 38.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.874 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.9 m -120.02 94.79 4.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -164.12 -60.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.85 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.613 ' O ' HD12 ' A' ' 7' ' ' LEU . 1.2 mmp_? 63.57 -79.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.889 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -154.37 -77.5 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.81 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 56.94 87.52 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.024 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.719 ' O ' HD12 ' A' ' 10' ' ' LEU . . . -175.5 132.4 0.28 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.149 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 9' ' ' ALA . 1.2 mp -153.77 -66.92 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.966 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.469 ' CD ' ' CB ' ' A' ' 10' ' ' LEU . 73.7 Cg_endo -76.62 -168.26 0.55 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.291 1.994 . . . . 0.0 112.284 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -90.76 -56.64 3.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.811 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 14' ' ' THR . 6.5 p -169.7 -50.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.943 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.507 ' N ' HG13 ' A' ' 13' ' ' VAL . 76.4 p -116.4 -139.35 0.37 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.279 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.57 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 49.3 t -73.4 137.9 78.07 Favored Pre-proline 0 C--O 1.232 0.172 0 O-C-N 122.402 -0.186 . . . . 0.0 110.571 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.85 -21.85 71.94 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.182 1.921 . . . . 0.0 111.989 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -119.73 -7.56 10.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.384 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.691 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . 37.6 m80 -131.18 86.75 50.09 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-O 120.624 0.249 . . . . 0.0 111.11 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.15 -33.63 90.5 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.416 2.077 . . . . 0.0 112.011 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -83.3 -24.94 31.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.161 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.758 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -82.39 81.93 8.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.336 0.589 . . . . 0.0 110.638 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.51 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -66.68 78.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.47 -1.241 . . . . 0.0 113.395 -178.054 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.839 HD21 HD11 ' A' ' 39' ' ' LEU . 1.7 mp -22.43 106.95 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.712 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.509 HG12 ' H ' ' A' ' 25' ' ' GLU . 3.4 t -75.24 167.93 2.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.192 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.509 ' H ' HG12 ' A' ' 24' ' ' VAL . 2.9 mm-40 -82.96 141.18 32.32 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-O 121.922 0.867 . . . . 0.0 110.602 -178.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.525 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 0.1 OUTLIER 55.42 94.49 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.06 -1.427 . . . . 0.0 114.675 178.67 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.598 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -68.82 111.05 4.66 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.62 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 43.51 33.59 0.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.903 0.382 . . . . 0.0 110.168 -179.438 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 92.17 41.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.519 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -136.18 -123.21 2.25 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.792 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.545 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 1.6 m-20 -97.14 -145.04 0.3 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.475 0.178 . . . . 0.0 111.065 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.586 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 53.5 mtp -85.83 116.85 24.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.364 0.602 . . . . 0.0 111.882 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.698 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -103.61 123.22 57.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.056 -176.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.75 ' O ' ' N ' ' A' ' 38' ' ' GLY . 44.5 t -86.24 96.77 0.52 Allowed Pre-proline 0 N--CA 1.448 -0.529 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 2.2 Cg_endo -43.2 -14.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 123.232 2.622 . . . . 0.0 113.935 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.758 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 8.7 mm-40 -88.89 -64.28 1.17 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.632 0.253 . . . . 0.0 110.952 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.774 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.6 p -91.16 -19.52 22.99 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.75 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.5 37.46 89.87 Favored Glycine 0 N--CA 1.432 -1.567 0 CA-C-N 113.822 -1.535 . . . . 0.0 111.986 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.839 HD11 HD21 ' A' ' 23' ' ' LEU . 1.2 pp -76.91 148.66 36.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.569 -0.816 . . . . 0.0 110.053 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 32' ' ' MET . 34.8 t -113.74 113.33 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.776 HG23 HD11 ' A' ' 39' ' ' LEU . 42.1 t -109.88 133.06 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.497 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.36 159.03 10.7 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.871 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 45' ' ' VAL . 2.9 m-20 173.02 -89.08 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.853 ' O ' HG22 ' A' ' 45' ' ' VAL . 0.1 OUTLIER 58.94 -73.8 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 112.035 0.384 . . . . 0.0 112.035 178.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 44' ' ' ARG . 1.2 m 87.66 -9.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.497 0.719 . . . . 0.0 111.123 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.526 HG13 HG23 ' A' ' 45' ' ' VAL . 2.6 mt -131.96 112.59 20.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.743 0.306 . . . . 0.0 110.609 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.06 -79.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.323 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 m -112.81 113.86 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.091 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.84 -32.41 2.46 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.432 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.9 t -65.02 144.97 56.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.755 0.312 . . . . 0.0 110.906 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 58.71 -169.08 0.13 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.742 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -78.06 -91.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.82 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.19 138.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.915 0.388 . . . . 0.0 111.134 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -137.88 162.64 33.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.769 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.4 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 13.2 p90 -100.68 86.96 3.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.901 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m 60.87 91.73 0.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.89 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -68.0 168.22 12.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.0 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.6 -47.18 0.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.869 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.812 0.339 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.65 31.71 3.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.94 -35.18 9.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.886 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.05 96.5 5.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.813 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -59.4 -38.36 80.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.822 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.5 mp -90.65 141.79 28.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.752 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.2 -56.63 0.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.06 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.729 ' O ' HD23 ' A' ' 10' ' ' LEU . . . -153.67 178.12 10.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.903 0.383 . . . . 0.0 111.483 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.729 HD23 ' O ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER 168.7 -44.5 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.398 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 10' ' ' LEU . 18.9 Cg_endo -57.94 -158.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.924 1.749 . . . . 0.0 112.224 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 11' ' ' PRO . 7.6 tpp180 83.95 21.41 0.15 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.011 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.2 t -88.11 -17.64 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.834 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 58.79 176.93 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.807 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 48.0 t -77.01 137.31 65.64 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.726 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.46 -23.2 71.23 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.403 2.069 . . . . 0.0 112.444 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -117.68 -7.28 11.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.506 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.717 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.0 m80 -130.3 83.28 63.27 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.666 0.27 . . . . 0.0 111.049 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.3 -36.47 87.55 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.323 2.015 . . . . 0.0 111.769 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.77 -34.96 62.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.043 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -76.81 85.43 3.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.016 0.436 . . . . 0.0 110.968 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' C ' ' A' ' 23' ' ' LEU . 8.9 mm -69.96 74.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.295 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.704 HD11 HD21 ' A' ' 39' ' ' LEU . 1.3 mp -12.86 114.2 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.596 0.56 . . . . 0.0 110.893 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 32' ' ' MET . 5.9 t -83.53 157.49 3.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.387 0.613 . . . . 0.0 111.957 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.6 136.44 42.03 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.826 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.556 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 0.9 OUTLIER 59.28 89.44 0.06 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.843 -1.526 . . . . 0.0 114.257 178.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.64 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 3.2 t80 -55.69 84.14 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.42 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.615 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 53.7 42.48 31.81 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.354 -0.539 . . . . 0.0 109.698 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 93.65 33.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.338 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.556 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -132.83 -129.8 3.03 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.426 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.9 OUTLIER -96.68 -139.32 0.27 Allowed 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.561 ' O ' HD23 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -95.8 114.17 25.88 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.086 -0.384 . . . . 0.0 110.87 -179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.73 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 5.8 tp -104.13 132.72 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.767 ' O ' ' N ' ' A' ' 38' ' ' GLY . 41.7 t -90.86 96.3 0.95 Allowed Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 176.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 5.1 Cg_endo -44.56 -10.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.102 2.534 . . . . 0.0 113.878 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.717 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 3.5 mm-40 -88.21 -64.0 1.21 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.632 ' SG ' HD23 ' A' ' 39' ' ' LEU . 6.0 p -91.32 -23.07 20.23 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.767 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 71.82 46.83 35.7 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.341 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.73 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.6 OUTLIER -86.68 139.42 30.78 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.053 -1.074 . . . . 0.0 109.607 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 32' ' ' MET . 18.6 t -108.41 119.72 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 O-C-N 123.679 0.612 . . . . 0.0 111.476 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.607 HG22 ' CD1' ' A' ' 39' ' ' LEU . 0.8 OUTLIER -119.47 133.14 67.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.57 179.038 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.98 159.55 10.93 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.472 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -174.21 105.16 0.11 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.792 0.33 . . . . 0.0 110.244 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.3 125.75 6.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.042 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.3 p -117.09 -39.24 2.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.107 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.579 ' O ' HG23 ' A' ' 46' ' ' ILE . 1.6 tp -80.27 111.99 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.106 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.61 -165.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.815 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.528 HG23 ' HE ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -105.86 113.35 42.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.138 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -162.14 28.81 0.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.46 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.6 p -89.2 -31.02 18.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.75 0.309 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -120.51 74.17 1.04 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.811 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.5 m0 63.36 -79.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.061 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.528 ' HE ' HG23 ' A' ' 48' ' ' VAL . 2.1 tmt_? 59.93 69.22 0.72 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.883 0.373 . . . . 0.0 110.796 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.89 167.19 17.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -103.0 64.56 0.85 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.7 m 59.69 177.94 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -113.53 153.3 28.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.032 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -85.15 -44.1 13.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.746 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.846 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.924 0.392 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.5 m -93.82 -21.52 19.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.128 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -53.58 -62.57 1.57 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.123 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 t -63.78 -172.66 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.831 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -68.92 0.29 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 mp -109.68 -177.57 3.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.999 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -89.66 -67.08 0.86 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.94 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.43 142.85 34.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.194 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.478 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . 7.6 mt -102.92 -67.29 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.532 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 10' ' ' LEU . 42.0 Cg_endo -68.02 136.21 37.32 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.312 2.008 . . . . 0.0 112.549 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.7 -167.19 1.19 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.549 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 13' ' ' VAL . 5.7 m -113.71 97.11 5.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.883 0.373 . . . . 0.0 111.459 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.5 p 57.45 -177.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.479 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.567 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 35.8 t -70.4 137.57 86.35 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.008 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.92 -19.27 66.46 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.297 1.998 . . . . 0.0 111.818 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.21 -13.0 12.4 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.011 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.712 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.5 m80 -130.79 87.63 48.76 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.284 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.96 -35.0 94.8 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.453 2.102 . . . . 0.0 111.927 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.38 -28.79 41.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.048 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.613 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -79.85 88.21 5.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.066 0.46 . . . . 0.0 111.2 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.551 ' O ' ' C ' ' A' ' 23' ' ' LEU . 17.7 mt -74.7 72.25 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.793 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 32' ' ' MET . 0.9 OUTLIER -14.08 103.02 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.034 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.1 t -75.19 166.27 2.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.652 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.535 ' O ' ' O ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -85.72 124.5 32.3 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.965 -179.172 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.535 ' O ' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER 46.95 127.32 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.437 -1.256 . . . . 0.0 113.158 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.955 ' CB ' HG21 ' A' ' 33' ' ' ILE . 0.5 OUTLIER 178.09 -51.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.204 178.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.43 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -87.4 -54.94 4.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.716 0.293 . . . . 0.0 111.008 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.018 ' HB3' HG11 ' A' ' 40' ' ' VAL . . . -130.2 14.21 5.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.369 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.19 -19.47 53.99 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.973 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.778 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -90.2 -142.07 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.738 ' O ' HD23 ' A' ' 23' ' ' LEU . 1.1 mtp -92.35 110.42 21.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.961 0.41 . . . . 0.0 110.398 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.955 HG21 ' CB ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -99.95 124.78 53.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.158 -177.573 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.77 ' O ' ' N ' ' A' ' 38' ' ' GLY . 32.1 t -87.53 97.2 0.69 Allowed Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.3 Cg_endo -40.3 -17.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.548 2.832 . . . . 0.0 113.913 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.712 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 8.4 mm-40 -87.28 -65.88 0.97 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.591 0.234 . . . . 0.0 110.877 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.628 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.6 p -90.07 -18.6 25.62 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.77 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.93 33.39 83.8 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 114.084 -1.416 . . . . 0.0 111.769 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.82 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -72.61 145.58 47.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.916 -0.642 . . . . 0.0 109.592 179.105 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.018 HG11 ' HB3' ' A' ' 29' ' ' ALA . 2.4 t -115.08 117.61 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 120.983 0.42 . . . . 0.0 111.586 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.82 HG23 ' CD1' ' A' ' 39' ' ' LEU . 86.3 t -117.12 137.34 51.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.408 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.79 159.45 11.09 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.486 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.422 ' C ' ' HG2' ' A' ' 44' ' ' ARG . 8.0 t0 -178.94 31.37 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.576 -0.312 . . . . 0.0 110.426 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.422 ' HG2' ' C ' ' A' ' 43' ' ' ASP . 0.0 OUTLIER 41.42 -169.93 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.559 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.0 t -82.41 -24.86 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.922 0.391 . . . . 0.0 110.75 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.757 ' O ' HG23 ' A' ' 48' ' ' VAL . 0.9 OUTLIER -176.69 -177.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.32 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -55.91 89.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.819 0.342 . . . . 0.0 110.812 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 46' ' ' ILE . 11.0 t -124.44 161.05 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.042 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.48 ' N ' HG12 ' A' ' 48' ' ' VAL . . . 128.31 74.43 0.17 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.433 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -103.16 179.94 4.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.403 . . . . 0.0 110.96 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -177.39 -70.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.683 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 11.5 t90 64.08 -77.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.054 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.1 ttm-85 45.84 93.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.862 0.363 . . . . 0.0 111.39 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.2 p -68.36 158.92 32.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.801 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -127.27 3.97 6.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.537 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.4 m 55.21 -177.95 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.858 0.361 . . . . 0.0 111.02 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -139.5 -167.2 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.956 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -58.32 -57.26 13.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.967 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.86 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.739 0.304 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -95.21 53.19 1.5 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.904 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.21 31.15 3.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.687 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.6 83.8 2.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.881 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -88.2 -176.17 5.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.3 mt -51.2 94.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.134 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 -70.27 -30.41 67.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.49 128.86 47.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.12 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.611 ' N ' HD23 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -84.89 -55.55 0.42 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.012 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -78.35 -160.09 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.46 2.106 . . . . 0.0 112.107 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.658 ' O ' HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -87.27 24.03 1.7 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.139 179.892 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 12' ' ' ARG . 16.9 m 51.48 8.84 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.82 HG22 ' HA ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER 176.85 -173.78 0.11 Allowed 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.016 0.436 . . . . 0.0 110.908 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.557 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 40.1 t -70.37 136.79 86.37 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.904 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.94 -20.59 70.01 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.3 2.0 . . . . 0.0 111.976 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -116.5 -11.91 11.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.199 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.679 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.2 m80 -130.04 88.57 48.09 Favored Pre-proline 0 C--N 1.333 -0.142 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.803 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.546 ' O ' HG21 ' A' ' 14' ' ' THR . 18.2 Cg_endo -59.74 -37.16 88.9 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.474 2.116 . . . . 0.0 111.922 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -78.57 -32.82 47.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.417 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.774 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -75.42 84.77 2.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.238 0.542 . . . . 0.0 110.891 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.82 ' HA ' HG22 ' A' ' 14' ' ' THR . 1.2 mp -70.61 73.67 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.177 -178.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.603 HD11 HD21 ' A' ' 39' ' ' LEU . 1.9 mp -15.49 118.95 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.524 0.515 . . . . 0.0 110.508 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 32' ' ' MET . 22.6 t -86.57 151.15 3.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.638 0.732 . . . . 0.0 112.469 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.49 ' O ' ' O ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -71.13 130.12 40.68 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.935 -179.365 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 1.8 t70 45.68 111.21 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.558 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.496 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -166.9 166.99 15.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.493 179.361 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 50.25 32.67 6.39 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.07 35.04 16.1 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.237 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -147.11 -155.81 6.7 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.101 -1.047 . . . . 0.0 114.937 -178.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 7.9 m-20 -78.27 -115.93 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.896 0.878 . . . . 0.0 112.357 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.621 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 22.8 mtm -95.47 113.77 25.46 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.66 0.743 . . . . 0.0 111.389 -178.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.908 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -102.15 128.4 54.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.996 -177.59 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.784 ' O ' ' N ' ' A' ' 38' ' ' GLY . 41.5 t -85.68 98.67 0.76 Allowed Pre-proline 0 N--CA 1.445 -0.717 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 1.2 Cg_endo -42.68 -16.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.16 2.573 . . . . 0.0 113.699 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.774 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 14.4 mm-40 -89.2 -63.92 1.22 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.504 0.193 . . . . 0.0 111.076 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.589 ' SG ' HD23 ' A' ' 39' ' ' LEU . 6.0 p -90.74 -21.46 21.56 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.908 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 70.12 38.18 72.93 Favored Glycine 0 N--CA 1.432 -1.606 0 CA-C-N 113.546 -1.661 . . . . 0.0 112.449 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.889 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -78.08 146.02 35.47 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.753 -0.724 . . . . 0.0 110.021 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 32' ' ' MET . 23.0 t -110.81 117.7 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 O-C-N 123.43 0.456 . . . . 0.0 111.705 -178.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.889 HG23 ' CD1' ' A' ' 39' ' ' LEU . 63.2 t -125.23 138.1 55.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.869 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 31' ' ' ASP . . . 130.34 160.56 10.09 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.754 178.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 t0 177.39 99.32 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.574 -0.313 . . . . 0.0 110.186 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.26 121.76 26.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.935 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.47 ' O ' HG23 ' A' ' 45' ' ' VAL . 18.2 m -146.48 115.92 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.142 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.485 HG23 ' N ' ' A' ' 47' ' ' ASP . 6.6 tt -132.79 -45.56 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.485 ' N ' HG23 ' A' ' 46' ' ' ILE . 38.7 t70 -177.19 77.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.812 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 49' ' ' GLY . 11.6 p -106.76 157.8 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.099 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.481 ' N ' HG22 ' A' ' 48' ' ' VAL . . . 148.15 -60.87 0.45 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.377 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.25 89.71 1.57 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.81 0.338 . . . . 0.0 110.856 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -114.2 22.36 13.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.285 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.418 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 3.4 m0 57.63 -167.95 0.13 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.977 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.418 ' CB ' ' O ' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 82.08 115.54 0.06 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.959 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.65 -163.06 1.38 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.638 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -96.5 36.28 1.39 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.975 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 m 62.74 147.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.899 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -76.54 160.17 29.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -112.53 -36.63 5.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.873 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.817 0.342 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.4 m -79.64 -31.87 41.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 p -68.9 79.58 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.1 t -177.19 42.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.73 -79.79 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 176.89 141.03 0.07 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.785 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -130.29 31.36 4.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.834 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.84 ' O ' HD23 ' A' ' 10' ' ' LEU . . . -108.25 137.66 45.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.188 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.84 HD23 ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -157.09 -64.81 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.497 ' O ' HG23 ' A' ' 13' ' ' VAL . 32.0 Cg_endo -63.42 154.75 66.45 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.336 2.024 . . . . 0.0 112.263 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.05 -42.81 91.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.8 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 11' ' ' PRO . 32.2 t 66.54 103.34 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.647 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.566 HG21 ' O ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER 66.14 169.84 0.23 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.456 179.467 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.435 ' HB2' HD12 ' A' ' 23' ' ' LEU . 7.7 t -70.31 136.26 86.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.227 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -66.86 -20.91 51.3 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.327 2.018 . . . . 0.0 111.967 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -111.7 -14.83 13.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.979 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.703 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.0 m80 -130.47 87.32 50.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.668 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.566 ' O ' HG21 ' A' ' 14' ' ' THR . 18.2 Cg_endo -59.87 -38.09 81.79 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.395 2.063 . . . . 0.0 111.967 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.96 -39.07 61.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.226 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -70.82 91.93 0.87 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.968 0.413 . . . . 0.0 111.149 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.586 ' O ' ' C ' ' A' ' 23' ' ' LEU . 8.6 mm -77.86 67.21 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.432 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.639 HD11 HD21 ' A' ' 39' ' ' LEU . 0.9 OUTLIER -5.32 102.84 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.154 179.614 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.5 t -77.22 163.58 3.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 121.339 0.59 . . . . 0.0 111.781 -178.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.445 ' N ' HG12 ' A' ' 24' ' ' VAL . 2.0 mm-40 -60.33 -164.46 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.782 -178.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 27' ' ' TYR . 7.6 t0 -36.67 116.27 0.42 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.888 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.93 ' HB3' HG21 ' A' ' 33' ' ' ILE . 0.8 OUTLIER 176.0 140.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.327 179.111 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 2.5 tpm_? 64.43 16.06 9.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.871 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.007 ' HB3' HG11 ' A' ' 40' ' ' VAL . . . 173.67 -70.31 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.436 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 161.78 -27.74 0.27 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.32 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.835 ' OD2' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -94.58 -118.03 0.1 Allowed 'General case' 0 CA--C 1.536 0.417 0 O-C-N 122.824 -0.221 . . . . 0.0 110.705 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.833 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 15.5 mtt -112.86 126.81 55.85 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 121.698 -0.626 . . . . 0.0 110.619 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.93 HG21 ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -112.99 134.07 56.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -177.719 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.821 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.4 t -87.63 97.75 0.81 Allowed Pre-proline 0 C--O 1.218 -0.569 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.8 Cg_endo -39.22 -19.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.549 2.833 . . . . 0.0 113.627 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.703 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 12.1 mm-40 -85.58 -66.84 0.85 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.732 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.668 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.7 p -90.08 -20.69 22.88 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 177.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.821 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 70.25 32.36 68.77 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 114.025 -1.443 . . . . 0.0 112.217 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.714 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -71.51 141.41 50.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.717 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.007 HG11 ' HB3' ' A' ' 29' ' ' ALA . 1.3 t -108.8 127.0 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-O 120.692 0.282 . . . . 0.0 111.004 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.6 OUTLIER -128.86 126.67 65.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.986 178.448 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.415 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 133.54 -176.61 19.57 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.261 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.55 84.03 0.13 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.822 0.344 . . . . 0.0 110.646 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.715 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -121.17 -75.3 0.59 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.164 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -175.72 -81.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.306 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.463 HG23 ' H ' ' A' ' 47' ' ' ASP . 0.4 OUTLIER 44.37 -83.55 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.706 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 45' ' ' VAL . 1.5 m-20 67.12 137.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.899 0.38 . . . . 0.0 111.129 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.32 80.75 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.834 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.42 -89.85 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.608 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.7 t -60.14 86.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.942 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -178.51 37.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.976 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 13.3 m0 61.33 -145.3 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.59 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.67 36.16 1.3 Allowed 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 120.975 0.417 . . . . 0.0 110.807 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 55' ' ' PHE . 1.2 m -137.7 172.99 12.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.682 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.504 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 40.8 p90 -74.08 62.61 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.036 0.446 . . . . 0.0 110.951 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 m 60.34 165.59 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -114.56 174.69 5.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.944 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.25 -69.07 0.89 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.898 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.822 0.344 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.3 m -75.13 65.2 1.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 p -140.96 88.02 2.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -168.14 73.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.08 121.51 12.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mt -60.27 162.37 6.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.61 107.04 4.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.859 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.508 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . 63.26 125.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.087 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.682 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.6 OUTLIER -88.97 -19.83 0.25 Allowed Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.682 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 95.1 Cg_endo -85.15 -168.89 0.55 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.803 1.669 . . . . 0.0 112.379 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.2 112.1 17.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.932 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.574 HG23 ' H ' ' A' ' 14' ' ' THR . 0.1 OUTLIER -48.84 -68.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.491 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.65 HG22 HG23 ' A' ' 22' ' ' ILE . 59.9 p -97.92 -143.21 0.3 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.233 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.495 ' CB ' ' HG ' ' A' ' 34' ' ' CYS . 48.3 t -73.28 136.71 78.6 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-O 120.508 0.194 . . . . 0.0 110.757 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.62 -24.09 77.37 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.266 1.978 . . . . 0.0 112.068 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -118.06 -7.25 10.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.484 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.744 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 32.7 m80 -133.15 80.76 58.54 Favored Pre-proline 0 C--N 1.333 -0.129 0 CA-C-O 120.734 0.302 . . . . 0.0 111.692 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -57.74 -36.52 98.36 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.887 1.725 . . . . 0.0 111.06 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.53 -48.73 63.56 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.258 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.604 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -71.09 85.98 0.74 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.248 0.547 . . . . 0.0 111.073 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.65 HG23 HG22 ' A' ' 14' ' ' THR . 1.6 mp -67.75 75.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.846 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.667 HD11 HD21 ' A' ' 39' ' ' LEU . 1.1 mp -14.24 112.2 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.912 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -81.31 160.19 3.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.277 0.56 . . . . 0.0 111.644 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.489 ' O ' ' O ' ' A' ' 26' ' ' ASP . 15.6 mm-40 -81.04 129.22 34.44 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.85 -179.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 25' ' ' GLU . 6.5 t70 45.68 116.29 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.403 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.622 ' CG ' HG21 ' A' ' 33' ' ' ILE . 2.1 t80 -146.67 145.88 30.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.125 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.461 ' O ' ' CG ' ' A' ' 28' ' ' ARG . 0.2 OUTLIER 51.19 31.99 7.47 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.395 -179.014 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 68.07 38.32 2.74 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.996 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -128.62 -155.73 8.72 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.579 -0.82 . . . . 0.0 114.412 -178.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.67 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 4.5 m-20 -88.88 -128.19 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.655 -0.772 . . . . 0.0 111.801 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.598 ' O ' HD23 ' A' ' 23' ' ' LEU . 73.3 mtp -90.64 112.69 24.52 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.475 0.655 . . . . 0.0 110.247 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.73 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -100.68 125.68 54.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.403 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.731 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.0 t -88.87 98.27 1.09 Allowed Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.1 Cg_endo -43.57 -14.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.181 2.587 . . . . 0.0 114.068 -178.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.744 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 4.0 mm-40 -89.45 -63.07 1.34 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 121.215 -0.194 . . . . 0.0 111.409 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.658 ' SG ' HD23 ' A' ' 39' ' ' LEU . 16.1 p -91.37 -23.23 20.13 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.731 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 72.18 37.53 59.6 Favored Glycine 0 N--CA 1.428 -1.892 0 CA-C-N 113.285 -1.78 . . . . 0.0 112.651 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.698 ' CD1' HG22 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -77.36 145.82 37.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.155 179.672 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 32' ' ' MET . 59.0 t -111.35 116.1 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 O-C-N 123.847 0.717 . . . . 0.0 111.069 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.698 HG22 ' CD1' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -113.9 143.88 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.471 179.005 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . -27.62 -72.21 0.04 OUTLIER Glycine 0 CA--C 1.507 -0.423 0 O-C-N 123.657 0.598 . . . . 0.0 113.329 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 1.0 OUTLIER 156.63 -172.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.01 0.434 . . . . 0.0 110.969 179.461 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.469 ' C ' HG23 ' A' ' 45' ' ' VAL . 21.1 mmm180 -103.64 -41.16 6.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.257 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.469 HG23 ' C ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER 57.99 110.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.45 179.584 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.6 tt -160.56 42.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.954 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.448 ' C ' HG23 ' A' ' 48' ' ' VAL . 10.2 t70 -111.5 -23.9 10.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.136 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 49' ' ' GLY . 3.4 t 74.02 163.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.847 0.356 . . . . 0.0 110.952 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.454 ' N ' HG12 ' A' ' 48' ' ' VAL . . . -49.56 -50.42 30.61 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.821 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.0 p -172.65 -178.78 2.0 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 110.902 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -173.08 40.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.964 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.406 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER 69.35 -60.03 0.47 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.374 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.406 ' CB ' ' O ' ' A' ' 52' ' ' TRP . 0.9 OUTLIER 79.86 51.88 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.95 0.405 . . . . 0.0 110.823 -179.815 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -152.01 175.71 12.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.648 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.503 ' H ' HG22 ' A' ' 54' ' ' THR . 26.6 p90 -111.43 66.11 0.63 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.993 0.425 . . . . 0.0 110.994 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 m 61.48 162.23 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.886 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -68.93 168.92 12.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.967 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -62.4 -41.91 99.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.851 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.826 0.346 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 m -100.04 31.61 3.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.825 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 p -142.91 84.19 1.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.2 t -146.49 177.21 9.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.6 mmp_? -101.25 -73.84 0.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.902 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -165.15 70.37 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.934 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -128.29 140.24 51.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.775 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.03 143.19 33.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.322 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.52 ' O ' HG23 ' A' ' 13' ' ' VAL . 3.8 mm? -59.07 165.91 3.12 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.749 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 10' ' ' LEU . 76.8 Cg_endo -78.18 9.99 2.87 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.551 2.168 . . . . 0.0 112.984 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -86.76 7.63 26.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.608 0.242 . . . . 0.0 111.42 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 10' ' ' LEU . 3.8 t -84.47 -58.14 3.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.925 0.393 . . . . 0.0 111.053 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.52 171.13 0.19 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.898 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 10.5 t -67.69 135.73 92.57 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.119 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.8 -23.75 74.43 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.24 1.96 . . . . 0.0 111.995 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -106.93 -30.01 9.11 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.719 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.636 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 39.6 m80 -108.25 87.53 4.1 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.18 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.61 39.73 0.65 Allowed 'Trans proline' 0 CA--C 1.515 -0.444 0 C-N-CA 123.168 2.578 . . . . 0.0 111.013 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 18' ' ' HIS . 46.8 m-20 -152.64 -48.05 0.1 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.143 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.436 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -69.58 93.46 0.7 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.991 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.574 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.5 mp -76.04 71.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.946 -1.025 . . . . 0.0 113.182 -177.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.092 HD21 HD11 ' A' ' 39' ' ' LEU . 0.9 OUTLIER -8.84 111.35 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.901 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 32' ' ' MET . 15.4 t -81.76 152.44 4.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 121.646 0.736 . . . . 0.0 112.609 -177.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 26' ' ' ASP . 8.0 mt-10 -85.8 122.86 30.47 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.005 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.651 ' O ' ' HB3' ' A' ' 27' ' ' TYR . 24.7 m-20 47.84 115.67 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.762 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.784 ' CE2' HG23 ' A' ' 33' ' ' ILE . 0.1 OUTLIER 166.02 151.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.403 177.62 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.487 ' NE ' ' HA ' ' A' ' 28' ' ' ARG . 5.3 mmp_? 62.34 37.4 13.86 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.044 -176.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.56 34.96 24.29 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.82 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.604 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -138.27 155.18 23.29 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 119.873 -1.156 . . . . 0.0 115.577 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 26' ' ' ASP . 5.9 m-20 -60.76 -100.91 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.391 -0.904 . . . . 0.0 109.087 177.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.577 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 16.7 mtp -106.52 105.06 14.92 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.028 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -109.09 137.91 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 CA-C-O 122.113 0.959 . . . . 0.0 112.048 -176.396 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.811 ' O ' ' N ' ' A' ' 38' ' ' GLY . 33.1 t -91.25 99.17 2.07 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 113.542 -1.663 . . . . 0.0 109.181 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.476 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.1 Cg_endo -41.41 -15.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.312 2.675 . . . . 0.0 113.603 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.636 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 9.3 mm-40 -87.18 -65.0 1.06 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.484 0.183 . . . . 0.0 110.627 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.545 ' SG ' HD23 ' A' ' 39' ' ' LEU . 1.6 p -90.07 -21.0 22.52 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 176.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.811 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 69.06 40.16 83.66 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.963 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.092 HD11 HD21 ' A' ' 23' ' ' LEU . 1.5 pp -77.26 136.85 38.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.024 -1.088 . . . . 0.0 108.378 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 32' ' ' MET . 42.9 t -105.6 126.45 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 O-C-N 123.399 0.437 . . . . 0.0 111.234 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.567 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.4 t -125.77 127.69 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.224 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.91 159.57 10.11 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.723 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -171.67 69.61 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.866 0.365 . . . . 0.0 110.342 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.3 tpp85 62.59 20.63 12.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.133 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 45' ' ' VAL . 8.2 p -126.44 9.41 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.338 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.3 pp -132.49 15.31 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.307 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -70.12 155.9 39.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.75 0.309 . . . . 0.0 110.729 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.93 -83.55 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.156 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 49.15 -136.13 21.19 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.611 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 57.68 -160.5 0.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.639 0.257 . . . . 0.0 110.882 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 53' ' ' ARG . 19.2 mt-10 73.55 8.01 5.06 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.485 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 52.0 m0 62.89 -77.32 0.03 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.254 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.407 ' N ' ' O ' ' A' ' 51' ' ' GLU . 9.0 mmt180 64.61 115.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.864 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.26 -168.49 1.7 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.889 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -124.1 12.03 8.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.29 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.64 166.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.826 0.346 . . . . 0.0 110.935 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -171.79 174.66 4.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -63.12 -68.05 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.875 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.88 0.371 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.2 m -134.17 37.34 3.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.25 97.09 9.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -134.0 -65.74 0.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.6 mmp_? 61.74 -83.3 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.026 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 8' ' ' ASP . 0.2 OUTLIER 174.7 170.25 0.25 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.74 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.527 ' H ' HD23 ' A' ' 7' ' ' LEU . 34.4 p-10 -175.73 36.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.025 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -152.93 22.38 0.58 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.263 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.45 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 5.8 tp -86.94 -48.01 0.49 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.453 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 86.9 Cg_endo -82.61 -32.46 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.389 2.059 . . . . 0.0 112.456 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.29 172.73 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.749 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 13' ' ' VAL . 7.3 t -131.19 6.1 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.792 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -164.25 169.96 16.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.077 0.465 . . . . 0.0 111.016 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 42.7 t -69.96 134.29 87.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.065 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.18 -28.41 56.25 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.338 2.025 . . . . 0.0 111.238 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -91.08 -20.35 22.14 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.335 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.612 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 40.5 m80 -130.66 85.92 54.36 Favored Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.325 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.73 -40.54 53.86 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.958 1.772 . . . . 0.0 110.99 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.0 -13.96 59.69 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.974 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.58 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -97.76 133.77 41.83 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.66 0.743 . . . . 0.0 110.985 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.539 ' H ' HD12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -108.11 123.98 64.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.774 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.93 HD23 ' O ' ' A' ' 32' ' ' MET . 4.9 mp -67.89 93.86 0.43 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 32' ' ' MET . 2.7 t -49.91 161.83 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.208 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -89.38 121.7 31.89 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 122.428 1.109 . . . . 0.0 112.13 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER 56.75 105.42 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 113.121 -1.854 . . . . 0.0 113.15 179.137 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.538 ' CG ' HG21 ' A' ' 33' ' ' ILE . 2.6 t80 -140.13 148.96 42.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.194 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.478 ' HD3' ' O ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER 41.39 47.09 3.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.347 -178.667 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.38 40.77 23.95 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.88 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -130.52 -164.93 11.43 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.735 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 1.006 ' OD1' HG12 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -89.25 -105.58 0.09 Allowed 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 115.406 -0.397 . . . . 0.0 111.231 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.93 ' O ' HD23 ' A' ' 23' ' ' LEU . 36.2 mtm -106.58 115.04 29.51 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.308 0.575 . . . . 0.0 111.413 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.814 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -98.82 121.62 49.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.132 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.814 ' O ' ' N ' ' A' ' 38' ' ' GLY . 38.9 t -84.35 100.4 1.06 Allowed Pre-proline 0 C--O 1.221 -0.406 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.484 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 3.9 Cg_exo -36.8 -26.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.804 3.003 . . . . 0.0 114.064 -179.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.612 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 27.2 mm-40 -82.63 -67.36 0.79 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.523 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.731 ' SG ' HD23 ' A' ' 39' ' ' LEU . 2.6 p -87.92 -15.07 37.63 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.814 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 61.84 25.55 65.94 Favored Glycine 0 N--CA 1.433 -1.542 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.31 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.858 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -65.25 150.37 48.34 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.354 -0.923 . . . . 0.0 110.116 -179.844 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.006 HG12 ' OD1' ' A' ' 31' ' ' ASP . 2.7 t -118.17 120.19 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.858 HG23 ' CD1' ' A' ' 39' ' ' LEU . 84.9 t -130.3 132.84 64.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.164 178.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.69 -170.94 19.13 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.456 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 47.06 -160.69 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.769 0.319 . . . . 0.0 111.464 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.783 ' O ' HG13 ' A' ' 45' ' ' VAL . 25.5 mmm-85 73.98 -77.39 0.05 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.367 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.783 HG13 ' O ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -171.23 116.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.809 0.337 . . . . 0.0 111.32 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.692 HG23 ' H ' ' A' ' 47' ' ' ASP . 0.6 OUTLIER -160.03 -95.11 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.582 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.692 ' H ' HG23 ' A' ' 46' ' ' ILE . 3.2 p-10 29.17 52.12 0.08 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.438 HG22 ' N ' ' A' ' 49' ' ' GLY . 13.9 p -101.54 155.48 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.32 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 48' ' ' VAL . . . 115.58 126.21 4.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.493 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.27 97.86 5.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.809 0.338 . . . . 0.0 110.896 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.83 44.05 0.44 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.796 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 15.1 m0 62.47 -81.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.71 49.03 21.74 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.825 0.345 . . . . 0.0 111.095 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.456 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -112.94 -170.95 1.77 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.797 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.456 ' H ' HG22 ' A' ' 54' ' ' THR . 29.0 p90 -87.59 56.63 4.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.81 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.2 m 64.69 158.13 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.868 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -71.99 147.07 47.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.21 -64.27 0.78 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.922 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.837 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.734 0.302 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.68 -31.87 14.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.919 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.7 p -144.0 137.79 27.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.805 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.4 t -175.02 136.05 0.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.973 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -168.1 0.05 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.808 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.05 168.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.139 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -81.9 -176.71 6.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.976 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.08 113.1 1.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.488 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -75.9 -50.26 3.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.317 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 10' ' ' LEU . 73.3 Cg_endo -76.56 170.17 20.43 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.272 1.981 . . . . 0.0 112.397 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.92 131.88 54.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.0 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 13' ' ' VAL . 13.4 p -96.11 20.08 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.281 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.719 HG22 ' HA ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -179.35 -178.78 0.51 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.562 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 43.3 t -70.26 133.47 87.47 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.207 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.73 -28.97 51.57 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.601 2.201 . . . . 0.0 112.03 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.19 -16.31 19.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.713 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.672 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 39.9 m80 -131.92 85.23 51.45 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.293 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.68 -43.54 37.87 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.074 1.85 . . . . 0.0 111.321 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -74.64 -12.01 60.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.372 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -102.5 102.35 12.63 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.136 0.494 . . . . 0.0 111.812 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.719 ' HA ' HG22 ' A' ' 14' ' ' THR . 1.8 mp -76.38 130.76 35.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.755 HD23 ' O ' ' A' ' 32' ' ' MET . 3.2 mp -72.19 135.69 46.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.657 0.742 . . . . 0.0 111.125 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 32' ' ' MET . 42.9 t -87.63 156.84 3.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.208 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.21 124.45 29.92 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.936 0.874 . . . . 0.0 111.314 -177.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 31' ' ' ASP . 16.8 m-20 74.87 80.29 0.11 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.857 -1.519 . . . . 0.0 114.615 177.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.612 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 1.4 t80 -51.48 92.97 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.468 ' HD3' ' CE1' ' A' ' 27' ' ' TYR . 22.5 mtp180 66.21 -73.41 0.07 Allowed 'General case' 0 CA--C 1.522 -0.1 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 27' ' ' TYR . . . -143.96 31.92 1.26 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.324 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -123.3 -135.75 4.63 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 115.511 -0.768 . . . . 0.0 114.445 -178.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -91.56 -131.31 0.11 Allowed 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 122.871 0.468 . . . . 0.0 111.892 -178.397 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.755 ' O ' HD23 ' A' ' 23' ' ' LEU . 75.8 mtp -96.84 117.47 31.16 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.992 -0.443 . . . . 0.0 110.913 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.662 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -99.42 123.19 51.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -176.596 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.771 ' O ' ' N ' ' A' ' 38' ' ' GLY . 30.4 t -88.86 100.17 1.94 Allowed Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -40.11 -20.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.589 2.859 . . . . 0.0 114.09 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.672 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 6.4 mm-40 -87.36 -64.5 1.14 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.755 0.312 . . . . 0.0 111.409 -177.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.445 ' SG ' HD23 ' A' ' 39' ' ' LEU . 7.6 p -89.86 -20.23 23.68 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.771 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 68.15 29.14 73.2 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.222 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.808 HD11 HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -69.0 145.95 53.14 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.159 -0.521 . . . . 0.0 110.422 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' MET . 40.4 t -109.3 120.51 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 O-C-N 123.904 0.753 . . . . 0.0 110.493 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.808 HG22 HD11 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -123.58 126.26 72.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.1 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.643 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 124.18 -156.5 18.33 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.643 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 27.7 t70 111.76 25.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.984 0.514 . . . . 0.0 111.317 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -178.77 170.04 1.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.894 0.378 . . . . 0.0 111.162 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -105.38 133.42 49.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.846 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.507 ' O ' HG23 ' A' ' 46' ' ' ILE . 7.5 tt -54.19 119.04 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.249 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -55.9 97.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.125 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.582 ' O ' HG12 ' A' ' 48' ' ' VAL . 14.4 t -151.65 29.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.062 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.94 59.22 4.77 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.45 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.27 30.21 1.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.814 0.34 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -154.88 80.85 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 42.9 m0 61.51 -92.66 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.805 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.04 43.33 5.43 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.764 0.316 . . . . 0.0 111.386 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.469 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -108.01 -177.11 3.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.048 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.469 ' H ' HG22 ' A' ' 54' ' ' THR . 15.4 p90 -100.2 37.34 1.68 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.886 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.0 m 61.28 -177.07 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -120.41 -174.07 2.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -117.55 -42.14 2.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.935 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.843 0.354 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.5 94.94 4.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.798 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.57 73.6 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.986 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.4 -80.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.805 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.1 mtt85 53.81 -173.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.071 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.2 mt -102.23 -179.55 4.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.854 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.516 ' HB3' HG21 ' A' ' 13' ' ' VAL . 7.1 t0 -99.34 95.64 7.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.103 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.56 14.97 2.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.45 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.466 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 1.2 mt -98.63 -50.91 0.21 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.453 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 10' ' ' LEU . 56.3 Cg_endo -86.42 -85.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.459 2.106 . . . . 0.0 112.82 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -179.93 132.07 0.1 Allowed 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 120.81 0.338 . . . . 0.0 110.945 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 8' ' ' ASP . 37.5 t -129.11 106.32 13.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.92 177.3 0.13 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.943 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 19.2 t -73.01 132.83 82.33 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.318 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.85 -26.32 32.18 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.322 2.015 . . . . 0.0 111.535 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.55 -16.98 18.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.74 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.643 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 39.1 m80 -131.87 84.32 54.42 Favored Pre-proline 0 N--CA 1.455 -0.224 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.205 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.96 -44.86 27.24 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 121.937 1.758 . . . . 0.0 111.528 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.98 -12.77 60.74 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -102.12 102.37 12.83 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.826 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.461 ' H ' HD12 ' A' ' 22' ' ' ILE . 1.3 mp -75.65 125.11 34.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.797 HD22 HG23 ' A' ' 41' ' ' VAL . 2.7 mp -67.63 147.69 52.38 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.391 0.615 . . . . 0.0 110.509 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 32' ' ' MET . 50.2 t -95.08 146.78 6.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.039 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -71.68 124.47 24.81 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.323 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER 73.48 81.58 0.13 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.263 -1.335 . . . . 0.0 114.424 178.244 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.702 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -56.15 100.28 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.023 178.287 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.642 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 5.9 ttp-105 46.41 38.42 5.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.348 . . . . 0.0 110.372 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 92.03 34.57 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.59 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -133.06 -123.84 2.46 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.739 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -97.41 -135.63 0.25 Allowed 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 122.057 0.143 . . . . 0.0 110.88 -179.704 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.636 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 9.4 mtt -99.37 116.07 30.69 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-O 121.232 0.539 . . . . 0.0 111.564 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.771 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -98.23 123.26 50.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.894 -177.604 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.763 ' O ' ' N ' ' A' ' 38' ' ' GLY . 52.8 t -88.68 102.26 3.75 Favored Pre-proline 0 C--O 1.222 -0.379 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.489 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.7 Cg_endo -40.95 -20.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.398 2.732 . . . . 0.0 113.953 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.643 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 30.9 mm-40 -86.83 -65.52 1.01 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.571 -177.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.483 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 6.4 p -90.23 -20.47 22.96 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.771 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.29 30.29 71.62 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 113.715 -1.584 . . . . 0.0 112.437 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.737 ' CD1' HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -71.26 146.41 48.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.249 -0.475 . . . . 0.0 110.451 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.562 HG12 ' HB2' ' A' ' 31' ' ' ASP . 26.6 t -106.28 119.29 55.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 O-C-N 123.905 0.753 . . . . 0.0 109.489 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.797 HG23 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.33 133.89 67.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.824 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.3 160.56 10.41 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.086 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.452 ' O ' ' C ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER 179.37 70.16 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.452 ' C ' ' O ' ' A' ' 43' ' ' ASP . 3.7 ptm180 -18.34 -54.1 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 m -39.66 100.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.949 0.404 . . . . 0.0 111.929 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.8 tt -97.83 -39.64 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.196 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.17 176.52 8.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.884 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.0 t -105.12 -31.81 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.06 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.82 -144.53 17.35 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.523 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 m 60.06 44.42 13.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.926 0.393 . . . . 0.0 110.874 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -111.14 -67.46 1.0 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.003 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.422 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 0.5 OUTLIER -161.25 -41.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.0 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 52' ' ' TRP . 0.4 OUTLIER 82.43 -50.58 0.2 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.32 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.7 m -46.57 143.45 2.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.791 0.329 . . . . 0.0 111.279 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -155.08 131.48 10.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 65.5 m 59.28 86.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -60.28 177.56 0.26 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.25 -34.03 76.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.971 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.959 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.799 0.333 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -100.06 31.29 3.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.891 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.7 p -136.66 -47.47 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.45 -168.49 1.73 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.825 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.33 -55.74 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.896 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.1 mt -109.15 -48.83 3.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.993 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 63.04 -80.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.003 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.69 121.58 14.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.866 0.365 . . . . 0.0 110.895 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.451 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 1.3 mt -178.13 -61.93 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.022 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 10' ' ' LEU . 17.8 Cg_endo -58.07 128.66 29.66 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.546 2.164 . . . . 0.0 112.511 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.32 140.64 49.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.664 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 13' ' ' VAL . 14.4 p -99.4 34.51 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.163 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.436 HG22 ' CD1' ' A' ' 22' ' ' ILE . 3.6 p -145.26 156.73 44.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.04 0.448 . . . . 0.0 111.139 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 42.9 t -65.88 135.81 95.5 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.001 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.11 -28.49 48.72 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.389 2.06 . . . . 0.0 111.772 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -95.82 -18.18 20.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.522 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.706 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 40.1 m80 -131.31 86.18 51.23 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.329 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.31 -45.33 19.11 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 121.995 1.797 . . . . 0.0 111.309 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -72.33 -14.41 61.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.419 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -100.76 105.94 17.31 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.582 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.436 ' CD1' HG22 ' A' ' 14' ' ' THR . 3.6 mm -81.89 128.17 38.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.564 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.871 HD21 HD11 ' A' ' 39' ' ' LEU . 3.5 mp -67.32 137.55 56.14 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.095 0.474 . . . . 0.0 110.465 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.717 ' O ' ' HA ' ' A' ' 32' ' ' MET . 43.7 t -88.18 142.28 13.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.332 0.587 . . . . 0.0 111.482 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.32 120.42 23.05 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.09 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' A' ' 31' ' ' ASP . 1.8 t70 56.27 102.15 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.191 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.401 ' HB3' HG21 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -162.54 161.91 27.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.944 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 52.13 40.08 27.96 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.8 31.89 18.49 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.281 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -137.85 -160.4 8.5 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.516 -0.85 . . . . 0.0 114.243 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.903 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 1.2 m-20 -86.16 -99.14 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.366 0.666 . . . . 0.0 112.423 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.717 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -108.86 113.2 25.91 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.068 0.461 . . . . 0.0 111.451 -178.665 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.787 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -102.71 126.24 56.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.517 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.792 ' O ' ' N ' ' A' ' 38' ' ' GLY . 41.0 t -90.18 99.96 2.27 Favored Pre-proline 0 C--O 1.22 -0.453 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.8 Cg_endo -40.24 -21.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.458 2.772 . . . . 0.0 114.097 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.706 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 31.7 mm-40 -84.52 -65.31 1.02 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.669 0.271 . . . . 0.0 111.216 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.774 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.7 p -89.82 -18.51 26.12 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.792 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.51 28.49 73.6 Favored Glycine 0 N--CA 1.433 -1.545 0 CA-C-N 113.641 -1.618 . . . . 0.0 112.074 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.871 HD11 HD21 ' A' ' 23' ' ' LEU . 1.3 pp -67.09 140.67 57.6 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.615 -0.793 . . . . 0.0 110.558 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' A' ' 32' ' ' MET . 29.3 t -110.32 118.71 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.508 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.903 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 1.5 t -107.52 -165.69 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.183 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.623 ' H ' HG12 ' A' ' 41' ' ' VAL . . . -85.43 -160.23 32.77 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.286 -0.959 . . . . 0.0 110.898 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.402 ' CB ' ' OD2' ' A' ' 31' ' ' ASP . 28.0 t0 -168.59 -39.43 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.071 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.09 -82.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.447 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.695 HG13 ' N ' ' A' ' 46' ' ' ILE . 0.6 OUTLIER 38.3 -160.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.832 179.417 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.695 ' N ' HG13 ' A' ' 45' ' ' VAL . 9.4 tp -148.71 157.36 7.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.696 0.284 . . . . 0.0 110.743 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -47.83 95.39 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.883 0.373 . . . . 0.0 111.178 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 46' ' ' ILE . 29.4 m -84.34 161.16 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.224 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.44 58.98 4.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.481 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.77 95.88 2.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.34 . . . . 0.0 110.793 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -141.04 40.43 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.935 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 69.6 -60.41 0.47 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.272 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? 77.04 98.23 0.07 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.964 0.412 . . . . 0.0 110.959 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.67 178.02 10.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.743 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -132.24 103.2 6.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.8 m 59.57 174.09 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.018 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -129.74 170.35 13.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.13 -38.07 8.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.866 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.824 0.345 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.6 m -65.18 -31.48 72.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 65.7 p -60.81 -65.06 0.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.923 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.07 176.6 0.31 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.2 mtt85 -138.72 -75.86 0.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.989 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 7' ' ' LEU . 2.3 mt -108.58 85.81 2.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -133.01 70.53 1.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.844 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -167.35 38.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.183 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.497 ' O ' HD12 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -128.99 52.35 9.1 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.889 179.887 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.414 ' HD3' ' N ' ' A' ' 10' ' ' LEU . 91.1 Cg_endo -78.45 78.01 3.8 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.533 2.155 . . . . 0.0 112.607 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.887 ' HD2' HG11 ' A' ' 41' ' ' VAL . 4.6 ptp85 -85.89 141.95 29.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.615 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.456 ' O ' HG23 ' A' ' 14' ' ' THR . 30.7 m -124.65 18.66 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.634 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -166.09 169.49 14.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 110.809 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 11.3 t -79.46 134.58 58.07 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.188 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.3 -19.32 44.1 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.264 1.976 . . . . 0.0 111.6 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -115.09 -11.06 12.12 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.304 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.655 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . 38.6 m80 -130.96 87.31 49.26 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-O 120.624 0.249 . . . . 0.0 110.583 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.33 -36.2 88.33 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.313 2.008 . . . . 0.0 112.004 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -79.26 -31.92 43.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.005 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.655 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -75.05 88.45 2.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.058 0.456 . . . . 0.0 111.278 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.55 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.7 mp -75.2 70.12 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.201 -0.908 . . . . 0.0 112.827 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.832 HD21 HD11 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -12.22 111.25 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.536 179.481 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 25' ' ' GLU . 3.3 t -79.34 167.35 2.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.137 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.48 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -81.35 129.51 34.65 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 121.71 0.766 . . . . 0.0 110.229 -178.463 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.591 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 6.3 m-20 85.71 -160.28 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.222 -1.354 . . . . 0.0 112.975 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.859 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 14.3 t80 155.16 78.22 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 124.08 0.952 . . . . 0.0 108.788 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.572 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 15.1 mmp_? 61.96 41.43 11.29 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 79.97 42.08 0.07 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.693 -178.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -124.45 -156.66 9.5 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.749 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.538 ' O ' ' CA ' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -89.17 -135.7 0.1 Allowed 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 122.952 0.501 . . . . 0.0 111.216 -179.557 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.657 ' O ' HD23 ' A' ' 23' ' ' LEU . 1.9 mtt -88.1 117.11 26.76 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-O 121.402 0.62 . . . . 0.0 110.904 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.859 ' HB ' ' HB2' ' A' ' 27' ' ' TYR . 0.2 OUTLIER -99.97 123.4 52.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -176.149 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.74 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.8 t -88.56 96.28 0.65 Allowed Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.2 Cg_endo -41.84 -15.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.382 2.722 . . . . 0.0 113.743 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.646 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 18.2 mm-40 -85.1 -67.49 0.8 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.905 0.383 . . . . 0.0 111.034 -178.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.792 ' SG ' HD23 ' A' ' 39' ' ' LEU . 2.9 p -90.85 -19.56 23.25 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.851 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.18 38.72 82.99 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.149 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.832 HD11 HD21 ' A' ' 23' ' ' LEU . 1.6 pp -78.05 147.0 34.96 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.438 -0.881 . . . . 0.0 110.281 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 32' ' ' MET . 49.1 t -112.23 118.63 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 123.354 0.409 . . . . 0.0 111.945 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.887 HG11 ' HD2' ' A' ' 12' ' ' ARG . 0.2 OUTLIER -124.15 131.52 72.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.241 178.043 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.29 -173.9 18.94 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.047 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -111.47 138.05 48.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.841 0.353 . . . . 0.0 111.084 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -95.7 78.35 3.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.629 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.635 HG22 ' H ' ' A' ' 46' ' ' ILE . 2.1 p -150.29 175.82 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.928 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.635 ' H ' HG22 ' A' ' 45' ' ' VAL . 0.1 OUTLIER 84.42 154.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.0 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.97 140.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.705 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.97 -79.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.128 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.84 165.92 28.92 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.436 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.92 83.56 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.83 0.348 . . . . 0.0 110.913 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -122.0 21.47 10.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.223 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.42 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 57.33 -156.28 0.31 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.814 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.42 ' CB ' ' O ' ' A' ' 52' ' ' TRP . 1.0 OUTLIER 81.95 117.1 0.05 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.95 0.405 . . . . 0.0 111.016 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -136.44 -167.07 1.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.66 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.424 ' H ' HG22 ' A' ' 54' ' ' THR . 9.4 p90 -85.84 61.69 7.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.961 0.41 . . . . 0.0 110.837 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.4 m 63.27 165.97 0.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.951 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -100.5 121.69 41.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.985 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -70.06 -31.63 69.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.834 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.872 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.784 0.326 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.497 ' O ' HG23 ' A' ' 4' ' ' THR . 0.9 OUTLIER -99.6 29.32 4.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.976 179.976 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -178.3 92.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.813 179.986 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.0 m -147.92 147.42 29.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.978 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -82.27 144.62 30.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.784 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 mt -76.88 126.52 31.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.98 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.548 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 1.4 m-20 -73.84 -127.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.378 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . 76.22 -56.75 0.57 Allowed 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 179.809 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.515 ' C ' ' O ' ' A' ' 9' ' ' ALA . 3.9 mt -2.62 -70.65 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.66 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.636 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.515 ' CD ' ' CB ' ' A' ' 10' ' ' LEU . 67.9 Cg_endo -73.95 -92.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.05 1.834 . . . . 0.0 112.591 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 170.33 -50.99 0.01 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.958 0.409 . . . . 0.0 110.286 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.8 t 62.16 93.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.696 179.48 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.496 HG22 HD12 ' A' ' 22' ' ' ILE . 10.6 p 55.27 -175.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.527 179.432 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 32.8 t -74.43 135.3 75.75 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.922 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.5 -19.97 65.54 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.259 1.973 . . . . 0.0 111.911 179.39 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.16 -10.88 10.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.258 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.734 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.9 m80 -130.58 87.99 48.24 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.797 0.332 . . . . 0.0 110.829 179.575 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.32 -34.75 97.84 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.306 2.004 . . . . 0.0 111.752 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.96 -25.49 37.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.385 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.623 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -84.33 83.9 7.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.158 0.504 . . . . 0.0 111.377 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' C ' ' A' ' 23' ' ' LEU . 16.1 mm -72.18 74.27 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.737 -178.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.78 HD11 HD21 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -15.37 113.52 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.439 179.511 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 32' ' ' MET . 5.0 t -81.23 160.58 3.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.271 0.558 . . . . 0.0 111.822 -178.151 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.418 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -78.39 136.5 37.68 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.829 -178.115 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 31' ' ' ASP . 8.3 m-20 62.54 86.91 0.11 Allowed 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 113.833 -1.531 . . . . 0.0 114.128 179.024 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.603 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 2.0 t80 -58.84 85.92 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.007 178.302 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.604 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 51.71 49.11 21.52 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.965 -179.965 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 88.96 30.4 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.459 -178.786 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.604 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -131.75 -130.27 3.12 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.432 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.619 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 2.1 p30 -102.57 -127.96 0.22 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.462 0.171 . . . . 0.0 111.462 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.569 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 6.7 mtm -98.56 116.95 31.9 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.779 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.794 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -106.51 124.07 61.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.844 -178.154 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.752 ' O ' ' N ' ' A' ' 38' ' ' GLY . 40.4 t -86.83 97.04 0.59 Allowed Pre-proline 0 C--O 1.221 -0.446 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.3 Cg_endo -41.86 -15.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.378 2.719 . . . . 0.0 114.267 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.734 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 6.2 mm-40 -88.55 -64.51 1.14 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.738 0.304 . . . . 0.0 111.173 -178.73 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.75 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.5 p -90.94 -19.6 23.11 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.38 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.794 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 67.1 36.42 90.45 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.684 -179.397 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.78 HD21 HD11 ' A' ' 23' ' ' LEU . 1.2 pp -73.16 145.01 46.66 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.569 -0.816 . . . . 0.0 109.315 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.596 HG21 ' CD2' ' A' ' 27' ' ' TYR . 53.7 t -114.66 119.94 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 121.044 0.45 . . . . 0.0 112.08 -176.669 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.706 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.2 t -131.98 139.18 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.247 179.563 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.471 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 128.83 155.49 8.61 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.135 178.671 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.5 t0 178.56 -67.61 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.985 -0.608 . . . . 0.0 110.003 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.21 86.74 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.985 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.701 ' O ' HD12 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -88.77 178.28 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.9 -179.937 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.701 HD12 ' O ' ' A' ' 45' ' ' VAL . 1.1 mp 75.05 38.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.917 0.389 . . . . 0.0 110.944 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.47 137.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.895 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.6 p -146.67 148.95 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.99 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 142.67 -130.36 4.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.399 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.6 35.43 19.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 110.894 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.68 35.75 4.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.824 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 54.1 m0 62.61 -81.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.015 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 53.4 81.75 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.847 0.356 . . . . 0.0 111.025 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.455 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -149.91 175.91 11.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 -179.913 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.455 ' H ' HG22 ' A' ' 54' ' ' THR . 1.6 p90 -104.94 39.14 1.77 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.31 159.61 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.878 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -125.39 165.07 19.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.934 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -101.23 -31.58 10.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.314 -0.85 . . . . 0.0 110.805 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.822 0.344 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.33 121.79 44.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.78 72.57 0.73 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.845 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.7 t -176.73 106.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.84 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -96.15 -34.77 11.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.952 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 59.42 69.26 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.724 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.557 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 27.5 p-10 -168.97 -149.92 0.08 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.683 -179.769 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . 77.18 160.0 0.21 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.901 0.382 . . . . 0.0 111.106 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.7 56.55 5.18 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.834 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.18 -70.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.632 2.221 . . . . 0.0 112.328 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 58.0 mtm-85 -99.95 109.03 21.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.906 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.3 p -65.77 -32.34 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.859 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.475 HG22 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER 54.11 -174.39 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.843 -179.728 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB2' HD12 ' A' ' 23' ' ' LEU . 9.3 t -88.09 135.13 33.67 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.15 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.1 -18.9 39.9 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.285 1.99 . . . . 0.0 111.861 179.473 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -115.91 -9.46 11.8 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.266 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.738 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 36.1 m80 -131.03 88.06 46.67 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.653 0.263 . . . . 0.0 111.043 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.19 -33.24 90.87 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.433 2.089 . . . . 0.0 112.072 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.79 -23.58 27.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.504 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.745 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -84.06 82.45 8.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.289 0.566 . . . . 0.0 110.671 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.535 ' O ' ' C ' ' A' ' 23' ' ' LEU . 3.7 mt -69.42 75.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.552 -177.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.621 HD11 HD21 ' A' ' 39' ' ' LEU . 1.3 mp -18.68 109.83 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 O-C-N 123.618 0.574 . . . . 0.0 110.577 179.04 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.4 t -78.24 163.02 3.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.234 0.54 . . . . 0.0 111.959 -178.108 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 26' ' ' ASP . 5.7 mt-10 -81.75 134.48 35.45 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.395 -178.639 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 25' ' ' GLU . 1.4 m-20 42.69 114.92 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.518 -1.219 . . . . 0.0 113.675 179.687 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.49 ' HB3' HG21 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -171.68 129.34 0.66 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.966 179.165 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.561 ' NH1' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 80.02 -60.35 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.723 -179.346 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.561 ' HB2' ' NH1' ' A' ' 28' ' ' ARG . . . -114.07 -38.73 4.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.345 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.42 -7.29 3.67 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.911 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.512 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -96.29 -151.2 0.34 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.742 0.271 . . . . 0.0 110.527 179.857 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.558 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 1.3 mtt -89.85 116.53 28.0 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 121.205 0.526 . . . . 0.0 111.935 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.665 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -104.03 125.96 58.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.898 0.38 . . . . 0.0 111.754 -178.87 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.813 ' O ' ' N ' ' A' ' 38' ' ' GLY . 40.5 t -85.8 97.62 0.61 Allowed Pre-proline 0 N--CA 1.447 -0.61 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.068 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 1.0 OUTLIER -41.11 -17.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.319 2.679 . . . . 0.0 113.742 -179.231 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.745 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 9.9 mm-40 -88.06 -65.48 1.01 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.672 0.273 . . . . 0.0 110.789 -178.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.662 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.0 p -90.36 -18.59 25.25 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.271 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.813 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.12 33.3 84.91 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.681 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.86 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -72.44 143.64 48.41 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.949 -0.626 . . . . 0.0 109.58 179.099 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 32' ' ' MET . 16.1 t -110.35 112.94 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 O-C-N 123.236 0.335 . . . . 0.0 111.514 -178.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.86 HG23 ' CD1' ' A' ' 39' ' ' LEU . 67.0 t -114.47 138.08 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.117 178.535 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.01 159.58 10.58 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.53 178.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -175.02 44.05 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.782 0.325 . . . . 0.0 110.372 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.424 ' C ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -89.92 11.22 21.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.428 -179.981 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.428 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 5.2 t 75.95 -54.71 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.521 HG22 ' O ' ' A' ' 46' ' ' ILE . 3.1 mm 67.96 102.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 120.848 0.356 . . . . 0.0 110.666 -179.453 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -128.36 149.32 50.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.837 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.0 m -97.79 -178.03 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.06 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.87 -44.65 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.587 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.37 -78.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 110.848 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 68.23 -69.8 0.14 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.996 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 31.1 m0 56.78 -90.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.053 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? 44.66 84.21 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.792 0.329 . . . . 0.0 111.347 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.46 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -133.49 -175.62 3.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.09 -179.946 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.46 ' H ' HG22 ' A' ' 54' ' ' THR . 2.5 p90 -148.7 61.68 1.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.902 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 62.32 174.66 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -121.12 167.58 12.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.756 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -72.2 -45.76 58.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.851 0.358 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.44 72.86 1.4 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.854 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.1 p -141.57 -70.91 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.846 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.0 m -90.64 125.02 35.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.818 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.9 mtt85 -86.63 -68.56 0.74 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.986 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.0 mt -68.81 -83.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.965 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 42.0 78.76 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.548 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -173.44 129.03 0.44 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.444 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 1.4 mp -88.26 -62.62 0.22 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.226 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.444 ' HD3' ' CB ' ' A' ' 10' ' ' LEU . 90.4 Cg_endo -78.15 -101.24 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.385 2.057 . . . . 0.0 112.395 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.638 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.0 OUTLIER 168.36 -80.22 0.0 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.725 0.297 . . . . 0.0 110.893 179.83 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.683 ' O ' HG23 ' A' ' 14' ' ' THR . 0.0 OUTLIER -166.72 -95.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.141 -179.995 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.683 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -175.56 169.42 3.1 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-O 121.337 0.589 . . . . 0.0 111.327 -179.932 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.752 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 14.5 t -78.96 147.0 69.33 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.732 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.573 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 29.5 Cg_endo -62.12 -44.33 20.2 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.91 2.407 . . . . 0.0 112.716 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.526 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 94.1 m-20 -107.48 38.12 2.23 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 122.119 0.962 . . . . 0.0 108.588 178.353 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.752 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 24.7 m80 -161.9 65.13 1.84 Allowed Pre-proline 0 C--N 1.308 -1.226 0 CA-C-O 123.114 1.435 . . . . 0.0 108.93 175.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 18' ' ' HIS . 55.6 Cg_endo -70.3 13.6 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.649 3.566 . . . . 0.0 113.103 -179.244 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.58 -17.48 1.49 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 120.999 0.428 . . . . 0.0 110.033 178.802 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.492 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -98.21 131.02 44.91 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.435 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.614 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.3 mp -106.87 87.51 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.781 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.614 ' C ' ' O ' ' A' ' 22' ' ' ILE . 3.9 mp -15.99 105.02 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 121.037 0.446 . . . . 0.0 109.934 178.43 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 25' ' ' GLU . 2.7 t -63.53 170.85 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.174 -178.309 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.557 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -104.83 97.25 7.15 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.501 -178.66 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 31' ' ' ASP . 1.6 m-20 82.08 89.44 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 179.513 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.535 ' CB ' HG21 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -167.66 143.94 4.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.35 179.136 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.634 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 71.14 6.59 5.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.631 -178.855 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.634 ' HB2' ' O ' ' A' ' 28' ' ' ARG . . . 158.2 -78.21 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.985 0.422 . . . . 0.0 110.489 179.752 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.428 ' O ' HG13 ' A' ' 40' ' ' VAL . . . -177.02 -179.65 47.5 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.586 179.591 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.469 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.5 OUTLIER 64.43 -141.69 0.27 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 117.436 0.618 . . . . 0.0 109.544 -179.157 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.58 ' O ' HD23 ' A' ' 23' ' ' LEU . 66.3 mtm -112.72 116.5 30.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.923 0.392 . . . . 0.0 111.121 -179.551 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.762 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -110.43 123.81 66.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.402 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.873 ' O ' ' N ' ' A' ' 38' ' ' GLY . 6.5 t -83.45 101.69 1.48 Allowed Pre-proline 0 C--O 1.215 -0.744 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.725 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.463 ' HD3' HG23 ' A' ' 24' ' ' VAL . 1.6 Cg_endo -44.24 -20.99 0.35 Allowed 'Trans proline' 0 N--CA 1.475 0.413 0 C-N-CA 122.152 1.901 . . . . 0.0 112.809 -179.333 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.636 ' HB3' ' NE2' ' A' ' 18' ' ' HIS . 29.8 mm-40 -85.03 -60.52 2.02 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.457 -178.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.916 ' SG ' HD23 ' A' ' 39' ' ' LEU . 25.6 p -93.61 -11.97 30.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.636 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.873 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 54.32 26.28 36.22 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 114.79 -1.096 . . . . 0.0 113.581 178.574 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.011 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.6 OUTLIER -71.6 157.22 38.36 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.005 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.539 ' N ' HD12 ' A' ' 39' ' ' LEU . 5.9 t -118.41 118.12 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.054 0.454 . . . . 0.0 111.936 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.011 HG23 ' CD1' ' A' ' 39' ' ' LEU . 68.1 t -132.14 133.8 60.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.546 178.633 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.06 165.2 10.53 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.073 -1.061 . . . . 0.0 112.967 179.464 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -142.14 -39.99 0.36 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.689 0.28 . . . . 0.0 110.531 179.567 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.84 81.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.432 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.678 HG13 ' H ' ' A' ' 46' ' ' ILE . 1.2 p -50.2 -69.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.555 -179.506 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.678 ' H ' HG13 ' A' ' 45' ' ' VAL . 0.1 OUTLIER 58.85 151.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.899 0.38 . . . . 0.0 110.919 -179.839 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 p30 176.28 175.5 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.944 -179.857 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 49' ' ' GLY . 3.9 m -130.44 -51.83 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.974 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.437 ' H ' HG23 ' A' ' 48' ' ' VAL . . . 44.72 56.04 5.91 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.047 -0.596 . . . . 0.0 113.011 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.9 t -176.87 97.03 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.327 . . . . 0.0 111.141 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.4 OUTLIER -138.32 11.6 2.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.339 179.888 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 9.7 m0 61.41 -80.72 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.81 0.338 . . . . 0.0 111.067 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER 66.33 140.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.837 0.351 . . . . 0.0 110.963 179.897 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 55' ' ' PHE . 15.1 m -161.9 164.28 28.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.791 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.421 ' N ' HG22 ' A' ' 54' ' ' THR . 23.0 p90 -140.35 109.74 6.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.043 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.0 m 58.31 173.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.028 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -165.54 -175.94 3.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.808 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -108.07 -38.09 5.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.915 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.858 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.841 0.353 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.1 m -118.79 31.52 6.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.9 p -94.55 -31.55 13.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.907 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.53 -169.6 2.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.852 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.9 mtp85 -80.08 -74.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.94 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.32 -169.13 2.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.876 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -170.76 117.84 0.5 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.95 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.98 61.56 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.073 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.8 mt -109.29 159.13 32.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.866 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -62.04 177.82 0.97 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.52 2.147 . . . . 0.0 112.061 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -130.01 5.7 4.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.593 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.472 ' O ' HG13 ' A' ' 13' ' ' VAL . 10.7 p -178.88 121.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.758 0.313 . . . . 0.0 111.359 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.7 p 51.88 -169.63 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.226 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 49.2 t -73.21 137.0 78.68 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.73 -21.28 72.85 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.334 2.023 . . . . 0.0 112.189 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -116.96 -9.52 11.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.367 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.702 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 37.2 m80 -130.24 88.78 46.87 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.786 0.327 . . . . 0.0 110.676 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.23 -34.61 93.83 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.356 2.038 . . . . 0.0 111.891 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.86 -23.84 33.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.32 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.705 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -83.81 84.15 7.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.22 0.534 . . . . 0.0 111.197 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.522 ' O ' ' C ' ' A' ' 23' ' ' LEU . 6.3 mt -70.4 77.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.658 -1.155 . . . . 0.0 113.147 -178.205 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.662 HD11 HD21 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -20.04 106.26 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.902 179.327 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 25' ' ' GLU . 3.2 t -74.9 168.24 2.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.155 -178.919 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.516 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -84.44 138.61 32.72 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.996 0.903 . . . . 0.0 110.895 -178.153 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 32.1 m-20 60.09 91.24 0.05 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 113.899 -1.501 . . . . 0.0 114.873 178.487 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.663 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 2.0 t80 -62.78 95.43 0.08 Allowed 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.827 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.606 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 52.74 41.92 31.65 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.444 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 86.67 36.02 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.321 -178.75 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -132.87 -124.62 2.55 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.886 -179.674 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.564 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -96.2 -146.42 0.29 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 122.3 0.24 . . . . 0.0 111.014 -179.097 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.648 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.8 mtm -86.2 116.8 24.62 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-O 121.09 0.471 . . . . 0.0 111.638 -179.195 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.713 HD13 ' N ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -104.22 123.03 57.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.121 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.745 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.0 t -87.23 96.58 0.58 Allowed Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.492 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.6 Cg_endo -42.52 -14.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.373 2.716 . . . . 0.0 114.072 -179.001 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.705 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 9.2 mm-40 -87.94 -65.19 1.04 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.66 0.266 . . . . 0.0 110.881 -178.962 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.646 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.5 p -91.0 -19.16 23.52 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.323 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.745 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.23 35.91 88.99 Favored Glycine 0 N--CA 1.433 -1.505 0 CA-C-N 113.87 -1.514 . . . . 0.0 111.929 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.841 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -75.51 147.82 39.46 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.75 179.192 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.648 ' HA ' ' O ' ' A' ' 32' ' ' MET . 18.6 t -114.87 113.74 44.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.71 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.841 HG23 ' CD1' ' A' ' 39' ' ' LEU . 86.0 t -119.15 138.5 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.879 178.033 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.401 ' O ' ' OD2' ' A' ' 31' ' ' ASP . . . 105.26 -171.32 18.52 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 179.554 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.417 ' HB3' ' OD1' ' A' ' 31' ' ' ASP . 0.4 OUTLIER 40.84 -163.7 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 179.162 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 177.43 149.76 0.17 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.818 179.656 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.402 ' O ' HG22 ' A' ' 46' ' ' ILE . 13.5 t -56.51 130.81 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.221 -179.872 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.567 HG23 ' N ' ' A' ' 47' ' ' ASP . 0.1 OUTLIER 52.5 176.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.432 179.857 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.567 ' N ' HG23 ' A' ' 46' ' ' ILE . 32.2 t70 -67.01 97.37 0.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.56 ' O ' HG12 ' A' ' 48' ' ' VAL . 18.2 t -101.43 36.74 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.004 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -135.45 114.95 1.29 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.478 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.51 100.98 10.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.798 0.332 . . . . 0.0 110.959 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.18 66.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.838 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 41.2 m0 62.34 -81.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.956 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? 56.66 78.46 0.21 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.978 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 55' ' ' PHE . 2.0 m -154.9 168.82 25.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.426 ' H ' HG22 ' A' ' 54' ' ' THR . 2.8 p90 -133.56 97.89 4.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.94 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 m 60.98 110.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -60.22 153.65 21.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.905 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -64.85 -62.25 1.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.956 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.854 0.359 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.3 m -77.73 -27.28 50.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.002 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.44 67.36 0.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.82 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.3 t -135.95 133.65 37.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.867 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -48.99 79.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.602 HD13 HD21 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -154.93 124.24 6.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.82 179.95 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -80.84 -49.06 11.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.043 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.92 99.29 3.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.153 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.602 HD21 HD13 ' A' ' 7' ' ' LEU . 1.1 mp -70.81 -50.21 13.1 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.411 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 10' ' ' LEU . 56.0 Cg_endo -70.37 156.9 60.76 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.167 1.912 . . . . 0.0 112.316 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -87.44 175.93 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.009 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.3 t -109.63 -23.13 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.171 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.638 HG22 HD13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -163.64 168.55 19.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.9 0.381 . . . . 0.0 110.942 179.982 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.507 ' HB2' HD12 ' A' ' 23' ' ' LEU . 41.8 t -75.75 136.03 70.88 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.577 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.84 -22.74 68.99 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.426 2.084 . . . . 0.0 112.656 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -115.79 -8.9 11.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.431 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.731 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.0 m80 -131.58 85.88 50.96 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.746 0.308 . . . . 0.0 110.809 179.581 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.05 -34.47 98.95 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.318 2.012 . . . . 0.0 111.64 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.13 -30.65 39.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.368 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -79.0 87.72 4.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.182 0.515 . . . . 0.0 111.419 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.638 HD13 HG22 ' A' ' 14' ' ' THR . 22.3 mm -73.24 72.98 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.734 -178.705 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.729 HD11 HD21 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -13.71 110.25 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.49 179.258 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 32' ' ' MET . 4.2 t -79.52 160.72 4.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.322 0.582 . . . . 0.0 112.181 -177.84 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.424 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -78.53 133.95 37.32 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.028 -177.967 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.684 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.4 OUTLIER 70.77 81.27 0.16 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.708 -1.587 . . . . 0.0 114.3 178.479 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.595 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -60.33 107.35 0.64 Allowed 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.309 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.618 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER 44.36 36.61 1.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.958 0.409 . . . . 0.0 110.418 -179.474 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 90.58 36.19 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.586 -179.039 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -133.22 -119.16 1.99 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.692 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.684 ' O ' ' N ' ' A' ' 26' ' ' ASP . 2.0 p30 -100.94 -127.23 0.2 Allowed 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.642 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.55 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -100.65 120.16 39.64 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.079 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.805 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -109.4 126.8 66.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.781 -178.223 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.783 ' O ' ' N ' ' A' ' 38' ' ' GLY . 38.5 t -86.12 97.51 0.62 Allowed Pre-proline 0 C--O 1.22 -0.475 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.027 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -41.43 -16.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.321 2.681 . . . . 0.0 113.946 -179.141 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.731 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 2.2 mm-40 -87.82 -65.21 1.04 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.703 0.287 . . . . 0.0 111.073 -178.797 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.762 ' SG ' HD23 ' A' ' 39' ' ' LEU . 6.1 p -90.9 -19.68 23.06 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.479 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.805 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 66.89 34.95 88.74 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 113.86 -1.518 . . . . 0.0 111.741 -179.552 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.762 HD23 ' SG ' ' A' ' 37' ' ' CYS . 1.3 pp -71.22 145.65 49.51 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.877 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.527 HG11 ' CD2' ' A' ' 27' ' ' TYR . 86.5 t -113.54 121.99 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-O 121.209 0.528 . . . . 0.0 112.138 -176.591 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.698 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.4 t -134.01 133.69 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.64 179.298 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.584 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 128.67 171.81 13.06 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.308 179.287 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.403 ' OD2' HD11 ' A' ' 46' ' ' ILE . 6.6 t0 -103.68 129.09 50.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.86 0.362 . . . . 0.0 111.15 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.78 ' HG3' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -127.72 -43.52 1.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.751 179.796 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.78 HG12 ' HG3' ' A' ' 44' ' ' ARG . 10.3 p 178.0 111.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.009 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 46' ' ' ILE . 1.5 mp -114.58 26.81 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.195 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 t0 56.61 28.06 13.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.033 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -67.34 77.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 174.4 39.28 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.474 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.6 t -97.45 -33.67 11.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.764 0.316 . . . . 0.0 110.836 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -106.64 108.44 19.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.904 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 15.1 m0 59.31 -89.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? 44.58 60.06 3.05 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.826 0.346 . . . . 0.0 111.355 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.92 158.14 18.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.925 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -101.27 48.99 0.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.818 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.9 m 63.74 173.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.92 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -60.24 132.18 53.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -75.15 -54.28 7.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.851 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.904 0.383 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -79.12 86.36 4.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.961 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.36 26.47 1.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.014 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.27 122.64 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.889 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -122.98 -46.2 2.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.994 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.1 mp -94.96 154.27 17.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.861 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -167.2 47.31 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -173.31 83.79 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.093 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.41 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 0.4 OUTLIER -76.45 -61.03 0.83 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.823 179.914 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.41 ' HD3' ' CB ' ' A' ' 10' ' ' LEU . 75.4 Cg_endo -77.01 -168.06 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.607 2.205 . . . . 0.0 112.261 179.911 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.527 ' C ' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -100.15 -3.54 31.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.274 179.779 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.527 HG23 ' C ' ' A' ' 12' ' ' ARG . 6.7 t 84.85 -23.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.775 -179.844 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.82 172.62 6.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.825 179.944 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 47.4 t -74.41 136.08 75.32 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.554 179.726 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.76 -21.61 73.17 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.28 1.986 . . . . 0.0 112.319 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -116.6 -9.53 11.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.348 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.738 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.1 m80 -131.48 87.19 47.39 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.775 0.322 . . . . 0.0 110.883 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.13 -34.1 94.61 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.345 2.03 . . . . 0.0 111.917 179.78 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.41 -26.76 35.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.231 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.62 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -81.52 87.62 6.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.201 0.524 . . . . 0.0 111.283 -179.882 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.569 ' O ' ' C ' ' A' ' 23' ' ' LEU . 15.3 mt -72.86 73.25 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.871 -178.556 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.663 HD11 HD21 ' A' ' 39' ' ' LEU . 1.5 mp -15.13 110.11 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.549 0.531 . . . . 0.0 110.513 179.321 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.8 t -79.09 161.58 4.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.202 0.525 . . . . 0.0 111.922 -177.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.422 ' N ' HG12 ' A' ' 24' ' ' VAL . 19.4 mm-40 -80.8 133.88 35.7 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.733 -178.24 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.4 OUTLIER 72.32 80.83 0.14 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.98 -1.464 . . . . 0.0 114.331 178.488 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.589 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -60.86 108.43 0.86 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.312 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.625 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 44.1 35.83 1.31 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.996 0.427 . . . . 0.0 110.417 -179.604 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 90.68 36.64 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.582 -178.99 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -134.01 -119.32 1.97 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.71 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.68 ' O ' ' N ' ' A' ' 26' ' ' ASP . 2.0 p30 -99.72 -128.64 0.2 Allowed 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -179.698 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.549 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 6.8 mtm -100.61 121.96 42.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.998 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.818 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -110.46 126.18 67.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.887 -178.226 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.791 ' O ' ' N ' ' A' ' 38' ' ' GLY . 42.0 t -85.7 98.07 0.67 Allowed Pre-proline 0 C--O 1.219 -0.546 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.158 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -41.61 -16.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.333 2.688 . . . . 0.0 114.05 -178.964 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.738 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 9.7 mm-40 -88.82 -64.37 1.16 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.725 0.298 . . . . 0.0 111.143 -178.792 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.634 ' SG ' HD23 ' A' ' 39' ' ' LEU . 5.9 p -90.62 -19.42 23.7 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.389 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.818 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 66.31 33.72 85.85 Favored Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 113.789 -1.55 . . . . 0.0 111.667 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.918 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.7 OUTLIER -69.77 143.08 53.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.954 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 32' ' ' MET . 72.9 t -109.75 114.55 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 O-C-N 123.384 0.428 . . . . 0.0 111.549 -177.777 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.918 HG23 ' CD1' ' A' ' 39' ' ' LEU . 76.0 t -121.46 134.42 64.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.467 178.711 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.595 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 130.34 19.14 1.39 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.543 178.672 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.69 -169.32 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 120.809 0.338 . . . . 0.0 111.464 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.62 133.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.301 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 46' ' ' ILE . 14.1 p -94.28 -42.34 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.762 -179.146 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.739 HG22 ' CG2' ' A' ' 48' ' ' VAL . 17.6 mt 75.33 -57.37 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.033 -179.42 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 76.99 -74.3 0.07 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.981 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.739 ' CG2' HG22 ' A' ' 46' ' ' ILE . 15.9 t 62.0 28.84 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.049 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -127.24 -126.87 2.96 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.0 t 59.17 68.65 0.79 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.948 0.404 . . . . 0.0 110.865 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -109.34 -162.58 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.852 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -47.87 -58.45 4.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.151 -179.886 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 60.16 66.22 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 m -108.68 159.36 16.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -129.32 30.07 5.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.2 m 59.74 171.62 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -115.2 172.54 7.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.19 -65.9 1.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.927 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.869 0.366 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.62 27.85 6.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.22 18.68 13.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.184 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.6 m -88.46 -176.03 5.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.767 0.317 . . . . 0.0 110.759 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.41 ' HB3' HD12 ' A' ' 7' ' ' LEU . 4.5 mmt85 -132.2 -93.64 0.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.029 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.41 HD12 ' HB3' ' A' ' 6' ' ' ARG . 4.5 mp -148.31 -132.0 0.06 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.846 -0.161 . . . . 0.0 110.614 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.422 ' HB3' ' CD1' ' A' ' 10' ' ' LEU . 0.6 OUTLIER 69.68 -67.66 0.22 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.842 0.353 . . . . 0.0 110.487 -179.858 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 55.63 68.65 0.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.81 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.682 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -120.62 23.27 0.1 Allowed Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 179.292 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.682 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 61.1 Cg_endo -83.14 102.35 1.07 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.136 1.891 . . . . 0.0 112.342 179.726 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.743 ' NH2' HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -176.32 168.23 2.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.938 0.399 . . . . 0.0 111.056 179.887 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.6 t -125.69 -22.19 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.786 -179.782 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.5 p -149.82 158.17 43.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.961 0.41 . . . . 0.0 111.253 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.6 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 45.9 t -61.94 137.88 95.52 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.139 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.51 -29.86 71.11 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.457 2.105 . . . . 0.0 111.589 179.328 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -93.96 -16.66 23.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.503 179.62 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.973 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 38.9 m80 -131.73 85.86 50.35 Favored Pre-proline 0 N--CA 1.453 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.337 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.85 -53.55 0.9 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.233 1.955 . . . . 0.0 111.701 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.24 -14.75 63.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.716 -179.832 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.973 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -101.09 114.01 27.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.113 0.482 . . . . 0.0 110.413 179.22 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.0 mt -91.83 127.5 44.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.823 -179.078 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.925 HD21 HD11 ' A' ' 39' ' ' LEU . 1.5 mp -59.45 102.07 0.13 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.845 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.527 HG23 ' HD3' ' A' ' 35' ' ' PRO . 3.1 t -66.48 157.17 5.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 121.293 0.568 . . . . 0.0 111.715 -178.603 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -86.95 102.6 14.52 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.007 -179.26 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 26' ' ' ASP . 0.4 OUTLIER 70.66 118.03 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.672 179.321 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.417 ' O ' ' HB2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER 178.99 36.13 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.767 179.767 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.55 ' HD3' HD12 ' A' ' 33' ' ' ILE . 64.4 ttt180 170.99 -84.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.68 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.08 ' HB3' HG11 ' A' ' 40' ' ' VAL . . . -80.12 -29.33 38.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.868 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.92 -7.66 21.68 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.169 178.733 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.568 ' HB2' HG12 ' A' ' 40' ' ' VAL . 23.2 m-20 -92.36 -119.42 0.08 Allowed 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.127 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.725 ' O ' HD23 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -117.39 110.23 17.78 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.637 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.895 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 1.2 tt -112.42 139.55 36.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.027 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.835 ' O ' ' N ' ' A' ' 38' ' ' GLY . 52.7 t -91.68 102.38 5.87 Favored Pre-proline 0 N--CA 1.448 -0.55 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.61 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.527 ' HD3' HG23 ' A' ' 24' ' ' VAL . 1.9 Cg_endo -40.13 -21.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.456 2.771 . . . . 0.0 113.614 -178.773 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.537 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 5.7 mm-40 -81.01 -68.25 0.7 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.743 -178.816 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.57 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.4 p -88.18 -18.68 28.19 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.548 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.835 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.66 22.39 71.67 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.089 -179.581 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.925 HD11 HD21 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -58.7 140.92 54.03 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.963 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.08 HG11 ' HB3' ' A' ' 29' ' ' ALA . 5.5 t -113.15 131.19 65.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.762 0.315 . . . . 0.0 110.586 -179.073 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.687 HG21 HH12 ' A' ' 12' ' ' ARG . 12.5 t -130.09 130.03 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.273 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.583 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 122.18 165.88 12.62 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.086 179.545 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.583 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 9.2 t0 138.72 -54.73 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.792 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.42 ' HE ' HG22 ' A' ' 45' ' ' VAL . 0.1 OUTLIER 51.6 -168.43 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.425 179.655 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.428 HG23 ' H ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -96.51 -81.14 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.151 179.981 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.428 ' H ' HG23 ' A' ' 45' ' ' VAL . 1.9 mp -86.47 127.07 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 0.0 111.02 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -63.32 -73.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.6 t -152.01 146.94 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 158.43 -28.53 0.44 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.545 179.975 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.2 m -69.27 -57.13 5.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 0.0 110.863 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -72.46 155.34 40.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.891 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -64.53 -75.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 59.48 96.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 55' ' ' PHE . 1.2 m -158.35 171.57 19.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.454 ' H ' HG22 ' A' ' 54' ' ' THR . 16.5 p90 -119.6 58.18 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.859 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.1 m 60.56 -174.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.87 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -114.49 -174.85 2.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -101.99 -34.78 9.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.88 179.856 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.811 0.339 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 m -117.26 132.66 56.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.901 -179.991 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.67 104.68 1.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.831 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.86 38.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.002 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.16 109.27 7.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.67 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.71 112.27 16.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.16 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.549 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 6.0 m-20 -64.71 -154.83 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.412 179.797 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.605 ' O ' ' CB ' ' A' ' 10' ' ' LEU . . . 76.72 179.67 0.15 Allowed 'General case' 0 C--N 1.334 -0.078 0 CA-C-O 120.576 0.227 . . . . 0.0 111.198 179.892 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.605 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 10.4 tt 120.72 -48.64 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 123.786 0.834 . . . . 0.0 110.485 -179.693 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.598 ' HG2' HG13 ' A' ' 13' ' ' VAL . 72.7 Cg_endo -87.88 2.71 6.43 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.596 2.197 . . . . 0.0 112.48 179.676 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.433 ' HG2' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER 58.29 48.41 12.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.905 0.384 . . . . 0.0 110.952 -179.813 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.598 HG13 ' HG2' ' A' ' 11' ' ' PRO . 1.5 m -54.79 -29.15 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.317 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 p -149.25 161.09 42.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.955 0.407 . . . . 0.0 111.348 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.504 ' HB2' HD12 ' A' ' 23' ' ' LEU . 45.5 t -75.81 136.41 70.4 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.724 179.839 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.04 -23.83 76.08 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.52 2.147 . . . . 0.0 112.522 -179.82 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -117.3 -7.69 11.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.449 -179.778 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.726 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.6 m80 -131.18 85.83 52.92 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.699 0.285 . . . . 0.0 110.779 179.63 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.98 -35.5 93.02 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.271 1.981 . . . . 0.0 111.897 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -78.57 -30.73 46.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.189 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -78.63 85.63 4.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.091 0.472 . . . . 0.0 111.246 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.529 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.8 mp -71.25 75.73 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.722 -178.6 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.847 HD21 HD11 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -18.09 107.53 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.002 179.419 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -75.91 167.6 2.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.225 -178.815 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.504 ' H ' HG12 ' A' ' 24' ' ' VAL . 1.9 mm-40 -81.91 139.32 34.71 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 122.105 0.955 . . . . 0.0 111.207 -177.882 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.535 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 0.5 OUTLIER 53.97 95.5 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.68 -1.6 . . . . 0.0 114.64 178.701 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.586 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -68.68 110.18 4.15 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 177.913 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.612 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 4.8 mtt85 44.64 33.89 1.03 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.976 0.417 . . . . 0.0 110.105 -179.373 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 91.82 40.07 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.492 -178.86 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -134.0 -124.72 2.51 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.834 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.491 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -95.8 -145.97 0.28 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.61 0.243 . . . . 0.0 111.009 -179.589 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.709 ' O ' HD23 ' A' ' 23' ' ' LEU . 52.6 mtp -85.73 116.06 23.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.38 0.61 . . . . 0.0 111.249 -179.31 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.669 HD13 ' N ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -100.82 123.24 53.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.496 -0.775 . . . . 0.0 113.047 -176.783 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.729 ' O ' ' N ' ' A' ' 38' ' ' GLY . 52.1 t -87.71 96.2 0.58 Allowed Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.525 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.5 Cg_endo -41.89 -15.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.405 2.737 . . . . 0.0 114.077 -179.089 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.726 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 4.2 mm-40 -87.14 -65.58 1.0 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.625 0.25 . . . . 0.0 111.057 -178.981 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.818 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.7 p -91.1 -20.68 21.77 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.221 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.729 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 69.99 38.56 74.43 Favored Glycine 0 N--CA 1.432 -1.624 0 CA-C-N 113.76 -1.564 . . . . 0.0 111.996 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.847 HD11 HD21 ' A' ' 23' ' ' LEU . 1.6 pp -76.53 149.11 36.72 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.835 -0.683 . . . . 0.0 109.872 179.375 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 32' ' ' MET . 38.4 t -117.53 119.68 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 121.088 0.471 . . . . 0.0 112.14 -177.427 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.681 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -132.73 136.07 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.385 179.57 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.93 162.52 10.98 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.755 179.455 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.725 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.6 m-20 -158.98 -86.09 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.476 0.179 . . . . 0.0 110.572 179.783 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 44.48 -89.3 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.575 179.65 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 43' ' ' ASP . 23.7 t 65.24 78.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.92 0.39 . . . . 0.0 111.217 179.964 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.415 HG23 HG22 ' A' ' 48' ' ' VAL . 13.4 tt -73.76 -30.03 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.048 179.856 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 t70 60.26 92.12 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.897 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.415 HG22 HG23 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -118.22 -75.4 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.005 179.925 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 133.71 -102.21 0.45 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.523 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.7 p -59.62 137.79 57.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.359 . . . . 0.0 110.948 -179.883 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -120.64 25.79 9.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.996 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.5 m0 59.94 -84.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.022 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? 48.66 79.68 0.07 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.733 0.301 . . . . 0.0 111.18 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.45 -172.96 3.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.952 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.434 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 27.4 p90 -109.92 64.39 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.87 172.56 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.812 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -117.1 176.3 5.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.937 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -74.01 -58.94 2.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.827 179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.939 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.444 ' HB3' ' OG ' ' A' ' 5' ' ' SER . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.803 0.335 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -68.34 -31.51 70.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.878 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.3 p -116.67 69.67 0.75 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.444 ' OG ' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -143.19 -70.18 0.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.783 -179.941 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.9 mtt180 65.29 -76.48 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.107 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.53 -46.97 4.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.142 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 61.68 23.18 13.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.867 -179.77 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 179.64 173.11 0.91 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.799 180.0 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.453 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . 1.5 mt -164.75 -64.81 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.043 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' A' ' 10' ' ' LEU . 55.6 Cg_endo -70.21 -176.31 1.57 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.365 2.043 . . . . 0.0 112.36 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.86 -169.41 1.92 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.682 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.4 t -74.43 -79.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.596 -179.608 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.5 p -96.27 -148.74 0.3 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.999 -179.518 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.585 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 47.3 t -69.86 137.92 87.75 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.76 179.86 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.1 -21.96 73.2 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.316 2.011 . . . . 0.0 112.002 179.687 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -116.14 -10.16 11.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.19 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.762 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 41.9 m80 -130.61 88.43 46.79 Favored Pre-proline 0 C--O 1.232 0.18 0 CA-C-O 120.701 0.286 . . . . 0.0 110.525 178.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.78 -35.27 94.83 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.292 1.995 . . . . 0.0 111.788 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.41 -29.74 42.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.038 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.654 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -77.01 97.91 4.81 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 122.241 1.02 . . . . 0.0 111.168 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.515 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -80.84 74.94 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 112.787 -2.006 . . . . 0.0 113.698 -177.696 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.625 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.1 mp -20.85 102.71 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.768 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.4 t -71.7 166.3 2.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.15 -178.976 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.472 ' H ' HG12 ' A' ' 24' ' ' VAL . 6.1 mm-40 -83.06 139.07 33.45 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-O 121.922 0.868 . . . . 0.0 110.76 -178.192 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.55 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 16.5 m-20 55.15 94.39 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 113.913 -1.494 . . . . 0.0 114.299 178.967 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.639 ' CD2' HG21 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -63.35 90.32 0.05 OUTLIER 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.337 177.774 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.621 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 7.8 ttp-105 55.16 43.19 29.82 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.366 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 87.64 34.1 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.379 -178.715 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -130.1 -128.97 3.06 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.681 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.595 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -95.58 -146.19 0.28 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 -179.777 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.559 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 6.2 mtm -87.06 116.61 25.23 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 121.375 0.607 . . . . 0.0 111.569 -179.309 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.758 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -102.81 121.63 54.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -176.885 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.743 ' O ' ' N ' ' A' ' 38' ' ' GLY . 25.7 t -86.79 96.84 0.57 Allowed Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.083 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.5 Cg_endo -41.79 -15.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.466 2.777 . . . . 0.0 114.069 -179.239 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.762 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 3.6 mm-40 -86.76 -65.9 0.96 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.675 0.274 . . . . 0.0 110.758 -178.764 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.694 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.9 p -90.71 -19.52 23.47 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.416 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.758 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 67.23 35.94 89.03 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 113.772 -1.558 . . . . 0.0 111.914 -179.728 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.906 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -74.27 150.54 40.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.762 -0.719 . . . . 0.0 109.878 179.379 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.639 HG21 ' CD2' ' A' ' 27' ' ' TYR . 23.7 t -115.87 116.11 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.825 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.906 HG23 ' CD1' ' A' ' 39' ' ' LEU . 97.6 t -123.3 133.16 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.931 178.256 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.436 ' CA ' ' HB3' ' A' ' 31' ' ' ASP . . . 125.25 -158.95 19.8 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.703 179.42 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.438 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . 7.4 t0 62.84 81.31 0.21 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.792 0.33 . . . . 0.0 110.626 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 44' ' ' ARG . 11.9 mtm105 -110.02 -70.32 0.82 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.397 -179.424 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.53 HG22 ' H ' ' A' ' 46' ' ' ILE . 2.8 p -155.82 170.32 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.828 0.346 . . . . 0.0 111.172 -179.714 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.53 ' H ' HG22 ' A' ' 45' ' ' VAL . 25.0 mt -115.06 127.7 72.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.933 0.397 . . . . 0.0 111.177 -179.972 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -178.31 -39.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.3 p -56.21 -32.14 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.236 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -88.83 73.87 2.12 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.538 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.9 t -172.93 76.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 110.937 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.9 145.08 25.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.673 179.793 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 39.3 t90 -63.06 -89.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.845 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.78 91.55 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.766 0.317 . . . . 0.0 111.555 179.784 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.5 m -97.27 151.03 20.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.94 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.423 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 42.3 p90 -88.29 108.91 19.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.828 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 m 53.89 96.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.054 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -62.89 155.86 25.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.815 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.78 -65.62 0.97 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.936 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.909 -179.989 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.613 ' HB3' ' HB2' ' A' ' 5' ' ' SER . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.804 0.335 . . . . 0.0 110.998 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.7 m -64.96 -31.41 72.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.876 179.942 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.9 p -75.65 -32.35 60.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.905 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.613 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 1.4 m -61.53 149.27 39.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.1 mtp85 -101.55 -78.76 0.52 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 179.62 -174.33 0.23 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.859 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -117.43 92.35 3.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.741 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.761 ' O ' HD12 ' A' ' 10' ' ' LEU . . . -99.45 112.76 24.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.254 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -179.84 -59.96 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.66 179.784 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.416 ' HD3' ' CB ' ' A' ' 10' ' ' LEU . 84.2 Cg_endo -81.03 -168.67 0.66 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.658 2.238 . . . . 0.0 112.407 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -141.77 129.5 21.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.504 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 94.5 t -51.16 -88.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.081 -179.83 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.74 177.18 2.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.046 0.451 . . . . 0.0 110.728 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 36.9 t -70.19 136.19 86.88 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.918 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.44 -21.72 73.12 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.275 1.984 . . . . 0.0 111.995 179.452 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -115.92 -12.32 11.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.241 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.701 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 31.6 m80 -125.14 86.71 56.49 Favored Pre-proline 0 N--CA 1.455 -0.193 0 CA-C-O 120.857 0.36 . . . . 0.0 111.456 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.84 38.3 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.192 2.595 . . . . 0.0 110.805 178.432 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -150.59 -43.03 0.12 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.76 179.742 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.52 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -78.62 86.1 4.63 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.894 178.612 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.566 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.2 mp -70.06 75.69 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.339 -178.119 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.839 HD11 HD21 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -14.52 113.74 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.735 179.656 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.603 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.8 t -82.06 159.33 3.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.223 0.535 . . . . 0.0 111.84 -178.231 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 26' ' ' ASP . 2.4 mt-10 -79.26 139.15 37.95 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.077 -178.073 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 31' ' ' ASP . 1.0 OUTLIER 40.44 110.57 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.912 -1.495 . . . . 0.0 114.78 179.237 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.622 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -148.86 130.17 14.67 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.124 178.494 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.523 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 13.6 mmm-85 55.38 22.81 5.2 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.471 -179.779 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 28' ' ' ARG . . . 170.04 -76.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.449 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.433 ' HA2' ' CB ' ' A' ' 26' ' ' ASP . . . 168.53 14.26 0.02 OUTLIER Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.473 179.464 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.531 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 65.4 m-20 -103.16 -166.69 1.3 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.71 0.255 . . . . 0.0 110.9 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.603 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -97.34 120.37 37.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.579 0.704 . . . . 0.0 112.257 -179.173 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.888 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -105.75 125.43 61.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.148 -177.712 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.721 ' O ' ' N ' ' A' ' 38' ' ' GLY . 39.8 t -88.43 97.33 0.81 Allowed Pre-proline 0 C--O 1.221 -0.398 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 177.23 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.0 Cg_endo -42.63 -14.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.405 2.737 . . . . 0.0 114.222 -178.877 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.701 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 1.9 mm-40 -89.25 -63.82 1.23 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.623 0.249 . . . . 0.0 111.326 -178.97 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.775 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.1 p -90.96 -21.15 21.47 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.247 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.888 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.38 39.0 81.17 Favored Glycine 0 N--CA 1.429 -1.772 0 CA-C-N 113.511 -1.677 . . . . 0.0 111.879 -179.692 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.839 HD21 HD11 ' A' ' 23' ' ' LEU . 1.4 pp -76.54 141.82 41.06 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.481 -0.859 . . . . 0.0 109.87 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.531 ' CG1' ' HB2' ' A' ' 31' ' ' ASP . 26.0 t -111.0 123.6 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-O 121.068 0.461 . . . . 0.0 111.46 -177.323 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.69 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.4 t -133.19 132.25 58.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.396 179.778 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.61 23.77 1.47 Allowed Glycine 0 CA--C 1.5 -0.881 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.012 179.835 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.15 62.88 6.1 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.607 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.5 mtt-85 -105.05 161.53 14.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.779 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.7 t -108.53 -94.71 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.87 179.881 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.624 HD12 ' N ' ' A' ' 46' ' ' ILE . 3.4 mp 42.08 86.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-O 120.817 0.342 . . . . 0.0 111.57 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.44 -30.66 61.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.996 -179.819 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.497 ' CG2' HG22 ' A' ' 46' ' ' ILE . 21.7 t 64.15 82.14 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.016 -179.903 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -120.97 -34.27 0.91 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.694 -179.873 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.4 t -72.25 64.32 0.56 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.876 0.37 . . . . 0.0 111.035 -179.882 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 53' ' ' ARG . 2.4 tm-20 -177.47 35.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 12.3 m0 64.34 -71.15 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.168 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.8 OUTLIER 70.06 59.16 0.27 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.871 -179.91 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.68 174.84 11.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.886 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.405 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 14.7 p90 -123.91 86.01 2.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.887 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.22 172.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.857 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -164.18 154.31 14.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.92 -40.97 68.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.842 0.353 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 m -92.53 54.24 2.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 179.921 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.3 p -149.84 36.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.5 t -153.37 116.59 4.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.953 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.9 mtt85 -102.25 -31.54 10.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.906 179.996 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.5 mp -76.68 73.62 3.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -120.52 77.93 1.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.796 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -172.91 129.1 0.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.105 179.942 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tp -65.09 132.54 95.44 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.52 -60.66 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.387 2.058 . . . . 0.0 112.194 179.929 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.603 ' O ' HG12 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -154.39 -68.42 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.86 179.959 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.71 ' O ' HG23 ' A' ' 14' ' ' THR . 0.3 OUTLIER 88.64 -20.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.669 -179.969 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -170.35 174.39 5.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.951 0.405 . . . . 0.0 110.972 179.75 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.498 ' HB2' HD12 ' A' ' 23' ' ' LEU . 18.1 t -77.84 135.32 63.68 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.963 -179.937 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.41 -21.33 53.86 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.481 2.12 . . . . 0.0 112.247 179.722 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -105.03 -29.61 10.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.862 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.655 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.8 m80 -118.42 88.59 34.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.065 179.784 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.12 -31.82 94.13 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.931 1.754 . . . . 0.0 110.993 179.188 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -81.33 -36.62 29.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.371 -179.911 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.643 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . . . -71.76 91.27 1.12 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.082 0.468 . . . . 0.0 110.697 179.808 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.548 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.8 mt -79.06 69.0 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.869 -178.411 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.697 HD21 ' HG ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -12.27 123.44 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.229 179.43 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 32' ' ' MET . 21.2 t -85.94 157.47 3.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-O 121.413 0.625 . . . . 0.0 112.361 -178.022 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -76.84 127.79 33.39 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.009 -178.892 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.665 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 36.2 m-20 48.21 112.76 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.211 -0.904 . . . . 0.0 113.03 179.51 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.471 ' CG ' HG21 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -160.26 150.25 18.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.787 178.898 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 22.6 tpp180 55.78 36.69 27.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.821 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.79 32.47 20.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.13 -178.143 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.665 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -135.49 -167.83 11.42 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.312 -0.947 . . . . 0.0 114.475 -178.619 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 10.2 m-20 -72.38 -118.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.681 0.792 . . . . 0.0 111.284 179.985 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.689 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 20.8 mtm -94.29 118.45 31.61 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.43 0.633 . . . . 0.0 111.39 -178.471 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.786 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -100.46 126.2 54.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.049 -177.481 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.84 ' O ' ' N ' ' A' ' 38' ' ' GLY . 7.0 t -86.85 99.73 1.24 Allowed Pre-proline 0 C--O 1.216 -0.671 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.527 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.0 Cg_endo -40.27 -20.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.19 2.594 . . . . 0.0 113.542 -179.351 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.655 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 14.8 mm-40 -89.78 -63.13 1.33 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.332 -178.569 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.965 ' SG ' HD23 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -89.44 -18.84 25.98 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 177.729 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.84 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 63.42 28.57 72.57 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 114.112 -1.403 . . . . 0.0 111.783 -179.551 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.965 HD23 ' SG ' ' A' ' 37' ' ' CYS . 1.3 pp -71.36 148.59 46.86 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.774 -0.713 . . . . 0.0 109.908 179.317 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 32' ' ' MET . 35.0 t -110.09 118.19 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 O-C-N 123.445 0.466 . . . . 0.0 110.983 -179.386 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.917 HG23 ' CD1' ' A' ' 39' ' ' LEU . 54.8 t -130.76 140.1 49.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.236 0.541 . . . . 0.0 111.238 179.892 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.15 162.37 10.36 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.533 179.046 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -173.32 -39.66 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.638 0.256 . . . . 0.0 110.896 179.887 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.24 121.86 2.34 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.418 -179.699 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.908 HG13 HG13 ' A' ' 46' ' ' ILE . 7.8 p -131.97 167.83 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.067 -179.558 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.908 HG13 HG13 ' A' ' 45' ' ' VAL . 24.1 mt 79.99 127.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.012 0.434 . . . . 0.0 111.235 -179.94 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -141.92 28.7 1.73 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.77 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t 60.4 97.89 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.169 -179.949 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.29 27.84 1.97 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.502 -179.922 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.86 66.25 0.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.957 0.408 . . . . 0.0 110.906 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 53' ' ' ARG . 8.4 mt-10 -152.97 70.67 0.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.965 -179.934 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.402 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 6.9 m-90 66.21 -66.07 0.18 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.283 -179.985 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER 69.45 80.0 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.017 0.437 . . . . 0.0 110.752 -179.904 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.34 -164.16 1.85 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.723 -179.987 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -70.31 65.66 0.28 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.992 0.425 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.0 t 61.6 153.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.83 179.915 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -118.0 123.3 45.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -147.6 73.18 1.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.886 179.941 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.846 0.355 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 m -80.15 -49.08 12.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.987 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.3 m -106.51 68.31 0.75 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.91 -179.966 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.99 -39.53 3.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.857 -179.982 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? 60.97 172.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.853 -179.963 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.8 mp -131.64 -45.33 0.97 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 179.962 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.531 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 0.5 OUTLIER -178.36 -74.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.964 179.968 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . 76.29 -79.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.286 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.463 HD12 ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -84.85 -60.72 0.29 Allowed Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.702 -179.566 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.463 ' HD2' HD12 ' A' ' 10' ' ' LEU . 14.6 Cg_endo -56.85 -66.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.335 2.023 . . . . 0.0 112.697 -179.604 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 69.09 76.64 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.95 0.405 . . . . 0.0 110.586 -179.512 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.7 m -64.06 138.84 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.183 -179.759 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.9 p 57.69 179.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.712 -179.667 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 11.3 t -75.38 134.56 73.29 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.333 -179.776 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.98 -19.67 45.61 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.264 1.976 . . . . 0.0 111.516 178.837 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -112.56 -11.58 13.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.133 179.878 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.664 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 31.6 m80 -131.79 84.72 53.56 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-O 120.619 0.247 . . . . 0.0 111.455 179.838 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.57 -41.68 62.07 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.979 1.786 . . . . 0.0 110.773 178.832 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.54 -8.83 57.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.574 179.975 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -100.99 109.04 20.91 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.734 0.778 . . . . 0.0 110.856 179.187 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.598 HD13 ' N ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -90.98 66.24 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 114.024 -1.444 . . . . 0.0 113.422 -177.632 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.599 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 2.7 mp -10.9 115.29 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.445 179.038 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 32' ' ' MET . 16.2 t -82.39 154.88 3.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.435 0.636 . . . . 0.0 112.708 -177.518 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.404 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -75.4 126.87 31.89 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.989 -178.584 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.4 OUTLIER 50.54 105.68 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.349 179.881 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.446 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -158.0 159.99 37.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.711 179.419 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 51.49 35.19 13.73 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.143 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.92 33.51 19.83 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.178 -178.249 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -138.57 -158.45 7.73 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.455 -0.879 . . . . 0.0 114.504 -178.634 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.985 ' OD1' HG12 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -82.34 -106.3 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.965 -0.617 . . . . 0.0 111.847 -179.479 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.679 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 15.7 mtp -103.4 114.85 29.44 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.574 0.702 . . . . 0.0 111.929 -177.756 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.911 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -101.41 128.22 53.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.55 -177.198 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.794 ' O ' ' N ' ' A' ' 38' ' ' GLY . 45.0 t -83.22 99.43 0.69 Allowed Pre-proline 0 N--CA 1.448 -0.541 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.522 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.0 Cg_endo -39.9 -20.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.281 2.654 . . . . 0.0 113.742 -179.464 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.664 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 5.3 mm-40 -87.9 -64.9 1.08 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.592 -178.262 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.488 ' SG ' HD23 ' A' ' 39' ' ' LEU . 7.0 p -89.84 -20.02 23.94 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.788 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.911 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 67.25 32.0 78.77 Favored Glycine 0 N--CA 1.431 -1.657 0 CA-C-N 113.652 -1.613 . . . . 0.0 112.754 179.406 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.892 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -71.12 155.33 40.89 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.725 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.985 HG12 ' OD1' ' A' ' 31' ' ' ASP . 4.1 t -118.34 120.28 63.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 O-C-N 123.309 0.381 . . . . 0.0 111.595 -178.35 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.795 HG23 ' CD1' ' A' ' 39' ' ' LEU . 53.1 t -132.89 134.27 58.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.714 178.916 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.514 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 135.28 -172.65 22.02 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.42 178.824 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.718 ' O ' HG23 ' A' ' 45' ' ' VAL . 3.1 t0 83.22 99.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.897 0.38 . . . . 0.0 110.549 -179.667 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -53.12 -44.17 67.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.175 -179.815 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 43' ' ' ASP . 19.3 t 68.11 32.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.994 -179.921 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.821 ' CG2' HG12 ' A' ' 48' ' ' VAL . 35.2 mt -107.86 143.56 18.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.063 179.949 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -111.38 -26.84 8.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.152 -179.964 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.821 HG12 ' CG2' ' A' ' 46' ' ' ILE . 11.7 p -55.13 148.44 3.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.251 -179.915 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -160.04 161.66 32.59 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.403 179.907 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 t -175.06 45.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.888 0.375 . . . . 0.0 110.94 -179.931 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.43 16.68 21.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.153 179.974 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER 64.56 -75.81 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.091 179.92 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.99 83.55 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.934 -179.992 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -142.35 177.17 8.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.805 179.95 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.4 ' H ' HG22 ' A' ' 54' ' ' THR . 3.2 p90 -145.15 21.84 1.56 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 179.95 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 53.45 -168.6 0.06 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.809 0.338 . . . . 0.0 111.09 179.902 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -113.99 176.64 4.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 179.906 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -60.15 -63.54 1.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 179.924 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.826 0.346 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 m -95.81 14.5 23.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.271 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 49.7 p -86.72 -21.44 26.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.968 179.855 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.5 m -58.24 106.8 0.41 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.996 -179.995 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.1 mtt85 -147.2 -166.94 2.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.652 179.989 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.1 mt -51.49 98.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.015 179.953 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -142.29 -166.8 2.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.027 -179.892 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 66.1 -87.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.265 179.979 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 10' ' ' LEU . 19.3 mt -158.73 161.17 28.82 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.817 -179.963 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.31 -166.08 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.488 2.125 . . . . 0.0 112.205 179.864 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.96 138.44 34.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.113 -179.814 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.661 ' O ' HG23 ' A' ' 14' ' ' THR . 30.5 m -99.47 35.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.964 179.773 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.1 OUTLIER 172.45 -173.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.63 -179.99 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 13.3 t -83.69 135.07 43.56 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.804 179.657 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -68.38 -18.38 44.1 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.115 1.877 . . . . 0.0 111.95 179.256 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.35 -8.1 11.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.336 179.929 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.677 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 37.9 m80 -130.95 88.35 46.05 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 120.693 0.282 . . . . 0.0 110.529 179.216 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.78 -35.02 90.78 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.408 2.072 . . . . 0.0 112.082 179.875 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.39 -28.25 31.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.308 -179.747 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.665 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -78.12 87.73 4.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.23 0.538 . . . . 0.0 111.057 -179.881 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.568 ' HA ' HG22 ' A' ' 14' ' ' THR . 14.3 mt -72.09 73.9 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.091 -178.347 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.602 HD11 HD21 ' A' ' 39' ' ' LEU . 2.2 mp -17.78 109.14 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.709 179.333 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.5 t -76.57 165.67 3.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.564 -178.512 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.462 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -81.13 137.03 35.96 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-O 121.941 0.877 . . . . 0.0 110.968 -177.874 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.535 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 18.8 m-20 59.27 91.98 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 178.273 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.67 ' CD2' HG21 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -63.71 99.46 0.23 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.552 177.935 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.627 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 6.8 mtp85 48.55 37.31 8.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.982 0.42 . . . . 0.0 110.098 -179.821 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 92.35 36.95 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.554 -178.911 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -133.25 -126.73 2.71 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.472 179.944 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.475 ' O ' ' CA ' ' A' ' 26' ' ' ASP . 4.5 m-20 -95.38 -143.49 0.26 Allowed 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 179.787 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.56 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -88.79 119.23 29.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.584 0.707 . . . . 0.0 111.733 -179.028 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.666 ' HB ' ' HB2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -103.63 123.7 57.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.621 -176.817 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.766 ' O ' ' N ' ' A' ' 38' ' ' GLY . 47.9 t -86.87 96.81 0.57 Allowed Pre-proline 0 N--CA 1.445 -0.687 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.898 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.2 Cg_endo -41.91 -15.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.28 2.654 . . . . 0.0 113.695 -179.278 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.677 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 13.1 mm-40 -86.3 -66.83 0.86 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.76 0.314 . . . . 0.0 110.845 -179.155 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.599 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.7 p -90.93 -19.86 22.83 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.429 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.766 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.68 36.24 87.26 Favored Glycine 0 N--CA 1.432 -1.626 0 CA-C-N 114.011 -1.45 . . . . 0.0 111.81 -179.737 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.835 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -75.5 148.84 38.66 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.884 -0.658 . . . . 0.0 109.772 179.229 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.67 HG21 ' CD2' ' A' ' 27' ' ' TYR . 37.0 t -111.74 115.7 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 123.295 0.372 . . . . 0.0 111.926 -178.39 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.835 HG23 ' CD1' ' A' ' 39' ' ' LEU . 54.4 t -123.82 135.55 63.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.253 178.551 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.09 164.24 10.79 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.914 178.837 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -167.39 -55.09 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.832 0.349 . . . . 0.0 110.573 179.74 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -139.41 144.57 38.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.907 179.858 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.95 128.65 52.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.292 -179.893 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.0 tp -148.42 136.52 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.027 179.928 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.18 -78.42 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.933 -179.962 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.481 HG13 ' N ' ' A' ' 49' ' ' GLY . 11.1 p -178.77 -44.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 -179.94 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.481 ' N ' HG13 ' A' ' 48' ' ' VAL . . . -132.19 100.08 0.41 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.508 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.89 118.34 1.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.729 0.3 . . . . 0.0 110.912 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -171.44 150.06 2.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.983 0.42 . . . . 0.0 111.059 -179.943 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 29.6 t90 61.05 -97.95 0.07 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.067 179.923 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 24.5 ttm-85 51.8 100.4 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.828 0.347 . . . . 0.0 111.343 179.829 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.424 HG22 ' N ' ' A' ' 55' ' ' PHE . 23.9 m -111.07 163.24 14.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.872 179.816 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.424 ' N ' HG22 ' A' ' 54' ' ' THR . 55.3 p90 -105.04 30.62 5.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.948 179.948 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 59.61 -173.57 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.953 179.894 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -173.04 170.24 4.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 179.956 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.48 -55.05 23.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.973 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.908 179.951 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.827 0.346 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.59 83.33 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.903 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.8 m -89.75 135.07 33.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.3 m -128.71 -50.87 1.25 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.997 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? 58.46 103.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.829 -179.87 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.28 60.16 3.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.939 -179.861 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -82.26 59.83 4.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.676 179.738 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.63 66.64 1.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.218 -179.769 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.504 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -126.41 45.29 1.45 Allowed Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.281 179.831 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 83.0 Cg_endo -79.79 133.12 10.09 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.385 2.056 . . . . 0.0 112.257 179.691 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -124.03 90.81 3.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.819 179.815 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.953 HG22 HG23 ' A' ' 14' ' ' THR . 13.1 p -130.65 133.11 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.313 -179.824 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.953 HG23 HG22 ' A' ' 13' ' ' VAL . 11.2 p 56.72 179.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.08 179.968 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.553 ' CB ' ' HG ' ' A' ' 34' ' ' CYS . 39.1 t -78.69 135.07 60.32 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.876 -179.971 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.46 -19.89 54.73 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.379 2.053 . . . . 0.0 112.248 179.643 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -115.16 -10.25 12.18 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.411 -179.974 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.734 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.5 m80 -130.83 87.81 48.07 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.757 0.313 . . . . 0.0 110.663 179.508 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.84 -34.51 95.57 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.269 1.979 . . . . 0.0 111.812 179.789 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.44 -27.09 38.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.287 -179.892 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.602 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -82.85 85.14 7.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.146 0.498 . . . . 0.0 111.296 -179.78 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.2 mp -70.4 74.92 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.856 -1.066 . . . . 0.0 112.768 -178.69 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.721 HD11 HD21 ' A' ' 39' ' ' LEU . 1.1 mp -16.98 109.58 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.535 179.386 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.5 t -78.07 162.8 3.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.157 0.503 . . . . 0.0 111.758 -178.249 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.429 ' N ' HG12 ' A' ' 24' ' ' VAL . 3.0 mm-40 -80.81 135.4 35.95 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.579 -178.303 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.618 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.4 OUTLIER 67.64 85.13 0.15 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.095 -1.412 . . . . 0.0 114.7 178.271 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.624 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 1.2 t80 -57.47 97.52 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.052 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.625 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 48.16 33.17 3.43 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.409 -179.908 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 100.65 28.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.855 -179.223 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.588 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -126.48 -124.49 2.75 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.132 179.679 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.881 ' OD1' HG12 ' A' ' 40' ' ' VAL . 2.3 p30 -99.14 -130.7 0.22 Allowed 'General case' 0 C--O 1.223 -0.329 0 O-C-N 122.958 -0.142 . . . . 0.0 110.866 179.606 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.547 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 9.4 mtm -97.86 119.72 36.98 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -177.907 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.827 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -107.56 125.43 63.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.301 -177.876 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.743 ' O ' ' N ' ' A' ' 38' ' ' GLY . 34.8 t -87.13 97.06 0.62 Allowed Pre-proline 0 C--O 1.222 -0.395 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.863 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.5 Cg_endo -41.9 -15.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.384 2.722 . . . . 0.0 114.244 -179.084 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.734 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 2.3 mm-40 -88.74 -64.38 1.15 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.697 0.284 . . . . 0.0 111.133 -178.787 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.644 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.1 p -90.84 -18.96 23.95 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.322 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.827 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 66.28 35.86 90.91 Favored Glycine 0 N--CA 1.431 -1.682 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.771 -179.374 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.898 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -72.97 144.45 47.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.621 -0.79 . . . . 0.0 109.49 179.378 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.881 HG12 ' OD1' ' A' ' 31' ' ' ASP . 1.9 t -112.53 116.0 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-O 121.027 0.441 . . . . 0.0 111.779 -178.001 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.898 HG23 ' CD1' ' A' ' 39' ' ' LEU . 97.0 t -122.6 132.74 70.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.788 177.96 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.615 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 119.46 -164.44 13.37 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.69 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.602 ' HA ' HD11 ' A' ' 46' ' ' ILE . 10.1 t0 -9.37 86.44 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.864 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.9 55.37 0.67 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.993 -179.662 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.453 ' O ' HG12 ' A' ' 45' ' ' VAL . 21.1 t 64.99 54.24 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.186 179.903 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.602 HD11 ' HA ' ' A' ' 43' ' ' ASP . 1.1 pp -130.66 80.86 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.941 179.843 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.76 -75.89 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.96 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 48' ' ' VAL . 7.6 p -126.96 73.36 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.066 -179.907 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.25 70.19 0.48 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.468 179.941 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.1 t 61.2 31.99 19.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.767 0.318 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.1 16.65 25.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.296 179.98 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 2.1 m0 63.84 -78.31 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.022 179.937 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.95 82.8 0.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.84 -179.922 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.88 152.92 38.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 -179.909 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -98.05 39.07 1.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 179.969 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.65 164.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.978 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -74.13 135.13 42.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.883 -179.971 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -86.6 -34.64 19.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.867 -179.97 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.927 179.968 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.708 ' HB1' ' HB3' ' A' ' 5' ' ' SER . . . . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.761 0.315 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.3 m -70.98 -43.18 68.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.827 179.983 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.1 p -124.27 30.81 5.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.708 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 0.3 OUTLIER -100.05 137.36 38.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 179.918 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.24 144.54 31.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 -179.973 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.84 154.62 21.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.818 -179.949 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -79.06 -3.48 45.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.509 179.981 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.0 104.84 5.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.9 0.381 . . . . 0.0 111.081 179.968 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 10' ' ' LEU . 2.0 mt -177.2 -62.42 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.721 179.941 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.425 ' CD ' ' CB ' ' A' ' 10' ' ' LEU . 39.7 Cg_endo -66.92 -28.24 42.51 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.472 2.115 . . . . 0.0 111.96 179.747 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 63.27 142.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.011 179.838 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.3 -84.14 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.798 179.77 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.752 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -88.79 -154.45 0.29 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.714 0.292 . . . . 0.0 110.519 179.864 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.587 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 45.4 t -67.22 138.66 94.6 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.403 178.936 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.89 -22.32 68.02 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.177 1.918 . . . . 0.0 111.954 179.197 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.19 -9.09 10.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.345 179.995 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.711 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . 38.5 m80 -129.89 89.1 46.96 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.736 0.303 . . . . 0.0 110.937 179.238 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.413 ' O ' HG21 ' A' ' 14' ' ' THR . 19.5 Cg_endo -59.46 -37.23 90.71 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.241 1.961 . . . . 0.0 111.791 179.632 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.54 -32.96 36.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.548 -179.695 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.797 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -71.45 89.46 0.94 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.169 0.509 . . . . 0.0 111.004 -179.85 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.752 ' HA ' HG23 ' A' ' 14' ' ' THR . 9.8 mm -70.64 78.95 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.958 -177.757 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.631 HD11 HD21 ' A' ' 39' ' ' LEU . 2.2 mp -26.93 107.23 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.173 0.511 . . . . 0.0 110.242 178.913 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -75.34 164.16 3.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.887 -178.283 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.595 ' O ' ' O ' ' A' ' 26' ' ' ASP . 1.7 mm-40 -80.97 135.86 35.93 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.633 -179.29 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.595 ' O ' ' O ' ' A' ' 25' ' ' GLU . 6.3 t70 36.79 123.19 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 179.827 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.481 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 56.0 t80 -138.97 120.45 15.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.67 177.887 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 60.5 42.53 14.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.286 -178.525 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 64.89 37.38 7.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.384 -178.534 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -120.15 -158.91 10.7 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.669 -0.777 . . . . 0.0 114.022 -178.725 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -91.88 -139.55 0.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.1 0.56 . . . . 0.0 110.248 179.96 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.582 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 5.6 mtm -81.86 114.64 20.61 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.682 0.753 . . . . 0.0 110.921 -179.723 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.76 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -100.78 124.09 54.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.565 -176.588 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.74 ' O ' ' N ' ' A' ' 38' ' ' GLY . 47.2 t -85.73 97.85 0.64 Allowed Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.366 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 3.9 Cg_endo -45.61 -12.76 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.844 2.363 . . . . 0.0 113.628 -179.112 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.797 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 4.8 mm-40 -88.81 -63.98 1.21 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.66 0.266 . . . . 0.0 111.204 -179.413 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.691 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.7 p -91.45 -22.59 20.35 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.398 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.76 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 70.4 41.63 66.86 Favored Glycine 0 N--CA 1.43 -1.74 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.033 -179.964 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.924 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -81.91 152.97 26.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.65 -0.775 . . . . 0.0 109.992 179.819 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 32' ' ' MET . 66.1 t -117.1 116.63 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.701 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.924 HG23 ' CD1' ' A' ' 39' ' ' LEU . 95.5 t -127.5 132.4 69.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.767 178.234 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.76 -159.09 21.54 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.066 -1.064 . . . . 0.0 111.974 179.614 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.452 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . 26.3 t70 67.02 32.82 6.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.904 0.383 . . . . 0.0 110.751 179.994 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -75.09 -176.01 2.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.033 -179.952 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 45' ' ' VAL . 5.7 m -63.37 103.42 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.094 179.965 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.587 ' O ' HG23 ' A' ' 46' ' ' ILE . 8.8 tp -178.69 110.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.118 -179.984 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.06 140.61 52.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.907 179.975 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.4 t -135.48 33.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.0 98.1 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.629 -179.94 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.85 100.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.791 0.329 . . . . 0.0 110.915 179.918 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.4 ' O ' ' CD1' ' A' ' 52' ' ' TRP . 2.7 mm-40 -63.48 -72.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.801 -179.988 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.4 ' CD1' ' O ' ' A' ' 51' ' ' GLU . 3.9 m-90 -143.32 -44.52 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.072 -179.984 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.37 34.56 2.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.964 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -70.65 179.36 2.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.875 179.925 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.419 ' H ' HG22 ' A' ' 54' ' ' THR . 3.2 p90 -163.6 31.55 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 179.906 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m 59.29 174.94 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 179.974 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -131.66 168.31 17.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 -179.959 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -62.45 -60.22 3.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.813 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.894 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 35.2 t . . . . . 0 CA--C 1.527 0.06 0 CA-C-O 120.579 0.228 . . . . 0.0 110.838 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.49 -20.98 70.74 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.116 1.877 . . . . 0.0 111.905 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -116.79 -11.14 10.95 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.176 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.749 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 33.8 m80 -131.07 87.33 48.75 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.858 0.361 . . . . 0.0 110.603 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.93 -34.75 95.07 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.305 2.003 . . . . 0.0 111.903 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -79.4 -26.81 41.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.215 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -82.86 95.86 8.06 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 122.603 1.192 . . . . 0.0 111.599 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.535 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.89 72.61 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 112.228 -2.26 . . . . 0.0 112.956 -178.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.615 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.9 mp -19.71 108.75 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.88 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -77.0 165.81 2.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.182 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.467 ' H ' HG12 ' A' ' 24' ' ' VAL . 8.2 mt-10 . . . . . 0 N--CA 1.432 -1.358 0 CA-C-O 121.818 0.818 . . . . 0.0 110.105 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.607 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 29.0 mtt . . . . . 0 C--O 1.223 -0.291 0 CA-C-O 121.428 0.633 . . . . 0.0 111.57 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.692 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -105.03 123.52 59.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.988 -176.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.749 ' O ' ' N ' ' A' ' 38' ' ' GLY . 37.9 t -87.81 96.5 0.62 Allowed Pre-proline 0 N--CA 1.45 -0.461 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.5 Cg_endo -42.4 -14.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 123.304 2.669 . . . . 0.0 114.08 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.749 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 1.1 mm-40 -89.7 -63.75 1.24 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.576 0.227 . . . . 0.0 111.06 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.542 ' SG ' HD23 ' A' ' 39' ' ' LEU . 8.4 p -90.54 -20.44 22.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.749 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 68.39 33.76 78.14 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.314 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.774 ' CD1' HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -74.33 143.89 44.73 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 32' ' ' MET . 32.9 t -109.68 111.36 35.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.862 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.774 HG22 ' CD1' ' A' ' 39' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.606 0.241 . . . . 0.0 110.431 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 16.7 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.469 0.176 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.06 -18.94 63.17 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.068 1.845 . . . . 0.0 112.03 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -117.53 -9.32 10.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.35 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.683 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . 37.7 m80 -130.76 88.34 46.62 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-O 120.755 0.312 . . . . 0.0 110.437 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.67 -34.41 92.14 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.414 2.076 . . . . 0.0 112.03 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.25 -26.01 31.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.395 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.683 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -80.32 87.87 5.57 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.242 0.544 . . . . 0.0 111.255 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.535 ' O ' ' C ' ' A' ' 23' ' ' LEU . 13.6 mm -72.29 75.19 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.353 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.599 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 2.0 mp -20.5 107.47 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.556 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -74.94 167.95 2.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.181 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.512 ' H ' HG12 ' A' ' 24' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.432 -1.357 0 CA-C-O 122.051 0.929 . . . . 0.0 110.648 -178.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.561 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 8.2 mtt . . . . . 0 C--O 1.224 -0.245 0 CA-C-O 121.403 0.62 . . . . 0.0 111.597 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.603 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -103.68 121.3 54.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.826 -177.127 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.762 ' O ' ' N ' ' A' ' 38' ' ' GLY . 49.7 t -86.57 97.02 0.57 Allowed Pre-proline 0 N--CA 1.446 -0.635 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.2 Cg_endo -41.77 -15.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.343 2.695 . . . . 0.0 113.853 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.68 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 10.5 mm-40 -86.29 -66.89 0.85 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.8 0.333 . . . . 0.0 110.807 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.577 ' SG ' HD23 ' A' ' 39' ' ' LEU . 2.9 p -90.7 -18.7 24.59 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.762 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.24 35.18 90.0 Favored Glycine 0 N--CA 1.433 -1.551 0 CA-C-N 114.119 -1.401 . . . . 0.0 111.627 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.855 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -74.27 148.44 41.46 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.894 -0.653 . . . . 0.0 109.638 179.38 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 32' ' ' MET . 48.5 t -112.29 113.75 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 120.887 0.375 . . . . 0.0 111.847 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.855 HG23 ' CD1' ' A' ' 39' ' ' LEU . 55.5 t . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.063 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 14.5 t . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.518 0.199 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.87 -18.02 61.13 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.276 1.984 . . . . 0.0 112.304 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.07 -13.6 9.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.045 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.742 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 35.4 m80 -127.27 88.51 53.9 Favored Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.898 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.96 -40.12 55.16 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.417 2.078 . . . . 0.0 112.082 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -75.8 -35.4 60.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.346 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.783 ' HB2' ' HG2' ' A' ' 36' ' ' GLU . . . -75.85 79.64 2.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.234 0.54 . . . . 0.0 110.974 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.581 ' O ' ' C ' ' A' ' 23' ' ' LEU . 12.3 mt -69.88 72.44 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.918 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.817 HD11 HD21 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -7.61 110.77 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.73 179.163 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 32' ' ' MET . 14.2 t -83.3 155.86 3.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.514 0.673 . . . . 0.0 112.669 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.428 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.138 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.903 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.567 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 44.1 mtm . . . . . 0 N--CA 1.456 -0.144 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.773 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -141.7 130.9 23.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.494 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.791 ' O ' ' N ' ' A' ' 38' ' ' GLY . 18.0 t -88.97 97.58 0.93 Allowed Pre-proline 0 C--O 1.217 -0.637 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 2.7 Cg_endo -44.27 -14.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.921 2.414 . . . . 0.0 113.417 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.783 ' HG2' ' HB2' ' A' ' 21' ' ' ALA . 8.2 mm-40 -86.72 -65.14 1.05 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.567 0.222 . . . . 0.0 110.784 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.571 ' SG ' HD23 ' A' ' 39' ' ' LEU . 2.5 p -91.8 -24.7 19.31 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.791 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 74.1 41.19 40.39 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 113.395 -1.73 . . . . 0.0 112.103 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.817 HD21 HD11 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -79.14 146.5 33.13 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.928 -0.636 . . . . 0.0 109.534 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 32' ' ' MET . 95.9 t -111.94 122.75 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 O-C-N 123.532 0.52 . . . . 0.0 111.736 -177.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.734 HG23 ' CD1' ' A' ' 39' ' ' LEU . 22.4 t . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.797 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB2' HD12 ' A' ' 23' ' ' LEU . 38.5 t . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.532 0.206 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.49 -20.35 65.87 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.349 2.033 . . . . 0.0 112.405 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -114.75 -12.02 12.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.241 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.739 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.9 m80 -130.46 87.95 48.72 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 120.688 0.28 . . . . 0.0 110.565 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.56 -36.75 92.01 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.328 2.018 . . . . 0.0 111.785 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.28 -33.09 55.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.233 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -76.19 88.11 3.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.098 0.475 . . . . 0.0 111.307 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.568 ' O ' ' C ' ' A' ' 23' ' ' LEU . 9.9 mt -74.49 71.22 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.807 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.691 HD11 HD21 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -12.33 107.35 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.666 0.604 . . . . 0.0 110.886 179.419 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -77.86 164.42 3.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.171 0.51 . . . . 0.0 111.406 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.439 ' N ' HG12 ' A' ' 24' ' ' VAL . 4.0 mm-40 . . . . . 0 N--CA 1.432 -1.326 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.746 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.854 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 28.1 mtp . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 121.537 0.684 . . . . 0.0 112.194 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.857 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -101.49 123.41 54.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.762 -177.018 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.729 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.1 t -87.47 97.05 0.65 Allowed Pre-proline 0 N--CA 1.449 -0.495 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -40.78 -16.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.379 2.719 . . . . 0.0 114.149 -179.228 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.739 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 13.5 mm-40 -87.83 -64.81 1.09 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.634 0.254 . . . . 0.0 111.307 -178.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.684 ' SG ' HD23 ' A' ' 39' ' ' LEU . 5.7 p -90.37 -20.6 22.66 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.857 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.49 36.64 77.54 Favored Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 113.572 -1.649 . . . . 0.0 112.52 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.792 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -79.75 150.42 30.82 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.588 -0.806 . . . . 0.0 110.405 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.854 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.1 t -119.56 121.37 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-O 121.275 0.56 . . . . 0.0 112.429 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.792 HG23 ' CD1' ' A' ' 39' ' ' LEU . 87.3 t . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.01 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 15.0 t . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.421 0.153 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.1 -25.37 79.66 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.286 1.991 . . . . 0.0 111.961 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -108.48 -30.29 8.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.675 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.712 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 38.3 m80 -113.32 81.64 5.24 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.436 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.11 -33.48 97.44 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.03 1.82 . . . . 0.0 110.935 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -73.01 -42.39 63.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.285 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.579 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -74.97 87.52 2.33 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.11 0.481 . . . . 0.0 110.979 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.547 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.3 mp -68.93 74.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.713 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.72 HD22 HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -14.64 112.7 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.37 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.1 t -81.18 163.24 3.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.254 0.55 . . . . 0.0 111.222 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.415 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.428 -1.54 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.852 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 35.3 mtp . . . . . 0 C--O 1.227 -0.123 0 CA-C-O 121.662 0.744 . . . . 0.0 112.39 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.851 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -104.17 126.08 58.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.89 -177.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.752 ' O ' ' N ' ' A' ' 38' ' ' GLY . 42.1 t -91.16 98.82 1.83 Allowed Pre-proline 0 C--O 1.219 -0.545 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.3 Cg_endo -43.44 -14.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.216 2.611 . . . . 0.0 113.881 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.712 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 2.9 mm-40 -87.92 -64.69 1.11 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.759 0.314 . . . . 0.0 111.08 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.46 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 3.3 p -91.19 -21.3 21.2 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.851 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.67 38.76 77.95 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 113.645 -1.616 . . . . 0.0 111.739 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.977 HD11 HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -80.03 144.06 33.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.7 -0.75 . . . . 0.0 110.726 -179.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 32' ' ' MET . 47.4 t -104.89 112.84 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.016 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.977 HG22 HD11 ' A' ' 39' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 120.901 0.382 . . . . 0.0 110.868 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.652 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 47.4 t . . . . . 0 C--O 1.232 0.17 0 N-CA-C 110.442 -0.206 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 14.3 Cg_endo -56.12 -28.33 69.67 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.468 2.112 . . . . 0.0 111.865 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.41 -6.19 10.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.602 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.706 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . 39.4 m80 -128.62 88.63 51.65 Favored Pre-proline 0 C--O 1.231 0.121 0 CA-C-O 120.668 0.27 . . . . 0.0 111.265 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -61.58 -32.82 87.83 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.3 2.0 . . . . 0.0 112.008 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.53 -19.41 29.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.423 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.752 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -85.3 83.33 8.01 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.198 0.523 . . . . 0.0 110.834 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.445 ' O ' ' C ' ' A' ' 23' ' ' LEU . 5.4 mm -63.44 83.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.019 -1.446 . . . . 0.0 113.869 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.854 HD21 HD11 ' A' ' 39' ' ' LEU . 1.9 mp -34.02 111.87 0.12 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 32' ' ' MET . 2.8 t -73.5 163.33 4.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 121.344 0.592 . . . . 0.0 110.953 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.409 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.43 -1.438 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.873 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.602 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.221 -0.4 0 CA-C-O 121.252 0.549 . . . . 0.0 111.827 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.619 HG23 ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -102.76 119.18 50.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.756 ' O ' ' N ' ' A' ' 38' ' ' GLY . 35.9 t -85.79 97.14 0.53 Allowed Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 5.0 Cg_endo -44.97 -11.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.011 2.474 . . . . 0.0 113.951 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.752 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 5.5 mm-40 -89.93 -63.56 1.26 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 121.115 -0.234 . . . . 0.0 110.725 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.761 ' SG ' HD23 ' A' ' 39' ' ' LEU . 2.7 p -91.95 -20.25 21.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 176.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.756 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.49 40.11 91.12 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 114.068 -1.424 . . . . 0.0 111.208 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.854 HD11 HD21 ' A' ' 23' ' ' LEU . 1.4 pp -79.12 149.73 31.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.378 -0.911 . . . . 0.0 109.758 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 32' ' ' MET . 44.8 t -115.08 110.46 32.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.782 HG23 HD11 ' A' ' 39' ' ' LEU . 22.9 t . . . . . 0 N--CA 1.468 0.449 0 CA-C-O 120.917 0.389 . . . . 0.0 111.393 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.632 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 53.2 t . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.614 0.245 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.54 -30.55 71.22 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.447 2.098 . . . . 0.0 111.848 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -96.69 -14.58 21.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.895 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.86 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 37.8 m80 -130.69 86.65 52.07 Favored Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.028 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.59 -47.92 6.55 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.21 1.94 . . . . 0.0 111.912 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.91 -10.13 59.17 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.205 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.86 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -103.44 106.02 16.43 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.458 0.647 . . . . 0.0 111.166 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.9 mt -82.79 126.05 40.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.548 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.788 HD23 ' O ' ' A' ' 32' ' ' MET . 2.8 mp -63.78 130.91 46.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.28 0.562 . . . . 0.0 109.503 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 32' ' ' MET . 11.9 t -88.24 157.65 3.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.833 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 . . . . . 0 N--CA 1.434 -1.237 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.758 -178.823 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.788 ' O ' HD23 ' A' ' 23' ' ' LEU . 4.9 mtp . . . . . 0 C--O 1.222 -0.376 0 CA-C-O 121.03 0.443 . . . . 0.0 110.499 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.807 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -99.71 124.62 53.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -176.323 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.751 ' O ' ' N ' ' A' ' 38' ' ' GLY . 43.4 t -87.51 103.23 4.29 Favored Pre-proline 0 C--O 1.222 -0.344 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.8 Cg_endo -41.1 -21.06 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.304 2.67 . . . . 0.0 114.056 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.633 ' HG3' ' HB2' ' A' ' 21' ' ' ALA . 4.5 mm-40 -85.4 -66.16 0.93 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.886 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.693 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.1 p -89.87 -18.94 25.23 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.807 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 67.43 30.84 75.6 Favored Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.074 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.826 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -71.17 149.75 46.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.349 -0.926 . . . . 0.0 110.895 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' A' ' 32' ' ' MET . 24.1 t -113.31 126.74 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.687 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.826 HG23 ' CD1' ' A' ' 39' ' ' LEU . 92.2 t . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.41 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.517 ' HB2' HD12 ' A' ' 23' ' ' LEU . 44.7 t . . . . . 0 CA--C 1.529 0.157 0 CA-C-O 120.548 0.213 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.14 -21.26 62.88 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.516 2.144 . . . . 0.0 112.356 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -112.05 -13.1 13.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.183 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.722 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.5 m80 -131.36 88.02 45.34 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.728 0.299 . . . . 0.0 110.622 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.0 -34.14 99.05 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.366 2.044 . . . . 0.0 111.709 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.37 -28.12 34.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.396 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.633 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -81.5 87.2 6.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.187 0.518 . . . . 0.0 111.15 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.582 ' O ' ' C ' ' A' ' 23' ' ' LEU . 2.8 mm -74.63 70.56 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.779 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.899 HD21 HD11 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -9.86 111.13 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.666 0.604 . . . . 0.0 110.657 179.349 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 32' ' ' MET . 7.3 t -81.9 158.78 3.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.514 0.673 . . . . 0.0 112.394 -177.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.422 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.834 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.256 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 88.6 mtp . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.754 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -115.35 136.84 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.508 0.67 . . . . 0.0 111.956 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.858 ' O ' ' N ' ' A' ' 38' ' ' GLY . 38.5 t -87.63 96.71 0.62 Allowed Pre-proline 0 N--CA 1.439 -1.024 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.435 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.8 Cg_endo -39.3 -19.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.551 2.834 . . . . 0.0 113.836 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.722 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 2.4 mm-40 -85.94 -66.18 0.93 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.72 0.295 . . . . 0.0 110.655 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.554 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.0 p -89.59 -17.93 27.54 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.858 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 65.63 31.28 79.53 Favored Glycine 0 N--CA 1.435 -1.424 0 CA-C-N 113.986 -1.461 . . . . 0.0 111.562 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.943 ' CD1' HG23 ' A' ' 41' ' ' VAL . 1.3 pp -65.25 136.65 56.87 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 32' ' ' MET . 77.3 t -107.0 114.85 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 O-C-N 123.358 0.411 . . . . 0.0 111.027 -178.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.943 HG23 ' CD1' ' A' ' 39' ' ' LEU . 95.8 t . . . . . 0 N--CA 1.448 -0.563 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.659 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.57 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 49.3 t . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.458 0.17 . . . . 0.0 110.571 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.85 -21.85 71.94 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.182 1.921 . . . . 0.0 111.989 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -119.73 -7.56 10.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.384 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.691 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . 37.6 m80 -131.18 86.75 50.09 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-O 120.624 0.249 . . . . 0.0 111.11 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.15 -33.63 90.5 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.416 2.077 . . . . 0.0 112.011 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -83.3 -24.94 31.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.161 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.758 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -82.39 81.93 8.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.336 0.589 . . . . 0.0 110.638 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.51 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -66.68 78.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.47 -1.241 . . . . 0.0 113.395 -178.054 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.839 HD21 HD11 ' A' ' 39' ' ' LEU . 1.7 mp -22.43 106.95 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.712 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.509 HG12 ' H ' ' A' ' 25' ' ' GLU . 3.4 t -75.24 167.93 2.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.192 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.509 ' H ' HG12 ' A' ' 24' ' ' VAL . 2.9 mm-40 . . . . . 0 N--CA 1.432 -1.329 0 CA-C-O 121.922 0.867 . . . . 0.0 110.602 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.586 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 53.5 mtp . . . . . 0 C--O 1.225 -0.231 0 CA-C-O 121.364 0.602 . . . . 0.0 111.882 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.698 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -103.61 123.22 57.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.056 -176.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.75 ' O ' ' N ' ' A' ' 38' ' ' GLY . 44.5 t -86.24 96.77 0.52 Allowed Pre-proline 0 N--CA 1.448 -0.529 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 2.2 Cg_endo -43.2 -14.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 123.232 2.622 . . . . 0.0 113.935 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.758 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 8.7 mm-40 -88.89 -64.28 1.17 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.632 0.253 . . . . 0.0 110.952 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.774 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.6 p -91.16 -19.52 22.99 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.75 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.5 37.46 89.87 Favored Glycine 0 N--CA 1.432 -1.567 0 CA-C-N 113.822 -1.535 . . . . 0.0 111.986 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.839 HD11 HD21 ' A' ' 23' ' ' LEU . 1.2 pp -76.91 148.66 36.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.569 -0.816 . . . . 0.0 110.053 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 32' ' ' MET . 34.8 t -113.74 113.33 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.776 HG23 HD11 ' A' ' 39' ' ' LEU . 42.1 t . . . . . 0 N--CA 1.462 0.155 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.497 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 48.0 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.486 0.184 . . . . 0.0 110.726 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.46 -23.2 71.23 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.403 2.069 . . . . 0.0 112.444 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -117.68 -7.28 11.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.506 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.717 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.0 m80 -130.3 83.28 63.27 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.666 0.27 . . . . 0.0 111.049 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.3 -36.47 87.55 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.323 2.015 . . . . 0.0 111.769 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.77 -34.96 62.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.043 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -76.81 85.43 3.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.016 0.436 . . . . 0.0 110.968 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' C ' ' A' ' 23' ' ' LEU . 8.9 mm -69.96 74.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.295 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.704 HD11 HD21 ' A' ' 39' ' ' LEU . 1.3 mp -12.86 114.2 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.596 0.56 . . . . 0.0 110.893 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 32' ' ' MET . 5.9 t -83.53 157.49 3.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.387 0.613 . . . . 0.0 111.957 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.306 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.826 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.561 ' O ' HD23 ' A' ' 23' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.904 0.383 . . . . 0.0 110.87 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.73 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 5.8 tp -104.13 132.72 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.767 ' O ' ' N ' ' A' ' 38' ' ' GLY . 41.7 t -90.86 96.3 0.95 Allowed Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 176.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 5.1 Cg_endo -44.56 -10.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.102 2.534 . . . . 0.0 113.878 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.717 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 3.5 mm-40 -88.21 -64.0 1.21 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.632 ' SG ' HD23 ' A' ' 39' ' ' LEU . 6.0 p -91.32 -23.07 20.23 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.767 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 71.82 46.83 35.7 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.341 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.73 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.6 OUTLIER -86.68 139.42 30.78 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.053 -1.074 . . . . 0.0 109.607 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 32' ' ' MET . 18.6 t -108.41 119.72 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 O-C-N 123.679 0.612 . . . . 0.0 111.476 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.607 HG22 ' CD1' ' A' ' 39' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.57 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.567 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 35.8 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.46 0.171 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.92 -19.27 66.46 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.297 1.998 . . . . 0.0 111.818 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.21 -13.0 12.4 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.011 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.712 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.5 m80 -130.79 87.63 48.76 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.284 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.96 -35.0 94.8 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.453 2.102 . . . . 0.0 111.927 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.38 -28.79 41.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.048 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.613 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -79.85 88.21 5.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.066 0.46 . . . . 0.0 111.2 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.551 ' O ' ' C ' ' A' ' 23' ' ' LEU . 17.7 mt -74.7 72.25 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.793 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 32' ' ' MET . 0.9 OUTLIER -14.08 103.02 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.034 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.1 t -75.19 166.27 2.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.652 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.463 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.443 -0.804 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.965 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.738 ' O ' HD23 ' A' ' 23' ' ' LEU . 1.1 mtp . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.961 0.41 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.628 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -99.95 124.78 53.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.158 -177.573 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.77 ' O ' ' N ' ' A' ' 38' ' ' GLY . 32.1 t -87.53 97.2 0.69 Allowed Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.3 Cg_endo -40.3 -17.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.548 2.832 . . . . 0.0 113.913 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.712 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 8.4 mm-40 -87.28 -65.88 0.97 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.591 0.234 . . . . 0.0 110.877 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.628 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.6 p -90.07 -18.6 25.62 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.77 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.93 33.39 83.8 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 114.084 -1.416 . . . . 0.0 111.769 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.82 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -72.61 145.58 47.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.916 -0.642 . . . . 0.0 109.592 179.105 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 32' ' ' MET . 2.4 t -115.08 117.61 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 120.983 0.42 . . . . 0.0 111.586 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.82 HG23 ' CD1' ' A' ' 39' ' ' LEU . 86.3 t . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.408 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.557 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 40.1 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.469 0.176 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.94 -20.59 70.01 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.3 2.0 . . . . 0.0 111.976 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -116.5 -11.91 11.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.199 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.679 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.2 m80 -130.04 88.57 48.09 Favored Pre-proline 0 C--N 1.333 -0.142 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.803 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.74 -37.16 88.9 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.474 2.116 . . . . 0.0 111.922 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -78.57 -32.82 47.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.417 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.774 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -75.42 84.77 2.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.238 0.542 . . . . 0.0 110.891 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.555 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.2 mp -70.61 73.67 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.177 -178.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.603 HD11 HD21 ' A' ' 39' ' ' LEU . 1.9 mp -15.49 118.95 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.524 0.515 . . . . 0.0 110.508 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 32' ' ' MET . 22.6 t -86.57 151.15 3.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.638 0.732 . . . . 0.0 112.469 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.441 -0.917 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.935 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.621 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 22.8 mtm . . . . . 0 N--CA 1.444 -0.77 0 CA-C-O 121.66 0.743 . . . . 0.0 111.389 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.908 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -102.15 128.4 54.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.996 -177.59 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.784 ' O ' ' N ' ' A' ' 38' ' ' GLY . 41.5 t -85.68 98.67 0.76 Allowed Pre-proline 0 N--CA 1.445 -0.717 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 1.2 Cg_endo -42.68 -16.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.16 2.573 . . . . 0.0 113.699 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.774 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 14.4 mm-40 -89.2 -63.92 1.22 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.504 0.193 . . . . 0.0 111.076 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.589 ' SG ' HD23 ' A' ' 39' ' ' LEU . 6.0 p -90.74 -21.46 21.56 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.908 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 70.12 38.18 72.93 Favored Glycine 0 N--CA 1.432 -1.606 0 CA-C-N 113.546 -1.661 . . . . 0.0 112.449 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.889 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -78.08 146.02 35.47 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.753 -0.724 . . . . 0.0 110.021 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 32' ' ' MET . 23.0 t -110.81 117.7 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 O-C-N 123.43 0.456 . . . . 0.0 111.705 -178.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.889 HG23 ' CD1' ' A' ' 39' ' ' LEU . 63.2 t . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.869 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.435 ' HB2' HD12 ' A' ' 23' ' ' LEU . 7.7 t . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.498 0.189 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -66.86 -20.91 51.3 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.327 2.018 . . . . 0.0 111.967 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -111.7 -14.83 13.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.979 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.703 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.0 m80 -130.47 87.32 50.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.668 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.87 -38.09 81.79 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.395 2.063 . . . . 0.0 111.967 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.96 -39.07 61.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.226 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -70.82 91.93 0.87 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.968 0.413 . . . . 0.0 111.149 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.586 ' O ' ' C ' ' A' ' 23' ' ' LEU . 8.6 mm -77.86 67.21 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.432 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.639 HD11 HD21 ' A' ' 39' ' ' LEU . 0.9 OUTLIER -5.32 102.84 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.154 179.614 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.5 t -77.22 163.58 3.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 121.339 0.59 . . . . 0.0 111.781 -178.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.445 ' N ' HG12 ' A' ' 24' ' ' VAL . 2.0 mm-40 . . . . . 0 N--CA 1.441 -0.916 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.782 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.833 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 15.5 mtt . . . . . 0 C--O 1.225 -0.219 0 N-CA-C 110.619 -0.141 . . . . 0.0 110.619 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.714 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -112.99 134.07 56.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -177.719 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.821 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.4 t -87.63 97.75 0.81 Allowed Pre-proline 0 C--O 1.218 -0.569 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.8 Cg_endo -39.22 -19.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.549 2.833 . . . . 0.0 113.627 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.703 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 12.1 mm-40 -85.58 -66.84 0.85 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.732 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.668 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.7 p -90.08 -20.69 22.88 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 177.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.821 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 70.25 32.36 68.77 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 114.025 -1.443 . . . . 0.0 112.217 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.714 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -71.51 141.41 50.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.833 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.3 t -108.8 127.0 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-O 120.692 0.282 . . . . 0.0 111.004 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.603 HG22 ' CD1' ' A' ' 39' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.986 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.495 ' CB ' ' HG ' ' A' ' 34' ' ' CYS . 48.3 t . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.508 0.194 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.62 -24.09 77.37 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.266 1.978 . . . . 0.0 112.068 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -118.06 -7.25 10.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.484 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.744 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 32.7 m80 -133.15 80.76 58.54 Favored Pre-proline 0 C--N 1.333 -0.129 0 CA-C-O 120.734 0.302 . . . . 0.0 111.692 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -57.74 -36.52 98.36 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.887 1.725 . . . . 0.0 111.06 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.53 -48.73 63.56 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.258 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.604 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -71.09 85.98 0.74 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.248 0.547 . . . . 0.0 111.073 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.555 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.6 mp -67.75 75.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.846 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.667 HD11 HD21 ' A' ' 39' ' ' LEU . 1.1 mp -14.24 112.2 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.912 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -81.31 160.19 3.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.277 0.56 . . . . 0.0 111.644 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.408 ' N ' HG12 ' A' ' 24' ' ' VAL . 15.6 mm-40 . . . . . 0 N--CA 1.44 -0.968 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.85 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.598 ' O ' HD23 ' A' ' 23' ' ' LEU . 73.3 mtp . . . . . 0 N--CA 1.446 -0.636 0 CA-C-O 121.475 0.655 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.73 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -100.68 125.68 54.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.403 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.731 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.0 t -88.87 98.27 1.09 Allowed Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.1 Cg_endo -43.57 -14.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.181 2.587 . . . . 0.0 114.068 -178.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.744 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 4.0 mm-40 -89.45 -63.07 1.34 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 121.215 -0.194 . . . . 0.0 111.409 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.658 ' SG ' HD23 ' A' ' 39' ' ' LEU . 16.1 p -91.37 -23.23 20.13 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.731 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 72.18 37.53 59.6 Favored Glycine 0 N--CA 1.428 -1.892 0 CA-C-N 113.285 -1.78 . . . . 0.0 112.651 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.698 ' CD1' HG22 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -77.36 145.82 37.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.155 179.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 32' ' ' MET . 59.0 t -111.35 116.1 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 O-C-N 123.847 0.717 . . . . 0.0 111.069 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.698 HG22 ' CD1' ' A' ' 39' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.471 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 10.5 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.566 0.222 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.8 -23.75 74.43 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.24 1.96 . . . . 0.0 111.995 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -106.93 -30.01 9.11 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.719 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.636 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 39.6 m80 -108.25 87.53 4.1 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.18 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.61 39.73 0.65 Allowed 'Trans proline' 0 CA--C 1.515 -0.444 0 C-N-CA 123.168 2.578 . . . . 0.0 111.013 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 18' ' ' HIS . 46.8 m-20 -152.64 -48.05 0.1 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.143 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.436 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -69.58 93.46 0.7 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.991 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.574 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.5 mp -76.04 71.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.946 -1.025 . . . . 0.0 113.182 -177.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.092 HD21 HD11 ' A' ' 39' ' ' LEU . 0.9 OUTLIER -8.84 111.35 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.901 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 32' ' ' MET . 15.4 t -81.76 152.44 4.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 121.646 0.736 . . . . 0.0 112.609 -177.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 . . . . . 0 C--N 1.318 -0.787 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.005 -179.041 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.577 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 16.7 mtp . . . . . 0 N--CA 1.434 -1.238 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.028 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -109.09 137.91 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 CA-C-O 122.113 0.959 . . . . 0.0 112.048 -176.396 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.811 ' O ' ' N ' ' A' ' 38' ' ' GLY . 33.1 t -91.25 99.17 2.07 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 113.542 -1.663 . . . . 0.0 109.181 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.476 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.1 Cg_endo -41.41 -15.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.312 2.675 . . . . 0.0 113.603 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.636 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 9.3 mm-40 -87.18 -65.0 1.06 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.484 0.183 . . . . 0.0 110.627 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.545 ' SG ' HD23 ' A' ' 39' ' ' LEU . 1.6 p -90.07 -21.0 22.52 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 176.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.811 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 69.06 40.16 83.66 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.963 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.092 HD11 HD21 ' A' ' 23' ' ' LEU . 1.5 pp -77.26 136.85 38.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.024 -1.088 . . . . 0.0 108.378 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 32' ' ' MET . 42.9 t -105.6 126.45 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 O-C-N 123.399 0.437 . . . . 0.0 111.234 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.567 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.4 t . . . . . 0 N--CA 1.448 -0.574 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.224 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 42.7 t . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.482 0.182 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.18 -28.41 56.25 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.338 2.025 . . . . 0.0 111.238 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -91.08 -20.35 22.14 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.335 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.612 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 40.5 m80 -130.66 85.92 54.36 Favored Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.325 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.73 -40.54 53.86 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.958 1.772 . . . . 0.0 110.99 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.0 -13.96 59.69 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.974 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.58 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -97.76 133.77 41.83 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.66 0.743 . . . . 0.0 110.985 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.539 ' H ' HD12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -108.11 123.98 64.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.774 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.93 HD23 ' O ' ' A' ' 32' ' ' MET . 4.9 mp -67.89 93.86 0.43 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 32' ' ' MET . 2.7 t -49.91 161.83 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.208 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 . . . . . 0 N--CA 1.442 -0.833 0 CA-C-O 122.428 1.109 . . . . 0.0 112.13 -176.926 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.93 ' O ' HD23 ' A' ' 23' ' ' LEU . 36.2 mtm . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 121.308 0.575 . . . . 0.0 111.413 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.814 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -98.82 121.62 49.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.132 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.814 ' O ' ' N ' ' A' ' 38' ' ' GLY . 38.9 t -84.35 100.4 1.06 Allowed Pre-proline 0 C--O 1.221 -0.406 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.484 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 3.9 Cg_exo -36.8 -26.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.804 3.003 . . . . 0.0 114.064 -179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.612 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 27.2 mm-40 -82.63 -67.36 0.79 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.523 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.731 ' SG ' HD23 ' A' ' 39' ' ' LEU . 2.6 p -87.92 -15.07 37.63 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.814 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 61.84 25.55 65.94 Favored Glycine 0 N--CA 1.433 -1.542 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.31 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.858 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -65.25 150.37 48.34 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.354 -0.923 . . . . 0.0 110.116 -179.844 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 32' ' ' MET . 2.7 t -118.17 120.19 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.858 HG23 ' CD1' ' A' ' 39' ' ' LEU . 84.9 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.164 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 43.3 t . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 120.65 0.262 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.73 -28.97 51.57 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.601 2.201 . . . . 0.0 112.03 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.19 -16.31 19.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.713 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.672 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 39.9 m80 -131.92 85.23 51.45 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.293 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.68 -43.54 37.87 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.074 1.85 . . . . 0.0 111.321 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -74.64 -12.01 60.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.372 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -102.5 102.35 12.63 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.136 0.494 . . . . 0.0 111.812 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.494 ' H ' HD12 ' A' ' 22' ' ' ILE . 1.8 mp -76.38 130.76 35.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.755 HD23 ' O ' ' A' ' 32' ' ' MET . 3.2 mp -72.19 135.69 46.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.657 0.742 . . . . 0.0 111.125 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 32' ' ' MET . 42.9 t -87.63 156.84 3.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.208 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.432 -1.338 0 CA-C-O 121.936 0.874 . . . . 0.0 111.314 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.755 ' O ' HD23 ' A' ' 23' ' ' LEU . 75.8 mtp . . . . . 0 C--O 1.223 -0.323 0 CA-C-O 121.01 0.433 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.662 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -99.42 123.19 51.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -176.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.771 ' O ' ' N ' ' A' ' 38' ' ' GLY . 30.4 t -88.86 100.17 1.94 Allowed Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -40.11 -20.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.589 2.859 . . . . 0.0 114.09 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.672 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 6.4 mm-40 -87.36 -64.5 1.14 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.755 0.312 . . . . 0.0 111.409 -177.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.445 ' SG ' HD23 ' A' ' 39' ' ' LEU . 7.6 p -89.86 -20.23 23.68 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.771 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 68.15 29.14 73.2 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.222 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.808 HD11 HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -69.0 145.95 53.14 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.159 -0.521 . . . . 0.0 110.422 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' MET . 40.4 t -109.3 120.51 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 O-C-N 123.904 0.753 . . . . 0.0 110.493 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.808 HG22 HD11 ' A' ' 39' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.367 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 19.2 t . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 120.532 0.206 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.85 -26.32 32.18 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.322 2.015 . . . . 0.0 111.535 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.55 -16.98 18.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.74 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.643 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 39.1 m80 -131.87 84.32 54.42 Favored Pre-proline 0 N--CA 1.455 -0.224 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.205 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.96 -44.86 27.24 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 121.937 1.758 . . . . 0.0 111.528 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.98 -12.77 60.74 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -102.12 102.37 12.83 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.826 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.461 ' H ' HD12 ' A' ' 22' ' ' ILE . 1.3 mp -75.65 125.11 34.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.797 HD22 HG23 ' A' ' 41' ' ' VAL . 2.7 mp -67.63 147.69 52.38 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.391 0.615 . . . . 0.0 110.509 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 32' ' ' MET . 50.2 t -95.08 146.78 6.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.039 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 . . . . . 0 N--CA 1.43 -1.425 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.323 -178.615 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.636 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 9.4 mtt . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 121.232 0.539 . . . . 0.0 111.564 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.771 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -98.23 123.26 50.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.894 -177.604 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.763 ' O ' ' N ' ' A' ' 38' ' ' GLY . 52.8 t -88.68 102.26 3.75 Favored Pre-proline 0 C--O 1.222 -0.379 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.489 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.7 Cg_endo -40.95 -20.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.398 2.732 . . . . 0.0 113.953 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.643 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 30.9 mm-40 -86.83 -65.52 1.01 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.571 -177.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.483 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 6.4 p -90.23 -20.47 22.96 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.771 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.29 30.29 71.62 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 113.715 -1.584 . . . . 0.0 112.437 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.737 ' CD1' HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -71.26 146.41 48.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.249 -0.475 . . . . 0.0 110.451 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 32' ' ' MET . 26.6 t -106.28 119.29 55.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 O-C-N 123.905 0.753 . . . . 0.0 109.489 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.797 HG23 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.44 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.824 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 42.9 t . . . . . 0 CA--C 1.53 0.173 0 CA-C-O 120.633 0.254 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.11 -28.49 48.72 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.389 2.06 . . . . 0.0 111.772 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -95.82 -18.18 20.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.522 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.706 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 40.1 m80 -131.31 86.18 51.23 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.329 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.31 -45.33 19.11 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 121.995 1.797 . . . . 0.0 111.309 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -72.33 -14.41 61.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.419 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -100.76 105.94 17.31 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.582 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.6 mm -81.89 128.17 38.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.564 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.871 HD21 HD11 ' A' ' 39' ' ' LEU . 3.5 mp -67.32 137.55 56.14 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.095 0.474 . . . . 0.0 110.465 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.717 ' O ' ' HA ' ' A' ' 32' ' ' MET . 43.7 t -88.18 142.28 13.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.332 0.587 . . . . 0.0 111.482 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.443 -0.805 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.09 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.717 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.66 0 CA-C-O 121.068 0.461 . . . . 0.0 111.451 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.787 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -102.71 126.24 56.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.517 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.792 ' O ' ' N ' ' A' ' 38' ' ' GLY . 41.0 t -90.18 99.96 2.27 Favored Pre-proline 0 C--O 1.22 -0.453 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.8 Cg_endo -40.24 -21.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.458 2.772 . . . . 0.0 114.097 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.706 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 31.7 mm-40 -84.52 -65.31 1.02 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.669 0.271 . . . . 0.0 111.216 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.774 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.7 p -89.82 -18.51 26.12 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.792 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.51 28.49 73.6 Favored Glycine 0 N--CA 1.433 -1.545 0 CA-C-N 113.641 -1.618 . . . . 0.0 112.074 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.871 HD11 HD21 ' A' ' 23' ' ' LEU . 1.3 pp -67.09 140.67 57.6 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.615 -0.793 . . . . 0.0 110.558 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' A' ' 32' ' ' MET . 29.3 t -110.32 118.71 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.508 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.608 HG22 ' CD1' ' A' ' 39' ' ' LEU . 1.5 t . . . . . 0 C--O 1.207 -1.183 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 11.3 t . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.523 0.202 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.3 -19.32 44.1 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.264 1.976 . . . . 0.0 111.6 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -115.09 -11.06 12.12 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.304 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.655 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . 38.6 m80 -130.96 87.31 49.26 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-O 120.624 0.249 . . . . 0.0 110.583 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.33 -36.2 88.33 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.313 2.008 . . . . 0.0 112.004 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -79.26 -31.92 43.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.005 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.655 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -75.05 88.45 2.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.058 0.456 . . . . 0.0 111.278 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.55 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.7 mp -75.2 70.12 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.201 -0.908 . . . . 0.0 112.827 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.832 HD21 HD11 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -12.22 111.25 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.536 179.481 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 25' ' ' GLU . 3.3 t -79.34 167.35 2.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.137 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.48 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.431 -1.393 0 CA-C-O 121.71 0.766 . . . . 0.0 110.229 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.657 ' O ' HD23 ' A' ' 23' ' ' LEU . 1.9 mtt . . . . . 0 C--O 1.221 -0.403 0 CA-C-O 121.402 0.62 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.851 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -99.97 123.4 52.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -176.149 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.74 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.8 t -88.56 96.28 0.65 Allowed Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.2 Cg_endo -41.84 -15.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.382 2.722 . . . . 0.0 113.743 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.646 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 18.2 mm-40 -85.1 -67.49 0.8 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.905 0.383 . . . . 0.0 111.034 -178.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.792 ' SG ' HD23 ' A' ' 39' ' ' LEU . 2.9 p -90.85 -19.56 23.25 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.851 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.18 38.72 82.99 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.149 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.832 HD11 HD21 ' A' ' 23' ' ' LEU . 1.6 pp -78.05 147.0 34.96 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.438 -0.881 . . . . 0.0 110.281 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 32' ' ' MET . 49.1 t -112.23 118.63 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 123.354 0.409 . . . . 0.0 111.945 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.692 HG22 ' CD1' ' A' ' 39' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.241 178.043 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 32.8 t . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.433 0.159 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.5 -19.97 65.54 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.259 1.973 . . . . 0.0 111.911 179.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.16 -10.88 10.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.258 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.734 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.9 m80 -130.58 87.99 48.24 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.797 0.332 . . . . 0.0 110.829 179.575 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.32 -34.75 97.84 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.306 2.004 . . . . 0.0 111.752 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.96 -25.49 37.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.385 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.623 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -84.33 83.9 7.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.158 0.504 . . . . 0.0 111.377 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' C ' ' A' ' 23' ' ' LEU . 16.1 mm -72.18 74.27 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.737 -178.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.78 HD11 HD21 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -15.37 113.52 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.439 179.511 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 32' ' ' MET . 5.0 t -81.23 160.58 3.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.271 0.558 . . . . 0.0 111.822 -178.151 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.418 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.319 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.829 -178.115 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.569 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 6.7 mtm . . . . . 0 CA--C 1.531 0.238 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.794 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -106.51 124.07 61.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.844 -178.154 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.752 ' O ' ' N ' ' A' ' 38' ' ' GLY . 40.4 t -86.83 97.04 0.59 Allowed Pre-proline 0 C--O 1.221 -0.446 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.3 Cg_endo -41.86 -15.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.378 2.719 . . . . 0.0 114.267 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.734 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 6.2 mm-40 -88.55 -64.51 1.14 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.738 0.304 . . . . 0.0 111.173 -178.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.75 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.5 p -90.94 -19.6 23.11 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.38 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.794 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 67.1 36.42 90.45 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.684 -179.397 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.78 HD21 HD11 ' A' ' 23' ' ' LEU . 1.2 pp -73.16 145.01 46.66 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.569 -0.816 . . . . 0.0 109.315 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 32' ' ' MET . 53.7 t -114.66 119.94 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 121.044 0.45 . . . . 0.0 112.08 -176.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.706 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.2 t . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.247 179.563 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB2' HD12 ' A' ' 23' ' ' LEU . 9.3 t . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.518 0.199 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.1 -18.9 39.9 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.285 1.99 . . . . 0.0 111.861 179.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -115.91 -9.46 11.8 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.266 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.738 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 36.1 m80 -131.03 88.06 46.67 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.653 0.263 . . . . 0.0 111.043 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.19 -33.24 90.87 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.433 2.089 . . . . 0.0 112.072 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.79 -23.58 27.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.504 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.745 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -84.06 82.45 8.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.289 0.566 . . . . 0.0 110.671 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.535 ' O ' ' C ' ' A' ' 23' ' ' LEU . 3.7 mt -69.42 75.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.552 -177.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.621 HD11 HD21 ' A' ' 39' ' ' LEU . 1.3 mp -18.68 109.83 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 O-C-N 123.618 0.574 . . . . 0.0 110.577 179.04 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.4 t -78.24 163.02 3.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.234 0.54 . . . . 0.0 111.959 -178.108 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.438 ' N ' HG12 ' A' ' 24' ' ' VAL . 5.7 mt-10 . . . . . 0 N--CA 1.44 -0.957 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.395 -178.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.558 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 1.3 mtt . . . . . 0 C--O 1.222 -0.387 0 CA-C-O 121.205 0.526 . . . . 0.0 111.935 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.665 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -104.03 125.96 58.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.898 0.38 . . . . 0.0 111.754 -178.87 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.813 ' O ' ' N ' ' A' ' 38' ' ' GLY . 40.5 t -85.8 97.62 0.61 Allowed Pre-proline 0 N--CA 1.447 -0.61 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.068 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 1.0 OUTLIER -41.11 -17.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.319 2.679 . . . . 0.0 113.742 -179.231 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.745 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 9.9 mm-40 -88.06 -65.48 1.01 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.672 0.273 . . . . 0.0 110.789 -178.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.662 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.0 p -90.36 -18.59 25.25 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.271 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.813 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.12 33.3 84.91 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.681 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.86 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -72.44 143.64 48.41 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.949 -0.626 . . . . 0.0 109.58 179.099 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 32' ' ' MET . 16.1 t -110.35 112.94 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 O-C-N 123.236 0.335 . . . . 0.0 111.514 -178.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.86 HG23 ' CD1' ' A' ' 39' ' ' LEU . 67.0 t . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.117 178.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.752 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 14.5 t . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.573 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 29.5 Cg_endo -62.12 -44.33 20.2 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.91 2.407 . . . . 0.0 112.716 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.526 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 94.1 m-20 -107.48 38.12 2.23 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 122.119 0.962 . . . . 0.0 108.588 178.353 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.752 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 24.7 m80 -161.9 65.13 1.84 Allowed Pre-proline 0 C--N 1.308 -1.226 0 CA-C-O 123.114 1.435 . . . . 0.0 108.93 175.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 18' ' ' HIS . 55.6 Cg_endo -70.3 13.6 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.649 3.566 . . . . 0.0 113.103 -179.244 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.58 -17.48 1.49 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 120.999 0.428 . . . . 0.0 110.033 178.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.492 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -98.21 131.02 44.91 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.435 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.614 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.3 mp -106.87 87.51 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.614 ' C ' ' O ' ' A' ' 22' ' ' ILE . 3.9 mp -15.99 105.02 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 121.037 0.446 . . . . 0.0 109.934 178.43 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 25' ' ' GLU . 2.7 t -63.53 170.85 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.174 -178.309 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.557 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.43 -1.436 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.501 -178.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.58 ' O ' HD23 ' A' ' 23' ' ' LEU . 66.3 mtm . . . . . 0 CA--C 1.53 0.176 0 CA-C-O 120.923 0.392 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.762 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -110.43 123.81 66.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.402 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.873 ' O ' ' N ' ' A' ' 38' ' ' GLY . 6.5 t -83.45 101.69 1.48 Allowed Pre-proline 0 C--O 1.215 -0.744 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.463 ' HD3' HG23 ' A' ' 24' ' ' VAL . 1.6 Cg_endo -44.24 -20.99 0.35 Allowed 'Trans proline' 0 N--CA 1.475 0.413 0 C-N-CA 122.152 1.901 . . . . 0.0 112.809 -179.333 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.636 ' HB3' ' NE2' ' A' ' 18' ' ' HIS . 29.8 mm-40 -85.03 -60.52 2.02 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.457 -178.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.916 ' SG ' HD23 ' A' ' 39' ' ' LEU . 25.6 p -93.61 -11.97 30.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.873 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 54.32 26.28 36.22 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 114.79 -1.096 . . . . 0.0 113.581 178.574 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.011 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.6 OUTLIER -71.6 157.22 38.36 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.005 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.539 ' N ' HD12 ' A' ' 39' ' ' LEU . 5.9 t -118.41 118.12 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.054 0.454 . . . . 0.0 111.936 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.011 HG23 ' CD1' ' A' ' 39' ' ' LEU . 68.1 t . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.546 178.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 49.2 t . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.51 0.195 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.73 -21.28 72.85 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.334 2.023 . . . . 0.0 112.189 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -116.96 -9.52 11.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.367 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.702 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 37.2 m80 -130.24 88.78 46.87 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.786 0.327 . . . . 0.0 110.676 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.23 -34.61 93.83 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.356 2.038 . . . . 0.0 111.891 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.86 -23.84 33.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.32 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.705 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -83.81 84.15 7.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.22 0.534 . . . . 0.0 111.197 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.522 ' O ' ' C ' ' A' ' 23' ' ' LEU . 6.3 mt -70.4 77.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.658 -1.155 . . . . 0.0 113.147 -178.205 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.662 HD11 HD21 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -20.04 106.26 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.902 179.327 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 25' ' ' GLU . 3.2 t -74.9 168.24 2.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.155 -178.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.516 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.432 -1.338 0 CA-C-O 121.996 0.903 . . . . 0.0 110.895 -178.153 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.648 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.8 mtm . . . . . 0 C--O 1.224 -0.251 0 CA-C-O 121.09 0.471 . . . . 0.0 111.638 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.713 HD13 ' N ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -104.22 123.03 57.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.121 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.745 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.0 t -87.23 96.58 0.58 Allowed Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.492 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.6 Cg_endo -42.52 -14.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.373 2.716 . . . . 0.0 114.072 -179.001 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.705 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 9.2 mm-40 -87.94 -65.19 1.04 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.66 0.266 . . . . 0.0 110.881 -178.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.646 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.5 p -91.0 -19.16 23.52 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.323 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.745 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.23 35.91 88.99 Favored Glycine 0 N--CA 1.433 -1.505 0 CA-C-N 113.87 -1.514 . . . . 0.0 111.929 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.841 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -75.51 147.82 39.46 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.75 179.192 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.648 ' HA ' ' O ' ' A' ' 32' ' ' MET . 18.6 t -114.87 113.74 44.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.841 HG23 ' CD1' ' A' ' 39' ' ' LEU . 86.0 t . . . . . 0 CA--C 1.518 -0.269 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.879 178.033 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.507 ' HB2' HD12 ' A' ' 23' ' ' LEU . 41.8 t . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.534 0.207 . . . . 0.0 110.577 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.84 -22.74 68.99 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.426 2.084 . . . . 0.0 112.656 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -115.79 -8.9 11.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.431 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.731 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.0 m80 -131.58 85.88 50.96 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.746 0.308 . . . . 0.0 110.809 179.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.05 -34.47 98.95 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.318 2.012 . . . . 0.0 111.64 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.13 -30.65 39.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.368 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -79.0 87.72 4.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.182 0.515 . . . . 0.0 111.419 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' C ' ' A' ' 23' ' ' LEU . 22.3 mm -73.24 72.98 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.734 -178.705 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.729 HD11 HD21 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -13.71 110.25 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.49 179.258 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 32' ' ' MET . 4.2 t -79.52 160.72 4.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.322 0.582 . . . . 0.0 112.181 -177.84 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.424 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.316 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.028 -177.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.55 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.53 0.198 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.805 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -109.4 126.8 66.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.781 -178.223 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.783 ' O ' ' N ' ' A' ' 38' ' ' GLY . 38.5 t -86.12 97.51 0.62 Allowed Pre-proline 0 C--O 1.22 -0.475 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.027 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -41.43 -16.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.321 2.681 . . . . 0.0 113.946 -179.141 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.731 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 2.2 mm-40 -87.82 -65.21 1.04 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.703 0.287 . . . . 0.0 111.073 -178.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.762 ' SG ' HD23 ' A' ' 39' ' ' LEU . 6.1 p -90.9 -19.68 23.06 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.479 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.805 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 66.89 34.95 88.74 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 113.86 -1.518 . . . . 0.0 111.741 -179.552 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.762 HD23 ' SG ' ' A' ' 37' ' ' CYS . 1.3 pp -71.22 145.65 49.51 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 32' ' ' MET . 86.5 t -113.54 121.99 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-O 121.209 0.528 . . . . 0.0 112.138 -176.591 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.698 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.4 t . . . . . 0 N--CA 1.45 -0.431 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.64 179.298 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 47.4 t . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.576 0.227 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.76 -21.61 73.17 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.28 1.986 . . . . 0.0 112.319 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -116.6 -9.53 11.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.348 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.738 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.1 m80 -131.48 87.19 47.39 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.775 0.322 . . . . 0.0 110.883 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.13 -34.1 94.61 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.345 2.03 . . . . 0.0 111.917 179.78 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.41 -26.76 35.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.231 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.62 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -81.52 87.62 6.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.201 0.524 . . . . 0.0 111.283 -179.882 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.569 ' O ' ' C ' ' A' ' 23' ' ' LEU . 15.3 mt -72.86 73.25 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.871 -178.556 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.663 HD11 HD21 ' A' ' 39' ' ' LEU . 1.5 mp -15.13 110.11 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.549 0.531 . . . . 0.0 110.513 179.321 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.8 t -79.09 161.58 4.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.202 0.525 . . . . 0.0 111.922 -177.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.422 ' N ' HG12 ' A' ' 24' ' ' VAL . 19.4 mm-40 . . . . . 0 N--CA 1.433 -1.277 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.733 -178.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.549 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 6.8 mtm . . . . . 0 C--O 1.227 -0.129 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.818 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -110.46 126.18 67.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.887 -178.226 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.791 ' O ' ' N ' ' A' ' 38' ' ' GLY . 42.0 t -85.7 98.07 0.67 Allowed Pre-proline 0 C--O 1.219 -0.546 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.158 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -41.61 -16.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.333 2.688 . . . . 0.0 114.05 -178.964 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.738 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 9.7 mm-40 -88.82 -64.37 1.16 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.725 0.298 . . . . 0.0 111.143 -178.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.634 ' SG ' HD23 ' A' ' 39' ' ' LEU . 5.9 p -90.62 -19.42 23.7 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.389 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.818 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 66.31 33.72 85.85 Favored Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 113.789 -1.55 . . . . 0.0 111.667 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.918 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.7 OUTLIER -69.77 143.08 53.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.954 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 32' ' ' MET . 72.9 t -109.75 114.55 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 O-C-N 123.384 0.428 . . . . 0.0 111.549 -177.777 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.918 HG23 ' CD1' ' A' ' 39' ' ' LEU . 76.0 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.467 178.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.6 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 45.9 t . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 120.577 0.227 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.51 -29.86 71.11 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.457 2.105 . . . . 0.0 111.589 179.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -93.96 -16.66 23.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.503 179.62 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.973 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 38.9 m80 -131.73 85.86 50.35 Favored Pre-proline 0 N--CA 1.453 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.337 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.85 -53.55 0.9 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.233 1.955 . . . . 0.0 111.701 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.24 -14.75 63.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.716 -179.832 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.973 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -101.09 114.01 27.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.113 0.482 . . . . 0.0 110.413 179.22 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.0 mt -91.83 127.5 44.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.823 -179.078 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.925 HD21 HD11 ' A' ' 39' ' ' LEU . 1.5 mp -59.45 102.07 0.13 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.845 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.527 HG23 ' HD3' ' A' ' 35' ' ' PRO . 3.1 t -66.48 157.17 5.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 121.293 0.568 . . . . 0.0 111.715 -178.603 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 . . . . . 0 C--N 1.317 -0.824 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.007 -179.26 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.725 ' O ' HD23 ' A' ' 23' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.095 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.895 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 1.2 tt -112.42 139.55 36.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.027 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.835 ' O ' ' N ' ' A' ' 38' ' ' GLY . 52.7 t -91.68 102.38 5.87 Favored Pre-proline 0 N--CA 1.448 -0.55 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.61 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.527 ' HD3' HG23 ' A' ' 24' ' ' VAL . 1.9 Cg_endo -40.13 -21.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.456 2.771 . . . . 0.0 113.614 -178.773 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.537 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 5.7 mm-40 -81.01 -68.25 0.7 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.743 -178.816 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.57 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.4 p -88.18 -18.68 28.19 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.548 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.835 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.66 22.39 71.67 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.089 -179.581 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.925 HD11 HD21 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -58.7 140.92 54.03 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.963 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 32' ' ' MET . 5.5 t -113.15 131.19 65.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.762 0.315 . . . . 0.0 110.586 -179.073 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.608 HG23 ' CD1' ' A' ' 39' ' ' LEU . 12.5 t . . . . . 0 N--CA 1.452 -0.361 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.273 179.375 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.504 ' HB2' HD12 ' A' ' 23' ' ' LEU . 45.5 t . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.501 0.191 . . . . 0.0 110.724 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.04 -23.83 76.08 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.52 2.147 . . . . 0.0 112.522 -179.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -117.3 -7.69 11.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.449 -179.778 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.726 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.6 m80 -131.18 85.83 52.92 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.699 0.285 . . . . 0.0 110.779 179.63 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.98 -35.5 93.02 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.271 1.981 . . . . 0.0 111.897 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -78.57 -30.73 46.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.189 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -78.63 85.63 4.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.091 0.472 . . . . 0.0 111.246 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.529 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.8 mp -71.25 75.73 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.722 -178.6 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.847 HD21 HD11 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -18.09 107.53 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.002 179.419 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -75.91 167.6 2.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.225 -178.815 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.504 ' H ' HG12 ' A' ' 24' ' ' VAL . 1.9 mm-40 . . . . . 0 N--CA 1.433 -1.298 0 CA-C-O 122.105 0.955 . . . . 0.0 111.207 -177.882 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.709 ' O ' HD23 ' A' ' 23' ' ' LEU . 52.6 mtp . . . . . 0 C--O 1.225 -0.196 0 CA-C-O 121.38 0.61 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.669 HD13 ' N ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -100.82 123.24 53.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.496 -0.775 . . . . 0.0 113.047 -176.783 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.729 ' O ' ' N ' ' A' ' 38' ' ' GLY . 52.1 t -87.71 96.2 0.58 Allowed Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.525 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.5 Cg_endo -41.89 -15.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.405 2.737 . . . . 0.0 114.077 -179.089 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.726 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 4.2 mm-40 -87.14 -65.58 1.0 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.625 0.25 . . . . 0.0 111.057 -178.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.818 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.7 p -91.1 -20.68 21.77 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.221 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.729 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 69.99 38.56 74.43 Favored Glycine 0 N--CA 1.432 -1.624 0 CA-C-N 113.76 -1.564 . . . . 0.0 111.996 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.847 HD11 HD21 ' A' ' 23' ' ' LEU . 1.6 pp -76.53 149.11 36.72 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.835 -0.683 . . . . 0.0 109.872 179.375 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 32' ' ' MET . 38.4 t -117.53 119.68 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 121.088 0.471 . . . . 0.0 112.14 -177.427 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.681 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.385 179.57 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.585 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 47.3 t . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.583 0.23 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.1 -21.96 73.2 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.316 2.011 . . . . 0.0 112.002 179.687 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -116.14 -10.16 11.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.19 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.762 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 41.9 m80 -130.61 88.43 46.79 Favored Pre-proline 0 C--O 1.232 0.18 0 CA-C-O 120.701 0.286 . . . . 0.0 110.525 178.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.78 -35.27 94.83 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.292 1.995 . . . . 0.0 111.788 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.41 -29.74 42.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.038 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.654 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -77.01 97.91 4.81 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 122.241 1.02 . . . . 0.0 111.168 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.515 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -80.84 74.94 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 112.787 -2.006 . . . . 0.0 113.698 -177.696 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.625 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.1 mp -20.85 102.71 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.768 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.4 t -71.7 166.3 2.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.15 -178.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.472 ' H ' HG12 ' A' ' 24' ' ' VAL . 6.1 mm-40 . . . . . 0 N--CA 1.433 -1.317 0 CA-C-O 121.922 0.868 . . . . 0.0 110.76 -178.192 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.559 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 6.2 mtm . . . . . 0 C--O 1.222 -0.349 0 CA-C-O 121.375 0.607 . . . . 0.0 111.569 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.758 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -102.81 121.63 54.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -176.885 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.743 ' O ' ' N ' ' A' ' 38' ' ' GLY . 25.7 t -86.79 96.84 0.57 Allowed Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.083 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.5 Cg_endo -41.79 -15.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.466 2.777 . . . . 0.0 114.069 -179.239 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.762 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 3.6 mm-40 -86.76 -65.9 0.96 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.675 0.274 . . . . 0.0 110.758 -178.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.694 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.9 p -90.71 -19.52 23.47 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.416 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.758 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 67.23 35.94 89.03 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 113.772 -1.558 . . . . 0.0 111.914 -179.728 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.906 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -74.27 150.54 40.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.762 -0.719 . . . . 0.0 109.878 179.379 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 32' ' ' MET . 23.7 t -115.87 116.11 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.825 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.906 HG23 ' CD1' ' A' ' 39' ' ' LEU . 97.6 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.931 178.256 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 36.9 t . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 120.528 0.204 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.44 -21.72 73.12 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.275 1.984 . . . . 0.0 111.995 179.452 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -115.92 -12.32 11.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.241 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.701 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 31.6 m80 -125.14 86.71 56.49 Favored Pre-proline 0 N--CA 1.455 -0.193 0 CA-C-O 120.857 0.36 . . . . 0.0 111.456 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.84 38.3 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.192 2.595 . . . . 0.0 110.805 178.432 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -150.59 -43.03 0.12 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.76 179.742 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.52 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -78.62 86.1 4.63 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.894 178.612 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.566 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.2 mp -70.06 75.69 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.339 -178.119 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.839 HD11 HD21 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -14.52 113.74 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.735 179.656 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.603 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.8 t -82.06 159.33 3.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.223 0.535 . . . . 0.0 111.84 -178.231 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.416 ' N ' HG12 ' A' ' 24' ' ' VAL . 2.4 mt-10 . . . . . 0 N--CA 1.436 -1.142 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.077 -178.073 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.603 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.243 0 CA-C-O 121.579 0.704 . . . . 0.0 112.257 . . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.888 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -105.75 125.43 61.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.148 -177.712 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.721 ' O ' ' N ' ' A' ' 38' ' ' GLY . 39.8 t -88.43 97.33 0.81 Allowed Pre-proline 0 C--O 1.221 -0.398 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 177.23 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.0 Cg_endo -42.63 -14.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.405 2.737 . . . . 0.0 114.222 -178.877 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.701 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 1.9 mm-40 -89.25 -63.82 1.23 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.623 0.249 . . . . 0.0 111.326 -178.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.775 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.1 p -90.96 -21.15 21.47 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.247 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.888 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.38 39.0 81.17 Favored Glycine 0 N--CA 1.429 -1.772 0 CA-C-N 113.511 -1.677 . . . . 0.0 111.879 -179.692 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.839 HD21 HD11 ' A' ' 23' ' ' LEU . 1.4 pp -76.54 141.82 41.06 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.481 -0.859 . . . . 0.0 109.87 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 32' ' ' MET . 26.0 t -111.0 123.6 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-O 121.068 0.461 . . . . 0.0 111.46 -177.323 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.69 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.4 t . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.396 179.778 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.498 ' HB2' HD12 ' A' ' 23' ' ' LEU . 18.1 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.596 0.236 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.41 -21.33 53.86 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.481 2.12 . . . . 0.0 112.247 179.722 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -105.03 -29.61 10.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.862 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.655 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.8 m80 -118.42 88.59 34.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.065 179.784 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.12 -31.82 94.13 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.931 1.754 . . . . 0.0 110.993 179.188 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -81.33 -36.62 29.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.371 -179.911 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.643 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . . . -71.76 91.27 1.12 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.082 0.468 . . . . 0.0 110.697 179.808 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.548 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.8 mt -79.06 69.0 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.869 -178.411 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.697 HD21 ' HG ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -12.27 123.44 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.229 179.43 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 32' ' ' MET . 21.2 t -85.94 157.47 3.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-O 121.413 0.625 . . . . 0.0 112.361 -178.022 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.433 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.007 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.009 -178.892 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.689 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 20.8 mtm . . . . . 0 N--CA 1.441 -0.885 0 CA-C-O 121.43 0.633 . . . . 0.0 111.39 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.786 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -100.46 126.2 54.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.049 -177.481 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.84 ' O ' ' N ' ' A' ' 38' ' ' GLY . 7.0 t -86.85 99.73 1.24 Allowed Pre-proline 0 C--O 1.216 -0.671 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.527 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.0 Cg_endo -40.27 -20.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.19 2.594 . . . . 0.0 113.542 -179.351 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.655 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 14.8 mm-40 -89.78 -63.13 1.33 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.332 -178.569 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.965 ' SG ' HD23 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -89.44 -18.84 25.98 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 177.729 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.84 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 63.42 28.57 72.57 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 114.112 -1.403 . . . . 0.0 111.783 -179.551 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.965 HD23 ' SG ' ' A' ' 37' ' ' CYS . 1.3 pp -71.36 148.59 46.86 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.774 -0.713 . . . . 0.0 109.908 179.317 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 32' ' ' MET . 35.0 t -110.09 118.19 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 O-C-N 123.445 0.466 . . . . 0.0 110.983 -179.386 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.917 HG23 ' CD1' ' A' ' 39' ' ' LEU . 54.8 t . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 121.236 0.541 . . . . 0.0 111.238 179.892 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 11.3 t . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.604 0.24 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.98 -19.67 45.61 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.264 1.976 . . . . 0.0 111.516 178.837 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -112.56 -11.58 13.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.133 179.878 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.664 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 31.6 m80 -131.79 84.72 53.56 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-O 120.619 0.247 . . . . 0.0 111.455 179.838 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.57 -41.68 62.07 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.979 1.786 . . . . 0.0 110.773 178.832 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.54 -8.83 57.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.574 179.975 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -100.99 109.04 20.91 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.734 0.778 . . . . 0.0 110.856 179.187 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.598 ' N ' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -90.98 66.24 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 114.024 -1.444 . . . . 0.0 113.422 -177.632 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.599 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 2.7 mp -10.9 115.29 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.445 179.038 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 32' ' ' MET . 16.2 t -82.39 154.88 3.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.435 0.636 . . . . 0.0 112.708 -177.518 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.404 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.718 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.989 -178.584 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.679 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 15.7 mtp . . . . . 0 N--CA 1.446 -0.629 0 CA-C-O 121.574 0.702 . . . . 0.0 111.929 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.911 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -101.41 128.22 53.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.55 -177.198 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.794 ' O ' ' N ' ' A' ' 38' ' ' GLY . 45.0 t -83.22 99.43 0.69 Allowed Pre-proline 0 N--CA 1.448 -0.541 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.522 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.0 Cg_endo -39.9 -20.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.281 2.654 . . . . 0.0 113.742 -179.464 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.664 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 5.3 mm-40 -87.9 -64.9 1.08 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.592 -178.262 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.488 ' SG ' HD23 ' A' ' 39' ' ' LEU . 7.0 p -89.84 -20.02 23.94 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.788 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.911 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 67.25 32.0 78.77 Favored Glycine 0 N--CA 1.431 -1.657 0 CA-C-N 113.652 -1.613 . . . . 0.0 112.754 179.406 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.892 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -71.12 155.33 40.89 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.725 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 32' ' ' MET . 4.1 t -118.34 120.28 63.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 O-C-N 123.309 0.381 . . . . 0.0 111.595 -178.35 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.795 HG23 ' CD1' ' A' ' 39' ' ' LEU . 53.1 t . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.714 178.916 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 13.3 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.492 0.187 . . . . 0.0 110.804 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -68.38 -18.38 44.1 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.115 1.877 . . . . 0.0 111.95 179.256 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.35 -8.1 11.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.336 179.929 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.677 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 37.9 m80 -130.95 88.35 46.05 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 120.693 0.282 . . . . 0.0 110.529 179.216 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.78 -35.02 90.78 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.408 2.072 . . . . 0.0 112.082 179.875 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.39 -28.25 31.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.308 -179.747 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.665 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -78.12 87.73 4.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.23 0.538 . . . . 0.0 111.057 -179.881 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.55 ' O ' ' C ' ' A' ' 23' ' ' LEU . 14.3 mt -72.09 73.9 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.091 -178.347 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.602 HD11 HD21 ' A' ' 39' ' ' LEU . 2.2 mp -17.78 109.14 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.709 179.333 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.5 t -76.57 165.67 3.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.564 -178.512 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.462 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.236 0 CA-C-O 121.941 0.877 . . . . 0.0 110.968 -177.874 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.56 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.584 0.707 . . . . 0.0 111.733 . . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.659 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -103.63 123.7 57.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.621 -176.817 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.766 ' O ' ' N ' ' A' ' 38' ' ' GLY . 47.9 t -86.87 96.81 0.57 Allowed Pre-proline 0 N--CA 1.445 -0.687 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.898 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.2 Cg_endo -41.91 -15.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.28 2.654 . . . . 0.0 113.695 -179.278 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.677 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 13.1 mm-40 -86.3 -66.83 0.86 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.76 0.314 . . . . 0.0 110.845 -179.155 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.599 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.7 p -90.93 -19.86 22.83 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.429 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.766 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.68 36.24 87.26 Favored Glycine 0 N--CA 1.432 -1.626 0 CA-C-N 114.011 -1.45 . . . . 0.0 111.81 -179.737 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.835 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -75.5 148.84 38.66 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.884 -0.658 . . . . 0.0 109.772 179.229 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 32' ' ' MET . 37.0 t -111.74 115.7 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 123.295 0.372 . . . . 0.0 111.926 -178.39 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.835 HG23 ' CD1' ' A' ' 39' ' ' LEU . 54.4 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.253 178.551 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.553 ' CB ' ' HG ' ' A' ' 34' ' ' CYS . 39.1 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.581 0.229 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.46 -19.89 54.73 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.379 2.053 . . . . 0.0 112.248 179.643 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -115.16 -10.25 12.18 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.411 -179.974 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.734 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.5 m80 -130.83 87.81 48.07 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.757 0.313 . . . . 0.0 110.663 179.508 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.84 -34.51 95.57 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.269 1.979 . . . . 0.0 111.812 179.789 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.44 -27.09 38.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.287 -179.892 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.602 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -82.85 85.14 7.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.146 0.498 . . . . 0.0 111.296 -179.78 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.2 mp -70.4 74.92 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.856 -1.066 . . . . 0.0 112.768 -178.69 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.721 HD11 HD21 ' A' ' 39' ' ' LEU . 1.1 mp -16.98 109.58 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.535 179.386 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.5 t -78.07 162.8 3.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.157 0.503 . . . . 0.0 111.758 -178.249 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.429 ' N ' HG12 ' A' ' 24' ' ' VAL . 3.0 mm-40 . . . . . 0 N--CA 1.434 -1.259 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.579 -178.303 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.547 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 9.4 mtm . . . . . 0 C--O 1.225 -0.194 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.827 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -107.56 125.43 63.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.301 -177.876 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.743 ' O ' ' N ' ' A' ' 38' ' ' GLY . 34.8 t -87.13 97.06 0.62 Allowed Pre-proline 0 C--O 1.222 -0.395 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.863 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.5 Cg_endo -41.9 -15.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.384 2.722 . . . . 0.0 114.244 -179.084 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.734 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 2.3 mm-40 -88.74 -64.38 1.15 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.697 0.284 . . . . 0.0 111.133 -178.787 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.644 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.1 p -90.84 -18.96 23.95 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.322 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.827 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 66.28 35.86 90.91 Favored Glycine 0 N--CA 1.431 -1.682 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.771 -179.374 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.898 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -72.97 144.45 47.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.621 -0.79 . . . . 0.0 109.49 179.378 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.9 t -112.53 116.0 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-O 121.027 0.441 . . . . 0.0 111.779 -178.001 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.898 HG23 ' CD1' ' A' ' 39' ' ' LEU . 97.0 t . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.788 177.96 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.587 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 45.4 t . . . . . 0 C--O 1.231 0.091 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.89 -22.32 68.02 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.177 1.918 . . . . 0.0 111.954 179.197 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.19 -9.09 10.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.345 179.995 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.711 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . 38.5 m80 -129.89 89.1 46.96 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.736 0.303 . . . . 0.0 110.937 179.238 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.46 -37.23 90.71 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.241 1.961 . . . . 0.0 111.791 179.632 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.54 -32.96 36.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.548 -179.695 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.797 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -71.45 89.46 0.94 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.169 0.509 . . . . 0.0 111.004 -179.85 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.511 ' O ' ' C ' ' A' ' 23' ' ' LEU . 9.8 mm -70.64 78.95 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.958 -177.757 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.631 HD11 HD21 ' A' ' 39' ' ' LEU . 2.2 mp -26.93 107.23 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.173 0.511 . . . . 0.0 110.242 178.913 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -75.34 164.16 3.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.887 -178.283 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.441 ' N ' HG12 ' A' ' 24' ' ' VAL . 1.7 mm-40 . . . . . 0 N--CA 1.441 -0.889 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.633 -179.29 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.582 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 5.6 mtm . . . . . 0 N--CA 1.446 -0.643 0 CA-C-O 121.682 0.753 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.76 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -100.78 124.09 54.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.565 -176.588 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.74 ' O ' ' N ' ' A' ' 38' ' ' GLY . 47.2 t -85.73 97.85 0.64 Allowed Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.366 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 3.9 Cg_endo -45.61 -12.76 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.844 2.363 . . . . 0.0 113.628 -179.112 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.797 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 4.8 mm-40 -88.81 -63.98 1.21 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.66 0.266 . . . . 0.0 111.204 -179.413 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.691 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.7 p -91.45 -22.59 20.35 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.398 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.76 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 70.4 41.63 66.86 Favored Glycine 0 N--CA 1.43 -1.74 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.033 -179.964 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.924 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -81.91 152.97 26.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.65 -0.775 . . . . 0.0 109.992 179.819 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 32' ' ' MET . 66.1 t -117.1 116.63 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.701 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.924 HG23 ' CD1' ' A' ' 39' ' ' LEU . 95.5 t . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.767 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.909 0.385 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.7 m -99.44 38.17 1.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.959 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.34 -31.94 13.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.913 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.54 138.99 49.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.34 -71.14 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.78 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.635 ' HB2' HG11 ' A' ' 48' ' ' VAL . 15.4 mt -158.1 -71.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.718 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 52.8 25.85 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.123 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -100.82 143.38 31.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.032 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.48 163.94 16.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.749 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.56 -173.57 0.3 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.559 2.173 . . . . 0.0 112.207 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.33 139.21 37.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.525 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 13' ' ' VAL . 8.4 p -47.33 96.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.182 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.5 p 55.46 -173.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.19 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 35.2 t -70.33 136.96 86.44 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.838 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.49 -20.98 70.74 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.116 1.877 . . . . 0.0 111.905 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -116.79 -11.14 10.95 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.176 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.749 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 33.8 m80 -131.07 87.33 48.75 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.858 0.361 . . . . 0.0 110.603 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.93 -34.75 95.07 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.305 2.003 . . . . 0.0 111.903 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -79.4 -26.81 41.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.215 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -82.86 95.86 8.06 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 122.603 1.192 . . . . 0.0 111.599 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.535 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.89 72.61 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 112.228 -2.26 . . . . 0.0 112.956 -178.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.615 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.9 mp -19.71 108.75 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.88 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -77.0 165.81 2.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.182 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.467 ' H ' HG12 ' A' ' 24' ' ' VAL . 8.2 mt-10 -83.02 137.1 34.27 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.818 0.818 . . . . 0.0 110.105 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.592 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 0.1 OUTLIER 62.33 89.86 0.08 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 178.357 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.683 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 1.0 OUTLIER -61.56 98.62 0.09 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.652 177.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.638 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.1 OUTLIER 49.47 38.48 14.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.955 0.407 . . . . 0.0 110.044 -179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 91.53 35.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.487 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -134.11 -124.67 2.5 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.761 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 27' ' ' TYR . 0.8 OUTLIER -95.03 -144.33 0.26 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.467 0.175 . . . . 0.0 111.139 -179.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.607 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 29.0 mtt -89.52 118.53 29.23 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 121.428 0.633 . . . . 0.0 111.57 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.692 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -105.03 123.52 59.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.988 -176.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.749 ' O ' ' N ' ' A' ' 38' ' ' GLY . 37.9 t -87.81 96.5 0.62 Allowed Pre-proline 0 N--CA 1.45 -0.461 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.5 Cg_endo -42.4 -14.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 123.304 2.669 . . . . 0.0 114.08 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.749 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 1.1 mm-40 -89.7 -63.75 1.24 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.576 0.227 . . . . 0.0 111.06 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.542 ' SG ' HD23 ' A' ' 39' ' ' LEU . 8.4 p -90.54 -20.44 22.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.749 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 68.39 33.76 78.14 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.314 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.774 ' CD1' HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -74.33 143.89 44.73 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 32' ' ' MET . 32.9 t -109.68 111.36 35.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.862 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.774 HG22 ' CD1' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -111.3 134.78 52.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.606 0.241 . . . . 0.0 110.431 179.274 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.84 160.21 10.81 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.55 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -173.85 110.31 0.16 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.624 -0.288 . . . . 0.0 110.269 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? 60.91 92.35 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.853 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.422 ' O ' ' CG1' ' A' ' 46' ' ' ILE . 19.6 t -103.46 -28.52 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.127 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.422 ' CG1' ' O ' ' A' ' 45' ' ' VAL . 39.4 pt 44.03 29.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.743 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 t0 54.08 101.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.178 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.635 HG11 ' HB2' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -105.18 -172.67 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.04 -95.9 2.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.534 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.9 t 60.36 98.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.774 0.321 . . . . 0.0 110.941 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.48 16.79 2.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.251 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 8.3 m0 61.88 -81.48 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.021 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 57.06 70.8 0.62 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.954 0.407 . . . . 0.0 110.991 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -141.68 -170.47 3.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.435 ' H ' HG22 ' A' ' 54' ' ' THR . 18.7 p90 -121.62 125.03 45.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.887 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.7 m 63.54 139.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.954 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -119.39 165.15 14.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.23 -45.42 2.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.805 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.879 -179.944 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.746 0.308 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.99 -33.73 21.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.847 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.9 p -65.57 -42.29 91.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.2 174.08 6.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -87.43 -74.57 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.019 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.6 mt -177.09 161.45 1.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.831 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -88.78 112.48 23.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.77 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -158.89 105.91 1.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.265 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.435 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 1.4 mt -175.51 -61.95 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.795 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.435 ' HD3' ' CB ' ' A' ' 10' ' ' LEU . 95.7 Cg_endo -79.39 165.29 23.36 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.437 2.091 . . . . 0.0 112.139 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.83 143.55 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.964 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.57 ' O ' HG12 ' A' ' 13' ' ' VAL . 14.4 t -99.2 30.18 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -164.44 169.11 17.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.825 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 16.7 t -78.23 134.91 62.42 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.897 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.06 -18.94 63.17 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.068 1.845 . . . . 0.0 112.03 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -117.53 -9.32 10.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.35 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.683 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . 37.7 m80 -130.76 88.34 46.62 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-O 120.755 0.312 . . . . 0.0 110.437 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.67 -34.41 92.14 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.414 2.076 . . . . 0.0 112.03 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.25 -26.01 31.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.395 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.683 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -80.32 87.87 5.57 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.242 0.544 . . . . 0.0 111.255 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.535 ' O ' ' C ' ' A' ' 23' ' ' LEU . 13.6 mm -72.29 75.19 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.353 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.599 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 2.0 mp -20.5 107.47 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.556 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -74.94 167.95 2.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.181 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.512 ' H ' HG12 ' A' ' 24' ' ' VAL . 1.0 OUTLIER -84.26 138.56 32.87 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 122.051 0.929 . . . . 0.0 110.648 -178.185 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 0.1 OUTLIER 57.55 93.38 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.958 -1.473 . . . . 0.0 114.48 178.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.622 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -65.64 104.44 1.03 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.629 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 45.76 36.09 2.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.932 0.396 . . . . 0.0 110.193 -179.267 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 93.27 38.47 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.587 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -134.81 -126.49 2.63 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.617 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 1.1 m-20 -94.98 -144.14 0.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.616 0.246 . . . . 0.0 110.981 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.561 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 8.2 mtt -86.23 116.9 24.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.403 0.62 . . . . 0.0 111.597 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.603 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -103.68 121.3 54.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.826 -177.127 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.762 ' O ' ' N ' ' A' ' 38' ' ' GLY . 49.7 t -86.57 97.02 0.57 Allowed Pre-proline 0 N--CA 1.446 -0.635 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.2 Cg_endo -41.77 -15.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.343 2.695 . . . . 0.0 113.853 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.68 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 10.5 mm-40 -86.29 -66.89 0.85 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.8 0.333 . . . . 0.0 110.807 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.577 ' SG ' HD23 ' A' ' 39' ' ' LEU . 2.9 p -90.7 -18.7 24.59 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.762 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.24 35.18 90.0 Favored Glycine 0 N--CA 1.433 -1.551 0 CA-C-N 114.119 -1.401 . . . . 0.0 111.627 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.855 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -74.27 148.44 41.46 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.894 -0.653 . . . . 0.0 109.638 179.38 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 32' ' ' MET . 48.5 t -112.29 113.75 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 120.887 0.375 . . . . 0.0 111.847 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.855 HG23 ' CD1' ' A' ' 39' ' ' LEU . 55.5 t -119.32 135.66 58.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.063 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.54 164.76 11.38 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.641 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.726 ' O ' HG13 ' A' ' 45' ' ' VAL . 23.8 t70 -175.85 -82.34 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.722 0.296 . . . . 0.0 110.48 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 46.22 29.03 0.75 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.773 0.32 . . . . 0.0 111.394 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.726 HG13 ' O ' ' A' ' 43' ' ' ASP . 27.4 m -116.2 -17.35 7.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.559 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.627 HG23 ' O ' ' A' ' 46' ' ' ILE . 16.8 tt -54.02 98.19 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.879 0.371 . . . . 0.0 111.244 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 62.02 146.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.983 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 49' ' ' GLY . 15.1 t -116.33 161.52 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.959 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.495 ' N ' HG12 ' A' ' 48' ' ' VAL . . . -47.43 98.38 0.01 OUTLIER Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.636 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.47 61.2 2.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.921 0.391 . . . . 0.0 111.146 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.1 75.34 9.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.557 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 2.4 t90 76.16 -57.77 0.55 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.019 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.86 81.31 0.12 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.945 0.402 . . . . 0.0 110.813 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.5 m -144.28 111.68 6.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.847 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -107.41 104.43 14.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m 62.14 118.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.978 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -83.52 119.05 24.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -98.12 -68.32 0.81 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.975 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.798 0.333 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.1 m -102.45 73.88 1.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.936 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.41 -30.28 7.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.971 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.4 -175.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.989 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.404 ' HB3' HD12 ' A' ' 7' ' ' LEU . 4.4 mtp85 -104.25 -75.58 0.62 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.404 HD12 ' HB3' ' A' ' 6' ' ' ARG . 2.0 mp -113.1 112.93 24.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.055 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -113.92 63.25 0.66 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.724 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.96 58.9 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.335 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.703 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 3.0 pp -115.37 17.5 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.703 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 65.2 Cg_endo -83.35 -36.47 0.21 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 121.876 1.717 . . . . 0.0 112.646 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.17 26.18 10.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.619 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.481 HG11 ' CE ' ' A' ' 32' ' ' MET . 63.8 t -92.7 144.55 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.739 0.304 . . . . 0.0 110.884 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.64 165.72 32.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.028 0.442 . . . . 0.0 111.094 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 14.5 t -72.49 135.99 81.27 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.91 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.87 -18.02 61.13 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.276 1.984 . . . . 0.0 112.304 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.07 -13.6 9.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.045 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.742 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 35.4 m80 -127.27 88.51 53.9 Favored Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.898 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.96 -40.12 55.16 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.417 2.078 . . . . 0.0 112.082 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -75.8 -35.4 60.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.346 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.783 ' HB2' ' HG2' ' A' ' 36' ' ' GLU . . . -75.85 79.64 2.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.234 0.54 . . . . 0.0 110.974 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.581 ' O ' ' C ' ' A' ' 23' ' ' LEU . 12.3 mt -69.88 72.44 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.918 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.817 HD11 HD21 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -7.61 110.77 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.73 179.163 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 32' ' ' MET . 14.2 t -83.3 155.86 3.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.514 0.673 . . . . 0.0 112.669 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.428 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -71.44 123.77 23.12 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.903 -178.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.614 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 2.8 m-20 80.42 -151.55 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.499 -1.228 . . . . 0.0 113.213 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.505 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 3.2 t80 89.02 114.48 0.03 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.254 0.55 . . . . 0.0 110.379 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.431 ' HD3' ' CD2' ' A' ' 27' ' ' TYR . 0.6 OUTLIER 70.95 -87.08 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.489 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.82 -82.5 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.767 0.318 . . . . 0.0 111.175 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.614 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -178.32 -38.65 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.797 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 2.7 p30 -74.86 -157.36 0.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.567 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 44.1 mtm -73.8 157.53 36.24 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.773 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -141.7 130.9 23.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.494 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.791 ' O ' ' N ' ' A' ' 38' ' ' GLY . 18.0 t -88.97 97.58 0.93 Allowed Pre-proline 0 C--O 1.217 -0.637 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 2.7 Cg_endo -44.27 -14.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.921 2.414 . . . . 0.0 113.417 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.783 ' HG2' ' HB2' ' A' ' 21' ' ' ALA . 8.2 mm-40 -86.72 -65.14 1.05 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.567 0.222 . . . . 0.0 110.784 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.571 ' SG ' HD23 ' A' ' 39' ' ' LEU . 2.5 p -91.8 -24.7 19.31 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.791 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 74.1 41.19 40.39 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 113.395 -1.73 . . . . 0.0 112.103 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.817 HD21 HD11 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -79.14 146.5 33.13 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.928 -0.636 . . . . 0.0 109.534 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 32' ' ' MET . 95.9 t -111.94 122.75 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 O-C-N 123.532 0.52 . . . . 0.0 111.736 -177.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.734 HG23 ' CD1' ' A' ' 39' ' ' LEU . 22.4 t -130.66 127.67 62.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.797 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.515 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 119.95 -159.27 15.04 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.848 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.509 ' N ' ' HB3' ' A' ' 31' ' ' ASP . 5.1 t70 77.51 130.62 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.04 0.447 . . . . 0.0 111.129 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.87 -169.63 1.98 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.793 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.528 ' O ' HG22 ' A' ' 45' ' ' VAL . 11.0 p -172.55 54.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.04 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 47' ' ' ASP . 18.4 tt -112.35 -44.99 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.166 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.489 ' N ' HG23 ' A' ' 46' ' ' ILE . 0.9 OUTLIER 57.95 81.33 0.15 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.953 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 48' ' ' VAL . 12.6 m -85.55 82.12 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.064 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.13 -98.65 0.25 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.449 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.4 t 60.73 31.32 20.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.792 0.33 . . . . 0.0 110.881 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -129.83 49.89 2.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.841 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.6 m0 62.53 -80.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.952 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.75 103.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 0.0 111.013 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.467 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -149.18 174.33 12.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.976 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.467 ' H ' HG22 ' A' ' 54' ' ' THR . 18.6 p90 -95.86 8.7 42.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.363 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 54.86 175.86 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.84 0.352 . . . . 0.0 111.089 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -121.12 -173.11 2.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -78.82 -57.85 3.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.819 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.902 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.724 0.297 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.8 m -89.79 53.23 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.909 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.9 40.45 3.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.85 123.13 41.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.65 -63.15 1.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.9 mt -175.23 77.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.93 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.29 120.75 24.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.783 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 60.66 -168.0 0.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.998 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.461 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . 6.2 mt -166.83 -64.86 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.461 ' CD ' ' CB ' ' A' ' 10' ' ' LEU . 19.1 Cg_endo -58.22 -168.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.511 2.141 . . . . 0.0 112.227 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.27 -177.59 4.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.798 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 13' ' ' VAL . 14.4 p -132.26 23.46 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.33 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.87 170.08 14.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.972 0.415 . . . . 0.0 110.967 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB2' HD12 ' A' ' 23' ' ' LEU . 38.5 t -72.47 135.68 81.45 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.642 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.49 -20.35 65.87 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.349 2.033 . . . . 0.0 112.405 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -114.75 -12.02 12.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.241 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.739 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.9 m80 -130.46 87.95 48.72 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 120.688 0.28 . . . . 0.0 110.565 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.56 -36.75 92.01 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.328 2.018 . . . . 0.0 111.785 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.28 -33.09 55.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.233 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -76.19 88.11 3.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.098 0.475 . . . . 0.0 111.307 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.568 ' O ' ' C ' ' A' ' 23' ' ' LEU . 9.9 mt -74.49 71.22 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.807 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.691 HD11 HD21 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -12.33 107.35 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.666 0.604 . . . . 0.0 110.886 179.419 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -77.86 164.42 3.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.171 0.51 . . . . 0.0 111.406 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.46 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 4.0 mm-40 -78.18 127.7 32.66 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.746 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.642 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.8 OUTLIER 89.72 -165.56 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.615 179.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.824 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 16.1 t80 164.08 74.99 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.597 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 5.0 mmp_? 59.32 41.21 20.19 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -178.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 84.42 41.8 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.8 -178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -127.42 -153.87 8.33 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.499 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.831 ' CG ' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -95.31 -124.21 0.11 Allowed 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 122.576 0.35 . . . . 0.0 111.614 -179.432 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.854 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 28.1 mtp -96.1 116.06 28.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 118.789 0.722 . . . . 0.0 112.194 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.857 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -101.49 123.41 54.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.762 -177.018 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.729 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.1 t -87.47 97.05 0.65 Allowed Pre-proline 0 N--CA 1.449 -0.495 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -40.78 -16.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.379 2.719 . . . . 0.0 114.149 -179.228 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.739 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 13.5 mm-40 -87.83 -64.81 1.09 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.634 0.254 . . . . 0.0 111.307 -178.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.684 ' SG ' HD23 ' A' ' 39' ' ' LEU . 5.7 p -90.37 -20.6 22.66 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.857 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.49 36.64 77.54 Favored Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 113.572 -1.649 . . . . 0.0 112.52 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.792 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -79.75 150.42 30.82 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.588 -0.806 . . . . 0.0 110.405 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.854 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.1 t -119.56 121.37 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-O 121.275 0.56 . . . . 0.0 112.429 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.792 HG23 ' CD1' ' A' ' 39' ' ' LEU . 87.3 t -125.71 132.04 71.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.01 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.55 166.05 11.41 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.543 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.15 -71.86 0.54 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.914 0.388 . . . . 0.0 110.578 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 169.68 -71.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.912 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 45' ' ' VAL . 11.1 p -120.52 116.32 49.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.244 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.691 HG23 ' N ' ' A' ' 47' ' ' ASP . 0.3 OUTLIER -73.12 -157.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.391 179.612 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.691 ' N ' HG23 ' A' ' 46' ' ' ILE . 11.1 m-20 -46.35 -53.91 9.99 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 120.745 0.307 . . . . 0.0 111.217 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 48' ' ' VAL . 11.1 p 43.62 33.26 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.69 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -120.6 159.23 15.4 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.538 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 63.04 -159.79 0.31 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.656 0.265 . . . . 0.0 110.771 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.27 -77.37 0.05 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.098 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -165.34 -58.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.996 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.71 36.59 8.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.76 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.55 161.29 19.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -124.75 38.38 4.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.013 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 m 60.26 172.92 0.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -96.43 168.67 10.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -74.81 -64.9 0.94 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.897 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.771 0.32 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 m -98.59 30.18 3.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.95 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.4 p -121.42 -42.89 2.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -94.32 -175.49 3.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.939 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.568 ' HB3' HD12 ' A' ' 7' ' ' LEU . 6.8 mtp85 -128.54 -69.02 0.73 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.822 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.568 HD12 ' HB3' ' A' ' 6' ' ' ARG . 4.9 mp -142.66 -179.55 6.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -142.16 30.05 1.61 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.914 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.95 135.68 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.659 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -133.85 -61.22 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.359 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.659 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 52.4 Cg_endo -68.43 64.42 1.14 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.031 1.821 . . . . 0.0 112.515 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.569 ' O ' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -85.13 110.26 18.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.552 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 12' ' ' ARG . 0.4 OUTLIER 75.52 164.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.623 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.798 HG22 HG23 ' A' ' 22' ' ' ILE . 52.3 p -90.07 -145.64 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.541 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 15.0 t -71.63 136.07 83.43 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.421 0.153 . . . . 0.0 110.778 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.1 -25.37 79.66 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.286 1.991 . . . . 0.0 111.961 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -108.48 -30.29 8.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.675 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.712 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 38.3 m80 -113.32 81.64 5.24 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.436 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.11 -33.48 97.44 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.03 1.82 . . . . 0.0 110.935 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -73.01 -42.39 63.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.285 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.579 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -74.97 87.52 2.33 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.11 0.481 . . . . 0.0 110.979 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.798 HG23 HG22 ' A' ' 14' ' ' THR . 1.3 mp -68.93 74.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.713 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.72 HD22 HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -14.64 112.7 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.37 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.1 t -81.18 163.24 3.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.254 0.55 . . . . 0.0 111.222 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -78.67 133.42 37.22 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.852 -178.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.658 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER 81.99 -157.94 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.056 178.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.58 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 45.9 t80 129.06 -84.48 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.908 0.883 . . . . 0.0 110.751 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.428 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -102.94 -62.36 1.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.576 ' HB3' ' OD1' ' A' ' 31' ' ' ASP . . . -106.95 28.72 7.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.811 0.339 . . . . 0.0 111.773 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.478 ' HA2' ' CG ' ' A' ' 26' ' ' ASP . . . 69.23 21.96 75.96 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.092 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.658 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -103.66 -161.77 0.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.794 0.33 . . . . 0.0 110.666 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 35.3 mtp -91.29 119.23 31.17 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-O 121.662 0.744 . . . . 0.0 112.39 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.851 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -104.17 126.08 58.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.89 -177.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.752 ' O ' ' N ' ' A' ' 38' ' ' GLY . 42.1 t -91.16 98.82 1.83 Allowed Pre-proline 0 C--O 1.219 -0.545 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.3 Cg_endo -43.44 -14.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.216 2.611 . . . . 0.0 113.881 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.712 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 2.9 mm-40 -87.92 -64.69 1.11 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.759 0.314 . . . . 0.0 111.08 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.46 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 3.3 p -91.19 -21.3 21.2 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.851 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.67 38.76 77.95 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 113.645 -1.616 . . . . 0.0 111.739 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.977 HD11 HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -80.03 144.06 33.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.7 -0.75 . . . . 0.0 110.726 -179.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 32' ' ' MET . 47.4 t -104.89 112.84 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.016 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.977 HG22 HD11 ' A' ' 39' ' ' LEU . 0.6 OUTLIER -109.02 133.46 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.901 0.382 . . . . 0.0 110.868 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.91 155.48 18.74 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.415 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 176.45 -172.75 0.09 Allowed 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.8 mtt85 54.06 104.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.267 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -93.75 168.83 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.094 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.5 pt -121.17 146.55 25.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.185 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -118.02 27.84 8.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.93 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.531 HG22 ' H ' ' A' ' 49' ' ' GLY . 0.3 OUTLIER 49.62 179.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.692 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.531 ' H ' HG22 ' A' ' 48' ' ' VAL . . . -131.06 61.75 0.66 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.437 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.9 t 61.32 65.56 0.96 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.79 0.328 . . . . 0.0 110.861 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -88.03 5.64 39.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.376 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 40.4 m95 61.75 -82.3 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.986 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 55.26 97.32 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.062 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.9 m -140.99 138.36 33.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 19.0 p90 -62.93 82.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.8 m 59.49 161.84 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -106.65 132.25 52.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.73 -40.42 8.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.908 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.802 0.334 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.494 ' O ' HG23 ' A' ' 4' ' ' THR . 58.3 m -98.82 31.58 2.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.893 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 3' ' ' SER . 7.7 p -158.75 35.88 0.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.73 -176.3 4.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.001 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.4 mtp85 -93.12 -161.85 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.654 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.6 mp -47.28 120.02 2.95 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.832 0.349 . . . . 0.0 111.139 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.16 -33.52 15.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.39 10.49 29.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.51 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mp 58.77 162.34 0.09 OUTLIER Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.729 0.299 . . . . 0.0 110.977 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.94 86.7 1.22 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.544 2.163 . . . . 0.0 112.098 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.3 mtm105 60.65 -176.58 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.612 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.516 HG23 ' N ' ' A' ' 14' ' ' THR . 28.0 m -104.7 -48.85 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.255 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.684 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -95.51 -153.31 0.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.717 0.294 . . . . 0.0 110.654 -179.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.652 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 47.4 t -70.05 142.23 90.13 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.442 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 14.3 Cg_endo -56.12 -28.33 69.67 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.468 2.112 . . . . 0.0 111.865 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.41 -6.19 10.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.602 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.706 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . 39.4 m80 -128.62 88.63 51.65 Favored Pre-proline 0 C--O 1.231 0.121 0 CA-C-O 120.668 0.27 . . . . 0.0 111.265 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.551 ' O ' HG21 ' A' ' 14' ' ' THR . 23.3 Cg_endo -61.58 -32.82 87.83 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.3 2.0 . . . . 0.0 112.008 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.53 -19.41 29.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.423 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.752 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -85.3 83.33 8.01 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.198 0.523 . . . . 0.0 110.834 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.684 ' HA ' HG23 ' A' ' 14' ' ' THR . 5.4 mm -63.44 83.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.019 -1.446 . . . . 0.0 113.869 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.854 HD21 HD11 ' A' ' 39' ' ' LEU . 1.9 mp -34.02 111.87 0.12 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 32' ' ' MET . 2.8 t -73.5 163.33 4.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 121.344 0.592 . . . . 0.0 110.953 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.577 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -89.18 89.33 7.89 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.873 -178.622 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 25' ' ' GLU . 7.6 m-20 111.65 99.67 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 O-C-N 124.529 1.143 . . . . 0.0 113.676 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.6 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -72.2 105.81 4.15 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.424 178.277 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.628 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 47.74 34.89 4.08 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 90.93 40.17 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.189 -178.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -133.8 -120.18 2.06 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.913 -0.661 . . . . 0.0 113.014 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -100.32 -153.58 0.45 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.643 0.259 . . . . 0.0 111.088 -179.203 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.602 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER -75.82 111.43 11.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.252 0.549 . . . . 0.0 111.827 -178.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.619 HG23 ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -102.76 119.18 50.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.756 ' O ' ' N ' ' A' ' 38' ' ' GLY . 35.9 t -85.79 97.14 0.53 Allowed Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 5.0 Cg_endo -44.97 -11.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.011 2.474 . . . . 0.0 113.951 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.752 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 5.5 mm-40 -89.93 -63.56 1.26 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 121.115 -0.234 . . . . 0.0 110.725 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.761 ' SG ' HD23 ' A' ' 39' ' ' LEU . 2.7 p -91.95 -20.25 21.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 176.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.756 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.49 40.11 91.12 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 114.068 -1.424 . . . . 0.0 111.208 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.854 HD11 HD21 ' A' ' 23' ' ' LEU . 1.4 pp -79.12 149.73 31.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.378 -0.911 . . . . 0.0 109.758 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 32' ' ' MET . 44.8 t -115.08 110.46 32.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.782 HG23 HD11 ' A' ' 39' ' ' LEU . 22.9 t -106.08 138.34 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.917 0.389 . . . . 0.0 111.393 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.27 93.89 2.19 Favored Glycine 0 CA--C 1.497 -1.076 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.484 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -123.89 106.95 10.86 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.87 147.9 17.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.923 0.392 . . . . 0.0 110.847 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.604 ' O ' HG22 ' A' ' 45' ' ' VAL . 13.7 p -179.65 42.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.946 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.421 HG22 ' OD2' ' A' ' 47' ' ' ASP . 38.9 mt -88.97 -75.34 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.257 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.421 ' OD2' HG22 ' A' ' 46' ' ' ILE . 1.2 p30 173.08 138.69 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.843 0.354 . . . . 0.0 110.822 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.6 p -153.85 142.02 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.041 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.59 61.3 0.59 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.395 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.3 t -86.33 93.55 9.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.835 0.35 . . . . 0.0 110.945 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.69 -77.24 0.56 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 171.6 -77.43 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.802 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 59.48 108.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.968 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.3 -175.32 2.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.826 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -131.54 -44.55 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.961 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m 64.81 166.28 0.16 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.913 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -110.23 -71.74 0.75 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.921 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -177.45 -69.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.914 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.153 -0.927 . . . . 0.0 111.025 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.822 0.344 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.0 m -98.9 31.61 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.22 -33.66 13.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.7 t -65.75 145.12 56.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 -69.19 -48.12 63.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.49 166.27 25.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.876 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.62 -60.91 1.82 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.012 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -173.24 38.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.809 0.337 . . . . 0.0 111.425 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.434 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER 62.5 167.08 0.1 Allowed Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.134 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 12' ' ' ARG . 16.8 Cg_endo -57.6 -157.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.809 2.34 . . . . 0.0 111.99 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.542 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -45.96 -101.18 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.156 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.679 ' O ' HG23 ' A' ' 14' ' ' THR . 14.4 p 172.03 21.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 13' ' ' VAL . 1.1 p -164.95 170.0 15.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.098 0.475 . . . . 0.0 111.502 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.632 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 53.2 t -64.96 137.38 97.13 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.192 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.54 -30.55 71.22 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.447 2.098 . . . . 0.0 111.848 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -96.69 -14.58 21.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.895 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.86 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 37.8 m80 -130.69 86.65 52.07 Favored Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.028 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.59 -47.92 6.55 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.21 1.94 . . . . 0.0 111.912 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.91 -10.13 59.17 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.205 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.86 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -103.44 106.02 16.43 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.458 0.647 . . . . 0.0 111.166 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.496 ' HA ' HG22 ' A' ' 14' ' ' THR . 16.9 mt -82.79 126.05 40.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.548 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.788 HD23 ' O ' ' A' ' 32' ' ' MET . 2.8 mp -63.78 130.91 46.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.28 0.562 . . . . 0.0 109.503 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 32' ' ' MET . 11.9 t -88.24 157.65 3.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.833 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.558 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 8.1 mm-40 -76.2 111.31 11.48 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.758 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.613 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 17.9 m-20 108.39 179.29 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.966 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.749 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 8.2 t80 179.67 84.15 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.858 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.607 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 7.2 mtt85 52.52 35.58 18.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 85.99 47.14 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.782 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.39 -141.23 4.52 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.404 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.613 ' O ' ' CA ' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -91.91 -126.75 0.09 Allowed 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 122.512 0.325 . . . . 0.0 110.952 -179.388 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.788 ' O ' HD23 ' A' ' 23' ' ' LEU . 4.9 mtp -102.54 120.64 40.88 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 121.03 0.443 . . . . 0.0 110.499 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.807 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -99.71 124.62 53.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -176.323 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.751 ' O ' ' N ' ' A' ' 38' ' ' GLY . 43.4 t -87.51 103.23 4.29 Favored Pre-proline 0 C--O 1.222 -0.344 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.8 Cg_endo -41.1 -21.06 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.304 2.67 . . . . 0.0 114.056 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.633 ' HG3' ' HB2' ' A' ' 21' ' ' ALA . 4.5 mm-40 -85.4 -66.16 0.93 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.886 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.693 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.1 p -89.87 -18.94 25.23 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.807 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 67.43 30.84 75.6 Favored Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.074 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.826 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -71.17 149.75 46.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.349 -0.926 . . . . 0.0 110.895 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.722 HG21 ' CD2' ' A' ' 27' ' ' TYR . 24.1 t -113.31 126.74 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.687 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.826 HG23 ' CD1' ' A' ' 39' ' ' LEU . 92.2 t -135.63 128.33 47.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.41 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 133.89 -163.83 24.47 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.968 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 0.8 OUTLIER 92.83 57.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.591 -179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.708 ' O ' HG13 ' A' ' 45' ' ' VAL . 2.1 ttt85 -100.18 138.05 37.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.198 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.708 HG13 ' O ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -179.76 -77.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.975 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.501 HD12 ' O ' ' A' ' 45' ' ' VAL . 0.3 OUTLIER 39.15 -87.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.063 179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 45' ' ' VAL . 0.4 OUTLIER -133.26 109.11 9.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.769 0.318 . . . . 0.0 110.887 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.5 t -105.86 145.38 13.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.035 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.84 166.74 3.57 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.641 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 t -101.05 42.12 1.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 111.003 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 12.0 mt-10 -83.68 -11.17 57.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.331 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.486 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 6.4 m0 70.73 -0.06 3.12 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 45.64 99.37 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.876 0.369 . . . . 0.0 111.851 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.9 158.64 16.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.821 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -143.98 89.33 2.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.926 0.393 . . . . 0.0 111.064 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 m 60.82 177.48 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.953 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -167.13 175.32 7.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.869 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -106.66 -32.08 8.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.878 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.822 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 120.818 0.342 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.04 -36.58 3.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.04 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.81 -34.91 65.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.057 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.7 t -78.86 157.9 28.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.809 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -83.51 -70.07 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.819 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.604 ' N ' HD12 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -165.91 -96.53 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.878 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.414 ' H ' HD13 ' A' ' 7' ' ' LEU . 19.5 t0 44.91 52.36 8.16 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.81 0.338 . . . . 0.0 111.439 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.4 141.27 27.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.3 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.408 ' CD2' ' HD2' ' A' ' 11' ' ' PRO . 9.2 mt -91.69 163.34 28.46 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.783 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.408 ' HD2' ' CD2' ' A' ' 10' ' ' LEU . 6.3 Cg_endo -48.37 -64.68 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.721 2.281 . . . . 0.0 112.179 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -155.31 -167.78 2.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.932 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 13' ' ' VAL . 27.2 m -92.16 53.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.649 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.444 HG22 HD12 ' A' ' 22' ' ' ILE . 75.3 p -155.26 162.84 40.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.958 0.409 . . . . 0.0 111.206 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.517 ' HB2' HD12 ' A' ' 23' ' ' LEU . 44.7 t -73.66 136.36 77.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.898 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.14 -21.26 62.88 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.516 2.144 . . . . 0.0 112.356 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -112.05 -13.1 13.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.183 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.722 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.5 m80 -131.36 88.02 45.34 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.728 0.299 . . . . 0.0 110.622 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.0 -34.14 99.05 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.366 2.044 . . . . 0.0 111.709 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.37 -28.12 34.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.396 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.633 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -81.5 87.2 6.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.187 0.518 . . . . 0.0 111.15 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.582 ' O ' ' C ' ' A' ' 23' ' ' LEU . 2.8 mm -74.63 70.56 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.779 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.899 HD21 HD11 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -9.86 111.13 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.666 0.604 . . . . 0.0 110.657 179.349 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 32' ' ' MET . 7.3 t -81.9 158.78 3.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.514 0.673 . . . . 0.0 112.394 -177.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.422 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -83.52 124.87 31.17 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.256 -178.71 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 31' ' ' ASP . 2.5 m-20 50.55 111.78 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.396 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.573 ' HB3' HG21 ' A' ' 33' ' ' ILE . 0.1 OUTLIER 173.07 139.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.211 179.374 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.587 ' HB3' HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER 51.97 26.17 3.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.461 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 28' ' ' ARG . . . 174.46 -74.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.477 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.03 -36.14 0.37 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.807 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.638 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . 1.8 p30 -89.92 -127.39 0.07 Allowed 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 88.6 mtp -106.51 125.0 50.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 118.248 0.477 . . . . 0.0 111.842 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.754 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -115.35 136.84 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.508 0.67 . . . . 0.0 111.956 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.858 ' O ' ' N ' ' A' ' 38' ' ' GLY . 38.5 t -87.63 96.71 0.62 Allowed Pre-proline 0 N--CA 1.439 -1.024 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.435 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.8 Cg_endo -39.3 -19.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.551 2.834 . . . . 0.0 113.836 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.722 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 2.4 mm-40 -85.94 -66.18 0.93 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.72 0.295 . . . . 0.0 110.655 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.554 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.0 p -89.59 -17.93 27.54 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.858 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 65.63 31.28 79.53 Favored Glycine 0 N--CA 1.435 -1.424 0 CA-C-N 113.986 -1.461 . . . . 0.0 111.562 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.943 ' CD1' HG23 ' A' ' 41' ' ' VAL . 1.3 pp -65.25 136.65 56.87 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.513 HG12 ' OD2' ' A' ' 31' ' ' ASP . 77.3 t -107.0 114.85 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 O-C-N 123.358 0.411 . . . . 0.0 111.027 -178.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.943 HG23 ' CD1' ' A' ' 39' ' ' LEU . 95.8 t -128.47 135.63 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.659 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.638 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 123.74 -161.69 18.0 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.567 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -40.4 105.58 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.989 0.423 . . . . 0.0 111.75 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.436 ' HG3' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -55.26 -30.14 59.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.018 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.436 HG23 ' HG3' ' A' ' 44' ' ' ARG . 2.7 t -134.55 -130.16 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.51 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.1 tp -177.17 138.58 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.154 0 O-C-N 122.184 -0.322 . . . . 0.0 111.132 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -170.56 93.37 0.2 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.923 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.7 t -119.76 -58.99 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.111 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.52 53.45 0.61 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.548 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.6 t -78.88 -27.99 44.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.72 0.295 . . . . 0.0 110.995 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -57.67 103.29 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.029 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 62.08 -83.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.781 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.1 67.11 0.67 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.877 0.37 . . . . 0.0 111.358 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.64 -167.43 1.77 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.001 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -100.0 62.23 1.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.3 m 61.66 168.19 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -71.78 136.98 47.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -110.6 -61.22 1.71 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.78 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.842 0.353 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.2 m -120.16 121.14 38.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.874 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.9 m -120.02 94.79 4.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -164.12 -60.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.85 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.613 ' O ' HD12 ' A' ' 7' ' ' LEU . 1.2 mmp_? 63.57 -79.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.889 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -154.37 -77.5 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.81 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 56.94 87.52 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.024 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.719 ' O ' HD12 ' A' ' 10' ' ' LEU . . . -175.5 132.4 0.28 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.149 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 9' ' ' ALA . 1.2 mp -153.77 -66.92 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.966 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.469 ' CD ' ' CB ' ' A' ' 10' ' ' LEU . 73.7 Cg_endo -76.62 -168.26 0.55 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.291 1.994 . . . . 0.0 112.284 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -90.76 -56.64 3.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.811 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 14' ' ' THR . 6.5 p -169.7 -50.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.943 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.507 ' N ' HG13 ' A' ' 13' ' ' VAL . 76.4 p -116.4 -139.35 0.37 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.279 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.57 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 49.3 t -73.4 137.9 78.07 Favored Pre-proline 0 C--O 1.232 0.172 0 O-C-N 122.402 -0.186 . . . . 0.0 110.571 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.85 -21.85 71.94 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.182 1.921 . . . . 0.0 111.989 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -119.73 -7.56 10.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.384 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.691 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . 37.6 m80 -131.18 86.75 50.09 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-O 120.624 0.249 . . . . 0.0 111.11 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.15 -33.63 90.5 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.416 2.077 . . . . 0.0 112.011 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -83.3 -24.94 31.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.161 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.758 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -82.39 81.93 8.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.336 0.589 . . . . 0.0 110.638 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.51 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -66.68 78.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.47 -1.241 . . . . 0.0 113.395 -178.054 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.839 HD21 HD11 ' A' ' 39' ' ' LEU . 1.7 mp -22.43 106.95 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.712 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.509 HG12 ' H ' ' A' ' 25' ' ' GLU . 3.4 t -75.24 167.93 2.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.192 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.509 ' H ' HG12 ' A' ' 24' ' ' VAL . 2.9 mm-40 -82.96 141.18 32.32 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-O 121.922 0.867 . . . . 0.0 110.602 -178.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.525 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 0.1 OUTLIER 55.42 94.49 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.06 -1.427 . . . . 0.0 114.675 178.67 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.598 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -68.82 111.05 4.66 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.62 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 43.51 33.59 0.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.903 0.382 . . . . 0.0 110.168 -179.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 92.17 41.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.519 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -136.18 -123.21 2.25 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.792 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.545 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 1.6 m-20 -97.14 -145.04 0.3 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.475 0.178 . . . . 0.0 111.065 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.586 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 53.5 mtp -85.83 116.85 24.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.364 0.602 . . . . 0.0 111.882 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.698 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -103.61 123.22 57.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.056 -176.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.75 ' O ' ' N ' ' A' ' 38' ' ' GLY . 44.5 t -86.24 96.77 0.52 Allowed Pre-proline 0 N--CA 1.448 -0.529 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 2.2 Cg_endo -43.2 -14.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 123.232 2.622 . . . . 0.0 113.935 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.758 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 8.7 mm-40 -88.89 -64.28 1.17 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.632 0.253 . . . . 0.0 110.952 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.774 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.6 p -91.16 -19.52 22.99 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.75 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.5 37.46 89.87 Favored Glycine 0 N--CA 1.432 -1.567 0 CA-C-N 113.822 -1.535 . . . . 0.0 111.986 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.839 HD11 HD21 ' A' ' 23' ' ' LEU . 1.2 pp -76.91 148.66 36.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.569 -0.816 . . . . 0.0 110.053 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 32' ' ' MET . 34.8 t -113.74 113.33 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.776 HG23 HD11 ' A' ' 39' ' ' LEU . 42.1 t -109.88 133.06 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.497 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.36 159.03 10.7 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.871 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 45' ' ' VAL . 2.9 m-20 173.02 -89.08 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.853 ' O ' HG22 ' A' ' 45' ' ' VAL . 0.1 OUTLIER 58.94 -73.8 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 112.035 0.384 . . . . 0.0 112.035 178.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 44' ' ' ARG . 1.2 m 87.66 -9.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.497 0.719 . . . . 0.0 111.123 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.526 HG13 HG23 ' A' ' 45' ' ' VAL . 2.6 mt -131.96 112.59 20.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.743 0.306 . . . . 0.0 110.609 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.06 -79.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.323 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 m -112.81 113.86 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.091 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.84 -32.41 2.46 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.432 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.9 t -65.02 144.97 56.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.755 0.312 . . . . 0.0 110.906 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 58.71 -169.08 0.13 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.742 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -78.06 -91.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.82 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.19 138.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.915 0.388 . . . . 0.0 111.134 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -137.88 162.64 33.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.769 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.4 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 13.2 p90 -100.68 86.96 3.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.901 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m 60.87 91.73 0.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.89 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -68.0 168.22 12.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.0 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.6 -47.18 0.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.869 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.812 0.339 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.65 31.71 3.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.94 -35.18 9.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.886 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.05 96.5 5.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.813 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -59.4 -38.36 80.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.822 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.5 mp -90.65 141.79 28.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.752 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.2 -56.63 0.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.06 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.729 ' O ' HD23 ' A' ' 10' ' ' LEU . . . -153.67 178.12 10.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.903 0.383 . . . . 0.0 111.483 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.729 HD23 ' O ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER 168.7 -44.5 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.398 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 10' ' ' LEU . 18.9 Cg_endo -57.94 -158.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.924 1.749 . . . . 0.0 112.224 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 11' ' ' PRO . 7.6 tpp180 83.95 21.41 0.15 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.011 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.2 t -88.11 -17.64 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.834 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 58.79 176.93 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.807 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 48.0 t -77.01 137.31 65.64 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.726 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.46 -23.2 71.23 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.403 2.069 . . . . 0.0 112.444 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -117.68 -7.28 11.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.506 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.717 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.0 m80 -130.3 83.28 63.27 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.666 0.27 . . . . 0.0 111.049 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.3 -36.47 87.55 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.323 2.015 . . . . 0.0 111.769 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.77 -34.96 62.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.043 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -76.81 85.43 3.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.016 0.436 . . . . 0.0 110.968 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' C ' ' A' ' 23' ' ' LEU . 8.9 mm -69.96 74.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.295 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.704 HD11 HD21 ' A' ' 39' ' ' LEU . 1.3 mp -12.86 114.2 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.596 0.56 . . . . 0.0 110.893 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 32' ' ' MET . 5.9 t -83.53 157.49 3.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.387 0.613 . . . . 0.0 111.957 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.6 136.44 42.03 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.826 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.556 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 0.9 OUTLIER 59.28 89.44 0.06 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.843 -1.526 . . . . 0.0 114.257 178.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.64 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 3.2 t80 -55.69 84.14 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.42 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.615 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 53.7 42.48 31.81 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.354 -0.539 . . . . 0.0 109.698 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 93.65 33.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.338 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.556 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -132.83 -129.8 3.03 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.426 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.9 OUTLIER -96.68 -139.32 0.27 Allowed 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.561 ' O ' HD23 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -95.8 114.17 25.88 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.086 -0.384 . . . . 0.0 110.87 -179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.73 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 5.8 tp -104.13 132.72 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.767 ' O ' ' N ' ' A' ' 38' ' ' GLY . 41.7 t -90.86 96.3 0.95 Allowed Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 176.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 5.1 Cg_endo -44.56 -10.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.102 2.534 . . . . 0.0 113.878 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.717 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 3.5 mm-40 -88.21 -64.0 1.21 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.632 ' SG ' HD23 ' A' ' 39' ' ' LEU . 6.0 p -91.32 -23.07 20.23 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.767 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 71.82 46.83 35.7 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.341 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.73 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.6 OUTLIER -86.68 139.42 30.78 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.053 -1.074 . . . . 0.0 109.607 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 32' ' ' MET . 18.6 t -108.41 119.72 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 O-C-N 123.679 0.612 . . . . 0.0 111.476 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.607 HG22 ' CD1' ' A' ' 39' ' ' LEU . 0.8 OUTLIER -119.47 133.14 67.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.57 179.038 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.98 159.55 10.93 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.472 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -174.21 105.16 0.11 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.792 0.33 . . . . 0.0 110.244 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.3 125.75 6.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.042 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.3 p -117.09 -39.24 2.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.107 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 46' ' ' ILE . 1.6 tp -80.27 111.99 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.106 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.61 -165.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.815 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.528 HG23 ' HE ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -105.86 113.35 42.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.138 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -162.14 28.81 0.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.46 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.6 p -89.2 -31.02 18.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.75 0.309 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -120.51 74.17 1.04 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.811 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.5 m0 63.36 -79.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.061 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.528 ' HE ' HG23 ' A' ' 48' ' ' VAL . 2.1 tmt_? 59.93 69.22 0.72 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.883 0.373 . . . . 0.0 110.796 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.89 167.19 17.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -103.0 64.56 0.85 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.7 m 59.69 177.94 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -113.53 153.3 28.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.032 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -85.15 -44.1 13.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.746 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.846 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.924 0.392 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.5 m -93.82 -21.52 19.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.128 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -53.58 -62.57 1.57 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.123 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 t -63.78 -172.66 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.831 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -68.92 0.29 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 mp -109.68 -177.57 3.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.999 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -89.66 -67.08 0.86 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.94 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.43 142.85 34.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.194 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.478 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . 7.6 mt -102.92 -67.29 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.532 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 10' ' ' LEU . 42.0 Cg_endo -68.02 136.21 37.32 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.312 2.008 . . . . 0.0 112.549 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.7 -167.19 1.19 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.549 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 13' ' ' VAL . 5.7 m -113.71 97.11 5.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.883 0.373 . . . . 0.0 111.459 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.5 p 57.45 -177.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.479 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.567 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 35.8 t -70.4 137.57 86.35 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.008 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.92 -19.27 66.46 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.297 1.998 . . . . 0.0 111.818 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.21 -13.0 12.4 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.011 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.712 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.5 m80 -130.79 87.63 48.76 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.284 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.96 -35.0 94.8 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.453 2.102 . . . . 0.0 111.927 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.38 -28.79 41.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.048 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.613 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -79.85 88.21 5.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.066 0.46 . . . . 0.0 111.2 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.551 ' O ' ' C ' ' A' ' 23' ' ' LEU . 17.7 mt -74.7 72.25 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.793 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 32' ' ' MET . 0.9 OUTLIER -14.08 103.02 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.034 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.1 t -75.19 166.27 2.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.652 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.535 ' O ' ' O ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -85.72 124.5 32.3 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.965 -179.172 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.535 ' O ' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER 46.95 127.32 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.437 -1.256 . . . . 0.0 113.158 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.955 ' CB ' HG21 ' A' ' 33' ' ' ILE . 0.5 OUTLIER 178.09 -51.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.204 178.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.43 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -87.4 -54.94 4.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.716 0.293 . . . . 0.0 111.008 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.018 ' HB3' HG11 ' A' ' 40' ' ' VAL . . . -130.2 14.21 5.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.369 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.19 -19.47 53.99 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.973 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.778 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -90.2 -142.07 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.738 ' O ' HD23 ' A' ' 23' ' ' LEU . 1.1 mtp -92.35 110.42 21.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.961 0.41 . . . . 0.0 110.398 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.955 HG21 ' CB ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -99.95 124.78 53.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.158 -177.573 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.77 ' O ' ' N ' ' A' ' 38' ' ' GLY . 32.1 t -87.53 97.2 0.69 Allowed Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.3 Cg_endo -40.3 -17.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.548 2.832 . . . . 0.0 113.913 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.712 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 8.4 mm-40 -87.28 -65.88 0.97 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.591 0.234 . . . . 0.0 110.877 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.628 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.6 p -90.07 -18.6 25.62 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.77 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.93 33.39 83.8 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 114.084 -1.416 . . . . 0.0 111.769 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.82 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -72.61 145.58 47.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.916 -0.642 . . . . 0.0 109.592 179.105 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.018 HG11 ' HB3' ' A' ' 29' ' ' ALA . 2.4 t -115.08 117.61 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 120.983 0.42 . . . . 0.0 111.586 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.82 HG23 ' CD1' ' A' ' 39' ' ' LEU . 86.3 t -117.12 137.34 51.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.408 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.79 159.45 11.09 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.486 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.422 ' C ' ' HG2' ' A' ' 44' ' ' ARG . 8.0 t0 -178.94 31.37 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.576 -0.312 . . . . 0.0 110.426 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.422 ' HG2' ' C ' ' A' ' 43' ' ' ASP . 0.0 OUTLIER 41.42 -169.93 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.559 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.0 t -82.41 -24.86 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.922 0.391 . . . . 0.0 110.75 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.757 ' O ' HG23 ' A' ' 48' ' ' VAL . 0.9 OUTLIER -176.69 -177.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.32 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -55.91 89.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.819 0.342 . . . . 0.0 110.812 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 46' ' ' ILE . 11.0 t -124.44 161.05 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.042 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.48 ' N ' HG12 ' A' ' 48' ' ' VAL . . . 128.31 74.43 0.17 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.433 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -103.16 179.94 4.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.403 . . . . 0.0 110.96 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -177.39 -70.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.683 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 11.5 t90 64.08 -77.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.054 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.1 ttm-85 45.84 93.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.862 0.363 . . . . 0.0 111.39 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.2 p -68.36 158.92 32.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.801 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -127.27 3.97 6.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.537 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.4 m 55.21 -177.95 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.858 0.361 . . . . 0.0 111.02 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -139.5 -167.2 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.956 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -58.32 -57.26 13.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.967 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.86 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.739 0.304 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -95.21 53.19 1.5 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.904 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.21 31.15 3.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.687 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.6 83.8 2.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.881 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -88.2 -176.17 5.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.3 mt -51.2 94.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.134 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 -70.27 -30.41 67.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.49 128.86 47.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.12 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.611 HD23 ' N ' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -84.89 -55.55 0.42 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.012 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -78.35 -160.09 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.46 2.106 . . . . 0.0 112.107 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.658 ' O ' HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -87.27 24.03 1.7 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.139 179.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 12' ' ' ARG . 16.9 m 51.48 8.84 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.82 HG22 ' HA ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER 176.85 -173.78 0.11 Allowed 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.016 0.436 . . . . 0.0 110.908 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.557 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 40.1 t -70.37 136.79 86.37 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.904 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.94 -20.59 70.01 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.3 2.0 . . . . 0.0 111.976 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -116.5 -11.91 11.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.199 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.679 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.2 m80 -130.04 88.57 48.09 Favored Pre-proline 0 C--N 1.333 -0.142 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.803 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.546 ' O ' HG21 ' A' ' 14' ' ' THR . 18.2 Cg_endo -59.74 -37.16 88.9 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.474 2.116 . . . . 0.0 111.922 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -78.57 -32.82 47.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.417 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.774 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -75.42 84.77 2.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.238 0.542 . . . . 0.0 110.891 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.82 ' HA ' HG22 ' A' ' 14' ' ' THR . 1.2 mp -70.61 73.67 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.177 -178.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.603 HD11 HD21 ' A' ' 39' ' ' LEU . 1.9 mp -15.49 118.95 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.524 0.515 . . . . 0.0 110.508 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 32' ' ' MET . 22.6 t -86.57 151.15 3.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.638 0.732 . . . . 0.0 112.469 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.49 ' O ' ' O ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -71.13 130.12 40.68 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.935 -179.365 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 1.8 t70 45.68 111.21 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.558 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.496 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -166.9 166.99 15.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.493 179.361 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 50.25 32.67 6.39 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.07 35.04 16.1 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.237 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -147.11 -155.81 6.7 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.101 -1.047 . . . . 0.0 114.937 -178.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 7.9 m-20 -78.27 -115.93 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.896 0.878 . . . . 0.0 112.357 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.621 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 22.8 mtm -95.47 113.77 25.46 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.66 0.743 . . . . 0.0 111.389 -178.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.908 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -102.15 128.4 54.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.996 -177.59 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.784 ' O ' ' N ' ' A' ' 38' ' ' GLY . 41.5 t -85.68 98.67 0.76 Allowed Pre-proline 0 N--CA 1.445 -0.717 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 1.2 Cg_endo -42.68 -16.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.16 2.573 . . . . 0.0 113.699 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.774 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 14.4 mm-40 -89.2 -63.92 1.22 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.504 0.193 . . . . 0.0 111.076 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.589 ' SG ' HD23 ' A' ' 39' ' ' LEU . 6.0 p -90.74 -21.46 21.56 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.908 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 70.12 38.18 72.93 Favored Glycine 0 N--CA 1.432 -1.606 0 CA-C-N 113.546 -1.661 . . . . 0.0 112.449 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.889 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -78.08 146.02 35.47 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.753 -0.724 . . . . 0.0 110.021 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 32' ' ' MET . 23.0 t -110.81 117.7 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 O-C-N 123.43 0.456 . . . . 0.0 111.705 -178.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.889 HG23 ' CD1' ' A' ' 39' ' ' LEU . 63.2 t -125.23 138.1 55.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.869 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 31' ' ' ASP . . . 130.34 160.56 10.09 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.754 178.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 t0 177.39 99.32 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.574 -0.313 . . . . 0.0 110.186 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.26 121.76 26.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.935 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 45' ' ' VAL . 18.2 m -146.48 115.92 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.142 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.485 HG23 ' N ' ' A' ' 47' ' ' ASP . 6.6 tt -132.79 -45.56 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.485 ' N ' HG23 ' A' ' 46' ' ' ILE . 38.7 t70 -177.19 77.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.812 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 49' ' ' GLY . 11.6 p -106.76 157.8 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.099 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.481 ' N ' HG22 ' A' ' 48' ' ' VAL . . . 148.15 -60.87 0.45 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.377 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.25 89.71 1.57 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.81 0.338 . . . . 0.0 110.856 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -114.2 22.36 13.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.285 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.418 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 3.4 m0 57.63 -167.95 0.13 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.977 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.418 ' CB ' ' O ' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 82.08 115.54 0.06 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.959 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.65 -163.06 1.38 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.638 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -96.5 36.28 1.39 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.975 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 m 62.74 147.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.899 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -76.54 160.17 29.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -112.53 -36.63 5.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.873 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.817 0.342 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.4 m -79.64 -31.87 41.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 p -68.9 79.58 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.1 t -177.19 42.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.73 -79.79 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 176.89 141.03 0.07 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.785 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -130.29 31.36 4.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.834 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.84 ' O ' HD23 ' A' ' 10' ' ' LEU . . . -108.25 137.66 45.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.188 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.84 HD23 ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -157.09 -64.81 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.497 ' O ' HG23 ' A' ' 13' ' ' VAL . 32.0 Cg_endo -63.42 154.75 66.45 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.336 2.024 . . . . 0.0 112.263 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.05 -42.81 91.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.8 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 11' ' ' PRO . 32.2 t 66.54 103.34 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.647 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.566 HG21 ' O ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER 66.14 169.84 0.23 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.456 179.467 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.435 ' HB2' HD12 ' A' ' 23' ' ' LEU . 7.7 t -70.31 136.26 86.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.227 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -66.86 -20.91 51.3 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.327 2.018 . . . . 0.0 111.967 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -111.7 -14.83 13.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.979 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.703 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.0 m80 -130.47 87.32 50.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.668 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.566 ' O ' HG21 ' A' ' 14' ' ' THR . 18.2 Cg_endo -59.87 -38.09 81.79 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.395 2.063 . . . . 0.0 111.967 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.96 -39.07 61.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.226 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -70.82 91.93 0.87 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.968 0.413 . . . . 0.0 111.149 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.586 ' O ' ' C ' ' A' ' 23' ' ' LEU . 8.6 mm -77.86 67.21 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.432 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.639 HD11 HD21 ' A' ' 39' ' ' LEU . 0.9 OUTLIER -5.32 102.84 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.154 179.614 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.5 t -77.22 163.58 3.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 121.339 0.59 . . . . 0.0 111.781 -178.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.445 ' N ' HG12 ' A' ' 24' ' ' VAL . 2.0 mm-40 -60.33 -164.46 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.782 -178.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 27' ' ' TYR . 7.6 t0 -36.67 116.27 0.42 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.888 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.93 ' HB3' HG21 ' A' ' 33' ' ' ILE . 0.8 OUTLIER 176.0 140.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.327 179.111 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 2.5 tpm_? 64.43 16.06 9.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.871 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.007 ' HB3' HG11 ' A' ' 40' ' ' VAL . . . 173.67 -70.31 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.436 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 161.78 -27.74 0.27 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.32 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.835 ' OD2' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -94.58 -118.03 0.1 Allowed 'General case' 0 CA--C 1.536 0.417 0 O-C-N 122.824 -0.221 . . . . 0.0 110.705 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.833 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 15.5 mtt -112.86 126.81 55.85 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 121.698 -0.626 . . . . 0.0 110.619 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.93 HG21 ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -112.99 134.07 56.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -177.719 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.821 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.4 t -87.63 97.75 0.81 Allowed Pre-proline 0 C--O 1.218 -0.569 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.8 Cg_endo -39.22 -19.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.549 2.833 . . . . 0.0 113.627 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.703 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 12.1 mm-40 -85.58 -66.84 0.85 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.732 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.668 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.7 p -90.08 -20.69 22.88 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 177.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.821 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 70.25 32.36 68.77 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 114.025 -1.443 . . . . 0.0 112.217 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.714 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -71.51 141.41 50.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.007 HG11 ' HB3' ' A' ' 29' ' ' ALA . 1.3 t -108.8 127.0 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-O 120.692 0.282 . . . . 0.0 111.004 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.6 OUTLIER -128.86 126.67 65.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.986 178.448 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.415 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 133.54 -176.61 19.57 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.261 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.55 84.03 0.13 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.822 0.344 . . . . 0.0 110.646 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.715 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -121.17 -75.3 0.59 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.164 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -175.72 -81.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.306 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.463 HG23 ' H ' ' A' ' 47' ' ' ASP . 0.4 OUTLIER 44.37 -83.55 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.706 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 45' ' ' VAL . 1.5 m-20 67.12 137.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.899 0.38 . . . . 0.0 111.129 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.32 80.75 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.834 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.42 -89.85 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.608 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.7 t -60.14 86.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.942 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -178.51 37.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.976 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 13.3 m0 61.33 -145.3 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.59 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.67 36.16 1.3 Allowed 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 120.975 0.417 . . . . 0.0 110.807 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 55' ' ' PHE . 1.2 m -137.7 172.99 12.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.682 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.504 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 40.8 p90 -74.08 62.61 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.036 0.446 . . . . 0.0 110.951 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 m 60.34 165.59 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -114.56 174.69 5.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.944 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.25 -69.07 0.89 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.898 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.822 0.344 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.3 m -75.13 65.2 1.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 p -140.96 88.02 2.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -168.14 73.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.08 121.51 12.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mt -60.27 162.37 6.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.61 107.04 4.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.859 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.508 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . 63.26 125.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.087 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.682 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.6 OUTLIER -88.97 -19.83 0.25 Allowed Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.682 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 95.1 Cg_endo -85.15 -168.89 0.55 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.803 1.669 . . . . 0.0 112.379 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.2 112.1 17.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.932 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.574 HG23 ' H ' ' A' ' 14' ' ' THR . 0.1 OUTLIER -48.84 -68.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.491 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.65 HG22 HG23 ' A' ' 22' ' ' ILE . 59.9 p -97.92 -143.21 0.3 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.233 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.495 ' CB ' ' HG ' ' A' ' 34' ' ' CYS . 48.3 t -73.28 136.71 78.6 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-O 120.508 0.194 . . . . 0.0 110.757 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.62 -24.09 77.37 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.266 1.978 . . . . 0.0 112.068 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -118.06 -7.25 10.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.484 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.744 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 32.7 m80 -133.15 80.76 58.54 Favored Pre-proline 0 C--N 1.333 -0.129 0 CA-C-O 120.734 0.302 . . . . 0.0 111.692 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -57.74 -36.52 98.36 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.887 1.725 . . . . 0.0 111.06 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.53 -48.73 63.56 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.258 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.604 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -71.09 85.98 0.74 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.248 0.547 . . . . 0.0 111.073 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.65 HG23 HG22 ' A' ' 14' ' ' THR . 1.6 mp -67.75 75.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.846 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.667 HD11 HD21 ' A' ' 39' ' ' LEU . 1.1 mp -14.24 112.2 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.912 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -81.31 160.19 3.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.277 0.56 . . . . 0.0 111.644 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.489 ' O ' ' O ' ' A' ' 26' ' ' ASP . 15.6 mm-40 -81.04 129.22 34.44 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.85 -179.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 25' ' ' GLU . 6.5 t70 45.68 116.29 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.403 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.622 ' CG ' HG21 ' A' ' 33' ' ' ILE . 2.1 t80 -146.67 145.88 30.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.125 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.461 ' O ' ' CG ' ' A' ' 28' ' ' ARG . 0.2 OUTLIER 51.19 31.99 7.47 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.395 -179.014 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 68.07 38.32 2.74 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.996 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -128.62 -155.73 8.72 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.579 -0.82 . . . . 0.0 114.412 -178.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.67 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 4.5 m-20 -88.88 -128.19 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.655 -0.772 . . . . 0.0 111.801 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.598 ' O ' HD23 ' A' ' 23' ' ' LEU . 73.3 mtp -90.64 112.69 24.52 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.475 0.655 . . . . 0.0 110.247 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.73 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -100.68 125.68 54.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.403 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.731 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.0 t -88.87 98.27 1.09 Allowed Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.1 Cg_endo -43.57 -14.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.181 2.587 . . . . 0.0 114.068 -178.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.744 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 4.0 mm-40 -89.45 -63.07 1.34 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 121.215 -0.194 . . . . 0.0 111.409 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.658 ' SG ' HD23 ' A' ' 39' ' ' LEU . 16.1 p -91.37 -23.23 20.13 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.731 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 72.18 37.53 59.6 Favored Glycine 0 N--CA 1.428 -1.892 0 CA-C-N 113.285 -1.78 . . . . 0.0 112.651 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.698 ' CD1' HG22 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -77.36 145.82 37.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.155 179.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 32' ' ' MET . 59.0 t -111.35 116.1 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 O-C-N 123.847 0.717 . . . . 0.0 111.069 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.698 HG22 ' CD1' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -113.9 143.88 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.471 179.005 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . -27.62 -72.21 0.04 OUTLIER Glycine 0 CA--C 1.507 -0.423 0 O-C-N 123.657 0.598 . . . . 0.0 113.329 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 1.0 OUTLIER 156.63 -172.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.01 0.434 . . . . 0.0 110.969 179.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.469 ' C ' HG23 ' A' ' 45' ' ' VAL . 21.1 mmm180 -103.64 -41.16 6.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.257 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.469 HG23 ' C ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER 57.99 110.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.45 179.584 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.6 tt -160.56 42.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.954 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.448 ' C ' HG23 ' A' ' 48' ' ' VAL . 10.2 t70 -111.5 -23.9 10.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.136 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 49' ' ' GLY . 3.4 t 74.02 163.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.847 0.356 . . . . 0.0 110.952 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.454 ' N ' HG12 ' A' ' 48' ' ' VAL . . . -49.56 -50.42 30.61 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.821 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.0 p -172.65 -178.78 2.0 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 110.902 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -173.08 40.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.964 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.406 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER 69.35 -60.03 0.47 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.374 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.406 ' CB ' ' O ' ' A' ' 52' ' ' TRP . 0.9 OUTLIER 79.86 51.88 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.95 0.405 . . . . 0.0 110.823 -179.815 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -152.01 175.71 12.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.648 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.503 ' H ' HG22 ' A' ' 54' ' ' THR . 26.6 p90 -111.43 66.11 0.63 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.993 0.425 . . . . 0.0 110.994 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 m 61.48 162.23 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.886 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -68.93 168.92 12.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.967 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -62.4 -41.91 99.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.851 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.826 0.346 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 m -100.04 31.61 3.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.825 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 p -142.91 84.19 1.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.2 t -146.49 177.21 9.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.6 mmp_? -101.25 -73.84 0.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.902 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -165.15 70.37 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.934 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -128.29 140.24 51.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.775 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.03 143.19 33.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.322 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.52 ' O ' HG23 ' A' ' 13' ' ' VAL . 3.8 mm? -59.07 165.91 3.12 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.749 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 10' ' ' LEU . 76.8 Cg_endo -78.18 9.99 2.87 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.551 2.168 . . . . 0.0 112.984 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -86.76 7.63 26.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.608 0.242 . . . . 0.0 111.42 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 10' ' ' LEU . 3.8 t -84.47 -58.14 3.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.925 0.393 . . . . 0.0 111.053 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.52 171.13 0.19 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.898 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 10.5 t -67.69 135.73 92.57 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.119 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.8 -23.75 74.43 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.24 1.96 . . . . 0.0 111.995 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -106.93 -30.01 9.11 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.719 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.636 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 39.6 m80 -108.25 87.53 4.1 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.18 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.61 39.73 0.65 Allowed 'Trans proline' 0 CA--C 1.515 -0.444 0 C-N-CA 123.168 2.578 . . . . 0.0 111.013 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 18' ' ' HIS . 46.8 m-20 -152.64 -48.05 0.1 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.143 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.436 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -69.58 93.46 0.7 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.991 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.574 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.5 mp -76.04 71.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.946 -1.025 . . . . 0.0 113.182 -177.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.092 HD21 HD11 ' A' ' 39' ' ' LEU . 0.9 OUTLIER -8.84 111.35 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.901 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 32' ' ' MET . 15.4 t -81.76 152.44 4.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 121.646 0.736 . . . . 0.0 112.609 -177.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 26' ' ' ASP . 8.0 mt-10 -85.8 122.86 30.47 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.005 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.651 ' O ' ' HB3' ' A' ' 27' ' ' TYR . 24.7 m-20 47.84 115.67 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.762 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.784 ' CE2' HG23 ' A' ' 33' ' ' ILE . 0.1 OUTLIER 166.02 151.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.403 177.62 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.487 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 5.3 mmp_? 62.34 37.4 13.86 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.044 -176.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.56 34.96 24.29 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.82 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.604 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -138.27 155.18 23.29 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 119.873 -1.156 . . . . 0.0 115.577 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 26' ' ' ASP . 5.9 m-20 -60.76 -100.91 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.391 -0.904 . . . . 0.0 109.087 177.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.577 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 16.7 mtp -106.52 105.06 14.92 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.028 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -109.09 137.91 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 CA-C-O 122.113 0.959 . . . . 0.0 112.048 -176.396 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.811 ' O ' ' N ' ' A' ' 38' ' ' GLY . 33.1 t -91.25 99.17 2.07 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 113.542 -1.663 . . . . 0.0 109.181 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.476 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.1 Cg_endo -41.41 -15.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.312 2.675 . . . . 0.0 113.603 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.636 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 9.3 mm-40 -87.18 -65.0 1.06 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.484 0.183 . . . . 0.0 110.627 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.545 ' SG ' HD23 ' A' ' 39' ' ' LEU . 1.6 p -90.07 -21.0 22.52 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 176.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.811 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 69.06 40.16 83.66 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.963 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.092 HD11 HD21 ' A' ' 23' ' ' LEU . 1.5 pp -77.26 136.85 38.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.024 -1.088 . . . . 0.0 108.378 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 32' ' ' MET . 42.9 t -105.6 126.45 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 O-C-N 123.399 0.437 . . . . 0.0 111.234 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.567 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.4 t -125.77 127.69 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.224 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.91 159.57 10.11 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.723 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -171.67 69.61 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.866 0.365 . . . . 0.0 110.342 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.3 tpp85 62.59 20.63 12.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.133 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.491 ' O ' HG22 ' A' ' 45' ' ' VAL . 8.2 p -126.44 9.41 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.338 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.3 pp -132.49 15.31 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.307 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -70.12 155.9 39.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.75 0.309 . . . . 0.0 110.729 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.93 -83.55 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.156 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 49.15 -136.13 21.19 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.611 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 57.68 -160.5 0.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.639 0.257 . . . . 0.0 110.882 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 53' ' ' ARG . 19.2 mt-10 73.55 8.01 5.06 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.485 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 52.0 m0 62.89 -77.32 0.03 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.254 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.407 ' N ' ' O ' ' A' ' 51' ' ' GLU . 9.0 mmt180 64.61 115.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.864 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.26 -168.49 1.7 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.889 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -124.1 12.03 8.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.29 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.64 166.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.826 0.346 . . . . 0.0 110.935 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -171.79 174.66 4.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -63.12 -68.05 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.875 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.88 0.371 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.2 m -134.17 37.34 3.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.25 97.09 9.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -134.0 -65.74 0.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.6 mmp_? 61.74 -83.3 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.026 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 8' ' ' ASP . 0.2 OUTLIER 174.7 170.25 0.25 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.74 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.527 ' H ' HD23 ' A' ' 7' ' ' LEU . 34.4 p-10 -175.73 36.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.025 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -152.93 22.38 0.58 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.263 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.45 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 5.8 tp -86.94 -48.01 0.49 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.453 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 86.9 Cg_endo -82.61 -32.46 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.389 2.059 . . . . 0.0 112.456 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.29 172.73 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.749 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 13' ' ' VAL . 7.3 t -131.19 6.1 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.792 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -164.25 169.96 16.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.077 0.465 . . . . 0.0 111.016 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 42.7 t -69.96 134.29 87.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.065 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.18 -28.41 56.25 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.338 2.025 . . . . 0.0 111.238 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -91.08 -20.35 22.14 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.335 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.612 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 40.5 m80 -130.66 85.92 54.36 Favored Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.325 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.73 -40.54 53.86 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.958 1.772 . . . . 0.0 110.99 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.0 -13.96 59.69 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.974 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.58 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -97.76 133.77 41.83 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.66 0.743 . . . . 0.0 110.985 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.539 ' H ' HD12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -108.11 123.98 64.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.774 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.93 HD23 ' O ' ' A' ' 32' ' ' MET . 4.9 mp -67.89 93.86 0.43 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 32' ' ' MET . 2.7 t -49.91 161.83 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.208 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -89.38 121.7 31.89 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 122.428 1.109 . . . . 0.0 112.13 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER 56.75 105.42 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 113.121 -1.854 . . . . 0.0 113.15 179.137 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.538 ' CG ' HG21 ' A' ' 33' ' ' ILE . 2.6 t80 -140.13 148.96 42.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.194 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.478 ' HD3' ' O ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER 41.39 47.09 3.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.347 -178.667 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.38 40.77 23.95 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.88 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -130.52 -164.93 11.43 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.735 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 1.006 ' OD1' HG12 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -89.25 -105.58 0.09 Allowed 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 115.406 -0.397 . . . . 0.0 111.231 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.93 ' O ' HD23 ' A' ' 23' ' ' LEU . 36.2 mtm -106.58 115.04 29.51 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.308 0.575 . . . . 0.0 111.413 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.814 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -98.82 121.62 49.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.132 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.814 ' O ' ' N ' ' A' ' 38' ' ' GLY . 38.9 t -84.35 100.4 1.06 Allowed Pre-proline 0 C--O 1.221 -0.406 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.484 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 3.9 Cg_exo -36.8 -26.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.804 3.003 . . . . 0.0 114.064 -179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.612 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 27.2 mm-40 -82.63 -67.36 0.79 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.523 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.731 ' SG ' HD23 ' A' ' 39' ' ' LEU . 2.6 p -87.92 -15.07 37.63 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.814 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 61.84 25.55 65.94 Favored Glycine 0 N--CA 1.433 -1.542 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.31 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.858 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -65.25 150.37 48.34 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.354 -0.923 . . . . 0.0 110.116 -179.844 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.006 HG12 ' OD1' ' A' ' 31' ' ' ASP . 2.7 t -118.17 120.19 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.858 HG23 ' CD1' ' A' ' 39' ' ' LEU . 84.9 t -130.3 132.84 64.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.164 178.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.69 -170.94 19.13 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.456 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 47.06 -160.69 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.769 0.319 . . . . 0.0 111.464 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.783 ' O ' HG13 ' A' ' 45' ' ' VAL . 25.5 mmm-85 73.98 -77.39 0.05 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.367 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.783 HG13 ' O ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -171.23 116.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.809 0.337 . . . . 0.0 111.32 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.692 HG23 ' H ' ' A' ' 47' ' ' ASP . 0.6 OUTLIER -160.03 -95.11 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.582 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.692 ' H ' HG23 ' A' ' 46' ' ' ILE . 3.2 p-10 29.17 52.12 0.08 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.438 HG22 ' N ' ' A' ' 49' ' ' GLY . 13.9 p -101.54 155.48 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.32 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 48' ' ' VAL . . . 115.58 126.21 4.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.493 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.27 97.86 5.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.809 0.338 . . . . 0.0 110.896 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.83 44.05 0.44 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.796 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 15.1 m0 62.47 -81.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.71 49.03 21.74 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.825 0.345 . . . . 0.0 111.095 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.456 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -112.94 -170.95 1.77 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.797 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.456 ' H ' HG22 ' A' ' 54' ' ' THR . 29.0 p90 -87.59 56.63 4.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.81 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.2 m 64.69 158.13 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.868 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -71.99 147.07 47.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.21 -64.27 0.78 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.922 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.837 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.734 0.302 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.68 -31.87 14.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.919 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.7 p -144.0 137.79 27.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.805 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.4 t -175.02 136.05 0.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.973 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -168.1 0.05 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.808 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.05 168.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.139 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -81.9 -176.71 6.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.976 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.08 113.1 1.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.488 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -75.9 -50.26 3.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.317 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 10' ' ' LEU . 73.3 Cg_endo -76.56 170.17 20.43 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.272 1.981 . . . . 0.0 112.397 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.92 131.88 54.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.0 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 13' ' ' VAL . 13.4 p -96.11 20.08 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.281 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.719 HG22 ' HA ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -179.35 -178.78 0.51 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.562 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 43.3 t -70.26 133.47 87.47 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.207 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.73 -28.97 51.57 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.601 2.201 . . . . 0.0 112.03 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.19 -16.31 19.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.713 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.672 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 39.9 m80 -131.92 85.23 51.45 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.293 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.68 -43.54 37.87 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.074 1.85 . . . . 0.0 111.321 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -74.64 -12.01 60.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.372 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -102.5 102.35 12.63 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.136 0.494 . . . . 0.0 111.812 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.719 ' HA ' HG22 ' A' ' 14' ' ' THR . 1.8 mp -76.38 130.76 35.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.755 HD23 ' O ' ' A' ' 32' ' ' MET . 3.2 mp -72.19 135.69 46.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.657 0.742 . . . . 0.0 111.125 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 32' ' ' MET . 42.9 t -87.63 156.84 3.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.208 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.21 124.45 29.92 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.936 0.874 . . . . 0.0 111.314 -177.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 31' ' ' ASP . 16.8 m-20 74.87 80.29 0.11 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.857 -1.519 . . . . 0.0 114.615 177.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.612 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 1.4 t80 -51.48 92.97 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.468 ' HD3' ' CE1' ' A' ' 27' ' ' TYR . 22.5 mtp180 66.21 -73.41 0.07 Allowed 'General case' 0 CA--C 1.522 -0.1 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 27' ' ' TYR . . . -143.96 31.92 1.26 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.324 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -123.3 -135.75 4.63 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 115.511 -0.768 . . . . 0.0 114.445 -178.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -91.56 -131.31 0.11 Allowed 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 122.871 0.468 . . . . 0.0 111.892 -178.397 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.755 ' O ' HD23 ' A' ' 23' ' ' LEU . 75.8 mtp -96.84 117.47 31.16 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.992 -0.443 . . . . 0.0 110.913 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.662 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -99.42 123.19 51.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -176.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.771 ' O ' ' N ' ' A' ' 38' ' ' GLY . 30.4 t -88.86 100.17 1.94 Allowed Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -40.11 -20.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.589 2.859 . . . . 0.0 114.09 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.672 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 6.4 mm-40 -87.36 -64.5 1.14 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.755 0.312 . . . . 0.0 111.409 -177.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.445 ' SG ' HD23 ' A' ' 39' ' ' LEU . 7.6 p -89.86 -20.23 23.68 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.771 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 68.15 29.14 73.2 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.222 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.808 HD11 HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -69.0 145.95 53.14 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.159 -0.521 . . . . 0.0 110.422 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' MET . 40.4 t -109.3 120.51 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 O-C-N 123.904 0.753 . . . . 0.0 110.493 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.808 HG22 HD11 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -123.58 126.26 72.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.1 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.643 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 124.18 -156.5 18.33 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.643 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 27.7 t70 111.76 25.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.984 0.514 . . . . 0.0 111.317 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -178.77 170.04 1.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.894 0.378 . . . . 0.0 111.162 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -105.38 133.42 49.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.846 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.507 HG23 ' O ' ' A' ' 46' ' ' ILE . 7.5 tt -54.19 119.04 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.249 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -55.9 97.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.125 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.582 ' O ' HG12 ' A' ' 48' ' ' VAL . 14.4 t -151.65 29.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.062 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.94 59.22 4.77 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.45 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.27 30.21 1.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.814 0.34 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -154.88 80.85 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 42.9 m0 61.51 -92.66 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.805 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.04 43.33 5.43 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.764 0.316 . . . . 0.0 111.386 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.469 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -108.01 -177.11 3.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.048 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.469 ' H ' HG22 ' A' ' 54' ' ' THR . 15.4 p90 -100.2 37.34 1.68 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.886 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.0 m 61.28 -177.07 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -120.41 -174.07 2.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -117.55 -42.14 2.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.935 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.843 0.354 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.5 94.94 4.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.798 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.57 73.6 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.986 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.4 -80.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.805 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.1 mtt85 53.81 -173.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.071 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.2 mt -102.23 -179.55 4.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.854 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.516 ' HB3' HG21 ' A' ' 13' ' ' VAL . 7.1 t0 -99.34 95.64 7.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.103 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.56 14.97 2.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.45 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.466 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 1.2 mt -98.63 -50.91 0.21 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.453 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 10' ' ' LEU . 56.3 Cg_endo -86.42 -85.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.459 2.106 . . . . 0.0 112.82 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -179.93 132.07 0.1 Allowed 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 120.81 0.338 . . . . 0.0 110.945 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 8' ' ' ASP . 37.5 t -129.11 106.32 13.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.92 177.3 0.13 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.943 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 19.2 t -73.01 132.83 82.33 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.318 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.85 -26.32 32.18 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.322 2.015 . . . . 0.0 111.535 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.55 -16.98 18.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.74 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.643 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 39.1 m80 -131.87 84.32 54.42 Favored Pre-proline 0 N--CA 1.455 -0.224 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.205 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.96 -44.86 27.24 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 121.937 1.758 . . . . 0.0 111.528 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.98 -12.77 60.74 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -102.12 102.37 12.83 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.826 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.461 ' H ' HD12 ' A' ' 22' ' ' ILE . 1.3 mp -75.65 125.11 34.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.797 HD22 HG23 ' A' ' 41' ' ' VAL . 2.7 mp -67.63 147.69 52.38 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.391 0.615 . . . . 0.0 110.509 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 32' ' ' MET . 50.2 t -95.08 146.78 6.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.039 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -71.68 124.47 24.81 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.323 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER 73.48 81.58 0.13 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.263 -1.335 . . . . 0.0 114.424 178.244 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.702 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -56.15 100.28 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.023 178.287 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.642 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 5.9 ttp-105 46.41 38.42 5.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.348 . . . . 0.0 110.372 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 92.03 34.57 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.59 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -133.06 -123.84 2.46 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.739 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -97.41 -135.63 0.25 Allowed 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 122.057 0.143 . . . . 0.0 110.88 -179.704 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.636 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 9.4 mtt -99.37 116.07 30.69 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-O 121.232 0.539 . . . . 0.0 111.564 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.771 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -98.23 123.26 50.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.894 -177.604 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.763 ' O ' ' N ' ' A' ' 38' ' ' GLY . 52.8 t -88.68 102.26 3.75 Favored Pre-proline 0 C--O 1.222 -0.379 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.489 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.7 Cg_endo -40.95 -20.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.398 2.732 . . . . 0.0 113.953 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.643 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 30.9 mm-40 -86.83 -65.52 1.01 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.571 -177.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.483 ' HB3' ' HE1' ' A' ' 18' ' ' HIS . 6.4 p -90.23 -20.47 22.96 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.771 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.29 30.29 71.62 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 113.715 -1.584 . . . . 0.0 112.437 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.737 ' CD1' HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -71.26 146.41 48.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.249 -0.475 . . . . 0.0 110.451 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.562 HG12 ' HB2' ' A' ' 31' ' ' ASP . 26.6 t -106.28 119.29 55.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 O-C-N 123.905 0.753 . . . . 0.0 109.489 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.797 HG23 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.33 133.89 67.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.824 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.3 160.56 10.41 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.086 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.452 ' O ' ' C ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER 179.37 70.16 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.452 ' C ' ' O ' ' A' ' 43' ' ' ASP . 3.7 ptm180 -18.34 -54.1 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 m -39.66 100.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.949 0.404 . . . . 0.0 111.929 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.8 tt -97.83 -39.64 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.196 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.17 176.52 8.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.884 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.0 t -105.12 -31.81 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.06 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.82 -144.53 17.35 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.523 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 m 60.06 44.42 13.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.926 0.393 . . . . 0.0 110.874 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -111.14 -67.46 1.0 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.003 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.422 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 0.5 OUTLIER -161.25 -41.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.0 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 52' ' ' TRP . 0.4 OUTLIER 82.43 -50.58 0.2 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.32 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.7 m -46.57 143.45 2.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.791 0.329 . . . . 0.0 111.279 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -155.08 131.48 10.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 65.5 m 59.28 86.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -60.28 177.56 0.26 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.25 -34.03 76.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.971 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.959 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.799 0.333 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -100.06 31.29 3.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.891 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.7 p -136.66 -47.47 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.45 -168.49 1.73 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.825 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.33 -55.74 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.896 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.1 mt -109.15 -48.83 3.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.993 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 63.04 -80.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.003 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.69 121.58 14.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.866 0.365 . . . . 0.0 110.895 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.451 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 1.3 mt -178.13 -61.93 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.022 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 10' ' ' LEU . 17.8 Cg_endo -58.07 128.66 29.66 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.546 2.164 . . . . 0.0 112.511 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.32 140.64 49.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.664 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 13' ' ' VAL . 14.4 p -99.4 34.51 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.163 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.436 HG22 ' CD1' ' A' ' 22' ' ' ILE . 3.6 p -145.26 156.73 44.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.04 0.448 . . . . 0.0 111.139 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 42.9 t -65.88 135.81 95.5 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.001 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.11 -28.49 48.72 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.389 2.06 . . . . 0.0 111.772 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -95.82 -18.18 20.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.522 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.706 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 40.1 m80 -131.31 86.18 51.23 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.329 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.31 -45.33 19.11 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 121.995 1.797 . . . . 0.0 111.309 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -72.33 -14.41 61.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.419 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -100.76 105.94 17.31 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.582 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.436 ' CD1' HG22 ' A' ' 14' ' ' THR . 3.6 mm -81.89 128.17 38.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.564 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.871 HD21 HD11 ' A' ' 39' ' ' LEU . 3.5 mp -67.32 137.55 56.14 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.095 0.474 . . . . 0.0 110.465 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.717 ' O ' ' HA ' ' A' ' 32' ' ' MET . 43.7 t -88.18 142.28 13.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.332 0.587 . . . . 0.0 111.482 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.32 120.42 23.05 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.09 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' A' ' 31' ' ' ASP . 1.8 t70 56.27 102.15 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.191 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.401 ' HB3' HG21 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -162.54 161.91 27.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.944 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 52.13 40.08 27.96 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.8 31.89 18.49 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.281 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -137.85 -160.4 8.5 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.516 -0.85 . . . . 0.0 114.243 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.903 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 1.2 m-20 -86.16 -99.14 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.366 0.666 . . . . 0.0 112.423 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.717 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -108.86 113.2 25.91 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.068 0.461 . . . . 0.0 111.451 -178.665 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.787 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -102.71 126.24 56.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.517 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.792 ' O ' ' N ' ' A' ' 38' ' ' GLY . 41.0 t -90.18 99.96 2.27 Favored Pre-proline 0 C--O 1.22 -0.453 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.8 Cg_endo -40.24 -21.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.458 2.772 . . . . 0.0 114.097 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.706 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 31.7 mm-40 -84.52 -65.31 1.02 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.669 0.271 . . . . 0.0 111.216 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.774 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.7 p -89.82 -18.51 26.12 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.792 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.51 28.49 73.6 Favored Glycine 0 N--CA 1.433 -1.545 0 CA-C-N 113.641 -1.618 . . . . 0.0 112.074 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.871 HD11 HD21 ' A' ' 23' ' ' LEU . 1.3 pp -67.09 140.67 57.6 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.615 -0.793 . . . . 0.0 110.558 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' A' ' 32' ' ' MET . 29.3 t -110.32 118.71 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.508 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.903 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 1.5 t -107.52 -165.69 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.183 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.623 ' H ' HG12 ' A' ' 41' ' ' VAL . . . -85.43 -160.23 32.77 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.286 -0.959 . . . . 0.0 110.898 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.402 ' CB ' ' OD2' ' A' ' 31' ' ' ASP . 28.0 t0 -168.59 -39.43 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.071 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.09 -82.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.447 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.695 HG13 ' N ' ' A' ' 46' ' ' ILE . 0.6 OUTLIER 38.3 -160.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.832 179.417 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.695 ' N ' HG13 ' A' ' 45' ' ' VAL . 9.4 tp -148.71 157.36 7.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.696 0.284 . . . . 0.0 110.743 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -47.83 95.39 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.883 0.373 . . . . 0.0 111.178 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 46' ' ' ILE . 29.4 m -84.34 161.16 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.224 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.44 58.98 4.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.481 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.77 95.88 2.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.34 . . . . 0.0 110.793 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -141.04 40.43 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.935 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 69.6 -60.41 0.47 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.272 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? 77.04 98.23 0.07 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.964 0.412 . . . . 0.0 110.959 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.67 178.02 10.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.743 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -132.24 103.2 6.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.8 m 59.57 174.09 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.018 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -129.74 170.35 13.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.13 -38.07 8.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.866 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.824 0.345 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.6 m -65.18 -31.48 72.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 65.7 p -60.81 -65.06 0.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.923 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.07 176.6 0.31 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.2 mtt85 -138.72 -75.86 0.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.989 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 7' ' ' LEU . 2.3 mt -108.58 85.81 2.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -133.01 70.53 1.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.844 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -167.35 38.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.183 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.497 ' O ' HD12 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -128.99 52.35 9.1 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.889 179.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.414 ' HD3' ' N ' ' A' ' 10' ' ' LEU . 91.1 Cg_endo -78.45 78.01 3.8 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.533 2.155 . . . . 0.0 112.607 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.887 ' HD2' HG11 ' A' ' 41' ' ' VAL . 4.6 ptp85 -85.89 141.95 29.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.615 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.456 ' O ' HG23 ' A' ' 14' ' ' THR . 30.7 m -124.65 18.66 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.634 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -166.09 169.49 14.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 110.809 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 11.3 t -79.46 134.58 58.07 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.188 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.3 -19.32 44.1 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.264 1.976 . . . . 0.0 111.6 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -115.09 -11.06 12.12 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.304 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.655 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . 38.6 m80 -130.96 87.31 49.26 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-O 120.624 0.249 . . . . 0.0 110.583 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.33 -36.2 88.33 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.313 2.008 . . . . 0.0 112.004 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -79.26 -31.92 43.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.005 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.655 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -75.05 88.45 2.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.058 0.456 . . . . 0.0 111.278 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.55 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.7 mp -75.2 70.12 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.201 -0.908 . . . . 0.0 112.827 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.832 HD21 HD11 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -12.22 111.25 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.536 179.481 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 25' ' ' GLU . 3.3 t -79.34 167.35 2.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.137 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.48 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -81.35 129.51 34.65 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 121.71 0.766 . . . . 0.0 110.229 -178.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.591 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 6.3 m-20 85.71 -160.28 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.222 -1.354 . . . . 0.0 112.975 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.859 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 14.3 t80 155.16 78.22 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 124.08 0.952 . . . . 0.0 108.788 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.572 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 15.1 mmp_? 61.96 41.43 11.29 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 79.97 42.08 0.07 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.693 -178.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -124.45 -156.66 9.5 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.749 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.538 ' O ' ' CA ' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -89.17 -135.7 0.1 Allowed 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 122.952 0.501 . . . . 0.0 111.216 -179.557 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.657 ' O ' HD23 ' A' ' 23' ' ' LEU . 1.9 mtt -88.1 117.11 26.76 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-O 121.402 0.62 . . . . 0.0 110.904 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.859 ' HB ' ' HB2' ' A' ' 27' ' ' TYR . 0.2 OUTLIER -99.97 123.4 52.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -176.149 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.74 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.8 t -88.56 96.28 0.65 Allowed Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.2 Cg_endo -41.84 -15.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.382 2.722 . . . . 0.0 113.743 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.646 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 18.2 mm-40 -85.1 -67.49 0.8 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.905 0.383 . . . . 0.0 111.034 -178.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.792 ' SG ' HD23 ' A' ' 39' ' ' LEU . 2.9 p -90.85 -19.56 23.25 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.851 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.18 38.72 82.99 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.149 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.832 HD11 HD21 ' A' ' 23' ' ' LEU . 1.6 pp -78.05 147.0 34.96 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.438 -0.881 . . . . 0.0 110.281 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 32' ' ' MET . 49.1 t -112.23 118.63 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 123.354 0.409 . . . . 0.0 111.945 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.887 HG11 ' HD2' ' A' ' 12' ' ' ARG . 0.2 OUTLIER -124.15 131.52 72.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.241 178.043 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.29 -173.9 18.94 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.047 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -111.47 138.05 48.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.841 0.353 . . . . 0.0 111.084 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -95.7 78.35 3.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.629 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.635 HG22 ' H ' ' A' ' 46' ' ' ILE . 2.1 p -150.29 175.82 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.928 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.635 ' H ' HG22 ' A' ' 45' ' ' VAL . 0.1 OUTLIER 84.42 154.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.0 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.97 140.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.705 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.97 -79.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.128 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.84 165.92 28.92 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.436 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.92 83.56 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.83 0.348 . . . . 0.0 110.913 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -122.0 21.47 10.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.223 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.42 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 57.33 -156.28 0.31 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.814 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.42 ' CB ' ' O ' ' A' ' 52' ' ' TRP . 1.0 OUTLIER 81.95 117.1 0.05 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.95 0.405 . . . . 0.0 111.016 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -136.44 -167.07 1.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.66 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.424 ' H ' HG22 ' A' ' 54' ' ' THR . 9.4 p90 -85.84 61.69 7.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.961 0.41 . . . . 0.0 110.837 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.4 m 63.27 165.97 0.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.951 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -100.5 121.69 41.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.985 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -70.06 -31.63 69.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.834 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.872 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.784 0.326 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.497 ' O ' HG23 ' A' ' 4' ' ' THR . 0.9 OUTLIER -99.6 29.32 4.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.976 179.976 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -178.3 92.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.813 179.986 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.0 m -147.92 147.42 29.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.978 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -82.27 144.62 30.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.784 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 mt -76.88 126.52 31.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.98 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.548 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 1.4 m-20 -73.84 -127.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.378 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . 76.22 -56.75 0.57 Allowed 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 179.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.515 ' C ' ' O ' ' A' ' 9' ' ' ALA . 3.9 mt -2.62 -70.65 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.66 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.515 ' CD ' ' CB ' ' A' ' 10' ' ' LEU . 67.9 Cg_endo -73.95 -92.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.05 1.834 . . . . 0.0 112.591 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 170.33 -50.99 0.01 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.958 0.409 . . . . 0.0 110.286 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.8 t 62.16 93.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.696 179.48 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.496 HG22 HD12 ' A' ' 22' ' ' ILE . 10.6 p 55.27 -175.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.527 179.432 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 32.8 t -74.43 135.3 75.75 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.922 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.5 -19.97 65.54 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.259 1.973 . . . . 0.0 111.911 179.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.16 -10.88 10.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.258 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.734 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.9 m80 -130.58 87.99 48.24 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.797 0.332 . . . . 0.0 110.829 179.575 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.32 -34.75 97.84 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.306 2.004 . . . . 0.0 111.752 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.96 -25.49 37.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.385 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.623 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -84.33 83.9 7.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.158 0.504 . . . . 0.0 111.377 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' C ' ' A' ' 23' ' ' LEU . 16.1 mm -72.18 74.27 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.737 -178.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.78 HD11 HD21 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -15.37 113.52 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.439 179.511 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 32' ' ' MET . 5.0 t -81.23 160.58 3.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.271 0.558 . . . . 0.0 111.822 -178.151 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.418 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -78.39 136.5 37.68 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.829 -178.115 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 31' ' ' ASP . 8.3 m-20 62.54 86.91 0.11 Allowed 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 113.833 -1.531 . . . . 0.0 114.128 179.024 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.603 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 2.0 t80 -58.84 85.92 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.007 178.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.604 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 51.71 49.11 21.52 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.965 -179.965 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 88.96 30.4 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.459 -178.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.604 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -131.75 -130.27 3.12 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.432 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.619 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 2.1 p30 -102.57 -127.96 0.22 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.462 0.171 . . . . 0.0 111.462 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.569 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 6.7 mtm -98.56 116.95 31.9 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.794 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -106.51 124.07 61.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.844 -178.154 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.752 ' O ' ' N ' ' A' ' 38' ' ' GLY . 40.4 t -86.83 97.04 0.59 Allowed Pre-proline 0 C--O 1.221 -0.446 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.3 Cg_endo -41.86 -15.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.378 2.719 . . . . 0.0 114.267 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.734 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 6.2 mm-40 -88.55 -64.51 1.14 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.738 0.304 . . . . 0.0 111.173 -178.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.75 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.5 p -90.94 -19.6 23.11 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.38 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.794 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 67.1 36.42 90.45 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.684 -179.397 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.78 HD21 HD11 ' A' ' 23' ' ' LEU . 1.2 pp -73.16 145.01 46.66 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.569 -0.816 . . . . 0.0 109.315 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.596 HG21 ' CD2' ' A' ' 27' ' ' TYR . 53.7 t -114.66 119.94 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 121.044 0.45 . . . . 0.0 112.08 -176.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.706 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.2 t -131.98 139.18 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.247 179.563 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.471 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 128.83 155.49 8.61 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.135 178.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.5 t0 178.56 -67.61 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.985 -0.608 . . . . 0.0 110.003 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.21 86.74 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.985 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.701 ' O ' HD12 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -88.77 178.28 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.9 -179.937 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.701 HD12 ' O ' ' A' ' 45' ' ' VAL . 1.1 mp 75.05 38.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.917 0.389 . . . . 0.0 110.944 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.47 137.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.895 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.6 p -146.67 148.95 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.99 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 142.67 -130.36 4.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.399 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.6 35.43 19.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 110.894 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.68 35.75 4.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.824 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 54.1 m0 62.61 -81.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.015 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 53.4 81.75 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.847 0.356 . . . . 0.0 111.025 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.455 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -149.91 175.91 11.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 -179.913 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.455 ' H ' HG22 ' A' ' 54' ' ' THR . 1.6 p90 -104.94 39.14 1.77 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.31 159.61 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.878 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -125.39 165.07 19.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.934 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -101.23 -31.58 10.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.314 -0.85 . . . . 0.0 110.805 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.822 0.344 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.33 121.79 44.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.78 72.57 0.73 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.845 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.7 t -176.73 106.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.84 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -96.15 -34.77 11.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.952 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 59.42 69.26 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.724 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.557 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 27.5 p-10 -168.97 -149.92 0.08 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.683 -179.769 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . 77.18 160.0 0.21 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.901 0.382 . . . . 0.0 111.106 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.7 56.55 5.18 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.834 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.18 -70.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.632 2.221 . . . . 0.0 112.328 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 58.0 mtm-85 -99.95 109.03 21.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.906 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.3 p -65.77 -32.34 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.859 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.475 HG22 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER 54.11 -174.39 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.843 -179.728 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB2' HD12 ' A' ' 23' ' ' LEU . 9.3 t -88.09 135.13 33.67 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.15 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.1 -18.9 39.9 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.285 1.99 . . . . 0.0 111.861 179.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -115.91 -9.46 11.8 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.266 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.738 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 36.1 m80 -131.03 88.06 46.67 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.653 0.263 . . . . 0.0 111.043 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.19 -33.24 90.87 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.433 2.089 . . . . 0.0 112.072 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.79 -23.58 27.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.504 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.745 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -84.06 82.45 8.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.289 0.566 . . . . 0.0 110.671 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.535 ' O ' ' C ' ' A' ' 23' ' ' LEU . 3.7 mt -69.42 75.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.552 -177.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.621 HD11 HD21 ' A' ' 39' ' ' LEU . 1.3 mp -18.68 109.83 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 O-C-N 123.618 0.574 . . . . 0.0 110.577 179.04 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.4 t -78.24 163.02 3.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.234 0.54 . . . . 0.0 111.959 -178.108 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 26' ' ' ASP . 5.7 mt-10 -81.75 134.48 35.45 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.395 -178.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 25' ' ' GLU . 1.4 m-20 42.69 114.92 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.518 -1.219 . . . . 0.0 113.675 179.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.49 ' HB3' HG21 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -171.68 129.34 0.66 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.966 179.165 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.561 ' NH1' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 80.02 -60.35 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.723 -179.346 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.561 ' HB2' ' NH1' ' A' ' 28' ' ' ARG . . . -114.07 -38.73 4.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.345 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.42 -7.29 3.67 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.911 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.512 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -96.29 -151.2 0.34 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.742 0.271 . . . . 0.0 110.527 179.857 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.558 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 1.3 mtt -89.85 116.53 28.0 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 121.205 0.526 . . . . 0.0 111.935 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.665 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -104.03 125.96 58.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.898 0.38 . . . . 0.0 111.754 -178.87 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.813 ' O ' ' N ' ' A' ' 38' ' ' GLY . 40.5 t -85.8 97.62 0.61 Allowed Pre-proline 0 N--CA 1.447 -0.61 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.068 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 1.0 OUTLIER -41.11 -17.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.319 2.679 . . . . 0.0 113.742 -179.231 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.745 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 9.9 mm-40 -88.06 -65.48 1.01 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.672 0.273 . . . . 0.0 110.789 -178.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.662 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.0 p -90.36 -18.59 25.25 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.271 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.813 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.12 33.3 84.91 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.681 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.86 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -72.44 143.64 48.41 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.949 -0.626 . . . . 0.0 109.58 179.099 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 32' ' ' MET . 16.1 t -110.35 112.94 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 O-C-N 123.236 0.335 . . . . 0.0 111.514 -178.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.86 HG23 ' CD1' ' A' ' 39' ' ' LEU . 67.0 t -114.47 138.08 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.117 178.535 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.01 159.58 10.58 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.53 178.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -175.02 44.05 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.782 0.325 . . . . 0.0 110.372 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.424 ' C ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -89.92 11.22 21.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.428 -179.981 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.428 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 5.2 t 75.95 -54.71 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.521 HG22 ' O ' ' A' ' 46' ' ' ILE . 3.1 mm 67.96 102.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 120.848 0.356 . . . . 0.0 110.666 -179.453 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -128.36 149.32 50.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.837 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.0 m -97.79 -178.03 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.06 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.87 -44.65 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.587 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.37 -78.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 110.848 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 68.23 -69.8 0.14 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.996 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 31.1 m0 56.78 -90.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.053 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? 44.66 84.21 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.792 0.329 . . . . 0.0 111.347 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.46 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -133.49 -175.62 3.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.09 -179.946 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.46 ' H ' HG22 ' A' ' 54' ' ' THR . 2.5 p90 -148.7 61.68 1.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.902 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 62.32 174.66 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -121.12 167.58 12.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.756 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -72.2 -45.76 58.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.851 0.358 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.44 72.86 1.4 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.854 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.1 p -141.57 -70.91 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.846 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.0 m -90.64 125.02 35.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.818 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.9 mtt85 -86.63 -68.56 0.74 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.986 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.0 mt -68.81 -83.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.965 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 42.0 78.76 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.548 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -173.44 129.03 0.44 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.444 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 1.4 mp -88.26 -62.62 0.22 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.226 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.444 ' HD3' ' CB ' ' A' ' 10' ' ' LEU . 90.4 Cg_endo -78.15 -101.24 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.385 2.057 . . . . 0.0 112.395 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.638 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.0 OUTLIER 168.36 -80.22 0.0 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.725 0.297 . . . . 0.0 110.893 179.83 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.683 ' O ' HG23 ' A' ' 14' ' ' THR . 0.0 OUTLIER -166.72 -95.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.141 -179.995 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.683 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -175.56 169.42 3.1 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-O 121.337 0.589 . . . . 0.0 111.327 -179.932 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.752 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 14.5 t -78.96 147.0 69.33 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.732 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.573 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 29.5 Cg_endo -62.12 -44.33 20.2 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.91 2.407 . . . . 0.0 112.716 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.526 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 94.1 m-20 -107.48 38.12 2.23 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 122.119 0.962 . . . . 0.0 108.588 178.353 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.752 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 24.7 m80 -161.9 65.13 1.84 Allowed Pre-proline 0 C--N 1.308 -1.226 0 CA-C-O 123.114 1.435 . . . . 0.0 108.93 175.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 18' ' ' HIS . 55.6 Cg_endo -70.3 13.6 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.649 3.566 . . . . 0.0 113.103 -179.244 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.58 -17.48 1.49 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 120.999 0.428 . . . . 0.0 110.033 178.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.492 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -98.21 131.02 44.91 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.435 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.614 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.3 mp -106.87 87.51 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.614 ' C ' ' O ' ' A' ' 22' ' ' ILE . 3.9 mp -15.99 105.02 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 121.037 0.446 . . . . 0.0 109.934 178.43 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 25' ' ' GLU . 2.7 t -63.53 170.85 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.174 -178.309 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.557 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -104.83 97.25 7.15 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.501 -178.66 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 31' ' ' ASP . 1.6 m-20 82.08 89.44 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 179.513 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.535 ' CB ' HG21 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -167.66 143.94 4.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.35 179.136 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.634 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 71.14 6.59 5.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.631 -178.855 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.634 ' HB2' ' O ' ' A' ' 28' ' ' ARG . . . 158.2 -78.21 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.985 0.422 . . . . 0.0 110.489 179.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.428 ' O ' HG13 ' A' ' 40' ' ' VAL . . . -177.02 -179.65 47.5 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.586 179.591 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.469 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.5 OUTLIER 64.43 -141.69 0.27 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 117.436 0.618 . . . . 0.0 109.544 -179.157 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.58 ' O ' HD23 ' A' ' 23' ' ' LEU . 66.3 mtm -112.72 116.5 30.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.923 0.392 . . . . 0.0 111.121 -179.551 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.762 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -110.43 123.81 66.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.402 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.873 ' O ' ' N ' ' A' ' 38' ' ' GLY . 6.5 t -83.45 101.69 1.48 Allowed Pre-proline 0 C--O 1.215 -0.744 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.463 ' HD3' HG23 ' A' ' 24' ' ' VAL . 1.6 Cg_endo -44.24 -20.99 0.35 Allowed 'Trans proline' 0 N--CA 1.475 0.413 0 C-N-CA 122.152 1.901 . . . . 0.0 112.809 -179.333 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.636 ' HB3' ' NE2' ' A' ' 18' ' ' HIS . 29.8 mm-40 -85.03 -60.52 2.02 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.457 -178.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.916 ' SG ' HD23 ' A' ' 39' ' ' LEU . 25.6 p -93.61 -11.97 30.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.873 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 54.32 26.28 36.22 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 114.79 -1.096 . . . . 0.0 113.581 178.574 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.011 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.6 OUTLIER -71.6 157.22 38.36 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.005 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.539 ' N ' HD12 ' A' ' 39' ' ' LEU . 5.9 t -118.41 118.12 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.054 0.454 . . . . 0.0 111.936 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.011 HG23 ' CD1' ' A' ' 39' ' ' LEU . 68.1 t -132.14 133.8 60.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.546 178.633 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.06 165.2 10.53 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.073 -1.061 . . . . 0.0 112.967 179.464 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -142.14 -39.99 0.36 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.689 0.28 . . . . 0.0 110.531 179.567 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.84 81.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.432 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.678 HG13 ' H ' ' A' ' 46' ' ' ILE . 1.2 p -50.2 -69.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.555 -179.506 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.678 ' H ' HG13 ' A' ' 45' ' ' VAL . 0.1 OUTLIER 58.85 151.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.899 0.38 . . . . 0.0 110.919 -179.839 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 p30 176.28 175.5 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.944 -179.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 49' ' ' GLY . 3.9 m -130.44 -51.83 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.974 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.437 ' H ' HG23 ' A' ' 48' ' ' VAL . . . 44.72 56.04 5.91 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.047 -0.596 . . . . 0.0 113.011 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.9 t -176.87 97.03 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.327 . . . . 0.0 111.141 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.4 OUTLIER -138.32 11.6 2.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.339 179.888 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 9.7 m0 61.41 -80.72 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.81 0.338 . . . . 0.0 111.067 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER 66.33 140.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.837 0.351 . . . . 0.0 110.963 179.897 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 55' ' ' PHE . 15.1 m -161.9 164.28 28.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.791 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.421 ' N ' HG22 ' A' ' 54' ' ' THR . 23.0 p90 -140.35 109.74 6.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.043 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.0 m 58.31 173.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.028 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -165.54 -175.94 3.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.808 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -108.07 -38.09 5.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.915 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.858 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.841 0.353 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.1 m -118.79 31.52 6.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.9 p -94.55 -31.55 13.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.907 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.53 -169.6 2.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.852 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.9 mtp85 -80.08 -74.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.94 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.32 -169.13 2.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.876 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -170.76 117.84 0.5 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.95 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.98 61.56 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.073 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.8 mt -109.29 159.13 32.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.866 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -62.04 177.82 0.97 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.52 2.147 . . . . 0.0 112.061 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -130.01 5.7 4.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.593 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 13' ' ' VAL . 10.7 p -178.88 121.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.758 0.313 . . . . 0.0 111.359 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.7 p 51.88 -169.63 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.226 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 49.2 t -73.21 137.0 78.68 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.73 -21.28 72.85 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.334 2.023 . . . . 0.0 112.189 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -116.96 -9.52 11.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.367 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.702 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 37.2 m80 -130.24 88.78 46.87 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.786 0.327 . . . . 0.0 110.676 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.23 -34.61 93.83 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.356 2.038 . . . . 0.0 111.891 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.86 -23.84 33.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.32 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.705 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -83.81 84.15 7.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.22 0.534 . . . . 0.0 111.197 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.522 ' O ' ' C ' ' A' ' 23' ' ' LEU . 6.3 mt -70.4 77.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.658 -1.155 . . . . 0.0 113.147 -178.205 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.662 HD11 HD21 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -20.04 106.26 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.902 179.327 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 25' ' ' GLU . 3.2 t -74.9 168.24 2.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.155 -178.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.516 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -84.44 138.61 32.72 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.996 0.903 . . . . 0.0 110.895 -178.153 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 32.1 m-20 60.09 91.24 0.05 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 113.899 -1.501 . . . . 0.0 114.873 178.487 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.663 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 2.0 t80 -62.78 95.43 0.08 Allowed 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.606 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 52.74 41.92 31.65 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.444 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 86.67 36.02 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.321 -178.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -132.87 -124.62 2.55 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.886 -179.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.564 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -96.2 -146.42 0.29 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 122.3 0.24 . . . . 0.0 111.014 -179.097 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.648 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.8 mtm -86.2 116.8 24.62 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-O 121.09 0.471 . . . . 0.0 111.638 -179.195 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.713 HD13 ' N ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -104.22 123.03 57.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.121 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.745 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.0 t -87.23 96.58 0.58 Allowed Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.492 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.6 Cg_endo -42.52 -14.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.373 2.716 . . . . 0.0 114.072 -179.001 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.705 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 9.2 mm-40 -87.94 -65.19 1.04 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.66 0.266 . . . . 0.0 110.881 -178.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.646 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.5 p -91.0 -19.16 23.52 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.323 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.745 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.23 35.91 88.99 Favored Glycine 0 N--CA 1.433 -1.505 0 CA-C-N 113.87 -1.514 . . . . 0.0 111.929 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.841 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -75.51 147.82 39.46 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.75 179.192 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.648 ' HA ' ' O ' ' A' ' 32' ' ' MET . 18.6 t -114.87 113.74 44.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.841 HG23 ' CD1' ' A' ' 39' ' ' LEU . 86.0 t -119.15 138.5 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.879 178.033 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.401 ' O ' ' OD2' ' A' ' 31' ' ' ASP . . . 105.26 -171.32 18.52 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 179.554 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.417 ' HB3' ' OD1' ' A' ' 31' ' ' ASP . 0.4 OUTLIER 40.84 -163.7 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 179.162 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 177.43 149.76 0.17 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.818 179.656 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.402 ' O ' HG22 ' A' ' 46' ' ' ILE . 13.5 t -56.51 130.81 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.221 -179.872 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.567 HG23 ' N ' ' A' ' 47' ' ' ASP . 0.1 OUTLIER 52.5 176.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.432 179.857 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.567 ' N ' HG23 ' A' ' 46' ' ' ILE . 32.2 t70 -67.01 97.37 0.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.56 ' O ' HG12 ' A' ' 48' ' ' VAL . 18.2 t -101.43 36.74 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.004 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -135.45 114.95 1.29 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.478 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.51 100.98 10.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.798 0.332 . . . . 0.0 110.959 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.18 66.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.838 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 41.2 m0 62.34 -81.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.956 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? 56.66 78.46 0.21 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.978 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 55' ' ' PHE . 2.0 m -154.9 168.82 25.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.426 ' H ' HG22 ' A' ' 54' ' ' THR . 2.8 p90 -133.56 97.89 4.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.94 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 m 60.98 110.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -60.22 153.65 21.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.905 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -64.85 -62.25 1.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.956 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.854 0.359 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.3 m -77.73 -27.28 50.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.002 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.44 67.36 0.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.82 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.3 t -135.95 133.65 37.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.867 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -48.99 79.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.602 HD13 HD21 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -154.93 124.24 6.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.82 179.95 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -80.84 -49.06 11.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.043 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.92 99.29 3.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.153 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.602 HD21 HD13 ' A' ' 7' ' ' LEU . 1.1 mp -70.81 -50.21 13.1 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.411 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 10' ' ' LEU . 56.0 Cg_endo -70.37 156.9 60.76 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.167 1.912 . . . . 0.0 112.316 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -87.44 175.93 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.009 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.3 t -109.63 -23.13 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.171 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.638 HG22 HD13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -163.64 168.55 19.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.9 0.381 . . . . 0.0 110.942 179.982 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.507 ' HB2' HD12 ' A' ' 23' ' ' LEU . 41.8 t -75.75 136.03 70.88 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.577 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.84 -22.74 68.99 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.426 2.084 . . . . 0.0 112.656 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -115.79 -8.9 11.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.431 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.731 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.0 m80 -131.58 85.88 50.96 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.746 0.308 . . . . 0.0 110.809 179.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.05 -34.47 98.95 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.318 2.012 . . . . 0.0 111.64 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.13 -30.65 39.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.368 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -79.0 87.72 4.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.182 0.515 . . . . 0.0 111.419 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.638 HD13 HG22 ' A' ' 14' ' ' THR . 22.3 mm -73.24 72.98 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.734 -178.705 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.729 HD11 HD21 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -13.71 110.25 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.49 179.258 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 32' ' ' MET . 4.2 t -79.52 160.72 4.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.322 0.582 . . . . 0.0 112.181 -177.84 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.424 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -78.53 133.95 37.32 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.028 -177.967 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.684 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.4 OUTLIER 70.77 81.27 0.16 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.708 -1.587 . . . . 0.0 114.3 178.479 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.595 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -60.33 107.35 0.64 Allowed 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.309 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.618 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER 44.36 36.61 1.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.958 0.409 . . . . 0.0 110.418 -179.474 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 90.58 36.19 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.586 -179.039 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -133.22 -119.16 1.99 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.692 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.684 ' O ' ' N ' ' A' ' 26' ' ' ASP . 2.0 p30 -100.94 -127.23 0.2 Allowed 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.642 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.55 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -100.65 120.16 39.64 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.079 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.805 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -109.4 126.8 66.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.781 -178.223 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.783 ' O ' ' N ' ' A' ' 38' ' ' GLY . 38.5 t -86.12 97.51 0.62 Allowed Pre-proline 0 C--O 1.22 -0.475 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.027 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -41.43 -16.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.321 2.681 . . . . 0.0 113.946 -179.141 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.731 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 2.2 mm-40 -87.82 -65.21 1.04 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.703 0.287 . . . . 0.0 111.073 -178.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.762 ' SG ' HD23 ' A' ' 39' ' ' LEU . 6.1 p -90.9 -19.68 23.06 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.479 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.805 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 66.89 34.95 88.74 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 113.86 -1.518 . . . . 0.0 111.741 -179.552 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.762 HD23 ' SG ' ' A' ' 37' ' ' CYS . 1.3 pp -71.22 145.65 49.51 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.527 HG11 ' CD2' ' A' ' 27' ' ' TYR . 86.5 t -113.54 121.99 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-O 121.209 0.528 . . . . 0.0 112.138 -176.591 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.698 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.4 t -134.01 133.69 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.64 179.298 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.584 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 128.67 171.81 13.06 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.308 179.287 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.403 ' OD2' HD11 ' A' ' 46' ' ' ILE . 6.6 t0 -103.68 129.09 50.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.86 0.362 . . . . 0.0 111.15 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.78 ' HG3' HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -127.72 -43.52 1.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.751 179.796 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.78 HG12 ' HG3' ' A' ' 44' ' ' ARG . 10.3 p 178.0 111.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.009 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 46' ' ' ILE . 1.5 mp -114.58 26.81 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.195 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 t0 56.61 28.06 13.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.033 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -67.34 77.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 174.4 39.28 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.474 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.6 t -97.45 -33.67 11.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.764 0.316 . . . . 0.0 110.836 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -106.64 108.44 19.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.904 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 15.1 m0 59.31 -89.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? 44.58 60.06 3.05 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.826 0.346 . . . . 0.0 111.355 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.92 158.14 18.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.925 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -101.27 48.99 0.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.818 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.9 m 63.74 173.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.92 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -60.24 132.18 53.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -75.15 -54.28 7.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.851 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.904 0.383 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -79.12 86.36 4.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.961 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.36 26.47 1.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.014 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.27 122.64 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.889 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -122.98 -46.2 2.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.1 mp -94.96 154.27 17.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.861 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -167.2 47.31 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -173.31 83.79 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.093 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.41 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 0.4 OUTLIER -76.45 -61.03 0.83 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.823 179.914 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.41 ' HD3' ' CB ' ' A' ' 10' ' ' LEU . 75.4 Cg_endo -77.01 -168.06 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.607 2.205 . . . . 0.0 112.261 179.911 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.527 ' C ' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -100.15 -3.54 31.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.274 179.779 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.527 HG23 ' C ' ' A' ' 12' ' ' ARG . 6.7 t 84.85 -23.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.775 -179.844 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.82 172.62 6.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.825 179.944 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 47.4 t -74.41 136.08 75.32 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.554 179.726 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.76 -21.61 73.17 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.28 1.986 . . . . 0.0 112.319 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -116.6 -9.53 11.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.348 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.738 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 36.1 m80 -131.48 87.19 47.39 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.775 0.322 . . . . 0.0 110.883 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.13 -34.1 94.61 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.345 2.03 . . . . 0.0 111.917 179.78 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.41 -26.76 35.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.231 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.62 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -81.52 87.62 6.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.201 0.524 . . . . 0.0 111.283 -179.882 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.569 ' O ' ' C ' ' A' ' 23' ' ' LEU . 15.3 mt -72.86 73.25 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.871 -178.556 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.663 HD11 HD21 ' A' ' 39' ' ' LEU . 1.5 mp -15.13 110.11 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.549 0.531 . . . . 0.0 110.513 179.321 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.8 t -79.09 161.58 4.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.202 0.525 . . . . 0.0 111.922 -177.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.422 ' N ' HG12 ' A' ' 24' ' ' VAL . 19.4 mm-40 -80.8 133.88 35.7 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.733 -178.24 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.4 OUTLIER 72.32 80.83 0.14 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.98 -1.464 . . . . 0.0 114.331 178.488 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.589 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -60.86 108.43 0.86 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.312 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.625 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 44.1 35.83 1.31 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.996 0.427 . . . . 0.0 110.417 -179.604 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 90.68 36.64 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.582 -178.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -134.01 -119.32 1.97 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.71 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.68 ' O ' ' N ' ' A' ' 26' ' ' ASP . 2.0 p30 -99.72 -128.64 0.2 Allowed 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -179.698 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.549 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 6.8 mtm -100.61 121.96 42.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.818 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -110.46 126.18 67.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.887 -178.226 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.791 ' O ' ' N ' ' A' ' 38' ' ' GLY . 42.0 t -85.7 98.07 0.67 Allowed Pre-proline 0 C--O 1.219 -0.546 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.158 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -41.61 -16.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.333 2.688 . . . . 0.0 114.05 -178.964 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.738 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 9.7 mm-40 -88.82 -64.37 1.16 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.725 0.298 . . . . 0.0 111.143 -178.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.634 ' SG ' HD23 ' A' ' 39' ' ' LEU . 5.9 p -90.62 -19.42 23.7 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.389 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.818 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 66.31 33.72 85.85 Favored Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 113.789 -1.55 . . . . 0.0 111.667 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.918 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.7 OUTLIER -69.77 143.08 53.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.954 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 32' ' ' MET . 72.9 t -109.75 114.55 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 O-C-N 123.384 0.428 . . . . 0.0 111.549 -177.777 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.918 HG23 ' CD1' ' A' ' 39' ' ' LEU . 76.0 t -121.46 134.42 64.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.467 178.711 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.595 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 130.34 19.14 1.39 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.543 178.672 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.69 -169.32 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 120.809 0.338 . . . . 0.0 111.464 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.62 133.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.301 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 46' ' ' ILE . 14.1 p -94.28 -42.34 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.762 -179.146 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.739 HG22 ' CG2' ' A' ' 48' ' ' VAL . 17.6 mt 75.33 -57.37 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.033 -179.42 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 76.99 -74.3 0.07 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.981 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.739 ' CG2' HG22 ' A' ' 46' ' ' ILE . 15.9 t 62.0 28.84 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.049 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -127.24 -126.87 2.96 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.0 t 59.17 68.65 0.79 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.948 0.404 . . . . 0.0 110.865 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -109.34 -162.58 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.852 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -47.87 -58.45 4.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.151 -179.886 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 60.16 66.22 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 m -108.68 159.36 16.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -129.32 30.07 5.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.2 m 59.74 171.62 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -115.2 172.54 7.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.19 -65.9 1.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.927 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.869 0.366 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.62 27.85 6.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.22 18.68 13.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.184 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.6 m -88.46 -176.03 5.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.767 0.317 . . . . 0.0 110.759 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.41 ' HB3' HD12 ' A' ' 7' ' ' LEU . 4.5 mmt85 -132.2 -93.64 0.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.029 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.41 HD12 ' HB3' ' A' ' 6' ' ' ARG . 4.5 mp -148.31 -132.0 0.06 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.846 -0.161 . . . . 0.0 110.614 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.422 ' HB3' ' CD1' ' A' ' 10' ' ' LEU . 0.6 OUTLIER 69.68 -67.66 0.22 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.842 0.353 . . . . 0.0 110.487 -179.858 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 55.63 68.65 0.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.81 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.682 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -120.62 23.27 0.1 Allowed Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 179.292 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.682 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 61.1 Cg_endo -83.14 102.35 1.07 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.136 1.891 . . . . 0.0 112.342 179.726 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.743 ' NH2' HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -176.32 168.23 2.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.938 0.399 . . . . 0.0 111.056 179.887 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.6 t -125.69 -22.19 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.786 -179.782 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.5 p -149.82 158.17 43.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.961 0.41 . . . . 0.0 111.253 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.6 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 45.9 t -61.94 137.88 95.52 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.139 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.51 -29.86 71.11 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.457 2.105 . . . . 0.0 111.589 179.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -93.96 -16.66 23.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.503 179.62 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.973 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 38.9 m80 -131.73 85.86 50.35 Favored Pre-proline 0 N--CA 1.453 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.337 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.85 -53.55 0.9 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.233 1.955 . . . . 0.0 111.701 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.24 -14.75 63.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.716 -179.832 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.973 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -101.09 114.01 27.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.113 0.482 . . . . 0.0 110.413 179.22 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.0 mt -91.83 127.5 44.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.823 -179.078 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.925 HD21 HD11 ' A' ' 39' ' ' LEU . 1.5 mp -59.45 102.07 0.13 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.845 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.527 HG23 ' HD3' ' A' ' 35' ' ' PRO . 3.1 t -66.48 157.17 5.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 121.293 0.568 . . . . 0.0 111.715 -178.603 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -86.95 102.6 14.52 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.007 -179.26 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 26' ' ' ASP . 0.4 OUTLIER 70.66 118.03 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.672 179.321 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.417 ' O ' ' HB2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER 178.99 36.13 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.767 179.767 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.55 ' HD3' HD12 ' A' ' 33' ' ' ILE . 64.4 ttt180 170.99 -84.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.68 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.08 ' HB3' HG11 ' A' ' 40' ' ' VAL . . . -80.12 -29.33 38.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.92 -7.66 21.68 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.169 178.733 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.568 ' HB2' HG12 ' A' ' 40' ' ' VAL . 23.2 m-20 -92.36 -119.42 0.08 Allowed 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.127 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.725 ' O ' HD23 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -117.39 110.23 17.78 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.637 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.895 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 1.2 tt -112.42 139.55 36.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.027 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.835 ' O ' ' N ' ' A' ' 38' ' ' GLY . 52.7 t -91.68 102.38 5.87 Favored Pre-proline 0 N--CA 1.448 -0.55 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.61 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.527 ' HD3' HG23 ' A' ' 24' ' ' VAL . 1.9 Cg_endo -40.13 -21.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.456 2.771 . . . . 0.0 113.614 -178.773 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.537 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 5.7 mm-40 -81.01 -68.25 0.7 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.743 -178.816 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.57 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.4 p -88.18 -18.68 28.19 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.548 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.835 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 66.66 22.39 71.67 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.089 -179.581 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.925 HD11 HD21 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -58.7 140.92 54.03 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.963 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.08 HG11 ' HB3' ' A' ' 29' ' ' ALA . 5.5 t -113.15 131.19 65.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.762 0.315 . . . . 0.0 110.586 -179.073 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.687 HG21 HH12 ' A' ' 12' ' ' ARG . 12.5 t -130.09 130.03 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.273 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.583 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 122.18 165.88 12.62 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.086 179.545 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.583 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 9.2 t0 138.72 -54.73 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.792 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.42 ' HE ' HG22 ' A' ' 45' ' ' VAL . 0.1 OUTLIER 51.6 -168.43 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.425 179.655 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.428 HG23 ' H ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -96.51 -81.14 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.151 179.981 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.428 ' H ' HG23 ' A' ' 45' ' ' VAL . 1.9 mp -86.47 127.07 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 0.0 111.02 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -63.32 -73.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.6 t -152.01 146.94 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 158.43 -28.53 0.44 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.545 179.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.2 m -69.27 -57.13 5.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 0.0 110.863 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -72.46 155.34 40.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.891 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -64.53 -75.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 59.48 96.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 55' ' ' PHE . 1.2 m -158.35 171.57 19.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.454 ' H ' HG22 ' A' ' 54' ' ' THR . 16.5 p90 -119.6 58.18 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.859 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.1 m 60.56 -174.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.87 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -114.49 -174.85 2.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -101.99 -34.78 9.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.88 179.856 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.811 0.339 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 m -117.26 132.66 56.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.901 -179.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.67 104.68 1.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.831 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.86 38.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.002 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.16 109.27 7.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.67 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.71 112.27 16.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.16 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.549 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 6.0 m-20 -64.71 -154.83 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.412 179.797 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.605 ' O ' ' CB ' ' A' ' 10' ' ' LEU . . . 76.72 179.67 0.15 Allowed 'General case' 0 C--N 1.334 -0.078 0 CA-C-O 120.576 0.227 . . . . 0.0 111.198 179.892 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.605 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 10.4 tt 120.72 -48.64 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 123.786 0.834 . . . . 0.0 110.485 -179.693 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.598 ' HG2' HG13 ' A' ' 13' ' ' VAL . 72.7 Cg_endo -87.88 2.71 6.43 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.596 2.197 . . . . 0.0 112.48 179.676 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.433 ' HG2' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER 58.29 48.41 12.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.905 0.384 . . . . 0.0 110.952 -179.813 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.598 HG13 ' HG2' ' A' ' 11' ' ' PRO . 1.5 m -54.79 -29.15 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.317 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 p -149.25 161.09 42.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.955 0.407 . . . . 0.0 111.348 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.504 ' HB2' HD12 ' A' ' 23' ' ' LEU . 45.5 t -75.81 136.41 70.4 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.724 179.839 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.04 -23.83 76.08 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.52 2.147 . . . . 0.0 112.522 -179.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -117.3 -7.69 11.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.449 -179.778 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.726 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.6 m80 -131.18 85.83 52.92 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.699 0.285 . . . . 0.0 110.779 179.63 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.98 -35.5 93.02 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.271 1.981 . . . . 0.0 111.897 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -78.57 -30.73 46.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.189 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -78.63 85.63 4.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.091 0.472 . . . . 0.0 111.246 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.529 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.8 mp -71.25 75.73 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.722 -178.6 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.847 HD21 HD11 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -18.09 107.53 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.002 179.419 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -75.91 167.6 2.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.225 -178.815 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.504 ' H ' HG12 ' A' ' 24' ' ' VAL . 1.9 mm-40 -81.91 139.32 34.71 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 122.105 0.955 . . . . 0.0 111.207 -177.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.535 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 0.5 OUTLIER 53.97 95.5 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.68 -1.6 . . . . 0.0 114.64 178.701 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.586 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -68.68 110.18 4.15 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 177.913 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.612 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 4.8 mtt85 44.64 33.89 1.03 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.976 0.417 . . . . 0.0 110.105 -179.373 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 91.82 40.07 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.492 -178.86 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -134.0 -124.72 2.51 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.834 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.491 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -95.8 -145.97 0.28 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.61 0.243 . . . . 0.0 111.009 -179.589 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.709 ' O ' HD23 ' A' ' 23' ' ' LEU . 52.6 mtp -85.73 116.06 23.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.38 0.61 . . . . 0.0 111.249 -179.31 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.669 HD13 ' N ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -100.82 123.24 53.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.496 -0.775 . . . . 0.0 113.047 -176.783 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.729 ' O ' ' N ' ' A' ' 38' ' ' GLY . 52.1 t -87.71 96.2 0.58 Allowed Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.525 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.5 Cg_endo -41.89 -15.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.405 2.737 . . . . 0.0 114.077 -179.089 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.726 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 4.2 mm-40 -87.14 -65.58 1.0 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.625 0.25 . . . . 0.0 111.057 -178.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.818 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.7 p -91.1 -20.68 21.77 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.221 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.729 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 69.99 38.56 74.43 Favored Glycine 0 N--CA 1.432 -1.624 0 CA-C-N 113.76 -1.564 . . . . 0.0 111.996 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.847 HD11 HD21 ' A' ' 23' ' ' LEU . 1.6 pp -76.53 149.11 36.72 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.835 -0.683 . . . . 0.0 109.872 179.375 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 32' ' ' MET . 38.4 t -117.53 119.68 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 121.088 0.471 . . . . 0.0 112.14 -177.427 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.681 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -132.73 136.07 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.385 179.57 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.93 162.52 10.98 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.755 179.455 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.725 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.6 m-20 -158.98 -86.09 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.476 0.179 . . . . 0.0 110.572 179.783 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 44.48 -89.3 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.575 179.65 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 43' ' ' ASP . 23.7 t 65.24 78.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.92 0.39 . . . . 0.0 111.217 179.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.415 HG23 HG22 ' A' ' 48' ' ' VAL . 13.4 tt -73.76 -30.03 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.048 179.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 t70 60.26 92.12 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.897 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.415 HG22 HG23 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -118.22 -75.4 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.005 179.925 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 133.71 -102.21 0.45 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.523 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.7 p -59.62 137.79 57.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.359 . . . . 0.0 110.948 -179.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -120.64 25.79 9.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.996 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.5 m0 59.94 -84.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.022 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? 48.66 79.68 0.07 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.733 0.301 . . . . 0.0 111.18 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.45 -172.96 3.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.952 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.434 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 27.4 p90 -109.92 64.39 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.87 172.56 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.812 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -117.1 176.3 5.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.937 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -74.01 -58.94 2.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.827 179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.939 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.444 ' HB3' ' OG ' ' A' ' 5' ' ' SER . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.803 0.335 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -68.34 -31.51 70.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.878 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.3 p -116.67 69.67 0.75 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.444 ' OG ' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -143.19 -70.18 0.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.783 -179.941 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.9 mtt180 65.29 -76.48 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.107 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.53 -46.97 4.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.142 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 61.68 23.18 13.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.867 -179.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 179.64 173.11 0.91 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.799 180.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.453 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . 1.5 mt -164.75 -64.81 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.043 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' A' ' 10' ' ' LEU . 55.6 Cg_endo -70.21 -176.31 1.57 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.365 2.043 . . . . 0.0 112.36 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.86 -169.41 1.92 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.682 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.4 t -74.43 -79.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.596 -179.608 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.5 p -96.27 -148.74 0.3 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.999 -179.518 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.585 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 47.3 t -69.86 137.92 87.75 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.76 179.86 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.1 -21.96 73.2 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.316 2.011 . . . . 0.0 112.002 179.687 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -116.14 -10.16 11.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.19 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.762 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 41.9 m80 -130.61 88.43 46.79 Favored Pre-proline 0 C--O 1.232 0.18 0 CA-C-O 120.701 0.286 . . . . 0.0 110.525 178.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.78 -35.27 94.83 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.292 1.995 . . . . 0.0 111.788 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.41 -29.74 42.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.038 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.654 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -77.01 97.91 4.81 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 122.241 1.02 . . . . 0.0 111.168 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.515 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -80.84 74.94 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 112.787 -2.006 . . . . 0.0 113.698 -177.696 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.625 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 1.1 mp -20.85 102.71 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.768 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.4 t -71.7 166.3 2.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.15 -178.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.472 ' H ' HG12 ' A' ' 24' ' ' VAL . 6.1 mm-40 -83.06 139.07 33.45 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-O 121.922 0.868 . . . . 0.0 110.76 -178.192 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.55 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 16.5 m-20 55.15 94.39 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 113.913 -1.494 . . . . 0.0 114.299 178.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.639 ' CD2' HG21 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -63.35 90.32 0.05 OUTLIER 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.337 177.774 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.621 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 7.8 ttp-105 55.16 43.19 29.82 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.366 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 87.64 34.1 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.379 -178.715 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -130.1 -128.97 3.06 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.681 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.595 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -95.58 -146.19 0.28 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 -179.777 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.559 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 6.2 mtm -87.06 116.61 25.23 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 121.375 0.607 . . . . 0.0 111.569 -179.309 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.758 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -102.81 121.63 54.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -176.885 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.743 ' O ' ' N ' ' A' ' 38' ' ' GLY . 25.7 t -86.79 96.84 0.57 Allowed Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.083 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.5 Cg_endo -41.79 -15.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.466 2.777 . . . . 0.0 114.069 -179.239 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.762 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 3.6 mm-40 -86.76 -65.9 0.96 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.675 0.274 . . . . 0.0 110.758 -178.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.694 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.9 p -90.71 -19.52 23.47 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.416 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.758 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 67.23 35.94 89.03 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 113.772 -1.558 . . . . 0.0 111.914 -179.728 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.906 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -74.27 150.54 40.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.762 -0.719 . . . . 0.0 109.878 179.379 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.639 HG21 ' CD2' ' A' ' 27' ' ' TYR . 23.7 t -115.87 116.11 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.825 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.906 HG23 ' CD1' ' A' ' 39' ' ' LEU . 97.6 t -123.3 133.16 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.931 178.256 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.436 ' CA ' ' HB3' ' A' ' 31' ' ' ASP . . . 125.25 -158.95 19.8 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.703 179.42 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.438 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . 7.4 t0 62.84 81.31 0.21 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.792 0.33 . . . . 0.0 110.626 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 44' ' ' ARG . 11.9 mtm105 -110.02 -70.32 0.82 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.397 -179.424 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.53 HG22 ' H ' ' A' ' 46' ' ' ILE . 2.8 p -155.82 170.32 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.828 0.346 . . . . 0.0 111.172 -179.714 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.53 ' H ' HG22 ' A' ' 45' ' ' VAL . 25.0 mt -115.06 127.7 72.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.933 0.397 . . . . 0.0 111.177 -179.972 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -178.31 -39.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.3 p -56.21 -32.14 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.236 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -88.83 73.87 2.12 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.538 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.9 t -172.93 76.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 110.937 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.9 145.08 25.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.673 179.793 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 39.3 t90 -63.06 -89.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.845 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.78 91.55 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.766 0.317 . . . . 0.0 111.555 179.784 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.5 m -97.27 151.03 20.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.94 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.423 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 42.3 p90 -88.29 108.91 19.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.828 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 m 53.89 96.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.054 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -62.89 155.86 25.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.815 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.78 -65.62 0.97 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.936 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.909 -179.989 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.613 ' HB3' ' HB2' ' A' ' 5' ' ' SER . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.804 0.335 . . . . 0.0 110.998 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.7 m -64.96 -31.41 72.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.876 179.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.9 p -75.65 -32.35 60.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.905 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.613 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 1.4 m -61.53 149.27 39.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.1 mtp85 -101.55 -78.76 0.52 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 179.62 -174.33 0.23 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.859 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -117.43 92.35 3.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.741 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.761 ' O ' HD12 ' A' ' 10' ' ' LEU . . . -99.45 112.76 24.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.254 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -179.84 -59.96 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.66 179.784 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.416 ' HD3' ' CB ' ' A' ' 10' ' ' LEU . 84.2 Cg_endo -81.03 -168.67 0.66 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.658 2.238 . . . . 0.0 112.407 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -141.77 129.5 21.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.504 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 94.5 t -51.16 -88.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.081 -179.83 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.74 177.18 2.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.046 0.451 . . . . 0.0 110.728 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 36.9 t -70.19 136.19 86.88 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.918 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.44 -21.72 73.12 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.275 1.984 . . . . 0.0 111.995 179.452 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -115.92 -12.32 11.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.241 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.701 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 31.6 m80 -125.14 86.71 56.49 Favored Pre-proline 0 N--CA 1.455 -0.193 0 CA-C-O 120.857 0.36 . . . . 0.0 111.456 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.84 38.3 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.192 2.595 . . . . 0.0 110.805 178.432 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -150.59 -43.03 0.12 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.76 179.742 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.52 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -78.62 86.1 4.63 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.894 178.612 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.566 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.2 mp -70.06 75.69 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.339 -178.119 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.839 HD11 HD21 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -14.52 113.74 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.735 179.656 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.603 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.8 t -82.06 159.33 3.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.223 0.535 . . . . 0.0 111.84 -178.231 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 26' ' ' ASP . 2.4 mt-10 -79.26 139.15 37.95 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.077 -178.073 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 31' ' ' ASP . 1.0 OUTLIER 40.44 110.57 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.912 -1.495 . . . . 0.0 114.78 179.237 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.622 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -148.86 130.17 14.67 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.124 178.494 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.523 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 13.6 mmm-85 55.38 22.81 5.2 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.471 -179.779 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 28' ' ' ARG . . . 170.04 -76.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.449 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.433 ' HA2' ' CB ' ' A' ' 26' ' ' ASP . . . 168.53 14.26 0.02 OUTLIER Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.473 179.464 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.531 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 65.4 m-20 -103.16 -166.69 1.3 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.71 0.255 . . . . 0.0 110.9 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.603 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -97.34 120.37 37.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.579 0.704 . . . . 0.0 112.257 -179.173 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.888 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -105.75 125.43 61.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.148 -177.712 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.721 ' O ' ' N ' ' A' ' 38' ' ' GLY . 39.8 t -88.43 97.33 0.81 Allowed Pre-proline 0 C--O 1.221 -0.398 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 177.23 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.0 Cg_endo -42.63 -14.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.405 2.737 . . . . 0.0 114.222 -178.877 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.701 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 1.9 mm-40 -89.25 -63.82 1.23 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.623 0.249 . . . . 0.0 111.326 -178.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.775 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.1 p -90.96 -21.15 21.47 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.247 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.888 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 69.38 39.0 81.17 Favored Glycine 0 N--CA 1.429 -1.772 0 CA-C-N 113.511 -1.677 . . . . 0.0 111.879 -179.692 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.839 HD21 HD11 ' A' ' 23' ' ' LEU . 1.4 pp -76.54 141.82 41.06 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.481 -0.859 . . . . 0.0 109.87 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.531 ' CG1' ' HB2' ' A' ' 31' ' ' ASP . 26.0 t -111.0 123.6 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-O 121.068 0.461 . . . . 0.0 111.46 -177.323 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.69 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.4 t -133.19 132.25 58.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.396 179.778 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.61 23.77 1.47 Allowed Glycine 0 CA--C 1.5 -0.881 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.012 179.835 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.15 62.88 6.1 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.607 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.5 mtt-85 -105.05 161.53 14.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.779 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.7 t -108.53 -94.71 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.87 179.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.624 ' N ' HD12 ' A' ' 46' ' ' ILE . 3.4 mp 42.08 86.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-O 120.817 0.342 . . . . 0.0 111.57 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.44 -30.66 61.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.996 -179.819 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.497 ' CG2' HG22 ' A' ' 46' ' ' ILE . 21.7 t 64.15 82.14 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.016 -179.903 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -120.97 -34.27 0.91 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.694 -179.873 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.4 t -72.25 64.32 0.56 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.876 0.37 . . . . 0.0 111.035 -179.882 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 53' ' ' ARG . 2.4 tm-20 -177.47 35.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 12.3 m0 64.34 -71.15 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.168 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.8 OUTLIER 70.06 59.16 0.27 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.871 -179.91 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.68 174.84 11.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.886 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.405 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 14.7 p90 -123.91 86.01 2.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.887 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.22 172.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.857 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -164.18 154.31 14.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.92 -40.97 68.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.842 0.353 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 m -92.53 54.24 2.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 179.921 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.3 p -149.84 36.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.5 t -153.37 116.59 4.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.953 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.9 mtt85 -102.25 -31.54 10.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.906 179.996 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.5 mp -76.68 73.62 3.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -120.52 77.93 1.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.796 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -172.91 129.1 0.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.105 179.942 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tp -65.09 132.54 95.44 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.52 -60.66 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.387 2.058 . . . . 0.0 112.194 179.929 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.603 ' O ' HG12 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -154.39 -68.42 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.86 179.959 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.71 ' O ' HG23 ' A' ' 14' ' ' THR . 0.3 OUTLIER 88.64 -20.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.669 -179.969 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -170.35 174.39 5.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.951 0.405 . . . . 0.0 110.972 179.75 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.498 ' HB2' HD12 ' A' ' 23' ' ' LEU . 18.1 t -77.84 135.32 63.68 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.963 -179.937 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.41 -21.33 53.86 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.481 2.12 . . . . 0.0 112.247 179.722 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -105.03 -29.61 10.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.862 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.655 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.8 m80 -118.42 88.59 34.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.065 179.784 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.12 -31.82 94.13 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.931 1.754 . . . . 0.0 110.993 179.188 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -81.33 -36.62 29.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.371 -179.911 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.643 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . . . -71.76 91.27 1.12 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.082 0.468 . . . . 0.0 110.697 179.808 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.548 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.8 mt -79.06 69.0 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.869 -178.411 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.697 HD21 ' HG ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -12.27 123.44 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.229 179.43 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 32' ' ' MET . 21.2 t -85.94 157.47 3.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-O 121.413 0.625 . . . . 0.0 112.361 -178.022 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -76.84 127.79 33.39 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.009 -178.892 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.665 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 36.2 m-20 48.21 112.76 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.211 -0.904 . . . . 0.0 113.03 179.51 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.471 ' CG ' HG21 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -160.26 150.25 18.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.787 178.898 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 22.6 tpp180 55.78 36.69 27.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.821 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.79 32.47 20.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.13 -178.143 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.665 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -135.49 -167.83 11.42 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.312 -0.947 . . . . 0.0 114.475 -178.619 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 10.2 m-20 -72.38 -118.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.681 0.792 . . . . 0.0 111.284 179.985 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.689 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 20.8 mtm -94.29 118.45 31.61 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.43 0.633 . . . . 0.0 111.39 -178.471 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.786 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -100.46 126.2 54.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.049 -177.481 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.84 ' O ' ' N ' ' A' ' 38' ' ' GLY . 7.0 t -86.85 99.73 1.24 Allowed Pre-proline 0 C--O 1.216 -0.671 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.527 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.0 Cg_endo -40.27 -20.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.19 2.594 . . . . 0.0 113.542 -179.351 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.655 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 14.8 mm-40 -89.78 -63.13 1.33 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.332 -178.569 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.965 ' SG ' HD23 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -89.44 -18.84 25.98 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 177.729 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.84 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 63.42 28.57 72.57 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 114.112 -1.403 . . . . 0.0 111.783 -179.551 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.965 HD23 ' SG ' ' A' ' 37' ' ' CYS . 1.3 pp -71.36 148.59 46.86 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.774 -0.713 . . . . 0.0 109.908 179.317 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 32' ' ' MET . 35.0 t -110.09 118.19 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 O-C-N 123.445 0.466 . . . . 0.0 110.983 -179.386 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.917 HG23 ' CD1' ' A' ' 39' ' ' LEU . 54.8 t -130.76 140.1 49.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.236 0.541 . . . . 0.0 111.238 179.892 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.15 162.37 10.36 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.533 179.046 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -173.32 -39.66 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.638 0.256 . . . . 0.0 110.896 179.887 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.24 121.86 2.34 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.418 -179.699 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.908 HG13 HG13 ' A' ' 46' ' ' ILE . 7.8 p -131.97 167.83 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.067 -179.558 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.908 HG13 HG13 ' A' ' 45' ' ' VAL . 24.1 mt 79.99 127.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.012 0.434 . . . . 0.0 111.235 -179.94 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -141.92 28.7 1.73 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.77 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t 60.4 97.89 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.169 -179.949 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.29 27.84 1.97 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.502 -179.922 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.86 66.25 0.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.957 0.408 . . . . 0.0 110.906 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 53' ' ' ARG . 8.4 mt-10 -152.97 70.67 0.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.965 -179.934 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.402 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 6.9 m-90 66.21 -66.07 0.18 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.283 -179.985 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER 69.45 80.0 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.017 0.437 . . . . 0.0 110.752 -179.904 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.34 -164.16 1.85 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.723 -179.987 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -70.31 65.66 0.28 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.992 0.425 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.0 t 61.6 153.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.83 179.915 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -118.0 123.3 45.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -147.6 73.18 1.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.886 179.941 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.846 0.355 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 m -80.15 -49.08 12.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.987 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.3 m -106.51 68.31 0.75 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.91 -179.966 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.99 -39.53 3.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.857 -179.982 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? 60.97 172.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.853 -179.963 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.8 mp -131.64 -45.33 0.97 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 179.962 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.531 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 0.5 OUTLIER -178.36 -74.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.964 179.968 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . 76.29 -79.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.286 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.463 HD12 ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -84.85 -60.72 0.29 Allowed Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.702 -179.566 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.463 ' HD2' HD12 ' A' ' 10' ' ' LEU . 14.6 Cg_endo -56.85 -66.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.335 2.023 . . . . 0.0 112.697 -179.604 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 69.09 76.64 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.95 0.405 . . . . 0.0 110.586 -179.512 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.7 m -64.06 138.84 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.183 -179.759 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.9 p 57.69 179.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.712 -179.667 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 11.3 t -75.38 134.56 73.29 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.333 -179.776 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.98 -19.67 45.61 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.264 1.976 . . . . 0.0 111.516 178.837 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -112.56 -11.58 13.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.133 179.878 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.664 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 31.6 m80 -131.79 84.72 53.56 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-O 120.619 0.247 . . . . 0.0 111.455 179.838 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.57 -41.68 62.07 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.979 1.786 . . . . 0.0 110.773 178.832 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.54 -8.83 57.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.574 179.975 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 18' ' ' HIS . . . -100.99 109.04 20.91 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.734 0.778 . . . . 0.0 110.856 179.187 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.598 ' N ' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -90.98 66.24 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 114.024 -1.444 . . . . 0.0 113.422 -177.632 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.599 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 2.7 mp -10.9 115.29 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.445 179.038 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 32' ' ' MET . 16.2 t -82.39 154.88 3.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.435 0.636 . . . . 0.0 112.708 -177.518 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.404 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -75.4 126.87 31.89 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.989 -178.584 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.4 OUTLIER 50.54 105.68 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.349 179.881 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.446 ' O ' ' N ' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -158.0 159.99 37.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.711 179.419 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 51.49 35.19 13.73 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.143 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.92 33.51 19.83 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.178 -178.249 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -138.57 -158.45 7.73 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.455 -0.879 . . . . 0.0 114.504 -178.634 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.985 ' OD1' HG12 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -82.34 -106.3 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.965 -0.617 . . . . 0.0 111.847 -179.479 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.679 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 15.7 mtp -103.4 114.85 29.44 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.574 0.702 . . . . 0.0 111.929 -177.756 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.911 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -101.41 128.22 53.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.55 -177.198 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.794 ' O ' ' N ' ' A' ' 38' ' ' GLY . 45.0 t -83.22 99.43 0.69 Allowed Pre-proline 0 N--CA 1.448 -0.541 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.522 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 2.0 Cg_endo -39.9 -20.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.281 2.654 . . . . 0.0 113.742 -179.464 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.664 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 5.3 mm-40 -87.9 -64.9 1.08 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.592 -178.262 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.488 ' SG ' HD23 ' A' ' 39' ' ' LEU . 7.0 p -89.84 -20.02 23.94 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.788 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.911 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 67.25 32.0 78.77 Favored Glycine 0 N--CA 1.431 -1.657 0 CA-C-N 113.652 -1.613 . . . . 0.0 112.754 179.406 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.892 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -71.12 155.33 40.89 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.725 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.985 HG12 ' OD1' ' A' ' 31' ' ' ASP . 4.1 t -118.34 120.28 63.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 O-C-N 123.309 0.381 . . . . 0.0 111.595 -178.35 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.795 HG23 ' CD1' ' A' ' 39' ' ' LEU . 53.1 t -132.89 134.27 58.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.714 178.916 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.514 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 135.28 -172.65 22.02 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.42 178.824 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.718 ' O ' HG23 ' A' ' 45' ' ' VAL . 3.1 t0 83.22 99.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.897 0.38 . . . . 0.0 110.549 -179.667 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -53.12 -44.17 67.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.175 -179.815 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 43' ' ' ASP . 19.3 t 68.11 32.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.994 -179.921 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.821 ' CG2' HG12 ' A' ' 48' ' ' VAL . 35.2 mt -107.86 143.56 18.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.063 179.949 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -111.38 -26.84 8.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.152 -179.964 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.821 HG12 ' CG2' ' A' ' 46' ' ' ILE . 11.7 p -55.13 148.44 3.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.251 -179.915 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -160.04 161.66 32.59 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.403 179.907 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 t -175.06 45.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.888 0.375 . . . . 0.0 110.94 -179.931 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.43 16.68 21.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.153 179.974 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER 64.56 -75.81 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.091 179.92 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.99 83.55 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.934 -179.992 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -142.35 177.17 8.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.805 179.95 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.4 ' H ' HG22 ' A' ' 54' ' ' THR . 3.2 p90 -145.15 21.84 1.56 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 179.95 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 53.45 -168.6 0.06 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.809 0.338 . . . . 0.0 111.09 179.902 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -113.99 176.64 4.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 179.906 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -60.15 -63.54 1.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 179.924 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.826 0.346 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 m -95.81 14.5 23.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.271 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 49.7 p -86.72 -21.44 26.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.968 179.855 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.5 m -58.24 106.8 0.41 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.996 -179.995 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.1 mtt85 -147.2 -166.94 2.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.652 179.989 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.1 mt -51.49 98.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.015 179.953 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -142.29 -166.8 2.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.027 -179.892 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 66.1 -87.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.265 179.979 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 10' ' ' LEU . 19.3 mt -158.73 161.17 28.82 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.817 -179.963 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.31 -166.08 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.488 2.125 . . . . 0.0 112.205 179.864 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.96 138.44 34.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.113 -179.814 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.661 ' O ' HG23 ' A' ' 14' ' ' THR . 30.5 m -99.47 35.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.964 179.773 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.1 OUTLIER 172.45 -173.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.63 -179.99 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 13.3 t -83.69 135.07 43.56 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.804 179.657 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -68.38 -18.38 44.1 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.115 1.877 . . . . 0.0 111.95 179.256 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.35 -8.1 11.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.336 179.929 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.677 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 37.9 m80 -130.95 88.35 46.05 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 120.693 0.282 . . . . 0.0 110.529 179.216 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.78 -35.02 90.78 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.408 2.072 . . . . 0.0 112.082 179.875 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.39 -28.25 31.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.308 -179.747 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.665 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -78.12 87.73 4.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.23 0.538 . . . . 0.0 111.057 -179.881 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.568 ' HA ' HG22 ' A' ' 14' ' ' THR . 14.3 mt -72.09 73.9 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.091 -178.347 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.602 HD11 HD21 ' A' ' 39' ' ' LEU . 2.2 mp -17.78 109.14 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.709 179.333 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.5 t -76.57 165.67 3.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.564 -178.512 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.462 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -81.13 137.03 35.96 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-O 121.941 0.877 . . . . 0.0 110.968 -177.874 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.535 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 18.8 m-20 59.27 91.98 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 178.273 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.67 ' CD2' HG21 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -63.71 99.46 0.23 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.552 177.935 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.627 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 6.8 mtp85 48.55 37.31 8.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.982 0.42 . . . . 0.0 110.098 -179.821 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 92.35 36.95 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.554 -178.911 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -133.25 -126.73 2.71 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.472 179.944 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 27' ' ' TYR . 4.5 m-20 -95.38 -143.49 0.26 Allowed 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 179.787 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.56 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -88.79 119.23 29.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.584 0.707 . . . . 0.0 111.733 -179.028 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.666 ' HB ' ' HB2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -103.63 123.7 57.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.621 -176.817 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.766 ' O ' ' N ' ' A' ' 38' ' ' GLY . 47.9 t -86.87 96.81 0.57 Allowed Pre-proline 0 N--CA 1.445 -0.687 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.898 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.2 Cg_endo -41.91 -15.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.28 2.654 . . . . 0.0 113.695 -179.278 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.677 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 13.1 mm-40 -86.3 -66.83 0.86 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.76 0.314 . . . . 0.0 110.845 -179.155 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.599 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.7 p -90.93 -19.86 22.83 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.429 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.766 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 67.68 36.24 87.26 Favored Glycine 0 N--CA 1.432 -1.626 0 CA-C-N 114.011 -1.45 . . . . 0.0 111.81 -179.737 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.835 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -75.5 148.84 38.66 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.884 -0.658 . . . . 0.0 109.772 179.229 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.67 HG21 ' CD2' ' A' ' 27' ' ' TYR . 37.0 t -111.74 115.7 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 123.295 0.372 . . . . 0.0 111.926 -178.39 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.835 HG23 ' CD1' ' A' ' 39' ' ' LEU . 54.4 t -123.82 135.55 63.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.253 178.551 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.09 164.24 10.79 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.914 178.837 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -167.39 -55.09 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.832 0.349 . . . . 0.0 110.573 179.74 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -139.41 144.57 38.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.907 179.858 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.95 128.65 52.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.292 -179.893 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.0 tp -148.42 136.52 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.027 179.928 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.18 -78.42 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.933 -179.962 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.481 HG13 ' N ' ' A' ' 49' ' ' GLY . 11.1 p -178.77 -44.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 -179.94 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.481 ' N ' HG13 ' A' ' 48' ' ' VAL . . . -132.19 100.08 0.41 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.508 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.89 118.34 1.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.729 0.3 . . . . 0.0 110.912 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -171.44 150.06 2.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.983 0.42 . . . . 0.0 111.059 -179.943 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 29.6 t90 61.05 -97.95 0.07 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.067 179.923 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 24.5 ttm-85 51.8 100.4 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.828 0.347 . . . . 0.0 111.343 179.829 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.424 HG22 ' N ' ' A' ' 55' ' ' PHE . 23.9 m -111.07 163.24 14.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.872 179.816 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.424 ' N ' HG22 ' A' ' 54' ' ' THR . 55.3 p90 -105.04 30.62 5.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.948 179.948 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 59.61 -173.57 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.953 179.894 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -173.04 170.24 4.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 179.956 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.48 -55.05 23.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.973 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.908 179.951 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.827 0.346 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.59 83.33 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.903 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.8 m -89.75 135.07 33.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.3 m -128.71 -50.87 1.25 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.997 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? 58.46 103.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.829 -179.87 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.28 60.16 3.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.939 -179.861 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -82.26 59.83 4.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.676 179.738 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.63 66.64 1.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.218 -179.769 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.504 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -126.41 45.29 1.45 Allowed Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.281 179.831 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 83.0 Cg_endo -79.79 133.12 10.09 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.385 2.056 . . . . 0.0 112.257 179.691 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -124.03 90.81 3.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.819 179.815 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.953 HG22 HG23 ' A' ' 14' ' ' THR . 13.1 p -130.65 133.11 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.313 -179.824 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.953 HG23 HG22 ' A' ' 13' ' ' VAL . 11.2 p 56.72 179.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.08 179.968 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.553 ' CB ' ' HG ' ' A' ' 34' ' ' CYS . 39.1 t -78.69 135.07 60.32 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.876 -179.971 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.46 -19.89 54.73 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.379 2.053 . . . . 0.0 112.248 179.643 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -115.16 -10.25 12.18 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.411 -179.974 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.734 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 35.5 m80 -130.83 87.81 48.07 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.757 0.313 . . . . 0.0 110.663 179.508 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.84 -34.51 95.57 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.269 1.979 . . . . 0.0 111.812 179.789 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.44 -27.09 38.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.287 -179.892 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.602 ' HB3' ' CB ' ' A' ' 18' ' ' HIS . . . -82.85 85.14 7.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.146 0.498 . . . . 0.0 111.296 -179.78 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.2 mp -70.4 74.92 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.856 -1.066 . . . . 0.0 112.768 -178.69 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.721 HD11 HD21 ' A' ' 39' ' ' LEU . 1.1 mp -16.98 109.58 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.535 179.386 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.5 t -78.07 162.8 3.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.157 0.503 . . . . 0.0 111.758 -178.249 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.429 ' N ' HG12 ' A' ' 24' ' ' VAL . 3.0 mm-40 -80.81 135.4 35.95 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.579 -178.303 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.618 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.4 OUTLIER 67.64 85.13 0.15 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.095 -1.412 . . . . 0.0 114.7 178.271 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.624 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 1.2 t80 -57.47 97.52 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.052 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.625 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 48.16 33.17 3.43 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.409 -179.908 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 100.65 28.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.855 -179.223 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.588 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -126.48 -124.49 2.75 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.132 179.679 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.881 ' OD1' HG12 ' A' ' 40' ' ' VAL . 2.3 p30 -99.14 -130.7 0.22 Allowed 'General case' 0 C--O 1.223 -0.329 0 O-C-N 122.958 -0.142 . . . . 0.0 110.866 179.606 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.547 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 9.4 mtm -97.86 119.72 36.98 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -177.907 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.827 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -107.56 125.43 63.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.301 -177.876 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.743 ' O ' ' N ' ' A' ' 38' ' ' GLY . 34.8 t -87.13 97.06 0.62 Allowed Pre-proline 0 C--O 1.222 -0.395 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.863 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.5 Cg_endo -41.9 -15.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.384 2.722 . . . . 0.0 114.244 -179.084 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.734 ' HB3' ' CE1' ' A' ' 18' ' ' HIS . 2.3 mm-40 -88.74 -64.38 1.15 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.697 0.284 . . . . 0.0 111.133 -178.787 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.644 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.1 p -90.84 -18.96 23.95 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.322 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.827 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 66.28 35.86 90.91 Favored Glycine 0 N--CA 1.431 -1.682 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.771 -179.374 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.898 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -72.97 144.45 47.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.621 -0.79 . . . . 0.0 109.49 179.378 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.881 HG12 ' OD1' ' A' ' 31' ' ' ASP . 1.9 t -112.53 116.0 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-O 121.027 0.441 . . . . 0.0 111.779 -178.001 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.898 HG23 ' CD1' ' A' ' 39' ' ' LEU . 97.0 t -122.6 132.74 70.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.788 177.96 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.615 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 119.46 -164.44 13.37 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.69 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.602 ' HA ' HD11 ' A' ' 46' ' ' ILE . 10.1 t0 -9.37 86.44 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.864 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.9 55.37 0.67 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.993 -179.662 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.453 ' O ' HG12 ' A' ' 45' ' ' VAL . 21.1 t 64.99 54.24 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.186 179.903 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.602 HD11 ' HA ' ' A' ' 43' ' ' ASP . 1.1 pp -130.66 80.86 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.941 179.843 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.76 -75.89 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.96 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.605 ' O ' HG13 ' A' ' 48' ' ' VAL . 7.6 p -126.96 73.36 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.066 -179.907 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.25 70.19 0.48 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.468 179.941 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.1 t 61.2 31.99 19.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.767 0.318 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.1 16.65 25.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.296 179.98 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 2.1 m0 63.84 -78.31 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.022 179.937 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.95 82.8 0.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.84 -179.922 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.88 152.92 38.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 -179.909 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -98.05 39.07 1.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 179.969 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.65 164.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.978 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -74.13 135.13 42.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.883 -179.971 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -86.6 -34.64 19.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.867 -179.97 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.927 179.968 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.708 ' HB1' ' HB3' ' A' ' 5' ' ' SER . . . . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.761 0.315 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.3 m -70.98 -43.18 68.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.827 179.983 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.1 p -124.27 30.81 5.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.708 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 0.3 OUTLIER -100.05 137.36 38.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 179.918 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.24 144.54 31.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 -179.973 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.84 154.62 21.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.818 -179.949 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -79.06 -3.48 45.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.509 179.981 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.0 104.84 5.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.9 0.381 . . . . 0.0 111.081 179.968 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 10' ' ' LEU . 2.0 mt -177.2 -62.42 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.721 179.941 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.425 ' CD ' ' CB ' ' A' ' 10' ' ' LEU . 39.7 Cg_endo -66.92 -28.24 42.51 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.472 2.115 . . . . 0.0 111.96 179.747 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 63.27 142.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.011 179.838 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.3 -84.14 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.798 179.77 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.752 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -88.79 -154.45 0.29 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.714 0.292 . . . . 0.0 110.519 179.864 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.587 ' HB3' ' HB2' ' A' ' 18' ' ' HIS . 45.4 t -67.22 138.66 94.6 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.403 178.936 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.89 -22.32 68.02 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.177 1.918 . . . . 0.0 111.954 179.197 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.19 -9.09 10.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.345 179.995 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.711 ' CB ' ' HB3' ' A' ' 21' ' ' ALA . 38.5 m80 -129.89 89.1 46.96 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.736 0.303 . . . . 0.0 110.937 179.238 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.413 ' O ' HG21 ' A' ' 14' ' ' THR . 19.5 Cg_endo -59.46 -37.23 90.71 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.241 1.961 . . . . 0.0 111.791 179.632 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.54 -32.96 36.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.548 -179.695 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.797 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . . . -71.45 89.46 0.94 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.169 0.509 . . . . 0.0 111.004 -179.85 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.752 ' HA ' HG23 ' A' ' 14' ' ' THR . 9.8 mm -70.64 78.95 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.958 -177.757 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.631 HD11 HD21 ' A' ' 39' ' ' LEU . 2.2 mp -26.93 107.23 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.173 0.511 . . . . 0.0 110.242 178.913 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 32' ' ' MET . 3.2 t -75.34 164.16 3.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.887 -178.283 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.595 ' O ' ' O ' ' A' ' 26' ' ' ASP . 1.7 mm-40 -80.97 135.86 35.93 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.633 -179.29 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.595 ' O ' ' O ' ' A' ' 25' ' ' GLU . 6.3 t70 36.79 123.19 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 179.827 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.481 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 56.0 t80 -138.97 120.45 15.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.67 177.887 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 60.5 42.53 14.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.286 -178.525 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 64.89 37.38 7.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.384 -178.534 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -120.15 -158.91 10.7 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.669 -0.777 . . . . 0.0 114.022 -178.725 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -91.88 -139.55 0.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.1 0.56 . . . . 0.0 110.248 179.96 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.582 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 5.6 mtm -81.86 114.64 20.61 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.682 0.753 . . . . 0.0 110.921 -179.723 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.76 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -100.78 124.09 54.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.565 -176.588 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.74 ' O ' ' N ' ' A' ' 38' ' ' GLY . 47.2 t -85.73 97.85 0.64 Allowed Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.366 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 3.9 Cg_endo -45.61 -12.76 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.844 2.363 . . . . 0.0 113.628 -179.112 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.797 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 4.8 mm-40 -88.81 -63.98 1.21 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.66 0.266 . . . . 0.0 111.204 -179.413 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.691 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.7 p -91.45 -22.59 20.35 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.398 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.76 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 70.4 41.63 66.86 Favored Glycine 0 N--CA 1.43 -1.74 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.033 -179.964 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.924 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -81.91 152.97 26.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.65 -0.775 . . . . 0.0 109.992 179.819 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 32' ' ' MET . 66.1 t -117.1 116.63 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.701 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.924 HG23 ' CD1' ' A' ' 39' ' ' LEU . 95.5 t -127.5 132.4 69.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.767 178.234 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.76 -159.09 21.54 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.066 -1.064 . . . . 0.0 111.974 179.614 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.452 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . 26.3 t70 67.02 32.82 6.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.904 0.383 . . . . 0.0 110.751 179.994 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -75.09 -176.01 2.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.033 -179.952 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 45' ' ' VAL . 5.7 m -63.37 103.42 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.094 179.965 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.587 HG23 ' O ' ' A' ' 46' ' ' ILE . 8.8 tp -178.69 110.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.118 -179.984 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.06 140.61 52.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.907 179.975 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.4 t -135.48 33.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.0 98.1 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.629 -179.94 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.85 100.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.791 0.329 . . . . 0.0 110.915 179.918 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.4 ' O ' ' CD1' ' A' ' 52' ' ' TRP . 2.7 mm-40 -63.48 -72.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.801 -179.988 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.4 ' CD1' ' O ' ' A' ' 51' ' ' GLU . 3.9 m-90 -143.32 -44.52 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.072 -179.984 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.37 34.56 2.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.964 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -70.65 179.36 2.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.875 179.925 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.419 ' H ' HG22 ' A' ' 54' ' ' THR . 3.2 p90 -163.6 31.55 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 179.906 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m 59.29 174.94 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 179.974 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -131.66 168.31 17.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 -179.959 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -62.45 -60.22 3.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.813 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.894 179.926 . . . . . . . . 1 1 . 1 stop_ save_